<SEC-DOCUMENT>0001104659-17-050250.txt : 20170808
<SEC-HEADER>0001104659-17-050250.hdr.sgml : 20170808
<ACCEPTANCE-DATETIME>20170808160645
ACCESSION NUMBER:		0001104659-17-050250
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		60
CONFORMED PERIOD OF REPORT:	20170630
FILED AS OF DATE:		20170808
DATE AS OF CHANGE:		20170808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celldex Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000744218
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				133191702
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-15006
		FILM NUMBER:		171014745

	BUSINESS ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827
		BUSINESS PHONE:		908-200-7500

	MAIL ADDRESS:	
		STREET 1:		53 FRONTAGE ROAD
		STREET 2:		SUITE 220
		CITY:			HAMPTON
		STATE:			NJ
		ZIP:			08827

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AVANT IMMUNOTHERAPEUTICS INC
		DATE OF NAME CHANGE:	19980828

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	T CELL SCIENCES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>a17-13377_110q.htm
<DESCRIPTION>10-Q
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 1.0pt;border-left:none;border-right:none;border-top:solid windowtext 3.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">UNITED STATES</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Washington, D.C. 20549</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center" style="margin:0in 0in .0001pt;text-align:center;"><hr size="1" width="25%" noshade align="center" style="color:black;"></div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">FORM&nbsp;10-Q</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><b><font size="3" face="Wingdings" style="font-size:12.0pt;font-weight:bold;">x</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160; </font><b><font size="3" style="font-size:12.0pt;font-weight:bold;">QUARTERLY REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">For the quarterly period ended June&nbsp;30, 2017</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OR</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.25in;"><b><font size="3" face="Wingdings" style="font-size:12.0pt;font-weight:bold;">o</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><font size="3" style="font-size:12.0pt;font-weight:bold;">TRANSITION REPORT PURSUANT TO SECTION&nbsp;13 OR 15(d)&nbsp;OF THE SECURITIES EXCHANGE ACT OF 1934</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Commission File Number: 000-15006</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="5" face="Times New Roman" style="font-size:18.0pt;font-weight:bold;">CELLDEX THERAPEUTICS,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Exact name of registrant as specified in its charter)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Delaware</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">No.&nbsp;13-3191702</font></b></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(State or other jurisdiction of   incorporation or<br>   organization)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(I.R.S. Employer Identification   No.)</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Perryville III Building, 53 Frontage Road, Suite&nbsp;220, Hampton, New Jersey 08827</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Address of principal executive offices) (Zip Code)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(908) 200-7500</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Registrant&#146;s telephone number, including area code)</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant (1)&nbsp;has filed all reports required to be filed by Section&nbsp;13 or 15(d)&nbsp;of the Securities Exchange Act of 1934 during the preceding 12&nbsp;months (or for such shorter period that the registrant was required to file such reports), and (2)&nbsp;has been subject to such filing requirements for the past 90&nbsp;days. Yes&nbsp;</font><font face="Wingdings">x</font>&#160; No&nbsp;<font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule&nbsp;405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).&#160; </font>Yes&nbsp;<font face="Wingdings">x</font>&#160; No&nbsp;<font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and &#147;emerging growth company&#148; in Rule&nbsp;12b-2 of the Exchange Act. (Check one):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Large accelerated filer </font><font face="Wingdings">o</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accelerated filer&nbsp;</font><font face="Wingdings">x</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-accelerated filer </font><font face="Wingdings">o</font><br>   (Do not check if a smaller reporting company)</p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="49%" valign="top" style="padding:0in 0in 0in 0in;width:49.0%;">
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Smaller reporting company&nbsp;</font><font face="Wingdings">o</font><br>   Emerging growth company<font face="Wingdings">o</font></p>    </td>   </tr>  </table>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;13(a)&nbsp;of the Exchange Act.&nbsp;</font><font face="Wingdings">o</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indicate by check mark whether the registrant is a shell company (as defined in Rule&nbsp;12b-2 of the Exchange Act).&#160; Yes <i>&nbsp;</i></font><font face="Wingdings">o</font> No&nbsp;<font face="Wingdings">x</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.25in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As of July&nbsp;31, 2017, 128,341,785 shares of common stock, $.001 par value per share, were outstanding.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="border-bottom:solid windowtext 3.0pt;border-left:none;border-right:none;border-top:solid windowtext 1.0pt;padding:1.0pt 0in 1.0pt 0in;">
<p style="border:none;margin:0in 0in .0001pt;padding:0in;"><font size="1" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>
</div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-ba.htm',USER='108183',CD='Aug  1 19:38 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CELLDEX THERAPEUTICS,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">&nbsp;</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">FORM&nbsp;10-Q</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Quarter Ended June&nbsp;30, 2017</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><a name="TableOfContents"></a><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Table of Contents</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="91%" valign="bottom" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Page</font></b></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#PARTIFINANCIALINFORMATION_050139" title="Click to goto "><b>Part&nbsp;I&#151;Financial   Information</b></a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Item1_UnauditedFinancialStatemen_050143" title="Click to goto ">Item 1. Unaudited Financial Statements</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#CONDENSEDCONSOLIDATEDBALANCESHEE_050146" title="Click to goto ">Condensed Consolidated Balance Sheets at   June&nbsp;30, 2017 and December&nbsp;31, 2016</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#CONDENSEDCONSOLIDATEDSTATEMENTSO_050152" title="Click to goto ">Condensed Consolidated Statements of   Operations and Comprehensive Loss for the Three and Six Months Ended   June&nbsp;30, 2017 and&nbsp;2016</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#CONDENSEDCONSOLIDATEDSTATEMENTSO_050156" title="Click to goto ">Condensed Consolidated Statements of Cash   Flows for the Six Months Ended June&nbsp;30, 2017 and 2016</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 30.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#NotestoUnauditedCondensedConsoli_044619" title="Click to goto ">Notes to Unaudited Condensed Consolidated   Financial Statements</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Item2_ManagementsDiscussionandAn_052640" title="Click to goto ">Item 2. Management&#146;s Discussion and   Analysis of Financial Condition and Results of Operations</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Item3_QuantitativeandQualitative_050940" title="Click to goto ">Item 3. Quantitative and Qualitative   Disclosures About Market Risk</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Item4_ControlsandProcedures_050944" title="Click to goto ">Item 4. Controls and Procedures</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">29</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#PARTIIOTHERINFORMATION_051133" title="Click to goto "><b>Part&nbsp;II&#151;Other Information</b></a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Item1A_RiskFactors_051138" title="Click to goto ">Item   1A. Risk Factors</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#Item6_Exhibits_051137" title="Click to goto ">Item   6. Exhibits</a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#SIGNATURES_051223" title="Click to goto "><b>Signatures</b></a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">31</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="91%" valign="top" style="padding:0in 0in 0in 0in;width:91.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#EXHIBITINDEX_051225" title="Click to goto "><b>Exhibit&nbsp;Index</b></a></font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">2<a name="PB_2_164851_1900"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='2',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-bg.htm',USER='108183',CD='Aug  1 19:31 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PART&nbsp;I&#151;FINANCIAL INFORMATION</font></b><a name="PARTIFINANCIALINFORMATION_050139"></a></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 1. Unaudited Financial Statements</font></b><a name="Item1_UnauditedFinancialStatemen_050143"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CELLDEX THERAPEUTICS,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONDENSED CONSOLIDATED BALANCE SHEETS</font></b><a name="CONDENSEDCONSOLIDATEDBALANCESHEE_050146"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Unaudited)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(In thousands, except share and per share amounts)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="64%" valign="bottom" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">December&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">ASSETS</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Current Assets:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cash and Cash Equivalents</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66,162</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">42,461</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marketable Securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,822</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">147,315</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accounts and Other Receivables</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,359</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,784</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prepaid and Other Current Assets</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,709</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,009</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Current Assets</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">160,052</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">195,569</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Property and Equipment, Net</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,069</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,192</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intangible Assets, Net</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">81,039</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">81,487</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Assets</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,935</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,134</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Goodwill</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90,976</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90,976</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Assets</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">346,071</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">383,358</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">LIABILITIES AND   STOCKHOLDERS&#146; EQUITY</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Current Liabilities:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accounts Payable</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,975</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,740</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accrued Expenses</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21,275</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28,657</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Current Portion of Long-Term   Liabilities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5,538</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,826</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Current Liabilities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28,788</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">35,223</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Long-Term Liabilities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">85,826</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">82,704</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Liabilities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">114,614</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">117,927</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Commitments and Contingent   Liabilities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stockholders&#146; Equity:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Convertible Preferred Stock, $.01   Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at   June&nbsp;30, 2017 and December&nbsp;31, 2016</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Common Stock, $.001 Par Value;   297,000,000 Shares Authorized; 127,411,975 and&nbsp;120,516,654 Shares Issued   and Outstanding at June&nbsp;30, 2017 and December&nbsp;31, 2016,   respectively</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">127</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">121</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Additional Paid-In Capital</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,011,066</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">982,255</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accumulated Other Comprehensive   Income</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,577</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,541</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accumulated Deficit</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(782,313</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(719,486</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Stockholders&#146; Equity</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">231,457</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">265,431</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="64%" valign="top" style="padding:0in 0in 0in 0in;width:64.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Liabilities and   Stockholders&#146; Equity</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">346,071</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">383,358</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">See accompanying notes to unaudited condensed consolidated financial statements</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">3<a name="PB_3_165305_5315"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='3',FILE='C:\jms\109765\17-13377-1\task8522122\13377-1-fa.htm',USER='109765',CD='Aug  1 17:02 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CELLDEX THERAPEUTICS,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</font></b><a name="CONDENSEDCONSOLIDATEDSTATEMENTSO_050152"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Unaudited)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(In thousands, except per share amounts)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Three&nbsp;Months<br>   Ended<br>   June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Three&nbsp;Months<br>   Ended<br>   June&nbsp;30,&nbsp;2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months<br>   Ended<br>   June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months<br>   Ended<br>   June&nbsp;30,&nbsp;2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">REVENUE:</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product Development and Licensing   Agreements</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">694</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">604</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,250</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,057</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contracts and Grants</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,135</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">785</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,113</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,635</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Revenue</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,829</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,389</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5,363</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,692</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OPERATING EXPENSE:</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Research and Development</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24,999</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25,711</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,792</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53,158</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">General and Administrative</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6,534</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,790</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,763</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17,097</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Loss on Fair Value Remeasurement   of Contingent Consideration</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,400</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization of Acquired   Intangible Assets</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">224</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">254</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">448</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">507</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Operating Expense</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32,757</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33,755</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,403</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70,762</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operating Loss</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28,928</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(32,366</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(64,040</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(68,070</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment and Other Income, Net</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">362</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">414</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,213</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,445</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Loss</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28,566</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(31,952</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(62,827</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(66,625</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Basic and Diluted Net Loss Per   Common Share</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(0.23</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(0.32</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(0.51</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(0.67</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares Used in Calculating Basic   and Diluted Net Loss&nbsp;per Share</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">125,202</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">98,817</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">123,932</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">98,753</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">COMPREHENSIVE LOSS:</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Loss</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28,566</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(31,952</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(62,827</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(66,625</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Comprehensive Income:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Unrealized Gain on Marketable Securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">416</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Comprehensive Loss</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28,551</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(31,916</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(62,791</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(66,209</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">See accompanying notes to unaudited condensed consolidated financial statements</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">4<a name="PB_4_165431_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='4',FILE='C:\jms\109765\17-13377-1\task8522122\13377-1-fa.htm',USER='109765',CD='Aug  1 17:02 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CELLDEX THERAPEUTICS,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</font></b><a name="CONDENSEDCONSOLIDATEDSTATEMENTSO_050156"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(Unaudited)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(In thousands)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months<br>   Ended<br>   June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months<br>   Ended<br>   June&nbsp;30,&nbsp;2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-align:justify;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cash Flows from Operating Activities:</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Loss</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(62,827</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(66,625</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Adjustments to Reconcile Net Loss   to Net Cash Used in Operating Activities:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Depreciation and Amortization</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,367</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,434</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization of Intangible Assets</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">448</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">507</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization and Premium of   Marketable Securities, Net</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(161</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">612</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Loss on Sale or Disposal of   Assets</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">74</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Loss on Fair Value Remeasurement   of Contingent Consideration</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,400</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock-Based Compensation Expense</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6,989</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,913</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Non-Cash Expense</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,638</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Changes in Operating Assets and   Liabilities:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accounts and Other Receivables</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">425</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(146</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Prepaid and Other Current Assets</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(511</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3,124</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Assets</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">199</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accounts Payable and Accrued   Expenses</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6,812</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(10,212</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Liabilities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(566</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(803</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Cash Used in Operating   Activities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(56,049</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(68,732</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cash Flows from   Investing Activities:</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sales and Maturities of   Marketable Securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">151,470</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">149,367</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Purchases of Marketable   Securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(91,969</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(120,053</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment in Other</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1,801</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Acquisition of Property and   Equipment</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1,316</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1,307</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Cash Provided by Investing   Activities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">58,185</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26,206</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Cash Flows from   Financing Activities:</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Proceeds from Stock Issuances</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21,489</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,551</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Proceeds from Issuance of Stock   from Employee Benefit Plans</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">349</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Cash Provided by Financing   Activities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">21,565</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,900</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Increase (Decrease) in Cash   and Cash Equivalents</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">23,701</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(39,626</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cash and Cash Equivalents at Beginning   of Period</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">42,461</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">72,108</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cash and Cash Equivalents at End   of Period</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">66,162</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32,482</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Non-cash Investing   Activities</font></i></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Acquisition of Property and   Equipment included in Accounts Payable and Accrued Expenses</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">108</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Non-cash   Supplemental Disclosure</font></i></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares issued to former Kolltan   executive for settlement of severance</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">263</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">See accompanying notes to unaudited condensed consolidated financial statements</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">5<a name="PB_5_170109_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='5',FILE='C:\jms\109765\17-13377-1\task8522122\13377-1-fa.htm',USER='109765',CD='Aug  1 17:02 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CELLDEX THERAPEUTICS,&nbsp;INC.</font></b></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Notes to Unaudited Condensed Consolidated Financial Statements</font></b><a name="NotestoUnauditedCondensedConsoli_044619"></a></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">June&nbsp;30, 2017</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(1)&nbsp; Basis of Presentation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The accompanying unaudited condensed consolidated financial statements have been prepared by Celldex Therapeutics,&nbsp;Inc. (the &#147;Company&#148; or &#147;Celldex&#148;) in accordance with accounting principles generally accepted in the United States of America (&#147;U.S. GAAP&#148;) and reflect the operations of the Company and its wholly-owned subsidiaries. </font>In June&nbsp;2017, the Company liquidated its wholly-owned subsidiary, Celldex Therapeutics Europe&nbsp;GmbH. All intercompany balances and transactions have been eliminated in consolidation.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">These interim financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited financial statements for the year ended December&nbsp;31, 2016, which are included in the Company&#146;s Annual Report on Form&nbsp;10-K filed with the Securities and Exchange Commission on March&nbsp;14, 2017. In the opinion of management, the interim financial statements reflect all normal recurring adjustments necessary to fairly state the Company&#146;s financial position and results of operations for the interim periods presented. The year-end condensed balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for any future interim period or the fiscal year ending December&nbsp;31, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At June&nbsp;30, 2017, the Company had cash, cash equivalents and marketable securities of $154.0 million. The Company has had recurring losses and incurred a loss of $62.8 million for the six months ended June&nbsp;30, 2017. Net cash used in operations for the six months ended June&nbsp;30, 2017 was $56.0&nbsp;million. The Company believes that the cash, cash equivalents and marketable securities at August&nbsp;8, 2017 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months from the date of issuance of these financial statements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During the next twelve months and beyond, the Company will take further steps to raise additional capital to meet its liquidity needs. These capital raising activities may include, but may not be limited to, one or more of the following: the licensing of drug candidates with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While the Company may seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and the Company&#146;s negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the Company will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to the Company&#146;s stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict the Company&#146;s ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce the Company&#146;s economic potential from products under development. The Company&#146;s ability to continue funding its planned operations into and beyond twelve months from the issuance date is also dependent on the timing and manner of payment of future contingent milestones from the Kolltan acquisition, in the event that the Company achieves the drug candidate milestones related to those payments. The Company, at its option, may decide to pay those milestone payments in cash, shares of its common stock or a combination thereof. If the Company is unable to raise the funds necessary to meet its liquidity needs, it may have to delay or discontinue the development of one or more programs, discontinue or delay ongoing or anticipated clinical trials, license out programs earlier than expected, raise funds at a significant discount or on other unfavorable terms, if at all, or sell all or a part of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(2)&nbsp; Significant Accounting Policies</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:35.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and six months ended June&nbsp;30, 2017 are consistent with those discussed in Note 2 to the financial statements in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016, except for the adoption of new accounting standards during the first six months of 2017 as discussed below.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Newly-Adopted Accounting Pronouncements</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On January&nbsp;1, 2017, the Company adopted a new U.S.&nbsp;GAAP accounting standard which involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company elected to continue to estimate forfeitures expected to occur to determine stock-based compensation expense. Upon adoption, the Company&#146;s gross deferred tax assets and corresponding valuation allowance each increased by $17.7 million related to tax deductions from the exercise of stock options that previously would have been credited to additional paid-in-capital when realized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">6<a name="PB_6_164634_8802"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='6',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-fn.htm',USER='109765',CD='Aug  1 20:29 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">On January&nbsp;1, 2017, the Company adopted a new U.S.&nbsp;GAAP accounting standard which simplifies how an entity is required to test goodwill for impairment. A goodwill impairment will be measured by the amount by which a reporting unit&#146;s carrying value exceeds its fair value, with the amount of impairment not to exceed the carrying amount of goodwill.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Recent Accounting Pronouncements</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#146;s financial position or results of operations upon adoption.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In May&nbsp;2014, the FASB issued a new U.S GAAP accounting standard that updates guidance and disclosure requirements for recognizing revenue. The new revenue recognition standard provides a five-step model for recognizing revenue from contracts with customers. The core principle is that a company should recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard will be effective for the Company on January&nbsp;1, 2018 and can be applied using one of two methods: retrospectively to each prior period presented or a modified retrospective application by recognizing a cumulative-effect adjustment as a component of equity as of the date of adoption. The Company expects to adopt the new revenue standard using the modified retrospective application method. As of June&nbsp;30, 2017, the Company is still evaluating the impact the adoption of this standard will have on the Company&#146;s financial statements and disclosure. During the second half of 2017, the Company plans to finalize its review of all applicable contracts that will be affected by the adoption of this standard.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In February&nbsp;2016, the FASB issued a new U.S. GAAP accounting standard which requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for the Company on January&nbsp;1, 2019. The Company is currently evaluating the potential impact that this standard may have on the Company&#146;s financial statements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In August&nbsp;2016, </font>the FASB issued new U.S. GAAP guidance which clarifies the classification of certain cash receipts and payments in the statement of cash flows. This standard is effective for the company on January&nbsp;1, 2018. The adoption of this new guidance is not expected to have a material impact on the Company&#146;s financial statements.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(3)&nbsp; Fair Value Measurements</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following tables set forth the Company&#146;s financial assets and liabilities subject to fair value measurements:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">As&nbsp;of<br>   June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Level&nbsp;1</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Level&nbsp;2</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Level&nbsp;3</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="55%" colspan="11" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assets:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Money market funds and cash equivalents</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,622</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,622</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marketable securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,822</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,822</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">132,444</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">132,444</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liabilities:</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-11.2pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kolltan   acquisition contingent consideration</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,600</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,600</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-11.2pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,600</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,600</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">As&nbsp;of<br>   December&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Level&nbsp;1</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Level&nbsp;2</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Level&nbsp;3</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="55%" colspan="11" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Assets:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Money market funds and cash   equivalents</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20,445</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">20,445</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marketable securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">147,315</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">147,315</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">167,760</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">167,760</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Liabilities:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kolltan acquisition contingent   consideration</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">7<a name="PB_7_165456_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='7',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-fn.htm',USER='109765',CD='Aug  1 20:29 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company&#146;s financial assets consist mainly of cash and cash equivalents and marketable securities and are classified as Level 2 within the valuation hierarchy. The Company values its marketable securities utilizing independent pricing services which normally derive security prices from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. At each balance sheet date, observable market inputs may include trade information, broker or dealer quotes, bids, offers or a combination of these data sources. The Company did not have any transfers of assets or liabilities between the fair value measurement classifications during the six months ended June&nbsp;30, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contingent consideration liabilities related to acquisitions are classified as Level&nbsp;3 within the valuation hierarchy and are valued based on various estimates, including probability of success, discount rates and amount of time until the conditions of the milestone payments are met. In connection with the Kolltan acquisition, the Company may be required to pay future consideration of up to $172.5 million that is contingent upon the achievement of specified development, regulatory approvals or sales-based milestone events. The Company determines the fair value of these obligations on the acquisition date using various estimates that are not observable in the market and represent a Level&nbsp;3 measurement within the fair value hierarchy. During the three and six months ended June&nbsp;30, 2017, the Company recorded a $1.0 million and $4.4 million loss on fair value remeasurement of contingent consideration, respectively, primarily due to changes in discount rates and the passage of time. The following table reflects the activity for the Company&#146;s contingent consideration liabilities measured at fair value using Level 3 inputs for the six months ended June&nbsp;30, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="86%" style="border-collapse:collapse;margin-left:.5in;">
<tr>
<td width="77%" valign="bottom" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.92%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="19%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.04%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Other&nbsp;Long-Term<br>   Liabilities:<br>   Contingent<br>   Consideration</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="77%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Balance at December&nbsp;31, 2016</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:17.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="77%" valign="top" style="padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fair value adjustments included   in operating expenses</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="19%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:19.04%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,400</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="77%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:77.88%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Balance at June&nbsp;30, 2017</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.92%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="17%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:17.74%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,600</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(4)&nbsp; Marketable Securities</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following tables summarize our marketable securities, classified as available-for-sale:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="45%" valign="bottom" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Amortized<br>   Cost</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Gross<br>   Unrealized<br>   Gains</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Gross<br>   Unrealized<br>   Losses</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Fair&nbsp;Value</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="45%" valign="bottom" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="51%" colspan="11" valign="bottom" style="padding:0in 0in 0in 0in;width:51.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marketable securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">U.S. government and municipal   obligations</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing in one year or less</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,253</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,254</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing after one year through   three years</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total U.S. government and   municipal obligations</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,253</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,254</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporate debt securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing in one year or less</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,588</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(22</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,568</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing after one year through   three years</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total corporate debt securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,588</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(22</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,568</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total marketable securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,841</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 1.125pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,822</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">December&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Marketable securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">U.S. government and municipal   obligations</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing in one year or less</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52,754</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52,747</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing after one year through   three years</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">296</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">304</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total U.S. government and   municipal obligations</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53,050</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53,051</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Corporate debt securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing in one year or less</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">94,320</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(56</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">94,264</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 40.4pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Maturing after one year through   three years</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" style="padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 30.3pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total corporate debt securities</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">94,320</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(56</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">94,264</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="45%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:45.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total marketable securities</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">147,370</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(68</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:9.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">147,315</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The marketable securities held by the Company were high investment grade and there were no marketable securities that the Company considered to be other-than-temporarily impaired as of June&nbsp;30, 2017. Marketable securities include $0.4 million and $0.6 million in accrued interest at June&nbsp;30, 2017 and December&nbsp;31, 2016, respectively.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">8<a name="PB_8_165907_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='8',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-fn.htm',USER='109765',CD='Aug  1 20:29 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(5)&nbsp; Intangible Assets and Goodwill</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intangible assets, net of accumulated amortization, and goodwill are as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" colspan="8" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="32%" colspan="8" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:32.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">December&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="19%" valign="bottom" style="padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Estimated<br>   Life</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cost</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Accumulated<br>   Amortization</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Net</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Cost</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Accumulated<br>   Amortization</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="9%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Net</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="77%" colspan="19" valign="bottom" style="padding:0in 0in 0in 0in;width:77.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Intangible Assets:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">IPR&amp;D</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indefinite</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73,490</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73,490</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73,490</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73,490</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amgen Amendment</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">16 years</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14,500</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6,951</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,549</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">14,500</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6,503</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="9%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:9.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,997</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="top" style="padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Intangible Assets</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" style="padding:0in 0in 0in 0in;width:9.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,990</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6,951</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 1.125pt 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">81,039</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,990</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6,503</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 1.125pt 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">81,487</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="19%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:19.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Goodwill</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="9%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:9.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Indefinite</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90,976</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90,976</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90,976</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:8.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="7%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:7.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90,976</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The IPR&amp;D intangible asset recorded in connection with the CuraGen acquisition of $11.8&nbsp;million relates to the development of glembatumumab vedotin. At the date of acquisition and at June&nbsp;30, 2017, glembatumumab vedotin had not yet reached technological feasibility nor did it have any alternative future use. Glembatumumab vedotin is in a randomized, Phase&nbsp;2b study for the treatment of triple negative breast cancer and a Phase&nbsp;2 study for the treatment of metastatic melanoma.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company performed an impairment test of the </font>glembatumumab vedotin IPR&amp;D and goodwill assets as of July&nbsp;1, 2016 and concluded that goodwill was not impaired.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with the Kolltan Acquisition, effective November&nbsp;29, 2016, the Company recorded IPR&amp;D intangible assets primarily related to the development of the CDX-0158, CDX-3379 and TAM programs with a fair value of $40.0&nbsp;million, $3.5&nbsp;million and $18.0&nbsp;million, respectively. At the date of acquisition and at June&nbsp;30, 2017, the CDX-1058, CDX-3379 and TAM programs had not yet reached technological feasibility nor did they have any alternative future use. CDX-0158 is a humanized monoclonal antibody currently in a Phase&nbsp;1 dose escalation study in refractory gastrointestinal stromal tumors and CDX-3379 is a human monoclonal antibody which recently completed a Phase&nbsp;1b study in patients with solid tumors. The TAM program is a multi-faceted broad antibody discovery effort to generate antibodies that modulate the TAM family of RTKs, comprised of Tyro3, AXL and MerTK, which are expressed on tumor-infiltrating macrophages, dendritic cells and some tumors.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;punctuation-wrap:simple;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(6)&nbsp;Other Long-Term Liabilities</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other long-term liabilities include the following:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">June&nbsp;30,&nbsp;2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">December&nbsp;31,&nbsp;2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deferred Rent</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">710</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">398</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Deferred Tax Liabilities   related to IPR&amp;D</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28,054</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">28,054</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deferred Income from Sale of Tax   Benefits</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8,940</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9,436</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Accrued Lease Restructuring</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,150</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,154</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Long-Term Severance</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">181</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">539</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contingent Milestones</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">48,600</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deferred Revenue</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,729</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,749</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">91,364</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">87,530</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Less Current Portion</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(5,538</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4,826</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Long-Term Portion</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">85,826</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">82,704</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In November&nbsp;2015, December&nbsp;2014, January&nbsp;2014 and January&nbsp;2013, the Company received approval from the New Jersey Economic Development Authority and agreed to sell New Jersey tax benefits of $9.8 million, $1.9&nbsp;million, $1.1&nbsp;million and $0.8&nbsp;million to an independent third party for $9.2 million, $1.8&nbsp;million, $1.0&nbsp;million and $0.8&nbsp;million, respectively. Under the agreement, the Company must maintain a base of operations in New Jersey for five years or the tax benefits must be paid back on a pro-rata basis based on the number of years completed. The Company recorded $0.5 million and $0.6 million to other income related to the sale of these tax benefits during the six months ended June&nbsp;30, 2017 and 2016, respectively.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">9<a name="PB_9_170525_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='9',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-fn.htm',USER='109765',CD='Aug  1 20:29 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In December&nbsp;2016, the Company decided not to occupy the 11,500 square feet of expansion space (&#147;Needham Expansion&#148;) at its Needham, Massachusetts facility. The Company agreed to lease the Needham Expansion in August&nbsp;2015 and the term of the lease expires in July&nbsp;2020. The Company is actively trying to sublease the lease obligation. In March&nbsp;2017, the Company terminated its lease in Branford, CT and consolidated its Connecticut operations in its New Haven, CT facility. The Company recorded restructuring expense of $0.2 million to general and administrative expense related to the Branford, CT lease termination. The activity related to accrued lease restructuring for the six months ended June&nbsp;30, 2017 is presented below (in thousands):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="86%" style="border-collapse:collapse;margin-left:.5in;">
<tr>
<td width="82%" valign="bottom" style="padding:0in 0in 0in 0in;width:82.12%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.88%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Accrued&nbsp;Lease<br>   Restructuring</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="82%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:82.12%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Balance at December&nbsp;31, 2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.54%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,154</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.12%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expense</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:13.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">267</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="82%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:82.12%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Payments</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.84%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(271</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="82%" valign="top" style="padding:0in 0in 0in 0in;width:82.12%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Balance at June&nbsp;30, 2017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.88%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.3%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.54%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,150</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.16%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(7)&nbsp;Stockholders&#146; Equity</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In May&nbsp;2016, the Company entered into an agreement with Cantor Fitzgerald&nbsp;&amp;&nbsp;Co. (&#147;Cantor&#148;) to allow the Company to issue and sell shares of its common stock having an aggregate offering price of up to $60.0&nbsp;million from time to time through Cantor, acting as agent. During the </font>six months ended June&nbsp;30, 2017, Company issued 6,731,066 shares of its common stock under this controlled equity offering sales agreement with Cantor resulting in net proceeds to the Company of $21.5 million, after deducting commission and offering expenses. At June&nbsp;30, 2017, the Company had $23.1 million remaining in aggregate gross offering price available under the agreement.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(8)&nbsp; Stock-Based Compensation</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A summary of stock option activity for the six months ended June&nbsp;30, 2017 is as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="55%" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Shares</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Weighted<br>   Average<br>   Exercise<br>   Price<br>   Per&nbsp;Share</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Weighted<br>   Average<br>   Remaining<br>   Contractual<br>   Term&nbsp;(In&nbsp;Years)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Options Outstanding at   December&nbsp;31, 2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10,218,710</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11.14</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Granted</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,283,100</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.34</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Exercised</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Canceled</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(413,100</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.66</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Options Outstanding at   June&nbsp;30, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,088,710</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.49</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Options Vested and Expected to   Vest at June&nbsp;30, 2017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">11,931,869</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9.54</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.5</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Options Exercisable at   June&nbsp;30, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,085,429</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.93</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.7</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Shares Available for Grant under   the 2008 Plan</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,292,650</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The weighted average grant-date fair value of stock options granted during the six month period ended June&nbsp;30, 2017 was $1.57. Stock-based compensation expense for the three and six months ended June&nbsp;30, 2017 and 2016 was recorded as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="55%" colspan="11" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Research and development</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,871</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,008</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,764</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,824</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">General and administrative</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,579</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,965</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,225</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,089</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total stock-based compensation   expense</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,450</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,973</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6,989</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,913</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The fair value of employee and director stock options granted during the three and six month periods ended June&nbsp;30, 2017 and 2016 were valued using the Black-Scholes option-pricing model with the following assumptions:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expected stock price volatility</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76%</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">77%</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">76 &#150; 77%</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70 &#150; 77%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expected option term</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.0 years</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.0 years</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.0 years</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6.0 years</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Risk-free interest rate</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.0 &#150; 2.1%</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5%</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.0 &#150; 2.3%</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5 &#150; 1.6%</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Expected dividend yield</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">None</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">10<a name="PB_10_173603_141"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='10',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-fn.htm',USER='109765',CD='Aug  1 20:29 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(9)&nbsp;Accumulated Other Comprehensive Income</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:34.5pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The changes in accumulated other comprehensive income, which is reported as a component of stockholders&#146; equity, for the six months ended June&nbsp;30, 2017 are summarized below:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="55%" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Unrealized&nbsp;Gain<br>   (Loss)&nbsp;on<br>   Marketable<br>   Securities</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Foreign<br>   Currency&nbsp;Items</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Total</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="55%" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="41%" colspan="8" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Balance at December&nbsp;31, 2016</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(55</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,596</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,541</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" style="padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other comprehensive gain</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">36</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="55%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:55.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Balance at June&nbsp;30, 2017</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(19</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,596</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,577</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:34.55pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">No amounts were reclassified out of accumulated other comprehensive income during the six months ended June&nbsp;30, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(10)&nbsp; Revenue</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Bristol-Myers Squibb Company (BMS)</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In 2014, the Company entered into a clinical trial collaboration with BMS to evaluate the safety, tolerability and preliminary efficacy of varlilumab and Opdivo</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>, BMS&#146;s PD-1 immune checkpoint inhibitor, in a Phase 1/2 study. Under the terms of this clinical trial collaboration, BMS made a one-time payment to the Company of $5.0 million and BMS and the Company amended the terms of the Company&#146;s existing license agreement with Medarex, which was acquired by BMS, related to the Company&#146;s CD27 program whereby certain future milestone payments were waived and future royalty rates were reduced that may have been due from the Company to Medarex. In return, BMS was granted a time-limited right of first negotiation if the Company wishes to out-license varlilumab. The companies also agreed to work exclusively with each other to explore anti-PD-1 antagonist antibody and anti-CD27 agonist antibody combination regimens. The clinical trial collaboration provides that the companies share development costs and that the Company will be responsible for conducting the ongoing Phase 1/2 study.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company has determined that its performance obligations under the BMS agreement, which primarily include performing research and development, supplying varlilumab and participating in the joint development committee, should be accounted for as a single unit of accounting and estimated that its performance period under the BMS agreement would be 5 years. Accordingly, the $5.0 million up-front payment was initially recorded as deferred revenue and is being recognized as revenue on a straight-line basis over the estimated 5-year performance period using the Contingency Adjusted Performance Model (&#147;CAPM&#148;). The BMS agreement also provides for BMS to reimburse the Company for 50% of the external costs incurred by the Company in connection with the clinical trial. The BMS payments are recognized as revenue under the CAPM. The Company recorded $0.7 million and $1.2 million in revenue related to the BMS agreement during the three and six months ended June&nbsp;30, 2017, respectively, and $0.6&nbsp;million and $1.0 million during the three and six months ended June&nbsp;30, 2016, respectively.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Rockefeller University (Rockefeller)</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In 2013, the Company entered into an agreement, as amended, with Rockefeller pursuant to which the Company performs research and development services for Rockefeller. The Company bills Rockefeller quarterly for actual time and direct costs incurred and records those amounts to revenue in the quarter the services are performed. The Company recorded $0.3 million and $1.1 million in revenue related to the Rockefeller agreement during the three and six months ended June&nbsp;30, 2017, respectively, and $0.4&nbsp;million and $0.8 million during the three and six months ended June&nbsp;30, 2016, respectively.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">International AIDS Vaccine Initiative (IAVI)</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In 2017, the Company entered into an agreement with IAVI pursuant to which the Company will perform research and development services for IAVI outlined under subsequently negotiated task orders. Revenue is recognized as services are performed under the negotiated task orders. The Company recorded $2.3 million in revenue related to the IAVI agreement during the three and six months ended June&nbsp;30, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">11<a name="PB_11_172134_6234"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='11',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(11) Kolltan Acquisition</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In connection with the Kolltan Acquisition, effective November&nbsp;29, 2016, the Company issued 18,257,996 shares of common stock of the Company in exchange for all of the share and debt interests in Kolltan. The Company also agreed to issue an aggregate of 437,901 shares of its common stock, less tax withholdings, to certain former officers of Kolltan. During the six months ended June&nbsp;30, 2017, the Company issued 75,637 shares of its common stock and at June&nbsp;30, 2017, the Company&#146;s remaining obligation is to issue 150,185 shares of its common stock, less tax withholdings, related to this severance obligation. In addition, in the event that certain specified preclinical and clinical development milestones related to Kolltan&#146;s development programs and/or Celldex&#146;s development programs and certain commercial milestones related to Kolltan&#146;s drug candidates are achieved, Celldex will be required to pay Kolltan&#146;s stockholders milestone payments of up to $172.5&nbsp;million, which milestone payments may be made, at Celldex&#146;s sole election, in cash, in shares of Celldex&#146;s common stock or a combination of both, subject to provisions of the Merger Agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company acquired Kolltan to gain access to Kolltan&#146;s programs including: (i)&nbsp;CDX-0158 (formerly KTN0158) which is currently in a Phase&nbsp;1 dose escalation study in patients with refractory gastrointestinal stromal tumors (GIST); (ii)&nbsp;CDX-3379 (formerly KTN3379) which recently completed a Phase&nbsp;1b study with combination cohorts where meaningful responses and stable disease were observed in cetuximab (Erbitux</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>) refractory patients in patients with head and neck squamous cell carcinoma and in BRAF-mutant non-small cell lung cancer (NSCLC); and (iii)&nbsp;a multi-faceted TAM program, a broad antibody discovery effort underway to generate antibodies that modulate the TAM family of RTKs, comprised of Tyro3, AXL and MerTK, which are expressed on tumor-infiltrating macrophages, dendritic cells and some tumors.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The transaction was accounted for as a business combination with Celldex treated as the accounting acquirer. All of the assets acquired and liabilities assumed in the transaction are recognized at their acquisition-date fair values, while transaction costs associated with the transaction are expensed as incurred.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Purchase Price</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purchase price for Kolltan was based on the acquisition-date fair value of the consideration transferred, which was calculated based on the closing price of the Company&#146;s common stock of $4.02 per share on November&nbsp;29, 2016. The acquisition-date fair value of the consideration transferred consisted of the following (in thousands):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="80%" style="border-collapse:collapse;margin-left:.75in;">
<tr>
<td width="80%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fair value of common stock issued   for upfront payment</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.6%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">73,397</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" style="padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fair value of contingent   consideration</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">44,200</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Kolltan transaction expenses paid   in cash by the Company</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,768</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" style="padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total consideration transferred</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.58%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">121,365</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The contingent consideration relates to the achievement of certain regulatory and sales milestones as described in the agreement. The estimated fair value of contingent consideration of $48.6 million and $44.2&nbsp;million at June&nbsp;30, 2017 and December&nbsp;31, 2016, respectively, is recorded as a noncurrent liability. The Company determined the fair value of these obligations to pay additional milestone payments using various estimates, including probabilities of success, discount rates and amount of time until the conditions of the milestone payments are met. This fair value measurement is based on significant inputs not observable in the market, representing a Level&nbsp;3 measurement within the fair value hierarchy. The resulting probability-weighted cash flows were discounted using a cost of debt rate ranging from 10-11% for the milestones. The range of estimated milestone payments is from zero, if no milestones are achieved, to $172.5&nbsp;million if all milestones are met.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Changes in the fair value of the contingent consideration are recognized in operating earnings. Changes in fair values reflect new information about the probability and timing of meeting the conditions of the milestone payments or changes in discount rates. In the absence of new information, changes in fair value will only reflect the interest component of contingent consideration related to the passage of time as development work progresses towards the achievement of the milestones.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">12<a name="PB_12_172443_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='12',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Allocations of Assets and Liabilities</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company has allocated the consideration transferred for Kolltan to net tangible assets, intangible assets, and goodwill. The difference between the aggregate consideration transferred and the fair value of assets acquired and liabilities assumed was allocated to goodwill. This goodwill relates to the potential synergies from the Kolltan Acquisition and deferred tax liabilities related to acquired IPR&amp;D intangible assets. None of the goodwill is expected to be deductible for income tax purposes. The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands):</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="80%" style="border-collapse:collapse;margin-left:.75in;">
<tr>
<td width="80%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Cash&nbsp;and&nbsp;cash&nbsp;equivalents</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.6%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;8,160</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.26%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" style="padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other current and long-term   assets</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">799</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Property and equipment, net</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,072</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" style="padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In-process research and   development (IPR&amp;D)</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">61,690</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Goodwill</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">82,011</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" style="padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Deferred tax liabilities, net</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(23,393</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other assumed liabilities</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="15%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:15.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(9,974</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>   </tr>
<tr>
<td width="80%" valign="top" style="padding:0in 0in 0in 0in;width:80.62%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.4%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.58%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">121,365</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.26%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The purchase price allocation has been prepared on a preliminary basis and is subject to change as additional information becomes available concerning the fair value and tax basis of the acquired assets and liabilities. Any adjustments to the purchase price allocation will be made as soon as practicable but no later than one year from the acquisition date.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Pro Forma Financial Information</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">If the operations of the Company and Kolltan were combined as of January&nbsp;1, 2016, the unaudited pro forma net loss for the three and six months ended June&nbsp;30, 2016 would have been $39.5 million and $84.8 million, respectively, or $(0.34) and $(0.73) per share, respectively. The unaudited pro forma combined results are not necessarily indicative of the actual results that would have occurred had the acquisition been consummated at that date or of the future operations of the combined entities.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(12)&nbsp; Income Taxes</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Massachusetts, New Jersey and Connecticut are the three states in which the Company primarily operates or has operated and has income tax nexus. The Company&#146;s wholly-owned subsidiary Celldex Australia Pty Ltd operates in Brisbane, Australia. The Company is not currently under examination by any jurisdictions for any tax year.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Company has evaluated the positive and negative evidence bearing upon the realizability of its net deferred tax assets, which are comprised principally of net operating loss carryforwards, capitalized R&amp;D expenditures and R&amp;D tax credit carryforwards. The Company has determined that it is more likely than not that it will not recognize the benefits of federal and state deferred tax assets and, as a result, a full valuation allowance was maintained at June&nbsp;30, 2017 and December&nbsp;31, 2016 against the Company&#146;s net deferred tax assets.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">(13)&nbsp; Net Loss Per Share</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Stock options</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,088,710</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10,260,073</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Restricted stock</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">96,668</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">60,000</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,185,378</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10,320,073</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">13<a name="PB_13_172633_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='13',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 2.&#160; <u>Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations</u></font></b><a name="Item2_ManagementsDiscussionandAn_052640"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995:</font></i></b>&#160; This report on Form&nbsp;10-Q contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 under Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include statements with respect to our beliefs, plans, objectives, goals, expectations, anticipations, assumptions, estimates, intentions and future performance, and involve known and unknown risks, uncertainties and other factors, which may be beyond our control, and which may cause our actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. All statements other than statements of historical fact are statements that could be forward-looking statements. You can identify these forward-looking statements through our use of words such as &#147;may,&#148; &#147;will,&#148; &#147;can,&#148; &#147;anticipate,&#148; &#147;assume,&#148; &#147;should,&#148; &#147;indicate,&#148; &#147;would,&#148; &#147;believe,&#148; &#147;contemplate,&#148; &#147;expect,&#148; &#147;seek,&#148; &#147;estimate,&#148; &#147;continue,&#148; &#147;plan,&#148; &#147;point to,&#148; &#147;project,&#148; &#147;predict,&#148; &#147;could,&#148; &#147;intend,&#148; &#147;target,&#148; &#147;potential&#148; and other similar words and expressions of the future.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There are a number of important factors that could cause the actual results to differ materially from those expressed in any forward-looking statement made by us. These factors include, but are not limited to:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to successfully complete research and further development, including animal, preclinical and clinical studies, and, if we obtain regulatory approval, commercialization of glembatumumab vedotin (also referred to as CDX-011) and other drug candidates and the growth of the markets for those drug candidates;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to raise sufficient capital to fund our clinical studies and to meet our liquidity needs, on terms acceptable to us, or at all. If we are unable to raise the funds necessary to meet our liquidity needs, we may have to delay or discontinue the development of one or more programs, discontinue or delay ongoing or anticipated clinical trials, license out programs earlier than expected, raise funds at significant discount or on other unfavorable terms, if at all, or sell all or part of our business;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to negotiate strategic partnerships, where appropriate, for our programs, which may include, glembatumumab vedotin;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to realize the anticipated benefits from the acquisition of Kolltan and to operate the combined business efficiently;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to manage multiple clinical trials for a variety of drug candidates at different stages of development;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the cost, timing, scope and results of ongoing safety and efficacy trials of glembatumumab vedotin, and other preclinical and clinical testing;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the cost, timing, and uncertainty of obtaining regulatory approvals for our drug candidates;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the availability, cost, delivery and quality of clinical management services provided by our clinical research organization partners;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the availability, cost, delivery and quality of clinical and commercial-grade materials produced by our own manufacturing facility or supplied by contract manufacturers, suppliers and partners, who may be the sole source of supply;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to develop and commercialize products before competitors that are superior to the alternatives developed by such competitors;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to develop technological capabilities, including identification of novel and clinically important targets, exploiting our existing technology platforms to develop new drug candidates and expand our focus to broader markets for our existing targeted immunotherapeutics;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to adapt our proprietary antibody-targeted technology, or APC Targeting Technology&#153;, to develop new, safe and effective therapeutics for oncology and infectious disease indications;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>our ability to protect our intellectual property rights, including the ability to successfully defend patent oppositions filed against a European patent related to technology we use in varlilumab, and our ability to avoid intellectual property litigation, which can be costly and divert management time and attention; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the factors listed under the headings &#147;Business,&#148; &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; in the Company&#146;s annual report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016 and other reports that we file with the Securities and Exchange Commission<i>.</i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">14<a name="PB_14_172744_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='14',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">All forward-looking statements are expressly qualified in their entirety by this cautionary notice. You are cautioned not to place undue reliance on any forward-looking statements, which speak only as of the date of this report or the date of the document incorporated by reference into this report. We have no obligation, and expressly disclaim any obligation, to update, revise or correct any of the forward-looking statements, whether as a result of new information, future events or otherwise. We have expressed our expectations, beliefs and projections in good faith and we believe they have a reasonable basis. However, we cannot assure you that </font>our expectations, beliefs or projections will result or be achieved or accomplished.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">OVERVIEW</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We are a biopharmaceutical company focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. Our drug candidates, including antibodies, antibody-drug conjugates and other protein-based therapeutics, are derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our latest stage drug candidate, glembatumumab vedotin (also referred to as CDX-011) is a targeted antibody-drug conjugate in a randomized, Phase&nbsp;2b study for the treatment of triple negative breast cancer and a Phase&nbsp;2 study for the treatment of metastatic melanoma. Varlilumab (also referred to as CDX-1127) is an immune modulating antibody that is designed to enhance a patient&#146;s immune response against cancer. We established proof of principal in a Phase&nbsp;1 study with varlilumab, which supported the initiation of combination studies in various indications. We also have a number of earlier stage drug candidates in clinical development, including CDX-0158, a humanized monoclonal antibody (mAb) currently in a Phase&nbsp;1 dose escalation study in refractory gastrointestinal stromal tumors (GIST) and other KIT positive tumors; CDX-3379, a human monoclonal antibody which recently completed a Phase&nbsp;1b study in patients with solid tumors; CDX-014, an antibody-drug conjugate targeting renal and ovarian cancers; CDX-1401, a targeted immunotherapeutic aimed at antigen presenting cells, or APCs, for cancer indications; and, CDX-301, an immune cell mobilizing agent and dendritic cell growth factor. Our drug candidates address market opportunities for which we believe current cancer therapies are inadequate or non-existent.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We are building a fully integrated, commercial-stage biopharmaceutical company that develops important therapies for patients with unmet medical needs. Our program assets provide us with the strategic options to either retain full economic rights to our innovative therapies or seek favorable economic terms through advantageous commercial partnerships. This approach allows us to maximize the overall value of our technology and product portfolio while best ensuring the expeditious development of each individual product.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The following table reflects Celldex-sponsored clinical studies that we are actively pursuing at this time. All programs are currently fully owned by Celldex.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="28%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Product&nbsp;(generic)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="40%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:40.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Indication/Field</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Status</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Sponsor</font></b></p>    </td>   </tr>
<tr>
<td width="28%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Glembatumumab vedotin</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Triple negative breast cancer</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2b</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celldex</font></p>    </td>   </tr>
<tr>
<td width="28%" valign="top" style="padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Glembatumumab vedotin</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="top" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Metastatic melanoma (with varlilumab or CPI*)</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celldex</font></p>    </td>   </tr>
<tr>
<td width="28%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Varlilumab</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Multiple solid tumors (with nivolumab)</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celldex**</font></p>    </td>   </tr>
<tr>
<td width="28%" valign="top" style="padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-0158</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="top" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Gastrointestinal and other KIT-postive tumors</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;1</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celldex</font></p>    </td>   </tr>
<tr>
<td width="28%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-3379</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Multiple solid tumors (in combination regimens)</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;1</font></p>    </td>
<td width="2%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celldex</font></p>    </td>   </tr>
<tr>
<td width="28%" valign="top" style="padding:0in 0in 0in 0in;width:28.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-014</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="top" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Renal cell carcinoma</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;1</font></p>    </td>
<td width="2%" valign="top" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="top" style="padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Celldex</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><i>checkpoint inhibitor</i></p>
<p style="margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .5in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">**</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>BMS collaboration</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We also routinely work with external parties, such as government agencies, to collaboratively advance our drug candidates. The following pipeline reflects clinical trials of our drug candidates being actively pursued by outside organizations. In addition to the studies listed below, we also have an Investigator Initiated Research (IIR) program with seven studies ongoing with our drug candidates and additional studies currently under consideration.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="27%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:27.84%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Product&nbsp;(generic)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="40%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:40.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Indication/Field</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:11.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Status</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Sponsor</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.84%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Glembatumumab vedotin</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Uveal melanoma</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">NCI (CRADA)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" style="padding:0in 0in 0in 0in;width:27.84%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Glembatumumab vedotin</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="bottom" style="padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Squamous cell lung cancer</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">PrECOG,&nbsp;LLC</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="27%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:27.84%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-1401/CDX-301</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="40%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:40.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Multiple solid tumors</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CITN</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">15<a name="PB_15_173127_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='15',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The expenditures that will be necessary to execute our business plan are subject to numerous uncertainties. Completion of clinical trials may take several years or more, and the length of time generally varies substantially according to the type, complexity, novelty and intended use of a product candidate. It is not unusual for the clinical development of these types of product candidates to each take five years or more and for total development costs to exceed $100 million for each product candidate. We estimate that clinical trials of the type we generally conduct are typically completed over the following timelines:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="84%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Clinical&nbsp;Phase</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Estimated<br>   Completion<br>   Period</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;1</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1&nbsp;-&nbsp;2 Years</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" style="padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1&nbsp;-&nbsp;5 Years</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="84%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:84.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Phase&nbsp;3</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1&nbsp;-&nbsp;5 Years</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The duration and the cost of clinical trials may vary significantly over the life of a project as a result of differences arising during the clinical trial protocol, including, among others, the following:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the number of patients that ultimately participate in the trial;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the duration of patient follow-up that seems appropriate in view of results;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the number of clinical sites included in the trials;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the length of time required to enroll suitable patient subjects; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.25in;"><font size="2" face="Symbol" style="font-size:10.0pt;">&#183;</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>the efficacy and safety profile of the product candidate.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We test potential product candidates in numerous preclinical studies for safety, toxicology and immunogenicity. We may then conduct multiple clinical trials for each product candidate. As we obtain results from trials, we may elect to discontinue or delay clinical trials for certain product candidates in order to focus our resources on more promising product candidates.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">An element of our business strategy is to pursue the research and development of a broad portfolio of product candidates. This is intended to allow us to diversify the risks associated with our research and development expenditures. To the extent we are unable to maintain a broad range of product candidates, our dependence on the success of one or a few product candidates increases.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Regulatory approval is required before we can market our product candidates as therapeutic products. In order to proceed to subsequent clinical trial stages and to ultimately achieve regulatory approval, the regulatory agency must conclude that our clinical data are safe and effective. Historically, the results from preclinical testing and early clinical trials (through Phase&nbsp;2) have often not been predictive of results obtained in later clinical trials. A number of new drugs and biologics have shown promising results in early clinical trials but subsequently failed to establish sufficient safety and efficacy data to obtain necessary regulatory approvals.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Furthermore, our business strategy includes the option of entering into collaborative arrangements with third parties to complete the development and commercialization of our product candidates. In the event that third parties take over the clinical trial process for one of our product candidates, the estimated completion date would largely be under control of that third party rather than us. We cannot forecast with any degree of certainty which proprietary products, if any, will be subject to future collaborative arrangements, in whole or in part, and how such arrangements would affect our development plan or capital requirements. Our programs may also benefit from subsidies, grants, contracts or government or agency-sponsored studies that could reduce our development costs.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As a result of the uncertainties discussed above, among others, it is difficult to accurately estimate the duration and completion costs of our research and development projects or when, if ever, and to what extent we will receive cash inflows from the commercialization and sale of a product. Our inability to complete our research and development projects in a timely manner or our failure to enter into collaborative agreements, when appropriate, could significantly increase our capital requirements and could adversely impact our liquidity. These uncertainties could force us to seek additional, external sources of financing from time to time in order to continue with our business strategy. Our inability to raise additional capital, or to do so on terms reasonably acceptable to us, would jeopardize the future success of our business.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During the past five years through December&nbsp;31, 2016, we incurred an aggregate of $422.1 million in research and development expenses. The following table indicates the amount incurred for each of our significant research programs and for other identified research and development activities during the six months ended June&nbsp;30, 2017 and 2016. The amounts disclosed in the</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">16<a name="PB_16_173211_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='16',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">following table reflect direct research and development costs, license fees associated with the underlying technology and an allocation of indirect research and development costs to each program.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months&nbsp;Ended&nbsp;June&nbsp;30,</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="bottom" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Glembatumumab vedotin</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18,532</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,097</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Varlilumab</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8,620</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15,559</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-0158</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,376</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-3379</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,419</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-014</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,350</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,882</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-1401</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">314</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,039</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-301</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">661</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,643</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-1140</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,731</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">609</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">TAM Program</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,384</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Rintega</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,067</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,640</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 20.2pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Other Programs</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8,338</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,689</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="70%" valign="top" style="padding:0in 0in 0in 0in;width:70.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total R&amp;D Expense</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,792</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53,158</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Clinical Development Programs</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Glembatumumab Vedotin</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Glembatumumab vedotin is an antibody-drug conjugate, or ADC, that consists of a fully human monoclonal antibody, CR011, linked to a potent cell-killing drug, monomethyl auristatin E, or MMAE. The CR011 antibody specifically targets glycoprotein NMB, referred to as gpNMB that is over-expressed in a variety of cancers including breast cancer, melanoma, non-small cell lung cancer, uveal melanoma and osteosarcoma, among others. The ADC technology, comprised of MMAE and a stable linker system for attaching it to CR011, was licensed from Seattle Genetics,&nbsp;Inc. and is the same as that used in the marketed product Adcetris</font><font size="1" style="font-size:6.5pt;position:relative;top:-3.0pt;">&#174;</font>. The ADC is designed to be stable in the bloodstream. Following intravenous administration, glembatumumab vedotin targets and binds to gpNMB, and upon internalization into the targeted cell, glembatumumab vedotin is designed to release MMAE from CR011 to produce a cell-killing effect. Glembatumumab vedotin is being studied across multiple indications in company-sponsored trials and in collaborative studies with external parties. The U.S. Food and Drug Administration, or FDA, has granted Fast Track designation to glembatumumab vedotin for the treatment of advanced, refractory/resistant gpNMB-expressing breast cancer. A companion diagnostic is in development for certain indications, and we expect that, if necessary, such a companion diagnostic must be approved by the FDA or certain other foreign regulatory agencies before glembatumumab vedotin may be commercialized in those indications.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Treatment of Metastatic Breast Cancer:</font></b>&#160; The Phase 1/2 study of glembatumumab vedotin administered intravenously once every three weeks evaluated patients with locally advanced or metastatic breast cancer (MBC) who had received prior therapy (median of seven prior regimens). Results were published in the <i>Journal of Clinical Oncology</i> in September&nbsp;2014. The study began with a bridging phase to confirm the maximum tolerated dose, or MTD, and then expanded into a Phase&nbsp;2 open-label, multi-center study. The study supported an acceptable safety profile of glembatumumab vedotin at the pre-defined maximum dose level (1.88&nbsp;mg/kg) in 6 patients. An additional 28 patients with MBC were enrolled in an expanded Phase&nbsp;2 cohort (for a total of 34 treated patients at 1.88&nbsp;mg/kg, the Phase&nbsp;2 dose) to evaluate the progression-free survival (PFS) rate at 12&nbsp;weeks. The 1.88 mg/kg dose exhibited an acceptable safety profile in this patient population with the most common adverse events being rash, neuropathy and fatigue. The primary anti-cancer activity endpoint, which called for at least 5 of 25 (20%) patients in the Phase&nbsp;2 study portion to be progression-free at 12&nbsp;weeks, was met as 9 of 27 (33%) evaluable patients were progression-free at 12&nbsp;weeks. For all patients treated at the Phase&nbsp;2 dose, median PFS was 9.1&nbsp;weeks.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A subset of 10 patients had &#147;triple negative disease,&#148; a more aggressive metastatic breast cancer subtype that carries a high risk of relapse and reduced survival as well as limited therapeutic options. In these patients, the 12-week PFS rate was 60% (6/10), and median PFS was 17.9&nbsp;weeks. Tumor samples from a subset of patients across all dose groups were analyzed for gpNMB expression. The tumor samples from most patients showed evidence of stromal and/or tumor cell expression of gpNMB.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">17<a name="PB_17_173353_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='17',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-fp.htm',USER='108183',CD='Aug  1 19:37 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The subsequent EMERGE study was a randomized, multi-center Phase&nbsp;2b study of glembatumumab vedotin in 124 patients with heavily pre-treated, advanced, gpNMB-positive breast cancer. Results from EMERGE were published in the <i>Journal of Clinical Oncology</i> in April&nbsp;2015. Patients were randomized (2:1) to receive either glembatumumab vedotin or single-agent Investigator&#146;s Choice chemotherapy. Patients randomized to receive Investigator&#146;s Choice were allowed to cross over to receive glembatumumab vedotin following disease progression. Activity endpoints included response rate, PFS and overall survival (OS). The final study results, as shown below, suggested that glembatumumab vedotin induced significant response rates compared to currently available therapies in patient subsets with advanced, refractory breast cancers with high gpNMB expression (expression in at least 25% of tumor cells) and in patients with triple negative breast cancer. The OS and PFS of patients treated with glembatumumab vedotin were also observed to be greatest in patients with high gpNMB expression and, in particular, in patients with triple negative breast cancer who also had high gpNMB expression.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMERGE: Overall Response Rate and Disease Control Data (Intent-to-Treat Population)</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="27%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:27.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">High&nbsp;gpNMB&nbsp;Expression</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="27%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:27.66%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Triple&nbsp;Negative<br>   and&nbsp;gpNMB<br>   Over-Expression</font></b></p>    </td>
<td width="0%" valign="bottom" style="padding:0in 0in 0in 0in;width:.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Glembatumumab<br>   Vedotin</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Investigator&#146;s<br>   Choice</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Glembatumumab<br>   Vedotin</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Investigator&#146;s<br>   Choice</font></b></p>    </td>
<td width="0%" valign="bottom" style="padding:0in 0in 0in 0in;width:.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=23)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=11)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=10)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(n=6)</font></b></p>    </td>
<td width="0%" valign="bottom" style="padding:0in 0in 0in 0in;width:.84%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Response Rate</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">30</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">40</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">0</font></p>    </td>
<td width="0%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Disease Control Rate</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">65</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">27</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17</font></p>    </td>
<td width="0%" valign="bottom" style="padding:0in 0in 0in 0in;width:.84%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Tumor response assessed by RECIST 1.1, inclusive of response observed at a single time point.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EMERGE: Progression Free Survival (PFS) and Overall Survival (OS) Data</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="27%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:27.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">High&nbsp;gpNMB&nbsp;Expression</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="27%" colspan="3" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:27.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Triple&nbsp;Negative<br>   and&nbsp;gpNMB<br>   Over-Expression</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Glembatumumab<br>   Vedotin</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Investigator&#146;s<br>   Choice</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Glembatumumab<br>   Vedotin</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Investigator&#146;s<br>   Choice</font></b></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Median PFS (months)</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.8</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.5</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.5</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">p=0.18</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">p=0.0017</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Median OS (months)</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.7</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.0</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.5</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">p=0.31</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:13.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">p=0.003</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In December&nbsp;2013, we initiated METRIC, a randomized, controlled Phase 2b study of glembatumumab vedotin in patients with triple negative breast cancer that over-expresses gpNMB. Clinical trial study sites are open to enrollment across the U.S., Canada, Australia and the European Union. The METRIC protocol was amended in late 2014 based on feedback from clinical investigators conducting the study that the eligibility criteria for study entry were limiting their ability to enroll patients they felt were clinically appropriate. In addition, we had spoken to country-specific members of the European Medicines Agency, or EMA, and believed an opportunity existed to expand the study into the EU. The amendment expanded patient entry criteria to position it for the possibility of full marketing approval with global regulators, including the EMA, and to support improved enrollment in the study. The primary endpoint of the study is PFS as PFS is an established endpoint for full approval registration studies in this patient population in both the U.S. and the EU. The sample size (n=300) and the secondary endpoint of OS remained unchanged. Since implementation of these changes, both the FDA and central European regulatory authorities have reviewed the protocol design, and we believe the METRIC study could potentially support marketing approval in both the U.S. and Europe dependent upon data results and review. Target enrollment (n=300) in METRIC has been reached. Given the lack of treatment options for patients with triple negative breast cancer, previously screened patients whose tumors overexpress gpNMB will be allowed to enter the study before enrollment is formally completed, estimated to occur by the end of September&nbsp;2017. Efforts to ensure delivery of manufactured drug that is ready for commercialization and a companion diagnostic, including partnering with a diagnostic company, are underway. While we have made and continue to make progress on these fronts, we have made the decision to stage some of the more costly work in these areas to begin after we have received results from the study. While this step will extend the timeline to complete our regulatory filings, we believe this is the most prudent use of our funds as we seek to advance our pipeline overall.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">18<a name="PB_18_172656_5109"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='18',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Treatment of Metastatic Melanoma:</font></b>&#160; The Phase 1/2 open-label, multi-center, dose escalation study evaluated the safety, tolerability and pharmacokinetics of glembatumumab vedotin in 117 patients with unresectable stage&nbsp;III or IV melanoma who had failed no more than one prior line of cytotoxic therapy. The MTD and resulting Phase&nbsp;2 dose was determined to be 1.88 mg/kg administered intravenously once every three weeks. The study achieved its primary activity objective with an overall response rate (ORR) in the Phase&nbsp;2 cohort of 15% (5/34). Median PFS was 3.3&nbsp;months for patients treated with the Phase&nbsp;2 dose. Glembatumumab vedotin was generally well tolerated, with the most frequent treatment-related adverse events being rash, fatigue, alopecia, pruritus, diarrhea and nausea. The development of rash, which may be associated with the presence of gpNMB in the skin, also seemed to correlate with greater PFS.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In December&nbsp;2014, we initiated a single arm, single-agent, open-label Phase&nbsp;2 study of glembatumumab vedotin in patients with unresectable stage&nbsp;III or IV melanoma (n=60), and enrollment has been completed. In May&nbsp;2016, we amended the protocol to add a second cohort of patients to a glembatumumab vedotin and varlilumab combination arm to assess the potential clinical benefit of the combination and to explore varlilumab&#146;s potential biologic and immunologic effect when combined with an ADC and enrollment has been completed. In November&nbsp;2016, we amended the protocol again to add a third cohort of patients evaluating glembatumumab vedotin in combination with an approved checkpoint inhibitor (i.e.,&nbsp;nivolumab or pembrolizumab) following progression on the checkpoint inhibitor alone and enrollment is ongoing. The primary endpoint for each cohort is ORR. Secondary endpoints include analyses of PFS, duration of response, OS, retrospective investigation of whether the anti-cancer activity of glembatumumab vedotin is dependent upon the degree of gpNMB expression in tumor tissue and safety of both the monotherapy and combination regimens.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We presented mature data from the single-agent cohort in an oral presentation at the 2017 American Society of Clinical Oncology Annual Meeting in June. The cohort enrolled 62 evaluable patients with unresectable stage&nbsp;IV (n=62) melanoma. All patients had been heavily pre-treated (median prior therapies = 3; range 1-8) and had progressed during or after checkpoint inhibitor therapy, and almost all patients had received both ipilimumab (n=58; 94%) and anti-PD-1/anti-PD-L1 (n=58; 94%) therapy. Twelve patients presented with BRAF mutation, and fifteen had prior treatment with BRAF or BRAF/MEK targeted agents. Median overall survival (OS) for all patients was 9.0 months (95% CI: 6.1, 13.0). As previously reported in October&nbsp;2016, the primary endpoint of the cohort (threshold of 6 or more objective responses in 52 evaluable patients) was exceeded. 7 of 62 (11%) patients experienced a confirmed response, and an additional three patients also experienced single timepoint partial responses. Since data were reported in October&nbsp;2016, one patient converted from a confirmed partial response to a confirmed complete response. The median duration of response was 6.0 months. A 52% disease control rate (patients without progression for greater than three months) was demonstrated, and median progression free survival (PFS) for all patients was 4.4 months. Consistent with previous studies in melanoma and breast cancer, rash was associated with greater clinical benefit. Patients who experienced rash in Cycle 1 experienced a 21% confirmed response rate, a more prolonged PFS with a median of 5.5 months (p=0.006; HR=0.39) and a more prolonged OS with a median of 15.8 months (p=0.026, HR=0.44). The safety profile was consistent with prior studies of glembatumumab vedotin with rash, neutropenia and neuropathy experienced as the most significant adverse events. Pre-treatment tumor tissue was available for 59 patients. All samples were gpNMB positive, and 78% of patients had tumors with 100% of their epithelial cells expressing gpNMB. Given both the high level of expression and the intensity of expression across this patient population, identifying a potential population for gpNMB enrichment is not feasible; therefore, all patients with metastatic melanoma could be evaluated as potential candidates for treatment with glembatumumab vedotin in future studies. We intend to conduct exploratory analyses of pre-entry skin biopsies in future patients to investigate potential predictors of response to glembatumumab vedotin, given the association of rash and outcome.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Treatment of Other Indications:</font></b>&#160; We have entered into a collaborative relationship with PrECOG,&nbsp;LLC, which represents a research network established by the Eastern Cooperative Oncology Group (ECOG), under which PrECOG,&nbsp;LLC, is conducting an open-label Phase 1/2 study in patients with unresectable stage&nbsp;IIIB or IV, gpNMB-expressing, advanced or metastatic squamous cell carcinoma (SCC) of the lung, who have progressed on prior platinum-based chemotherapy. This study opened to enrollment in April&nbsp;2016 and is ongoing. The study includes a dose-escalation phase followed by a two-stage Phase&nbsp;2 portion (Simon two-stage design). The Phase&nbsp;1, dose-escalation portion of the study will assess the safety and tolerability of glembatumumab vedotin at the current dose of 1.9 mg/kg and then 2.2 mg/kg in order to determine whether higher dosing is feasible in this population. The first stage of the Phase&nbsp;2 portion plans to enroll approximately 20 patients, and if at least two patients achieve a partial response or complete response, a second stage may enroll an additional 15 patients. The primary objective of the Phase&nbsp;2 portion of the study is to assess the anti-tumor activity of glembatumumab vedotin in squamous cell lung cancer as measured by ORR. Secondary objectives of the study include analyses of safety and tolerability and further assessment of anti-tumor activity across a broad range of endpoints.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">19<a name="PB_19_172713_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='19',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have also entered into a Cooperative Research and Development Agreement, or CRADA, with the National Cancer Institute, or NCI, under which NCI is sponsoring a Phase 2 study of glembatumumab vedotin in uveal melanoma. The study is a single-arm, open-label study in patients with locally recurrent or metastatic uveal melanoma. The study has a two stage design with a pre-specified activity threshold necessary in the first stage to progress enrollment to the second stage. The primary outcome measure is ORR. Secondary outcome measures include change in gpNMB expression on tumor tissue via immunohistochemistry, safety, OS and PFS. Interim data from this study were presented at the International Society of Ocular Oncology Biennial Conference in March&nbsp;2017. Two (11%) objective responses were observed in 19 patients and 68% of patients experienced stable disease. Based on these interim data, the study met the activity threshold for progressing to stage&nbsp;2, and enrollment in this cohort was recently completed. We expect data from this study will be presented at a future medical meeting.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Varlilumab</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Varlilumab is a fully human monoclonal agonist antibody that binds to and activates CD27, a critical co-stimulatory molecule in the immune activation cascade. We believe varlilumab works primarily by stimulating T cells, an important component of a person&#146;s immune system, to attack cancer cells. Restricted expression and regulation of CD27 enables varlilumab specifically to activate T cells, resulting in an enhanced immune response with the potential for a favorable safety profile. In preclinical studies, varlilumab has been shown to directly kill or inhibit the growth of CD27 expressing lymphomas and leukemias in<i><font style="font-style:italic;"> in</font> vitro</i> and <i>in vivo</i> models. We have entered into license agreements with the University of Southampton, UK for intellectual property to use anti-CD27 antibodies and with Medarex (acquired by Bristol-Myers Squibb Company, or BMS) for access to the UltiMab technology to develop and commercialize human antibodies to CD27. Varlilumab was initially studied as a single-agent to establish a safety profile and assess immunologic and clinical activity in patients with cancer, but we believe the greatest opportunity for varlilumab is as an immune activator in combination with other agents. Currently, we are focusing our efforts on a Phase 1/2 clinical trial being conducted in collaboration with BMS and their PD-1 immune checkpoint inhibitor, Opdivo. Varlilumab is also being explored in combination studies, including with glembatumumab vedotin, and in ongoing and planned investigator-sponsored studies.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Single-Agent Phase&nbsp;1 Study:</font></b>&#160; Data from the completed, open-label Phase&nbsp;1 study of varlilumab in patients with selected malignant solid tumors or hematologic cancers were presented at the Annual Meeting of the American Society of Clinical Oncology in June&nbsp;2014. Varlilumab to date has shown an acceptable safety profile and induced immunologic activity in patients that is consistent with both its proposed mechanism of action and data in preclinical models. A total of 90 patients were dosed in the study at multiple clinical sites in the U.S. of which 56 patients were dosed in dose escalation cohorts (various solid and hematologic B-cell tumors), and 34 patients were dosed in the expansion cohorts (melanoma and RCC) at 3 mg/kg. In both the solid tumor and hematologic dose-escalations, the pre-specified maximum dose level (10 mg/kg) was reached without identification of a maximum tolerated dose. The majority of adverse events, or AEs, related to treatment have been mild to moderate (Grade 1/2) in severity, with only three serious AEs related to treatment reported. No significant immune-mediated adverse events (colitis, hepatitis,&nbsp;etc.) typically associated with checkpoint blockade have been observed to date. Two patients experienced significant objective responses including a complete response in Hodgkin lymphoma (continued at 33.1+ months as of September&nbsp;2016; patient no longer on study) and a partial response in renal cell carcinoma of 27.7+ months (as of September&nbsp;2016). Thirteen patients experienced stable disease with a range of 3-47.3+ months (as of September&nbsp;2016). As of December&nbsp;2016, there are two patients continuing in long term follow-up. Final results from the study in patients with solid tumors were published in the <i>Journal of Clinical Oncology </i>in April&nbsp;2017.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Phase 1/2 Varlilumab/Opdivo<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;Combination Study:</font></b>&#160; In 2014, we entered into a clinical trial collaboration with Bristol-Myers Squibb to evaluate the safety, tolerability and preliminary efficacy of varlilumab and Opdivo, Bristol-Myers Squibb&#146;s PD-1 immune checkpoint inhibitor, in a Phase 1/2 study. Under the terms of this clinical trial collaboration, Bristol-Myers Squibb made a one-time payment to us of $5.0&nbsp;million, and the companies amended the terms of our existing license agreement with Medarex (acquired by Bristol-Myers Squibb) related to our CD27 program whereby certain future milestone payments were waived and future royalty rates were reduced that may have been due from us to Medarex. In return, Bristol-Myers Squibb was granted a time-limited right of first negotiation if we wish to out-license varlilumab. The companies also agreed to work exclusively with each other to explore anti-PD-1 antagonist antibody and anti-CD27 agonist antibody combination regimens. The clinical trial collaboration provides that the companies will share development costs and that we will be responsible for conducting the Phase 1/2 study.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Phase 1/2 study was initiated in January&nbsp;2015 and is being conducted in adult patients with multiple solid tumors to assess the safety and tolerability of varlilumab at varying doses when administered with Opdivo, followed by a Phase&nbsp;2 expansion to evaluate the activity of the combination in disease specific cohorts. The Phase&nbsp;1 dose escalation portion of the study, conducted in patients with solid tumors, has completed enrollment (n=36) and primarily enrolled patients with colorectal and ovarian cancer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Data were presented from the Phase&nbsp;1 portion (n=36) of the varlilumab and Opdivo combination study in an oral presentation at the 2017 American Society of Clinical Oncology Annual Meeting in June. The majority of patients enrolled in the study had PD-L1 negative tumor at baseline and presented with stage IV, heavily-pretreated disease. 80% of patients enrolled presented with refractory or recurrent colorectal (n=21) or ovarian cancer (n=8), a population expected to have minimal response to checkpoint blockade. The</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">20<a name="PB_20_172732_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='20',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">primary objective of the Phase&nbsp;1 portion of the study was to evaluate the safety and tolerability of the combination. The combination was well tolerated at all varlilumab dose levels tested without any evidence of increased autoimmunity or inappropriate immune activation. Marked changes in the tumor microenvironment including increased infiltrating CD8+ T cells and increased PD-L1 expression, which have been shown to correlate with a greater magnitude of treatment effect from checkpoint inhibitors in other clinical studies, were observed. Additional evidence of immune activity, such as increase in inflammatory chemokines and decrease in T regulatory cells, was also noted. Notable disease control was also observed (stable disease or better for at least 3 months), considering the stage IV patient population contained mostly colorectal and ovarian cases (80%): 0.1 mg/kg varlilumab + 240 mg Opdivo: 1/5 (20%), 1 mg/kg varlilumab + 240 mg Opdivo: 5/15 (33%) and 10 mg/kg varlilumab + 240 mg Opdivo: 6/15 (40%).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Three partial responses (PR) were observed. A patient with PD-L1 negative, MMR proficient colorectal cancer, typically unlikely to respond to checkpoint blockade monotherapy, achieved a confirmed PR (95% decrease in target lesions) and, following completion of combination treatment, continues to receive treatment with Opdivo monotherapy at 22+ months. A patient with low PD-L1 (5% expression) squamous cell head and neck cancer achieved a confirmed PR (59% shrinkage) and experienced progression free survival of 6.7 months. A patient with PD-L1 negative ovarian cancer experienced a single timepoint PR (49% shrinkage) but discontinued treatment to a dose-limiting toxicity (immune hepatitis, an event known to be associated with checkpoint inhibition therapy). A subgroup analysis was conducted in patients with ovarian cancer based on an observed increase of PD-L1 and tumor-infiltrating lymphocytes in this patient population. In patients with paired baseline and on-treatment biopsies (n=13), only 15% were PD-L1 positive (<u>&gt;</u> 1% tumor cells) at baseline compared to 77% during treatment (p=0.015). Patients with increased tumor PD-L1 expression and tumor CD8 T cells correlated with better clinical outcome with treatment (stable disease or better).</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The Phase&nbsp;2 portion of the study opened to enrollment in April&nbsp;2016 and includes cohorts in colorectal cancer (n=18), ovarian cancer (n=54), head and neck squamous cell carcinoma (n=54), renal cell carcinoma (n=25) and glioblastoma (n=20). Based on recent protocol amendments, additional dosing schedules are being explored in ovarian cancer (versus renal cell carcinoma) and, as previously disclosed, in head and neck squamous cell carcinoma, increasing the overall size of the study compared to the original study design. The primary objective of the Phase&nbsp;2 cohorts is ORR, except glioblastoma, where the primary objective is the rate of 12-month overall survival. Secondary objectives include pharmacokinetics assessments, determining the immunogenicity of varlilumab when given in combination with Opdivo and further assessing the anti-tumor activity of combination treatment. We plan to complete enrollment across all cohorts in the Phase&nbsp;2 portion of the study in the first quarter of 2018 and expect to work with BMS to present data from the study at a future medical meeting.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">CDX-0158</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-0158 is a humanized monoclonal antibody designed to inhibit KIT activation in tumor cells and mast cells. KIT is expressed in many tumor types including gastrointestinal stromal tumors (or GIST), sarcomas, small cell lung cancer, melanoma, acute myeloid leukemia (AML) and mast cell leukemia. It has also been implicated in asthma and neurofibromatosis. We are currently developing CDX-0158 for the treatment of GIST. Small molecule drugs currently approved to treat GIST inhibit mutant KIT, but acquired resistance develops via secondary, drug-resistant KIT mutations in the majority of patients over time. CDX-0158 is designed to uniquely prevent KIT activation by inhibiting both receptor dimerization and ligand binding. CDX-0158 has demonstrated preclinical activity versus the most common c-KIT mutations in human GIST, including treatment of mastocytoma in a canine model.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Phase&nbsp;1 dose escalation study in patients with advanced refractory GIST and other KIT positive tumors opened to enrollment in December&nbsp;2015 to determine the maximum tolerated dose, recommend a dose for further study and characterize the safety profile. Enrollment is ongoing. Upon completion of Phase&nbsp;1 assuming a successful outcome, we plan to develop CDX-0158 in patients with refractory GIST given the significant unmet need for these patients.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Preclinical data published in <i>Molecular Cancer Therapeutics</i> in January&nbsp;2017 demonstrate that KIT inhibition in certain immune cells with CDX-0158 enhances the activity of checkpoint blockade, providing additional opportunities for combination therapy. This mechanism may also be effective with other immunotherapies, in particular with our CD27 agonist, varlilumab.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">CDX-3379</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-3379 is a human monoclonal antibody with half-life extension designed to block the activity of ErbB3 (HER3). We believe ErbB3 may be an important receptor regulating cancer cell growth and survival as well as resistance to targeted therapies and is expressed in many cancers, including head and neck, thyroid, breast, lung and gastric cancers, as well as melanoma. We believe the proposed mechanism of action for CDX-3379 sets it apart from other drugs in development in this class due to its ability to block both ligand-independent and ligand-dependent ErbB3 signaling by binding to a unique epitope. It has a favorable pharmacologic profile, including a longer half-life and slower clearance relative to other drug candidates in this class. CDX-3379 also has potential to enhance anti-tumor activity and/or overcome resistance in combination with other targeted and cytotoxic therapies to directly kill</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">21<a name="PB_21_172747_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='21',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">tumor cells. Tumor cell death and the ensuing release of new tumor antigens has the potential to serve as a focus for combination therapy with immuno-oncology approaches, even in refractory patients.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Phase&nbsp;1a/1b study was conducted, including a single-agent dose-escalation portion and combination expansion cohorts. Data from the dose-escalation portion, which completed enrollment in September&nbsp;2015, and initial data from the expansion cohorts (enrollment ongoing at the time) were presented at the American Society of Clinical Oncology Annual Meeting in June&nbsp;2016. The single-agent dose-escalation portion of the study did not identify an MTD, and there were no dose limiting toxicities. The most common adverse events included rash and diarrhea and were predominantly grade 1 or 2. Four combination arms across multiple tumor types were added to evaluate CDX-3379 with several drugs that target EGFR, HER2 or BRAF. They include combinations with Erbitux<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;(n=16), Tarceva<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;(n=8), Zelboraf<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;(n=4) and Herceptin<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;(n=10). Patients had advanced disease and were generally heavily pretreated. Across the combination arms, the most frequent adverse events were diarrhea, nausea, rash and fatigue. Objective responses were observed in the Erbitux and Zelboraf combination arms. In the Erbitux arm, there was one complete response in a patient with head and neck cancer, who had been previously treated with Erbitux and was refractory. In the Zelboraf arm, there were two partial responses in patients who had lung cancer, one of whom had been previously treated with Tafinlar<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;and was considered refractory. We have finalized plans for advancement into an open-label Phase&nbsp;2 study in patients with recurrent/metastatic head and neck squamous cell cancer who are refractory to Erbitux (cetuximab). We anticipate initiating this study in the fourth quarter of 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">CDX-1401</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-1401, developed from our APC Targeting Technology, is an NY-ESO-1-antibody fusion protein for immunotherapy in multiple solid tumors. CDX-1401, which is administered with an adjuvant, is composed of the cancer-specific antigen NY-ESO-1 fused to a fully human antibody that binds to DEC-205 for efficient delivery to dendritic cells. Delivery of tumor-specific proteins directly to dendritic cells <i>in vivo</i> elicits potent, broad, anti-tumor immune responses across populations with different genetic backgrounds. In humans, NY-ESO-1 has been detected in 20% to 30% of melanoma, lung, esophageal, liver, gastric, ovarian and bladder cancers, and up to 70% of synovial sarcomas, thus representing a broad opportunity. CDX-1401 is being developed for the treatment of malignant melanoma and a variety of solid tumors which express the cancer antigen NY-ESO-1. Preclinical studies have shown that CDX-1401 treatment results in activation of human T cell responses against NY-ESO-1.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have completed a Phase&nbsp;1 study of CDX-1401 which assessed the safety, immunogenicity and clinical activity of escalating doses of CDX-1401 with TLR agonists (resiquimod and/or poly-ICLC) in 45 patients with advanced malignancies refractory to all available therapies. Results were published in <i>Science Translational Medicine</i> in April&nbsp;2014. Sixty percent of patients had confirmed NY-ESO expression in archived tumor samples. Thirteen patients maintained stable disease for up to 13.4&nbsp;months with a median of 6.7&nbsp;months. Treatment indicates an acceptable safety profile to date, and there were no dose limiting toxicities. A variety of immune activation parameters were observed. Humoral responses were elicited in both NY-ESO-1 positive and negative patients. NY-ESO-1-specific T cell responses were absent or low at baseline, but increased post-vaccination in 56% of evaluable patients, including both CD4 and/or CD8 T cell responses. Robust immune responses were observed with CDX-1401 with resiquimod and poly-ICLC alone and in combination. Long-term patient follow up suggested that treatment with CDX-1401 may predispose patients to better outcomes on subsequent therapy with checkpoint inhibitors. Of the 45 patients in the Phase&nbsp;1 study, eight went on to receive subsequent therapy of either Yervoy<font style="position:relative;top:-3.0pt;">&#174;</font>&#160; or an investigational checkpoint inhibitor, and six of these patients had objective tumor regression. Six patients with melanoma received Yervoy within three months of treatment with CDX-1401, and four (67%) had objective tumor responses, including one complete response, which compares favorably to the overall response rate of 11% previously reported in metastatic melanoma patients treated with single-agent Yervoy. In addition, two patients with non-small cell lung cancer received an investigational checkpoint blockade within two months of completing treatment with CDX-1401, and both achieved partial responses. Together with Roche, we are supporting an investigator initiated study of CDX-1401 in combination with Tecentriq<font style="position:relative;top:-3.0pt;">&#174;</font>&#160;(atezolizumab; anti-PD-L1) in patients with lung cancer.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-1401&#146;s potential activity is being explored in investigator sponsored and collaborative studies. A Phase&nbsp;2 study of CDX-1401 in combination with CDX-301 is being conducted in metastatic melanoma by the Cancer Immunotherapy Trials Network (CITN) under a CRADA with the Cancer Therapy Evaluation Program of the NCI. This study was designed to determine the activity of CDX-1401 with or without CDX-301 in melanoma. The primary outcome measure of the study is immune response to NY-ESO-1. Secondary outcome measures include analysis and characterization of peripheral blood mononuclear cells (dendritic cells, T cells, natural killer cells,&nbsp;etc.), additional immune monitoring, safety and clinical outcomes (survival and time to tumor recurrence). Enrollment is complete, and initial results were presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting. The data confirmed that CDX-1401 is capable of driving NY-ESO-1 immunity and further demonstrated the potential of CDX-301 as a combination agent for enhancing tumor specific immune responses. The NCI and CITN are planning to enroll additional cohorts to investigate alternative regimens of CDX-301. Other studies are being considered through investigator-sponsored and collaborative agreements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">22<a name="PB_22_172803_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='22',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">CDX-301</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-301, a recombinant FMS-like tyrosine kinase 3 ligand, or Flt3L, is a hematopoietic cytokine that uniquely expands dendritic cells and hematopoietic stem cells in combination with other agents to potentiate the anti-tumor response. Depending on the setting, cells expanded by CDX-301 promote either enhanced or permissive immunity. CDX-301 is in clinical development for multiple cancers, in combination with vaccines, adjuvants and other treatments that release tumor antigens. We licensed CDX-301 from Amgen&nbsp;Inc. in March&nbsp;2009 and believe CDX-301 may hold significant opportunity for synergistic development in combination with other proprietary molecules in our portfolio.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">A Phase&nbsp;1 study of CDX-301 evaluated seven different dosing regimens of CDX-301 to determine the appropriate dose for further development based on safety, tolerability and biological activity. The data from the study were consistent with previous clinical experience and demonstrated that CDX-301 has an acceptable safety profile to date and can mobilize hematopoietic stem cell (HSC) populations in healthy volunteers.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At the 2016 ASCO Annual Meeting, initial results from a Phase&nbsp;2 study of CDX-1401 in combination with CDX-301 in metastatic melanoma were presented that further demonstrated the value of CDX-301 as a combination agent for enhancing tumor specific immune responses. The Phase&nbsp;2 study was conducted by the Cancer Immunotherapy Trials Network, or CITN, under a CRADA with the Cancer Therapy Evaluation Program of the NCI. Based on these results the CITN is planning to enroll additional cohorts to investigate alternative regimens of CDX-301. Other studies are being considered through investigator-sponsored and collaborative agreements.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">CDX-014</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">CDX-014 is a human monoclonal ADC that targets T cell immunoglobulin and mucin domain 1, or TIM-1. TIM-1 expression is upregulated in several cancers, most notably renal cell and ovarian carcinomas, and is associated with a more malignant phenotype of renal cell carcinoma (RCC) and tumor progression. TIM-1 has restricted expression in healthy tissues, making it potentially amenable to an ADC approach. The TIM-1 antibody is linked to MMAE using Seattle Genetics&#146; proprietary technology. The ADC is designed to be stable in the bloodstream but to release MMAE upon internalization into TIM-1-expressing tumor cells, resulting in a targeted cell-killing effect. CDX-014 has shown anti-tumor activity in preclinical models of ovarian and renal cancer. In July&nbsp;2016, we announced that enrollment had opened in a Phase 1/2 study of CDX-014 to patients with both clear cell and papillary RCC. The Phase&nbsp;1 dose-escalation portion of the study is evaluating cohorts of patients receiving increasing doses of CDX-014 to determine the maximum tolerated dose and a recommended dose for Phase&nbsp;2 study. We anticipate the Phase&nbsp;1 dose-escalation portion of the study will complete enrollment by year-end 2017. The Phase&nbsp;2 portion of the study plans to enroll approximately 25 patients to assess the anti-tumor activity of CDX-014 at the recommended dose in advanced renal cell carcinoma as measured by objective response rate. Secondary objectives include safety and tolerability, pharmacokinetics, immunogenicity and additional measures of anti-tumor activity.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CRITICAL ACCOUNTING POLICIES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">See Note 2 to the unaudited condensed consolidated financial statements included elsewhere in this quarterly report on Form&nbsp;10-Q for information regarding newly-adopted and recent accounting pronouncements. See also </font>Note 2 to our financial statements included in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016 for a discussion of our critical accounting policies. There have been no material changes to such critical accounting policies. We believe our most critical accounting policies include accounting for revenue recognition, impairment of long-lived assets, research and development expenses and stock-based compensation expense.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">23<a name="PB_23_172817_3020"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='23',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">RESULTS OF OPERATIONS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Three Months Ended June&nbsp;30, 2017 compared with Three Months Ended June&nbsp;30, 2016</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="29%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:29.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Three&nbsp;Months&nbsp;Ended<br>   June&nbsp;30,</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="14%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.16%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="8%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:8.32%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">%</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="55%" colspan="10" valign="bottom" style="padding:0in 0in 0in 0in;width:55.82%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Revenue:</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product   Development and Licensing Agreements</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="padding:0in 0in 0in 0in;width:13.04%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">694</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">604</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="padding:0in 0in 0in 0in;width:11.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">90</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">15</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contracts   and Grants</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,135</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">785</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,350</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">299</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total   Revenue</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.04%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3,829</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:11.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,389</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:11.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,440</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">176</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operating   Expense:</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Research   and Development</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">24,999</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">25,711</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(712</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">General   and Administrative</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">6,534</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">7,790</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1,256</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(16</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Loss on   Fair Value Remeasurement of Contingent Consideration</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,000</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">n/a</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization   of Acquired Intangible Assets</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">224</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">254</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(30</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total   Operating Expense</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">32,757</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">33,755</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(998</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operating   Loss</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28,928</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(32,366</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3,438</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" style="padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment   and Other Income, Net</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="14%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:14.16%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">362</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">414</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(52</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" style="padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(13</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="38%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:38.34%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Loss</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="13%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:13.04%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28,566</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:11.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(31,952</font></p>    </td>
<td width="3%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:3.34%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:11.38%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3,386</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="8%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:8.32%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(11</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Net Loss</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $3.4 million decrease in net loss for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily the result of an increase in contracts and grants revenue as well as a decrease in research and development and general and administrative expenses, partially offset by the loss on fair value remeasurement of contingent consideration.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Revenue</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $0.1 million increase in product development and licensing agreements revenue for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily related to our BMS agreement. In 2014, we entered into a clinical trial collaboration with BMS whereby BMS made a one-time payment to us of $5.0 million which we are recognizing as revenue along with BMS&#146;s 50% share of the clinical trial cost over our estimated performance period of five years. The $2.4 million increase in contracts and grants revenue for the three months ended June&nbsp;30, 2017, compared to the three months ended June&nbsp;30, 2016, was primarily related to our IAVI agreement pursuant to which we perform research and development services for IAVI.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Research and Development Expense</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Research and development expenses consist primarily of (i)&nbsp;personnel expenses, (ii)&nbsp;laboratory supply expenses relating to the development of our technology, (iii)&nbsp;facility expenses, (iv)&nbsp;license fees and (v)&nbsp;product development expenses associated with our product candidates as follows:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Three&nbsp;Months&nbsp;Ended<br>   June&nbsp;30,</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">%</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="bottom" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="54%" colspan="10" valign="bottom" style="padding:0in 0in 0in 0in;width:54.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Personnel</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9,123</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">8,779</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">344</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laboratory Supplies</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,356</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">877</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">479</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">55</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facility</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,113</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,391</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">722</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">52</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" style="padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">License Fees</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">147</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">386</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(239</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(62</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="41%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:41.0%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product Development</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9,704</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">12,246</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2,542</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:10.5%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(21</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr height="0">
<td width="290" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="8" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="8" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="8" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="74" style="border:none;"></td>
<td width="18" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">24<a name="PB_24_173323_7748"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='24',FILE='C:\JMS\C902417\17-13377-1\task8532905\13377-1-fr.htm',USER='C902417',CD='Aug  8 19:04 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Personnel expenses primarily include salary, benefits, stock-based compensation and payroll taxes. The $0.3 million increase in personnel expenses for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily due to an increase in salaries expense due to increased headcount, partially offset by lower stock based compensation expenses. We expect personnel expenses to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laboratory supplies expense include laboratory materials and supplies, services, and other related expenses incurred in the development of our technology. The $0.5 million increase in laboratory supplies expense for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily due to higher manufacturing supply purchases. We expect laboratory supplies expense to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facility expenses include depreciation, amortization, utilities, rent, maintenance, and other related expenses incurred at our facilities. The $0.7 million increase in facility expenses for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily due to the addition of the New Haven facility that we acquired with the Kolltan acquisition and higher depreciation expense of $0.3 million. </font>We expect facility expenses to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">License fees expense includes annual license maintenance fees and milestone payments due upon the achievement of certain development, regulatory and/or commercial milestones. The $0.2 million decrease in license fee expenses for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, </font>2016, was due to the timing of certain development and/or regulatory milestones achieved by our drug candidates. We expect license fees expense to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product development expenses include clinical investigator site fees, external trial monitoring costs, data accumulation costs, contracted research and outside clinical drug product manufacturing. The $2.5 million decrease in product development expenses for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily the result of a decrease in varlilumab contract manufacturing expenses of $4.3 million, partially offset by an increase in glembatumumab vedotin contract manufacturing expenses of $1.9 million. We expect product development expenses to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Loss on Fair Value Remeasurement of Contingent Consideration</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $1.0 million loss on fair value remeasurement of contingent consideration for the three months ended June&nbsp;30, 2017 relates to an increase in the estimate of the fair value of the contingent consideration primarily due to changes in discount rates and the passage of time. See Note 3 to the financial statements included herein for a discussion of the contingent consideration that may be payable to Kolltan.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">General and Administrative Expense</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $1.3 million decrease in general and administrative expenses for the three months ended June&nbsp;30, 2017, as compared to the three months ended June&nbsp;30, 2016, was primarily due to lower commercial planning costs of $0.6 million and lower stock-based compensation of $0.4 million. We expect general and administrative expense to remain relatively consistent over the next twelve months, although there may be fluctuations on a quarterly basis.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Amortization Expense</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization expenses for the three months ended June&nbsp;30, 2017 were relatively consistent with the three months ended June&nbsp;30, 2016. We expect amortization expense of acquired intangible assets to remain consistent over the next twelve months.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Investment and Other Income, Net</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment and other income, net for the three months ended June&nbsp;30, 2017 decreased slightly as compared to the three months ended June&nbsp;30, 2016 due to lower cash and investment balances. We anticipate investment income to decrease over the next twelve months.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">25<a name="PB_25_165346_6039"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='25',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-ft.htm',USER='109765',CD='Aug  1 20:32 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;font-weight:bold;">Six Months Ended June&nbsp;30, 2017 compared with Six Months Ended June&nbsp;30, 2016</font></i></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="26%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:26.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months&nbsp;Ended<br>   June&nbsp;30,</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="bottom" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">%</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="55%" colspan="10" valign="bottom" style="padding:0in 0in 0in 0in;width:55.5%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Revenue:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product Development and Licensing   Agreements</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,250</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,057</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">193</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">18</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Contracts and Grants</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,113</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,635</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,478</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">152</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Revenue</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5,363</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,692</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" style="border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,671</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">99</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operating Expense:</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Research and Development</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">50,792</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">53,158</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2,366</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">General and Administrative</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">13,763</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17,097</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3,334</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(20</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Loss on Fair Value Remeasurement   of Contingent Consideration</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,400</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&#151;</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,400</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">n/a</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 20.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization of Acquired   Intangible Assets</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">448</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">507</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(59</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(12</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Total Operating Expense</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">69,403</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">70,762</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(1,359</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(2</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Operating Loss</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(64,040</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(68,070</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(4,030</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" style="padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Investment and Other Income, Net</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,213</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,445</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(232</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0.375pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(16</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="39%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:39.5%;">
<p style="margin:0in 0in .0001pt 10.0pt;text-indent:-10.0pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net Loss</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(62,827</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(66,625</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:1.12%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="10%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;border:none;border-bottom:double windowtext 2.25pt;padding:0in 0in 0in 0in;width:10.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(3,798</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 2.25pt 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.0%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Net Loss</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $3.8 million decrease in net loss for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily the result of an increase in contracts and grants revenue and a decrease in general and administrative and research and development expenses, partially offset by a loss recognized on the fair value remeasurement of contingent consideration.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Revenue</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $0.2 million increase in product development and licensing agreements revenue for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily related to our BMS agreement. The $2.5 million increase in contracts and grants revenue for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily related to our IAVI agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Research and Development Expense</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="93%" style="border-collapse:collapse;margin-left:.25in;">
<tr>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="28%" colspan="5" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:28.42%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Six&nbsp;Months&nbsp;Ended<br>   June&nbsp;30,</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Increase/<br>   (Decrease)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.88%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2017</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.86%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">2016</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.86%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">$</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="12%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:12.86%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">%</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="35%" valign="bottom" style="padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="59%" colspan="10" valign="bottom" style="padding:0in 0in 0in 0in;width:59.48%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">(In&nbsp;thousands)</font></b></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>   </tr>
<tr>
<td width="35%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Personnel</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.24%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.66%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19,146</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.66%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">17,611</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="1%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:1.2%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">$</font></p>    </td>
<td width="11%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:11.64%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,535</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">9</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="35%" valign="top" style="padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Laboratory Supplies</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,312</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,661</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">651</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">39</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="35%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Facility</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4,593</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2,884</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1,709</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">59</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">%</font></p>    </td>   </tr>
<tr>
<td width="35%" valign="top" style="padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">License Fees</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">317</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">439</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(122</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" style="padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(28</font></p>    </td>
<td width="2%" valign="bottom" style="padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr>
<td width="35%" valign="top" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:35.18%;">
<p style="margin:0in 0in .0001pt 10.1pt;text-indent:-10.1pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Product Development</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.88%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">19,649</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">26,253</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="12%" colspan="2" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(6,604</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.68%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)</font></p>    </td>
<td width="12%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:12.86%;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(25</font></p>    </td>
<td width="2%" valign="bottom" bgcolor="#CCEEFF" style="background:#CCEEFF;padding:0in 0in 0in 0in;width:2.64%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">)%</font></p>    </td>   </tr>
<tr height="0">
<td width="232" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="8" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="8" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="8" style="border:none;"></td>
<td width="77" style="border:none;"></td>
<td width="18" style="border:none;"></td>
<td width="85" style="border:none;"></td>
<td width="17" style="border:none;"></td>   </tr> </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $1.5 million increase in personnel expenses for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily due to an increase in salaries expense and associated taxes due to increased headcount.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $0.7 million increase in laboratory supplies expense for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily due to higher manufacturing supply purchases.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $1.7 million increase in facility expenses for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016</font>, was primarily due to the addition of our New Haven facility that we acquired with the Kolltan acquisition and higher depreciation expense of $0.9 million. In March&nbsp;2017, the Company terminated its lease in Branford, CT and consolidated its Connecticut operations in its New Haven facility.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $0.1 million decrease in license fees expense for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016</font>, was due to the timing of certain development and/or regulatory milestones achieved by our drug candidates.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">26<a name="PB_26_170210_7056"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='26',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-ft.htm',USER='109765',CD='Aug  1 20:32 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $6.6 million decrease in product development expenses for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily the result of decreases in varlilumab and Rintega contract manufacturing expenses of $5.1 million and $2.6 million, respectively, partially offset by an increase in glembatumumab vedotin contract manufacturing expenses of $3.4 million. A decrease in Rintega clinical trial costs of $4.9 million was partially offset by increases in glembatumumab vedotin, CDX-0158 and CDX-3379 clinical trial costs of $2.9 million.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Loss on Fair Value Remeasurement of Contingent Consideration</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $4.4 million loss on fair value remeasurement of contingent consideration for the six months ended June&nbsp;30, 2017 relates to an increase in the estimate of the fair value of the contingent consideration primarily due to changes in discount rates and the passage of time.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">General and Administrative Expense</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $3.3 million decrease in general and administrative expenses for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily due to lower commercial planning costs of $2.4 million and lower stock-based compensation of $0.9 million.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Amortization Expense</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Amortization expenses for the six months ended June&nbsp;30, 2017 were relatively consistent as compared to the six months ended June&nbsp;30, 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Investment and Other Income, Net</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The $0.2 million decrease in investment and other income, net for the six months ended June&nbsp;30, 2017, as compared to the six months ended June&nbsp;30, 2016, was primarily due to lower levels of cash and investment balances.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">LIQUIDITY AND CAPITAL RESOURCES</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Our cash equivalents are highly liquid investments with a maturity of three months or less at the date of purchase and consist primarily of investments in money market mutual funds with commercial banks and financial institutions. We maintain cash balances with financial institutions in excess of insured limits. We do not anticipate any losses with respect to such cash balances. We invest our excess cash balances in marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds that meet high credit quality standards, as specified in our investment policy. Our investment policy seeks to manage these assets to achieve our goals of preserving principal and maintaining adequate liquidity.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The use of our cash flows for operations has primarily consisted of salaries and wages for our employees; facility and facility-related costs for our offices, laboratories and manufacturing facility; fees paid in connection with preclinical studies, clinical studies, contract manufacturing, laboratory supplies and services; and consulting, legal and other professional fees. To date, the primary sources of cash flows from operations have been payments received from our collaborative partners and from government entities. The timing of any new collaboration agreements, government contracts or grants and any payments under these agreements, contracts or grants cannot be easily predicted and may vary significantly from quarter to quarter.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">At June&nbsp;30, 2017, our principal sources of liquidity consisted of cash, cash equivalents and marketable securities of $154.0 million. We have had recurring losses and incurred a net loss of $62.8 million for the six months ended June&nbsp;30, 2017. Net cash used in operations for the six months ended June&nbsp;30, 2017 was $56.0 million. We believe that the cash, cash equivalents and marketable securities at June&nbsp;30, 2017 combined with the anticipated proceeds from future sales of our common stock under the Cantor agreement, are sufficient to meet estimated working capital requirements and fund planned operations through 2018</font>; however, this could be impacted if we elected to pay Kolltan contingent milestones, if any, in cash.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">During the next twelve months, we will take further steps to raise additional capital to meet our liquidity needs.&#160; Our capital raising activities may include, but may not be limited to, one or more of the following: the licensing of drug candidates with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While we may seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and our negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that we will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to our stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce our economic potential from products under development.</font> Our ability to continue funding our</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">27<a name="PB_27_170249_5335"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='27',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-ft.htm',USER='109765',CD='Aug  1 20:32 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">planned operations into and beyond twelve months from the issuance date is also dependent on the timing and manner of payment of future contingent milestones from the Kolltan acquisition, in the event that we achieve the drug candidate milestones related to those payments. We may decide to pay those milestone payments in cash, shares of our common stock or a combination thereof. If we are unable to raise the funds necessary to meet our liquidity needs, we may have to delay or discontinue the development of one or more programs, discontinue or delay ongoing or anticipated clinical trials, license out programs earlier than expected, raise funds at a significant discount or on other unfavorable terms, if at all, or sell all or a part of our business.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Operating Activities</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net cash used in operating activities was $56.0 million for the six months ended June&nbsp;30, 2017 as compared to $68.7 million for the six months ended June&nbsp;30, 2016. The decrease in net cash used in operating activities was primarily due to a decrease in net loss of $3.8 million and changes in operating assets and liabilities. We expect that cash used in operating activities will decrease over the next twelve months, although there may be fluctuations on a quarterly basis.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We have incurred and will continue to incur significant costs in the area of research and development, including preclinical studies and clinical trials, as our drug candidates are developed. We plan to spend significant amounts to progress our current drug candidates through the clinical trial and commercialization process as well as to develop additional drug candidates. As our drug candidates progress through the clinical trial process, we may be obligated to make significant milestone payments.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Investing Activities</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net cash provided by investing activities was $58.2 million for the six months ended June&nbsp;30, 2017 as compared to $26.2 million for the six months ended June&nbsp;30, 2016. The increase in net cash provided by investing activities was primarily due to net sales and maturities of marketable securities for the six months ended June&nbsp;30, 2017 of $59.5 million as compared to $29.3 million for the six months ended June&nbsp;30, 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Financing Activities</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Net cash provided by financing activities was $21.6 million for the six months ended June&nbsp;30, 2017 compared to $2.9 million for the six months ended June&nbsp;30, 2016. Net proceeds from stock issuances pursuant to employee benefit plans were $0.1 million during the six months ended June&nbsp;30, 2017 as compared to $0.3 million for the six months ended June&nbsp;30, 2016.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In May&nbsp;2016, we entered into an agreement with Cantor Fitzgerald&nbsp;&amp; Co. to allow us to issue and sell shares of our common stock having an aggregate offering price of up to $60.0 million from time to time through Cantor, acting as agent. During the six months ended June&nbsp;30, 2017 and 2016, we issued 6,731,066 and 593,111 shares under the agreement and raised $21.5 million and $2.7 million in net proceeds, respectively. At June&nbsp;30, 2017, we had $23.1 million remaining in aggregate offering price available under the agreement.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">AGGREGATE CONTRACTUAL OBLIGATIONS</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The disclosures relating to our contractual obligations reported in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016 which was filed with the SEC on March&nbsp;14, 2017 have not materially changed since we filed that report.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 3.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Quantitative and Qualitative Disclosures about Market Risk</u></b><a name="Item3_QuantitativeandQualitative_050940"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We own financial instruments that are sensitive to market risk as part of our investment portfolio. Our investment portfolio is used to preserve our capital until it is used to fund operations, including our research and development activities. None of these market-risk sensitive instruments are held for trading purposes. We invest our cash primarily in money market mutual funds. These investments are evaluated quarterly to determine the fair value of the portfolio. From time to time, we invest our excess cash balances in marketable securities including municipal bond securities, U.S. government agency securities, and high-grade corporate bonds that meet high credit quality standards, as specified in our investment policy. Our investment policy seeks to manage these assets to achieve our goals of preserving principal and maintaining adequate liquidity. Because of the short-term nature of these investments, we do not believe we have material exposure due to market risk. The impact to our financial position and results of operations from likely changes in interest rates is not material.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">We do not utilize derivative financial instruments. The carrying amounts reflected in the consolidated balance sheet of cash and cash equivalents, accounts receivables and accounts payable approximates fair value at June&nbsp;30, 2017 due to the short-term maturities of these instruments.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">28<a name="PB_28_170311_5796"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='28',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-ft.htm',USER='109765',CD='Aug  1 20:32 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 4.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b><u style="font-weight:bold;">Controls and Procedures</u></b><a name="Item4_ControlsandProcedures_050944"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Evaluation of Disclosure Controls and Procedures.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">As of June&nbsp;30, 2017, we evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures (as defined in Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)&nbsp;under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;)). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June&nbsp;30, 2017. Our disclosure controls and procedures are designed to provide reasonable assurance that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within time periods specified by the SEC&#146;s rules&nbsp;and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><i><font size="2" face="Times New Roman" style="font-size:10.0pt;font-style:italic;">Changes in Internal Control Over Financial Reporting.</font></i></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There were no changes in our internal control over financial reporting during the quarter ended June&nbsp;30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">29<a name="PB_29_170326_2897"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='29',FILE='C:\JMS\109765\17-13377-1\task8522382\13377-1-ft.htm',USER='109765',CD='Aug  1 20:32 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">PART&nbsp;II &#151; OTHER INFORMATION</font></b><a name="PARTIIOTHERINFORMATION_051133"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 1A.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Risk Factors</b><a name="Item1A_RiskFactors_051138"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part&nbsp;I, &#147;Item&nbsp;1A. Risk Factors&#148; in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form&nbsp;10-K may not be the only risks facing the Company. Additional risks and uncertainties not currently known to the Company or that the Company currently deems to be immaterial also may materially adversely affect the Company&#146;s business, financial condition and/or operating results.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">There were no material changes to the risk factors previously disclosed in our Annual Report on Form&nbsp;10-K filed with the Securities and Exchange Commission on March&nbsp;14, 2017.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Item 6.</font></b><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font><b>Exhibits</b><a name="Item6_Exhibits_051137"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">The exhibits filed as part of this quarterly report on Form&nbsp;10-Q are listed in the exhibit index immediately preceding the exhibits and are incorporated by reference herein.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">30<a name="PB_30_170431_3735"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='30',FILE='C:\JMS\109752\17-13377-1\task8522127\13377-1-ga.htm',USER='109752',CD='Aug  1 17:11 2017' -->


<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">SIGNATURES</font></b><a name="SIGNATURES_051223"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;text-indent:.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">CELLDEX   THERAPEUTICS,&nbsp;INC.</font></b></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">BY:</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   ANTHONY S. MARUCCI</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated:   August&nbsp;8, 2017</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anthony   S. Marucci</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President   and Chief Executive Officer</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Principal   Executive Officer)</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ SAM   MARTIN</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Dated:   August&nbsp;8, 2017</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sam   Martin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Senior   Vice President and Chief Financial Officer</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(Principal   Financial and Accounting Officer)</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">31<a name="PB_31_170609_9545"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='31',FILE='C:\JMS\109752\17-13377-1\task8522127\13377-1-ge.htm',USER='109752',CD='Aug  1 17:12 2017' -->

<br clear="all" style="page-break-before:always;">
<div style="font-family:Times New Roman;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;"><a href="#TableOfContents" title="Click to go to Table of Contents">Table of Contents</a></font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">EXHIBIT&nbsp;INDEX</font></b><a name="EXHIBITINDEX_051225"></a></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="10%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Exhibit<br>   No.</font></b></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:1.0pt;font-weight:bold;">&nbsp;</font></b></p>    </td>
<td width="87%" valign="bottom" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:87.0%;">
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><b><font size="1" face="Times New Roman" style="font-size:8.0pt;font-weight:bold;">Description</font></b></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Restated Certificate of   Incorporation of the Company, incorporated by reference to Exhibit&nbsp;3.1   of the Company&#146;s Registration Statement on Form&nbsp;S-4 (Reg.   No.&nbsp;333-59215), filed July&nbsp;16, 1998 with the Securities and   Exchange Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.2</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certificate of Amendment of Third   Restated Certificate of Incorporation of the Company, incorporated by   reference to Exhibit&nbsp;3.1 of the Company&#146;s Registration Statement on   Form&nbsp;S-4 (Reg. No.&nbsp;333-59215), filed July&nbsp;16, 1998 with the   Securities and Exchange Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.3</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Second Certificate of Amendment   of Third Restated Certificate of Incorporation of the Company, incorporated   by reference to Exhibit&nbsp;3.2 of the Company&#146;s Registration Statement on   Form&nbsp;S-4 (Reg. No.&nbsp;333-59215), filed July&nbsp;16, 1998 with the   Securities and Exchange Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.4</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Third Certificate of Amendment of   Third Restated Certificate of Incorporation of the Company, incorporated by   reference to Exhibit&nbsp;3.1 of the Company&#146;s Quarterly Report on   Form&nbsp;10-Q, filed May&nbsp;10, 2002 with the Securities and Exchange   Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.5</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fourth Certificate of Amendment   of Third Restated Certificate of Incorporation of the Company, incorporated   by reference to Exhibit&nbsp;3.1 of the Company&#146;s Current Report on   Form&nbsp;8-K, filed on March&nbsp;11, 2008 with the Securities and Exchange   Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.6</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Fifth Certificate of Amendment of   Third Restated Certificate of Incorporation of the Company, incorporated by   reference to Exhibit&nbsp;3.2 of the Company&#146;s Current Report on   Form&nbsp;8-K, filed on March&nbsp;11, 2008 with the Securities and Exchange   Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.7</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sixth Certificate of Amendment of   Third Restated Certificate of Incorporation of the Company, incorporated by   reference to Exhibit&nbsp;3.7 of the Company&#146;s Quarterly Report on   Form&nbsp;10-Q, filed November&nbsp;10, 2008 with the Securities and Exchange   Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*4.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Specimen of Common Stock   Certificate</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employment Agreement, dated   June&nbsp;15, 2017, by and between Sarah Cavanaugh and Celldex   Therapeutics.,&nbsp;Inc., incorporated by reference to Exhibit&nbsp;10.1 of   the Company&#146;s Current Report on Form&nbsp;8-K, filed on June&nbsp;16, 2017   with the Securities and Exchange Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">10.2</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Employment Agreement, dated   July&nbsp;1, 2017, by and between Sam Martin and Celldex   Therapeutics.,&nbsp;Inc., incorporated by reference to Exhibit&nbsp;10.1 of   the Company&#146;s Current Report on Form&nbsp;8-K, filed on July&nbsp;5, 2017   with the Securities and Exchange Commission.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*31.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certification of President and   Chief Executive Officer</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*31.2</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Certification of Senior Vice   President and Chief Financial Officer</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">**32.1</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Section&nbsp;1350 Certifications</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*101</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">XBRL Instance Document.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*101</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">XBRL Taxonomy Extension Schema Document.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*101</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">XBRL Taxonomy Extension   Calculation Linkbase Document.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*101</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">XBRL Taxonomy Extension   Definition Linkbase Document.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*101</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">XBRL Taxonomy Extension Label   Linkbase Document.</font></p>    </td>   </tr>
<tr>
<td width="10%" valign="top" style="padding:0in 0in 0in 0in;width:10.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*101</font></p>    </td>
<td width="3%" valign="bottom" style="padding:0in 0in 0in 0in;width:3.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="87%" valign="top" style="padding:0in 0in 0in 0in;width:87.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">XBRL Taxonomy Extension   Presentation Linkbase Document.</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="1" width="25%" noshade align="left" style="color:black;"></div>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">*</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Filed herewith.</p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .75in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">**</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Furnished herewith.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="font-size:10.0pt;margin:0in 0in .0001pt;text-align:center;">32<a name="PB_32_170824_136"></a></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='32',FILE='C:\JMS\109752\17-13377-1\task8522127\13377-1-ge.htm',USER='109752',CD='Aug  1 17:12 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>a17-13377_1ex4d1.htm
<DESCRIPTION>EX-4.1
<TEXT>


<html>
<head>



  </head>
<body link="blue" lang="EN-US">
<div>
<!-- COMMAND=ROTATED_TABLE WIDTH="150%" -->
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit 4.1</font></b></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS#   . COMMON STOCK PAR VALUE $0.001 COMMON STOCK THIS CERTIFICATE IS TRANSFERABLE   IN CANTON, MA, JERSEY CITY, NJ AND COLLEGE STATION, TX Shares * * 000000 * *   * * * * * * * * * * * * * * * * * * * 000000 * * * * * * * * * * * * * * * *   * * * * * 000000 * * * * * * * * * * * * * * * * * * * * * 000000 * * * * * *   * * * * * * * * * * * * * * * 000000 * * * * * * * * * * * * * * Certificate   Number ZQ00000000 INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE ** Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander   David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample   **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander   David THIS CERTIFIES THAT Sample **** Mr. Alexander David Sample **** Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander   David Sample **** Mr. Alexander Alexander David SamMple ***R* Mr.   A.lexaSnderADavidMSampPle ***L* MrE. Alexan&amp;der DavMid SamRple **S** Mr..   AleSxandeAr DaMvid SamPple *L*** MEr. Alex&amp;ander David Sample **** David   Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample ****   Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr. Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander   David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample   Sample **** Mr. AlexandeMr DaviRd Sam.ple S**** MAr. AleMxandePr DavLid   SEample *&amp;*** Mr. AMlexanRder DaSvid S.ampSle ***A* Mr.MAlexanPder   DLavidESample **** Mr. Alexander **** Mr. Alexander David Sample **** Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander   David Sample **** Mr. Alexander David SEE REVERSE FOR CERTAIN DEFINITIONS   David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample   **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Alexander   David Sample **** Mr. Alexander David Sample **** Mr. Alexander David Sample   **** Mr. Alexander David Sample **** Mr. Alexander David Sample **** Mr.   Alexander David Sample **** Mr. Alexander David Sample **** Mr. Sample ****   Mr. Sample is the owner of   **000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares***   *000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****   000000**Shar*es****0*000Z00**SEhareRs****00O0000**ShHares**U**0000N00**SDhares*R***000E000**DShares**T**000H000**SOhares*U***000S000**AShareNs****00D0000**Shares****0   00000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****00   0000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000   000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****0000   00**Shares****0Z0000E0**ShRares***O*000000*H*ShareUs****0N00000D**SharRes****0E0000D0**ShareAs****0N00000D**SharesZ****00E0000R**SharOes****0*000*00**Shares****00000   0**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000   **Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000*   *Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**   Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**Shares****000000**S   FULLY PAID AND NON-ASSESSABLE SHARES OF THE COMMON STOCK, $0.001 PAR VALUE   PER SHARE, OF CELLDEX THERAPEUTICS, INC. transferable on the books of the   Corporation by the holder hereof in person or by duly authorized attorney,   upon surrender of this Certificate properly endorsed. This Certificate is not   valid unless countersigned by the Transfer Agent and registered by the   Registrar. WITNESS the facsimile seal of the Corporation and the facsimile   signatures of its duly authorized officers. DATED DD-MMM-YYYY COUNTERSIGNED   AND REGISTERED: COMPUTERSHARE TRUST COMPANY, N.A. TRANSFER AGENT AND   REGISTRAR, President and Chief Executive Officer By Senior Vice President and   Chief Financial Officer AUTHORIZED SIGNATURE CUSIP Holder ID Insurance Value   Number of Shares DTC Certificate Numbers 1234567890/1234567890   1234567890/1234567890 1234567890/1234567890 1234567890/1234567890   1234567890/1234567890 1234567890/1234567890 Total Transaction XXXXXX XX X   XXXXXXXXXX 1,000,000.00 123456 12345678 123456789012345 PO BOX 43004,   Providence, RI 02940-3004 Num/No. Denom. Total 1 2 3 4 5 6 7 1 2 3 4 5 6 1 2   3 4 5 6 MR A SAMPLE DESIGNATION (IF ANY) ADD 1 ADD 2 ADD 3 ADD 4 CUSIP 15117B   10 3 </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="1507" height="914" src="g133771kk01i001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109206\17-13377-1\task8506101\13377-1-kk-01.htm',USER='109206',CD='Jul 19 14:03 2017' -->


<br clear="all" style="page-break-before:always;">
<div>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div align="center">
<div id="container" style="width:100%;"><div id="ImgContainer" style="border:0;width:100%;height:auto;">
<p style="margin:0in 0in .0001pt;height:1px;"><font size="1" color="white" face="Times New Roman" style="color:white;font-size:1.0pt;">. (Cust)   (Minor) (State) and not as tenants in common (Cust) (Minor) PLEASE INSERT   SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER OF ASSIGNEE For value received,   hereby sell, assign and transfer unto (PLEASE PRINT OR TYPEWRITE NAME AND   ADDRESS, INCLUDING POSTAL ZIP CODE, OF ASSIGNEE) Shares represented by the   within Certificate, and do hereby irrevocably constitute and appoint Attorney   to transfer the said shares on the books of the within-named Corporation with   full power of substitution in the premises. Dated: 20 Signature: Signature:   Notice: The signature to this assignment must correspond with the name as   written upon the face of the certificate, in every particular, without   alteration or enlargement, or any change whatever. Signature(s) Guaranteed: Medallion   Guarantee Stamp THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE   GUARANTOR INSTITUTION (Banks, Stockbrokers, Savings and Loan Associations and   Credit Unions) WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE MEDALLION   PROGRAM, PURSUANT TO S.E.C. RULE 17Ad-15. The following abbreviations, when   used in the inscription on the face of this certificate, shall be construed   as though they were written out in full according to applicable laws or   regulations: TEN COM - as tenants in commonUNIF GIFT MIN ACT-. . . . . . . .   . .Custodian . . . . . . . . . . . . . . . TEN ENT - as tenants by the   entiretiesunder Uniform Gifts to Minors Act . . . . . . . . . . . . . JT   TEN-as joint tenants with right of survivorshipUNIF TRF MIN ACT . . . . . . .   . . . . . . . .Custodian (until age. . . ). . . . . . . . . . . under Uniform   Transfers to Minors Act. . . . . . . . . . (State) Additional abbreviations   may also be used though not in the above list. </font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman"><img width="935" height="1539" src="g133771kk03i001.gif"></font></p>    </div></div>
</div>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\109206\17-13377-1\task8506101\13377-1-kk-03.htm',USER='109206',CD='Jul 19 14:05 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>a17-13377_1ex31d1.htm
<DESCRIPTION>EX-31.1
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;31.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">CERTIFICATION</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I, Anthony S. Marucci, certify that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form&nbsp;10-Q of Celldex Therapeutics,&nbsp;Inc.;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f)) for the registrant and have:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   August&nbsp;8, 2017</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   ANTHONY S. MARUCCI</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: </font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anthony   S. Marucci</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President   and Chief Executive Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-ma.htm',USER='108183',CD='Aug  1 19:36 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>a17-13377_1ex31d2.htm
<DESCRIPTION>EX-31.2
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div style="font-family:Times New Roman;">
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;31.2</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">CERTIFICATION</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">I, Sam Martin, certify that:</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">1.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>I have reviewed this report on Form&nbsp;10-Q of Celldex Therapeutics,&nbsp;Inc.;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">2.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">3.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">4.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&nbsp;13a-15(e)&nbsp;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules&nbsp;13a-15(f)&nbsp;and 15d-15(f)) for the registrant and have:</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(c)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Evaluated the effectiveness of the registrant&#146;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(d)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Disclosed in this report any change in the registrant&#146;s internal control over financial reporting that occurred during the registrant&#146;s most recent fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#146;s internal control over financial reporting; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt .55in;text-indent:-.3in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">5.</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>The registrant&#146;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#146;s auditors and the audit committee of the registrant&#146;s board of directors (or persons performing the equivalent functions):</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(a)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#146;s ability to record, process, summarize and report financial information; and</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="font-size:10.0pt;margin:0in 0in .0001pt 1.05in;text-indent:-.5in;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">(b)</font><font size="1" style="font-size:3.0pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </font>Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#146;s internal control over financial reporting.</p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   August&nbsp;8, 2017</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ SAM   MARTIN</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name: </font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sam   Martin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.5%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Senior   Vice President and Chief Financial Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-mc.htm',USER='108183',CD='Aug  1 19:36 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>a17-13377_1ex32d1.htm
<DESCRIPTION>EX-32.1
<TEXT>


<html>
<head>




  </head>
<body link=blue lang="EN-US">
<div>
<p align="right" style="margin:0in 0in .0001pt;text-align:right;"><b><font size="2" face="Times New Roman" style="font-size:10.0pt;font-weight:bold;">Exhibit&nbsp;32.1</font></b></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p align="center" style="margin:0in 0in .0001pt;text-align:center;"><u><font size="2" face="Times New Roman" style="font-size:10.0pt;">SECTION&nbsp;1350 CERTIFICATIONS</font></u></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Pursuant to 18 U.S.C. &#167;1350 as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of Celldex Therapeutics,&nbsp;Inc. (the &#147;Company&#148;) hereby certify that to their knowledge and in their respective capacities that the Company&#146;s quarterly report on Form&nbsp;10-Q to which this certification is attached (the &#147;Report&#148;), fully complies with the requirements of Section&nbsp;13(a)&nbsp;or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<table border="0" cellspacing="0" cellpadding="0" width="100%" style="border-collapse:collapse;">
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   August&nbsp;8, 2017</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/   ANTHONY S. MARUCCI</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Anthony   S. Marucci</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">President   and Chief Executive Officer</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>
<td width="50%" colspan="2" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Date:   August&nbsp;8, 2017</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">By:</font></p>    </td>
<td width="43%" valign="top" style="border:none;border-bottom:solid windowtext 1.0pt;padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">/s/ SAM   MARTIN</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Name:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Sam   Martin</font></p>    </td>   </tr>
<tr>
<td width="50%" valign="top" style="padding:0in 0in 0in 0in;width:50.0%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:1.0pt;">&nbsp;</font></p>    </td>
<td width="6%" valign="top" style="padding:0in 0in 0in 0in;width:6.42%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Title:</font></p>    </td>
<td width="43%" valign="top" style="padding:0in 0in 0in 0in;width:43.58%;">
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">Senior   Vice President and Chief Financial Officer</font></p>    </td>   </tr>  </table>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">This certification shall not be deemed &#147;filed&#148; for any purpose, nor shall it be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Exchange Act. A signed original of this written statement required by Section&nbsp;906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section&nbsp;906, has been provided to Celldex Therapeutics,&nbsp;Inc. and will be retained by Celldex Therapeutics,&nbsp;Inc. and furnished to the Securities and Exchange Commission or its staff upon request.</font></p>
<p style="margin:0in 0in .0001pt;"><font size="2" face="Times New Roman" style="font-size:10.0pt;">&nbsp;</font></p>
<div style="margin:0in 0in .0001pt;"><hr size="3" width="100%" noshade align="left" style="color:#010101;"></div>
</div>
<!-- SEQ.=1,FOLIO='',FILE='C:\JMS\108183\17-13377-1\task8522285\13377-1-me.htm',USER='108183',CD='Aug  1 19:37 2017' -->

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>6
<FILENAME>cldx-20170630.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--XBRL document created with Merrill Bridge  7.2.100.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2017 7:42:37 PM-->
<xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:cldx="http://www.celldextherapeutics.com/20170630" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:schemaRef xlink:type="simple" xlink:href="cldx-20170630.xsd" />
  <!--Context Section-->
  <context id="As_Of_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_12_31_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-12-31</endDate>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cldx:NeedhamExpansionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_us-gaap_RestructuringPlanAxis_cldx_BranfordCTMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cldx:BranfordCTMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:CantorFitzgeraldAndCompanyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cldx:NeedhamExpansionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_ProductOrServiceAxis_cldx_TMProgramMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:TMProgramMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-11-29</instant>
    </period>
  </context>
  <context id="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_ProductOrServiceAxis_cldx_CDX3379Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:CDX3379Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-11-29</instant>
    </period>
  </context>
  <context id="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_ProductOrServiceAxis_cldx_CDX1058Member">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:ProductOrServiceAxis">cldx:CDX1058Member</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-11-29</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_CuraGenCorporationMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:CuraGenCorporationMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:AmgenAmendmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:AmgenAmendmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">cldx:AmgenAmendmentMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_RangeAxis_us-gaap_MinimumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MinimumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-29</startDate>
      <endDate>2016-11-29</endDate>
    </period>
  </context>
  <context id="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_RangeAxis_us-gaap_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-29</startDate>
      <endDate>2016-11-29</endDate>
    </period>
  </context>
  <context id="As_Of_12_31_2014_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:BristolMeyersSquibbCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2014-12-31</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <instant>2016-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <instant>2015-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="Duration_12_1_2016_To_12_31_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-12-01</startDate>
      <endDate>2016-12-31</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementBasisAxis">us-gaap:EstimateOfFairValueFairValueDisclosureMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">cldx:NeedhamExpansionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cldx:EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="As_Of_7_31_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <instant>2017-07-31</instant>
    </period>
  </context>
  <context id="Duration_11_1_2015_To_11_30_2015">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2015-11-01</startDate>
      <endDate>2015-11-30</endDate>
    </period>
  </context>
  <context id="Duration_12_1_2014_To_12_31_2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2014-12-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2014_To_1_31_2014">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-01-31</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2013_To_1_31_2013">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2013-01-01</startDate>
      <endDate>2013-01-31</endDate>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:CantorFitzgeraldAndCompanyAgreementMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_5_31_2016_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:CantorFitzgeraldAndCompanyAgreementMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:RangeAxis">us-gaap:MaximumMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-05-31</instant>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:BristolMeyersSquibbCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:BristolMeyersSquibbCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:BristolMeyersSquibbCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:BristolMeyersSquibbCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:RockefellerUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_InternationalAidsVaccineInitiativeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:InternationalAidsVaccineInitiativeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2017_To_6_30_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2017-04-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:RockefellerUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_InternationalAidsVaccineInitiativeMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:InternationalAidsVaccineInitiativeMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:RockefellerUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:RockefellerUniversityMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_1_1_2017_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cldx_AccountingStandardsUpdateMember_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">cldx:AccountingStandardsUpdateMember</xbrldi:explicitMember>
        <xbrldi:explicitMember dimension="us-gaap:NewAccountingPronouncementEarlyAdoptionAxis">us-gaap:AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-01-01</endDate>
    </period>
  </context>
  <context id="As_Of_12_31_2016">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="Duration_1_1_2014_To_12_31_2014_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:CounterpartyNameAxis">cldx:BristolMeyersSquibbCompanyMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2014-01-01</startDate>
      <endDate>2014-12-31</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2017_To_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2017-01-01</startDate>
      <endDate>2017-06-30</endDate>
    </period>
  </context>
  <context id="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-11-29</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="Duration_4_1_2016_To_6_30_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-04-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_1_1_2016_To_6_30_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-01-01</startDate>
      <endDate>2016-06-30</endDate>
    </period>
  </context>
  <context id="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">cldx:KolltanPharmaceuticalsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <startDate>2016-11-29</startDate>
      <endDate>2016-11-29</endDate>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">cldx:USGovernmentAndMunicipalObligationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <context id="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
      <segment>
        <xbrldi:explicitMember dimension="us-gaap:MajorTypesOfDebtAndEquitySecuritiesAxis">cldx:USGovernmentAndMunicipalObligationsMember</xbrldi:explicitMember>
      </segment>
    </entity>
    <period>
      <instant>2016-12-31</instant>
    </period>
  </context>
  <context id="As_Of_6_30_2017">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0000744218</identifier>
    </entity>
    <period>
      <instant>2017-06-30</instant>
    </period>
  </context>
  <!--Unit Section-->
  <unit id="Unit16">
    <measure>cldx:state</measure>
  </unit>
  <unit id="Unit15">
    <measure>utr:sqft</measure>
  </unit>
  <unit id="Unit14">
    <measure>xbrli:pure</measure>
  </unit>
  <unit id="Unit13">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="Unit12">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <unit id="Unit1">
    <measure>iso4217:USD</measure>
  </unit>
  <!--Tuple Section-->
  <!--Element Section-->
  <cldx:AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">0</cldx:AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">296000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">304000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">8000</cldx:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">5000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">7000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">2000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">12000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">56000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">6000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">22000</cldx:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses>
  <cldx:BusinessAcquisitionMileStonePayments contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">172500000</cldx:BusinessAcquisitionMileStonePayments>
  <cldx:BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit12" decimals="INF">0.73</cldx:BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted>
  <cldx:BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit12" decimals="INF">0.34</cldx:BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted>
  <cldx:BusinessAcquisitionRemainingStockObligation contextRef="As_Of_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit13" decimals="INF">150185</cldx:BusinessAcquisitionRemainingStockObligation>
  <cldx:BusinessAcquisitionStockIssuableInLieuOfSeverance contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit13" decimals="INF">437901</cldx:BusinessAcquisitionStockIssuableInLieuOfSeverance>
  <cldx:BusinessAcquisitionStockIssuedInLieuOfSeverance contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit13" decimals="INF">75637</cldx:BusinessAcquisitionStockIssuedInLieuOfSeverance>
  <cldx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">799000</cldx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets>
  <cldx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">9974000</cldx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities>
  <cldx:CollaborativeArrangementAgreementTerm contextRef="Duration_1_1_2014_To_12_31_2014_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember">P5Y</cldx:CollaborativeArrangementAgreementTerm>
  <cldx:DeferredIncomeFromSaleOfTaxBenefits contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">9436000</cldx:DeferredIncomeFromSaleOfTaxBenefits>
  <cldx:DeferredIncomeFromSaleOfTaxBenefits contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">8940000</cldx:DeferredIncomeFromSaleOfTaxBenefits>
  <cldx:FairValueAssetsAmountTransfersBetweenMeasurementLevels contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">0</cldx:FairValueAssetsAmountTransfersBetweenMeasurementLevels>
  <cldx:FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">0</cldx:FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels>
  <cldx:GrossDeferredTaxAssetsAndCorrespondingValuation contextRef="Duration_1_1_2017_To_1_1_2017_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_cldx_AccountingStandardsUpdateMember_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" unitRef="Unit1" decimals="-5">17700000</cldx:GrossDeferredTaxAssetsAndCorrespondingValuation>
  <cldx:LongTermSeveranceLiability contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">539000</cldx:LongTermSeveranceLiability>
  <cldx:LongTermSeveranceLiability contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">181000</cldx:LongTermSeveranceLiability>
  <cldx:NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Newly-Adopted Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On January&amp;nbsp;1, 2017, the Company adopted a new U.S.&amp;nbsp;GAAP accounting standard which involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company elected to continue to estimate forfeitures expected to occur to determine stock-based compensation expense. Upon adoption, the Company&amp;#x2019;s gross deferred tax assets and corresponding valuation allowance each increased by $17.7 million related to tax deductions from the exercise of stock options that previously would have been credited to additional paid-in-capital when realized.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On January&amp;nbsp;1, 2017, the Company adopted a new U.S.&amp;nbsp;GAAP accounting standard which simplifies how an entity is required to test goodwill for impairment. A goodwill impairment will be measured by the amount by which a reporting unit&amp;#x2019;s carrying value exceeds its fair value, with the amount of impairment not to exceed the carrying amount of goodwill.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</cldx:NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock>
  <cldx:PeriodForWhichBaseOfOperationsMustBeMaintained contextRef="Duration_1_1_2017_To_6_30_2017">P5Y</cldx:PeriodForWhichBaseOfOperationsMustBeMaintained>
  <cldx:ReimbursementOfExternalCostsIncurredPercentage contextRef="Duration_1_1_2014_To_12_31_2014_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember" unitRef="Unit14" decimals="INF">0.5</cldx:ReimbursementOfExternalCostsIncurredPercentage>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1635000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember" unitRef="Unit1" decimals="-5">800000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">785000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember" unitRef="Unit1" decimals="-5">400000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">4113000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_InternationalAidsVaccineInitiativeMember" unitRef="Unit1" decimals="-5">2300000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember" unitRef="Unit1" decimals="-5">1100000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">3135000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_InternationalAidsVaccineInitiativeMember" unitRef="Unit1" decimals="-5">2300000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromContractsAndGrants contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_RockefellerUniversityMember" unitRef="Unit1" decimals="-5">300000</cldx:RevenueFromContractsAndGrants>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1057000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember" unitRef="Unit1" decimals="-5">1000000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">604000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember" unitRef="Unit1" decimals="-5">600000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">1250000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember" unitRef="Unit1" decimals="-5">1200000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">694000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:RevenueFromProductDevelopmentAndLicensingAgreements contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember" unitRef="Unit1" decimals="-5">700000</cldx:RevenueFromProductDevelopmentAndLicensingAgreements>
  <cldx:ScheduleOfOtherLongTermLiabilitiesTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:26.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred Rent&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;398
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Net Deferred Tax Liabilities related to IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;28,054
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;28,054
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred Income from Sale of Tax Benefits&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;8,940
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9,436
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Accrued Lease Restructuring&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,150
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,154
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Long-Term Severance&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;181
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;539
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Contingent Milestones&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred Revenue&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,729
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,749
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;91,364
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,530
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Less Current Portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(5,538
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(4,826
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Long-Term Portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;85,826
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;82,704
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</cldx:ScheduleOfOtherLongTermLiabilitiesTableTextBlock>
  <cldx:SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">263000</cldx:SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance>
  <cldx:SignificantRevenueArrangementsDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(10)&amp;nbsp; Revenue&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Bristol-Myers Squibb Company (BMS)&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In 2014, the Company entered into a clinical trial collaboration with BMS to evaluate the safety, tolerability and preliminary efficacy of varlilumab and Opdivo&lt;/font&gt;&lt;font style="display:inline;font-size:6.5pt;"&gt;&amp;#xAE;&lt;/font&gt;&lt;font style="display:inline;"&gt;, BMS&amp;#x2019;s PD-1 immune checkpoint inhibitor, in a Phase 1/2 study. Under the terms of this clinical trial collaboration, BMS made a one-time payment to the Company of $5.0 million and BMS and the Company amended the terms of the Company&amp;#x2019;s existing license agreement with Medarex, which was acquired by BMS, related to the Company&amp;#x2019;s CD27 program whereby certain future milestone payments were waived and future royalty rates were reduced that may have been due from the Company to Medarex. In return, BMS was granted a time-limited right of first negotiation if the Company wishes to out-license varlilumab. The companies also agreed to work exclusively with each other to explore anti-PD-1 antagonist antibody and anti-CD27 agonist antibody combination regimens. The clinical trial collaboration provides that the companies share development costs and that the Company will be responsible for conducting the ongoing Phase 1/2 study.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has determined that its performance obligations under the BMS agreement, which primarily include performing research and development, supplying varlilumab and participating in the joint development committee, should be accounted for as a single unit of accounting and estimated that its performance period under the BMS agreement would be 5 years. Accordingly, the $5.0 million up-front payment was initially recorded as deferred revenue and is being recognized as revenue on a straight-line basis over the estimated 5-year performance period using the Contingency Adjusted Performance Model (&amp;#x201C;CAPM&amp;#x201D;). The BMS agreement also provides for BMS to reimburse the Company for 50% of the external costs incurred by the Company in connection with the clinical trial. The BMS payments are recognized as revenue under the CAPM. The Company recorded $0.7 million and $1.2 million in revenue related to the BMS agreement during the three and six months ended June&amp;nbsp;30, 2017, respectively, and $0.6&amp;nbsp;million and $1.0 million during the three and six months ended June&amp;nbsp;30, 2016, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Rockefeller University (Rockefeller)&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In 2013, the Company entered into an agreement, as amended, with Rockefeller pursuant to which the Company performs research and development services for Rockefeller. The Company bills Rockefeller quarterly for actual time and direct costs incurred and records those amounts to revenue in the quarter the services are performed. The Company recorded $0.3 million and $1.1 million in revenue related to the Rockefeller agreement during the three and six months ended June&amp;nbsp;30, 2017, respectively, and $0.4&amp;nbsp;million and $0.8 million during the three and six months ended June&amp;nbsp;30, 2016, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;International AIDS Vaccine Initiative (IAVI)&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In 2017, the Company entered into an agreement with IAVI pursuant to which the Company will perform research and development services for IAVI outlined under subsequently negotiated task orders. Revenue is recognized as services are performed under the negotiated task orders. The Company recorded $2.3 million in revenue related to the IAVI agreement during the three and six months ended June&amp;nbsp;30, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</cldx:SignificantRevenueArrangementsDisclosureTextBlock>
  <cldx:StockIssuedAuthorizedAmount contextRef="As_Of_5_31_2016_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember_us-gaap_RangeAxis_us-gaap_MaximumMember" unitRef="Unit1" decimals="-5">60000000</cldx:StockIssuedAuthorizedAmount>
  <cldx:StockIssuedRemainingAuthorizedAmount contextRef="As_Of_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember" unitRef="Unit1" decimals="-5">23100000</cldx:StockIssuedRemainingAuthorizedAmount>
  <cldx:ValueAtWhichTaxBenefitsSold contextRef="Duration_1_1_2013_To_1_31_2013" unitRef="Unit1" decimals="-5">800000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:ValueAtWhichTaxBenefitsSold contextRef="Duration_1_1_2014_To_1_31_2014" unitRef="Unit1" decimals="-5">1000000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:ValueAtWhichTaxBenefitsSold contextRef="Duration_12_1_2014_To_12_31_2014" unitRef="Unit1" decimals="-5">1800000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:ValueAtWhichTaxBenefitsSold contextRef="Duration_11_1_2015_To_11_30_2015" unitRef="Unit1" decimals="-5">9200000</cldx:ValueAtWhichTaxBenefitsSold>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold contextRef="Duration_1_1_2013_To_1_31_2013" unitRef="Unit1" decimals="-5">800000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold contextRef="Duration_1_1_2014_To_1_31_2014" unitRef="Unit1" decimals="-5">1100000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold contextRef="Duration_12_1_2014_To_12_31_2014" unitRef="Unit1" decimals="-5">1900000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <cldx:ValueOfTaxBenefitsAgreedToBeSold contextRef="Duration_11_1_2015_To_11_30_2015" unitRef="Unit1" decimals="-5">9800000</cldx:ValueOfTaxBenefitsAgreedToBeSold>
  <dei:AmendmentFlag contextRef="Duration_1_1_2017_To_6_30_2017">false</dei:AmendmentFlag>
  <dei:CurrentFiscalYearEndDate contextRef="Duration_1_1_2017_To_6_30_2017">--12-31</dei:CurrentFiscalYearEndDate>
  <dei:DocumentFiscalPeriodFocus contextRef="Duration_1_1_2017_To_6_30_2017">Q2</dei:DocumentFiscalPeriodFocus>
  <dei:DocumentFiscalYearFocus contextRef="Duration_1_1_2017_To_6_30_2017">2017</dei:DocumentFiscalYearFocus>
  <dei:DocumentPeriodEndDate contextRef="Duration_1_1_2017_To_6_30_2017">2017-06-30</dei:DocumentPeriodEndDate>
  <dei:DocumentType contextRef="Duration_1_1_2017_To_6_30_2017">10-Q</dei:DocumentType>
  <dei:EntityCentralIndexKey contextRef="Duration_1_1_2017_To_6_30_2017">0000744218</dei:EntityCentralIndexKey>
  <dei:EntityCommonStockSharesOutstanding contextRef="As_Of_7_31_2017" unitRef="Unit13" decimals="INF">128341785</dei:EntityCommonStockSharesOutstanding>
  <dei:EntityCurrentReportingStatus contextRef="Duration_1_1_2017_To_6_30_2017">Yes</dei:EntityCurrentReportingStatus>
  <dei:EntityFilerCategory contextRef="Duration_1_1_2017_To_6_30_2017">Accelerated Filer</dei:EntityFilerCategory>
  <dei:EntityRegistrantName contextRef="Duration_1_1_2017_To_6_30_2017">Celldex Therapeutics, Inc.</dei:EntityRegistrantName>
  <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">1784000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <us-gaap:AccountsAndOtherReceivablesNetCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">1359000</us-gaap:AccountsAndOtherReceivablesNetCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">1740000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccountsPayableCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">1975000</us-gaap:AccountsPayableCurrent>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-612000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">161000</us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">28657000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccruedLiabilitiesCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">21275000</us-gaap:AccruedLiabilitiesCurrent>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">2541000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">2577000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">982255000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">1011066000</us-gaap:AdditionalPaidInCapitalCommonStock>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">7913000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit1" decimals="-3">4089000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit1" decimals="-3">3824000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">3973000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit1" decimals="-3">1965000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit1" decimals="-3">2008000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">6989000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit1" decimals="-3">3225000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit1" decimals="-3">3764000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">3450000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember" unitRef="Unit1" decimals="-3">1579000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AllocatedShareBasedCompensationExpense contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_ResearchAndDevelopmentExpenseMember" unitRef="Unit1" decimals="-3">1871000</us-gaap:AllocatedShareBasedCompensationExpense>
  <us-gaap:AmortizationOfDebtDiscountPremium contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1638000</us-gaap:AmortizationOfDebtDiscountPremium>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">507000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">254000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">448000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AmortizationOfIntangibleAssets contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">224000</us-gaap:AmortizationOfIntangibleAssets>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit13" decimals="INF">10320073</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">10260073</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockMember" unitRef="Unit13" decimals="INF">60000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit13" decimals="INF">12185378</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">12088710</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_RestrictedStockMember" unitRef="Unit13" decimals="INF">96668</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
  <us-gaap:AreaOfLand contextRef="As_Of_12_31_2016_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember" unitRef="Unit15" decimals="0">11500</us-gaap:AreaOfLand>
  <us-gaap:Assets contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">383358000</us-gaap:Assets>
  <us-gaap:Assets contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">346071000</us-gaap:Assets>
  <us-gaap:AssetsCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">195569000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">160052000</us-gaap:AssetsCurrent>
  <us-gaap:AssetsFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">167760000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">167760000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">132444000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AssetsFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">132444000</us-gaap:AssetsFairValueDisclosure>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">147370000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">53050000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">94320000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">87841000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">18253000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">69588000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
  <us-gaap:AvailableForSaleSecurities contextRef="As_Of_12_31_2016_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">147315000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities contextRef="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">147315000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities contextRef="As_Of_6_30_2017_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">87822000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecurities contextRef="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">87822000</us-gaap:AvailableForSaleSecurities>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">13000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">13000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">9000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">7000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">2000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">68000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">12000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">56000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">28000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">6000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">22000</us-gaap:AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">52754000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">94320000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">18253000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">69588000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">52747000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">94264000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">18254000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">69568000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">147315000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">53051000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="As_Of_12_31_2016_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">94264000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">87822000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_cldx_USGovernmentAndMunicipalObligationsMember" unitRef="Unit1" decimals="-3">18254000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="As_Of_6_30_2017_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_us-gaap_CorporateDebtSecuritiesMember" unitRef="Unit1" decimals="-3">69568000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
  <us-gaap:BasisOfAccounting contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(1)&amp;nbsp; Basis of Presentation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared by Celldex Therapeutics,&amp;nbsp;Inc. (the &amp;#x201C;Company&amp;#x201D; or &amp;#x201C;Celldex&amp;#x201D;) in accordance with accounting principles generally accepted in the United States of America (&amp;#x201C;U.S. GAAP&amp;#x201D;) and reflect the operations of the Company and its wholly-owned subsidiaries. In June&amp;nbsp;2017, the Company liquidated its wholly-owned subsidiary, Celldex Therapeutics Europe&amp;nbsp;GmbH. All intercompany balances and transactions have been eliminated in consolidation.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;These interim financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited financial statements for the year ended December&amp;nbsp;31, 2016, which are included in the Company&amp;#x2019;s Annual Report on Form&amp;nbsp;10-K filed with the Securities and Exchange Commission on March&amp;nbsp;14, 2017. In the opinion of management, the interim financial statements reflect all normal recurring adjustments necessary to fairly state the Company&amp;#x2019;s financial position and results of operations for the interim periods presented. The year-end condensed balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for any future interim period or the fiscal year ending December&amp;nbsp;31, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;At June&amp;nbsp;30, 2017, the Company had cash, cash equivalents and marketable securities of $154.0 million. The Company has had recurring losses and incurred a loss of $62.8 million for the six months ended June&amp;nbsp;30, 2017. Net cash used in operations for the six months ended June&amp;nbsp;30, 2017 was $56.0&amp;nbsp;million. The Company believes that the cash, cash equivalents and marketable securities at August&amp;nbsp;8, 2017 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months from the date of issuance of these financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;During the next twelve months and beyond, the Company will take further steps to raise additional capital to meet its liquidity needs. These capital raising activities may include, but may not be limited to, one or more of the following: the licensing of drug candidates with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While the Company may seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and the Company&amp;#x2019;s negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the Company will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to the Company&amp;#x2019;s stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict the Company&amp;#x2019;s ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce the Company&amp;#x2019;s economic potential from products under development. The Company&amp;#x2019;s ability to continue funding its planned operations into and beyond twelve months from the issuance date is also dependent on the timing and manner of payment of future contingent milestones from the Kolltan acquisition, in the event that the Company achieves the drug candidate milestones related to those payments. The Company, at its option, may decide to pay those milestone payments in cash, shares of its common stock or a combination thereof. If the Company is unable to raise the funds necessary to meet its liquidity needs, it may have to delay or discontinue the development of one or more programs, discontinue or delay ongoing or anticipated clinical trials, license out programs earlier than expected, raise funds at a significant discount or on other unfavorable terms, if at all, or sell all or a part of the Company.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:BasisOfAccounting>
  <us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit13" decimals="INF">18257996</us-gaap:BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued>
  <us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">0</us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">84800000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">39500000</us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss>
  <us-gaap:BusinessCombinationAcquisitionRelatedCosts contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">3768000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
  <us-gaap:BusinessCombinationConsiderationTransferred1 contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">121365000</us-gaap:BusinessCombinationConsiderationTransferred1>
  <us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">73397000</us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">4400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">4400000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-5">1000000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh contextRef="Duration_12_1_2016_To_12_31_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">172500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh>
  <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow contextRef="Duration_12_1_2016_To_12_31_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow>
  <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">44200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">44200000</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:BusinessCombinationContingentConsiderationLiability contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">48600000</us-gaap:BusinessCombinationContingentConsiderationLiability>
  <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="As_Of_12_31_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">44200000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
  <us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent contextRef="As_Of_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-5">48600000</us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent>
  <us-gaap:BusinessCombinationDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(11) Kolltan Acquisition&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In connection with the Kolltan Acquisition, effective November&amp;nbsp;29, 2016, the Company issued 18,257,996 shares of common stock of the Company in exchange for all of the share and debt interests in Kolltan. The Company also agreed to issue an aggregate of 437,901 shares of its common stock, less tax withholdings, to certain former officers of Kolltan. During the six months ended June&amp;nbsp;30, 2017, the Company issued 75,637 shares of its common stock and at June&amp;nbsp;30, 2017, the Company&amp;#x2019;s remaining obligation is to issue 150,185 shares of its common stock, less tax withholdings, related to this severance obligation. In addition, in the event that certain specified preclinical and clinical development milestones related to Kolltan&amp;#x2019;s development programs and/or Celldex&amp;#x2019;s development programs and certain commercial milestones related to Kolltan&amp;#x2019;s drug candidates are achieved, Celldex will be required to pay Kolltan&amp;#x2019;s stockholders milestone payments of up to $172.5&amp;nbsp;million, which milestone payments may be made, at Celldex&amp;#x2019;s sole election, in cash, in shares of Celldex&amp;#x2019;s common stock or a combination of both, subject to provisions of the Merger Agreement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company acquired Kolltan to gain access to Kolltan&amp;#x2019;s programs including: (i)&amp;nbsp;CDX-0158 (formerly KTN0158) which is currently in a Phase&amp;nbsp;1 dose escalation study in patients with refractory gastrointestinal stromal tumors (GIST); (ii)&amp;nbsp;CDX-3379 (formerly KTN3379) which recently completed a Phase&amp;nbsp;1b study with combination cohorts where meaningful responses and stable disease were observed in cetuximab (Erbitux&lt;/font&gt;&lt;font style="display:inline;font-size:6.5pt;"&gt;&amp;#xAE;&lt;/font&gt;&lt;font style="display:inline;"&gt;) refractory patients in patients with head and neck squamous cell carcinoma and in BRAF-mutant non-small cell lung cancer (NSCLC); and (iii)&amp;nbsp;a multi-faceted TAM program, a broad antibody discovery effort underway to generate antibodies that modulate the TAM family of RTKs, comprised of Tyro3, AXL and MerTK, which are expressed on tumor-infiltrating macrophages, dendritic cells and some tumors.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The transaction was accounted for as a business combination with Celldex treated as the accounting acquirer. All of the assets acquired and liabilities assumed in the transaction are recognized at their acquisition-date fair values, while transaction costs associated with the transaction are expensed as incurred.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Purchase Price&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The purchase price for Kolltan was based on the acquisition-date fair value of the consideration transferred, which was calculated based on the closing price of the Company&amp;#x2019;s common stock of $4.02 per share on November&amp;nbsp;29, 2016. The acquisition-date fair value of the consideration transferred consisted of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Fair value of common stock issued for upfront payment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.60%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,397
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Fair value of contingent consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Kolltan transaction expenses paid in cash by the Company&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,768
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total consideration transferred&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;121,365
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The contingent consideration relates to the achievement of certain regulatory and sales milestones as described in the agreement. The estimated fair value of contingent consideration of $48.6 million and $44.2&amp;nbsp;million at June&amp;nbsp;30, 2017 and December&amp;nbsp;31, 2016, respectively, is recorded as a noncurrent liability. The Company determined the fair value of these obligations to pay additional milestone payments using various estimates, including probabilities of success, discount rates and amount of time until the conditions of the milestone payments are met. This fair value measurement is based on significant inputs not observable in the market, representing a Level&amp;nbsp;3 measurement within the fair value hierarchy. The resulting probability-weighted cash flows were discounted using a cost of debt rate ranging from 10-11% for the milestones. The range of estimated milestone payments is from zero, if no milestones are achieved, to $172.5&amp;nbsp;million if all milestones are met.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Changes in the fair value of the contingent consideration are recognized in operating earnings. Changes in fair values reflect new information about the probability and timing of meeting the conditions of the milestone payments or changes in discount rates. In the absence of new information, changes in fair value will only reflect the interest component of contingent consideration related to the passage of time as development work progresses towards the achievement of the milestones.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Allocations of Assets and Liabilities&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has allocated the consideration transferred for Kolltan to net tangible assets, intangible assets, and goodwill. The difference between the aggregate consideration transferred and the fair value of assets acquired and liabilities assumed was allocated to goodwill. This goodwill relates to the potential synergies from the Kolltan Acquisition and deferred tax liabilities related to acquired IPR&amp;amp;D intangible assets. None of the goodwill is expected to be deductible for income tax purposes. The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Cash&amp;nbsp;and&amp;nbsp;cash&amp;nbsp;equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.60%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;8,160&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Other current and long-term assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;799
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,072
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;In-process research and development (IPR&amp;amp;D)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;61,690
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;82,011
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred tax liabilities, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(23,393
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Other assumed liabilities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(9,974
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;121,365
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The purchase price allocation has been prepared on a preliminary basis and is subject to change as additional information becomes available concerning the fair value and tax basis of the acquired assets and liabilities. Any adjustments to the purchase price allocation will be made as soon as practicable but no later than one year from the acquisition date.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Pro Forma Financial Information&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;If the operations of the Company and Kolltan were combined as of January&amp;nbsp;1, 2016, the unaudited pro forma net loss for the three and six months ended June&amp;nbsp;30, 2016 would have been $39.5 million and $84.8 million, respectively, or $(0.34) and $(0.73) per share, respectively. The unaudited pro forma combined results are not necessarily indicative of the actual results that would have occurred had the acquisition been consummated at that date or of the future operations of the combined entities.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">8160000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">23393000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">61690000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">2072000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
  <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">121365000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">108000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">87000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_12_31_2015" unitRef="Unit1" decimals="-3">72108000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_6_30_2016" unitRef="Unit1" decimals="-3">32482000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">42461000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">66162000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">20445000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">20445000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44622000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44622000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-39626000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">23701000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="As_Of_12_31_2016" unitRef="Unit1" />
  <us-gaap:CommitmentsAndContingencies xsi:nil="true" contextRef="As_Of_6_30_2017" unitRef="Unit1" />
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="As_Of_12_31_2016" unitRef="Unit12" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockParOrStatedValuePerShare contextRef="As_Of_6_30_2017" unitRef="Unit12" decimals="INF">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
  <us-gaap:CommonStockSharesAuthorized contextRef="As_Of_12_31_2016" unitRef="Unit13" decimals="INF">297000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesAuthorized contextRef="As_Of_6_30_2017" unitRef="Unit13" decimals="INF">297000000</us-gaap:CommonStockSharesAuthorized>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_12_31_2016" unitRef="Unit13" decimals="INF">120516654</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesIssued contextRef="As_Of_6_30_2017" unitRef="Unit13" decimals="INF">127411975</us-gaap:CommonStockSharesIssued>
  <us-gaap:CommonStockSharesOutstanding contextRef="As_Of_12_31_2016" unitRef="Unit13" decimals="INF">120516654</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockSharesOutstanding contextRef="As_Of_6_30_2017" unitRef="Unit13" decimals="INF">127411975</us-gaap:CommonStockSharesOutstanding>
  <us-gaap:CommonStockValue contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">121000</us-gaap:CommonStockValue>
  <us-gaap:CommonStockValue contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">127000</us-gaap:CommonStockValue>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-66209000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-31916000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-62791000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNetOfTax contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-28551000</us-gaap:ComprehensiveIncomeNetOfTax>
  <us-gaap:ComprehensiveIncomeNoteTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(9)&amp;nbsp;Accumulated Other Comprehensive Income&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:34.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The changes in accumulated other comprehensive income, which is reported as a component of stockholders&amp;#x2019; equity, for the six months ended June&amp;nbsp;30, 2017 are summarized below:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Unrealized&amp;nbsp;Gain&lt;br /&gt;(Loss)&amp;nbsp;on&lt;br /&gt;Marketable&lt;br /&gt;Securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Foreign&lt;br /&gt;Currency&amp;nbsp;Items&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(55
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,596
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,541
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Other comprehensive gain&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;36
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;36
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(19
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,596
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,577
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:34.55pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;No amounts were reclassified out of accumulated other comprehensive income during the six months ended June&amp;nbsp;30, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
  <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44200000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
  <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44200000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
  <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44200000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
  <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">48600000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
  <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">48600000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
  <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_BalanceSheetLocationAxis_us-gaap_OtherNoncurrentLiabilitiesMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">48600000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
  <us-gaap:CostsAndExpenses contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">70762000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">33755000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">69403000</us-gaap:CostsAndExpenses>
  <us-gaap:CostsAndExpenses contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">32757000</us-gaap:CostsAndExpenses>
  <us-gaap:DeferredRentCredit contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">398000</us-gaap:DeferredRentCredit>
  <us-gaap:DeferredRentCredit contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">710000</us-gaap:DeferredRentCredit>
  <us-gaap:DeferredRevenue contextRef="As_Of_12_31_2014_us-gaap_CounterpartyNameAxis_cldx_BristolMeyersSquibbCompanyMember" unitRef="Unit1" decimals="-5">5000000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">3749000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredRevenue contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">3729000</us-gaap:DeferredRevenue>
  <us-gaap:DeferredTaxLiabilities contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">28054000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:DeferredTaxLiabilities contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">28054000</us-gaap:DeferredTaxLiabilities>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1434000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DepreciationDepletionAndAmortization contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">2367000</us-gaap:DepreciationDepletionAndAmortization>
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(8)&amp;nbsp; Stock-Based Compensation&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;A summary of stock option activity for the six months ended June&amp;nbsp;30, 2017 is as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Weighted&lt;br /&gt;Average&lt;br /&gt;Exercise&lt;br /&gt;Price&lt;br /&gt;Per&amp;nbsp;Share&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Weighted&lt;br /&gt;Average&lt;br /&gt;Remaining&lt;br /&gt;Contractual&lt;br /&gt;Term&amp;nbsp;(In&amp;nbsp;Years)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Outstanding at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10,218,710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;11.14
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6.5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,283,100
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2.34
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Canceled&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(413,100
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10.66
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Outstanding at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;12,088,710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9.49
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6.5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Vested and Expected to Vest at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;11,931,869
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9.54
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6.5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Exercisable at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,085,429
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10.93
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;4.7
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Shares Available for Grant under the 2008 Plan&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,292,650
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The weighted average grant-date fair value of stock options granted during the six month period ended June&amp;nbsp;30, 2017 was $1.57. Stock-based compensation expense for the three and six months ended June&amp;nbsp;30, 2017 and 2016 was recorded as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Three&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Six&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,871
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,008
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,764
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,824
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,579
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,965
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,225
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;4,089
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,450
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,973
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6,989
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,913
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The fair value of employee and director stock options granted during the three and six month periods ended June&amp;nbsp;30, 2017 and 2016 were valued using the Black-Scholes option-pricing model with the following assumptions:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Three&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Six&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expected stock price volatility&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;76%
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;77%
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;76 &amp;#x2013; 77%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;70 &amp;#x2013; 77%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expected option term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;2.0 &amp;#x2013; 2.1%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1.5%
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;2.0 &amp;#x2013; 2.3%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;1.5 &amp;#x2013; 1.6%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit12" decimals="2">-0.67</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit12" decimals="2">-0.32</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit12" decimals="2">-0.51</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareBasicAndDiluted contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit12" decimals="2">-0.23</us-gaap:EarningsPerShareBasicAndDiluted>
  <us-gaap:EarningsPerShareTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(13)&amp;nbsp; Net Loss Per Share&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Six&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Stock options&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;12,088,710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10,260,073
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Restricted stock&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;96,668
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;60,000
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;12,185,378
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10,320,073
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
  <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;As&amp;nbsp;of&lt;br /&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,622
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,622
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,822
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,822
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;132,444
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;132,444
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Liabilities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Kolltan acquisition contingent consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;As&amp;nbsp;of&lt;br /&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;20,445
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;20,445
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,315
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,315
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;167,760
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;167,760
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Liabilities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Kolltan acquisition contingent consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
  <us-gaap:FairValueDisclosuresTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(3)&amp;nbsp; Fair Value Measurements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following tables set forth the Company&amp;#x2019;s financial assets and liabilities subject to fair value measurements:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;As&amp;nbsp;of&lt;br /&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,622
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,622
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,822
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,822
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;132,444
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;132,444
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Liabilities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Kolltan acquisition contingent consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;As&amp;nbsp;of&lt;br /&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;1&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;2&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Level&amp;nbsp;3&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Money market funds and cash equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;20,445
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;20,445
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,315
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,315
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;167,760
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;167,760
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Liabilities:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Kolltan acquisition contingent consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company&amp;#x2019;s financial assets consist mainly of cash and cash equivalents and marketable securities and are classified as Level 2 within the valuation hierarchy. The Company values its marketable securities utilizing independent pricing services which normally derive security prices from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. At each balance sheet date, observable market inputs may include trade information, broker or dealer quotes, bids, offers or a combination of these data sources. The Company did not have any transfers of assets or liabilities between the fair value measurement classifications during the six months ended June&amp;nbsp;30, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Contingent consideration liabilities related to acquisitions are classified as Level&amp;nbsp;3 within the valuation hierarchy and are valued based on various estimates, including probability of success, discount rates and amount of time until the conditions of the milestone payments are met. In connection with the Kolltan acquisition, the Company may be required to pay future consideration of up to $172.5 million that is contingent upon the achievement of specified development, regulatory approvals or sales-based milestone events. The Company determines the fair value of these obligations on the acquisition date using various estimates that are not observable in the market and represent a Level&amp;nbsp;3 measurement within the fair value hierarchy. During the three and six months ended June&amp;nbsp;30, 2017, the Company recorded a $1.0 million and $4.4 million loss on fair value remeasurement of contingent consideration, respectively, primarily due to changes in discount rates and the passage of time. The following table reflects the activity for the Company&amp;#x2019;s contingent consideration liabilities measured at fair value using Level 3 inputs for the six months ended June&amp;nbsp;30, 2017.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:77.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Other&amp;nbsp;Long-Term&lt;br /&gt;Liabilities:&lt;br /&gt;Contingent&lt;br /&gt;Consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Fair value adjustments included in operating expenses&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:19.04%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;4,400
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:17.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <us-gaap:FairValueInputsDiscountRate contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_RangeAxis_us-gaap_MaximumMember" unitRef="Unit14" decimals="2">0.11</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FairValueInputsDiscountRate contextRef="Duration_11_29_2016_To_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_RangeAxis_us-gaap_MinimumMember" unitRef="Unit14" decimals="2">0.10</us-gaap:FairValueInputsDiscountRate>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">6503000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="As_Of_12_31_2016_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember" unitRef="Unit1" decimals="-3">6503000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">6951000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="As_Of_6_30_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember" unitRef="Unit1" decimals="-3">6951000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="As_Of_12_31_2016_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember" unitRef="Unit1" decimals="-3">14500000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="As_Of_6_30_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember" unitRef="Unit1" decimals="-3">14500000</us-gaap:FiniteLivedIntangibleAssetsGross>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="As_Of_12_31_2016_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember" unitRef="Unit1" decimals="-3">7997000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="As_Of_6_30_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember" unitRef="Unit1" decimals="-3">7549000</us-gaap:FiniteLivedIntangibleAssetsNet>
  <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_cldx_AmgenAmendmentMember">P16Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-5">600000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:GainLossOnSaleOfOtherAssets contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-5">500000</us-gaap:GainLossOnSaleOfOtherAssets>
  <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-74000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">17097000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">7790000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">13763000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:GeneralAndAdministrativeExpense contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">6534000</us-gaap:GeneralAndAdministrativeExpense>
  <us-gaap:Goodwill contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit1" decimals="-3">82011000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">90976000</us-gaap:Goodwill>
  <us-gaap:Goodwill contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">90976000</us-gaap:Goodwill>
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(5)&amp;nbsp; Intangible Assets and Goodwill&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Intangible assets, net of accumulated amortization, and goodwill are as follows:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Estimated&lt;br /&gt;Life&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Accumulated&lt;br /&gt;Amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Accumulated&lt;br /&gt;Amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="19" valign="bottom" style="width:77.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Intangible Assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Indefinite&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Amgen Amendment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;16 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;14,500
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,951
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,549
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;14,500
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,503
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,997
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total Intangible Assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,990
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,951
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;81,039
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,990
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,503
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;81,487
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Indefinite&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The IPR&amp;amp;D intangible asset recorded in connection with the CuraGen acquisition of $11.8&amp;nbsp;million relates to the development of glembatumumab vedotin. At the date of acquisition and at June&amp;nbsp;30, 2017, glembatumumab vedotin had not yet reached technological feasibility nor did it have any alternative future use. Glembatumumab vedotin is in a randomized, Phase&amp;nbsp;2b study for the treatment of triple negative breast cancer and a Phase&amp;nbsp;2 study for the treatment of metastatic melanoma.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company performed an impairment test of the glembatumumab vedotin IPR&amp;amp;D and goodwill assets as of July&amp;nbsp;1, 2016 and concluded that goodwill was not impaired.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In connection with the Kolltan Acquisition, effective November&amp;nbsp;29, 2016, the Company recorded IPR&amp;amp;D intangible assets primarily related to the development of the CDX-0158, CDX-3379 and TAM programs with a fair value of $40.0&amp;nbsp;million, $3.5&amp;nbsp;million and $18.0&amp;nbsp;million, respectively. At the date of acquisition and at June&amp;nbsp;30, 2017, the CDX-1058, CDX-3379 and TAM programs had not yet reached technological feasibility nor did they have any alternative future use. CDX-0158 is a humanized monoclonal antibody currently in a Phase&amp;nbsp;1 dose escalation study in refractory gastrointestinal stromal tumors and CDX-3379 is a human monoclonal antibody which recently completed a Phase&amp;nbsp;1b study in patients with solid tumors. The TAM program is a multi-faceted broad antibody discovery effort to generate antibodies that modulate the TAM family of RTKs, comprised of Tyro3, AXL and MerTK, which are expressed on tumor-infiltrating macrophages, dendritic cells and some tumors.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(12)&amp;nbsp; Income Taxes&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Massachusetts, New Jersey and Connecticut are the three states in which the Company primarily operates or has operated and has income tax nexus. The Company&amp;#x2019;s wholly-owned subsidiary Celldex Australia Pty Ltd operates in Brisbane, Australia. The Company is not currently under examination by any jurisdictions for any tax year.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The Company has evaluated the positive and negative evidence bearing upon the realizability of its net deferred tax assets, which are comprised principally of net operating loss carryforwards, capitalized R&amp;amp;D expenditures and R&amp;amp;D tax credit carryforwards. The Company has determined that it is more likely than not that it will not recognize the benefits of federal and state deferred tax assets and, as a result, a full valuation allowance was maintained at June&amp;nbsp;30, 2017 and December&amp;nbsp;31, 2016 against the Company&amp;#x2019;s net deferred tax assets.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">146000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-425000</us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-10212000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-6812000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-199000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-803000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-566000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">3124000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">511000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="As_Of_12_31_2016_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="Unit1" decimals="-3">73490000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="As_Of_6_30_2017_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="Unit1" decimals="-3">73490000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill contextRef="As_Of_6_30_2017_us-gaap_BusinessAcquisitionAxis_cldx_CuraGenCorporationMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember" unitRef="Unit1" decimals="-5">11800000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_ProductOrServiceAxis_cldx_CDX1058Member" unitRef="Unit1" decimals="-5">40000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_ProductOrServiceAxis_cldx_CDX3379Member" unitRef="Unit1" decimals="-5">3500000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure>
  <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_InProcessResearchAndDevelopmentMember_us-gaap_ProductOrServiceAxis_cldx_TMProgramMember" unitRef="Unit1" decimals="-5">18000000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">87990000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsGrossExcludingGoodwill contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">87990000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">81487000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">81039000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <us-gaap:InterestAndOtherIncome contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1445000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">414000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">1213000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestAndOtherIncome contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">362000</us-gaap:InterestAndOtherIncome>
  <us-gaap:InterestReceivable contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-5">600000</us-gaap:InterestReceivable>
  <us-gaap:InterestReceivable contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-5">400000</us-gaap:InterestReceivable>
  <us-gaap:InvestmentsAndCash contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-5">154000000</us-gaap:InvestmentsAndCash>
  <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(4)&amp;nbsp; Marketable Securities&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following tables summarize our marketable securities, classified as available-for-sale:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Amortized&lt;br /&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Gross&lt;br /&gt;Unrealized&lt;br /&gt;Gains&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Gross&lt;br /&gt;Unrealized&lt;br /&gt;Losses&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Fair&amp;nbsp;Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:51.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;"&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,253
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,254
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,253
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,254
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,588
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(22
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,568
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,588
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(22
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,568
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,841
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(28
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,822
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;"&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;52,754
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(12
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;52,747
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;296
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;8
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;304
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;53,050
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;13
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(12
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;53,051
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,320
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(56
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,264
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,320
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(56
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,264
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,370
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;13
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(68
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,315
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The marketable securities held by the Company were high investment grade and there were no marketable securities that the Company considered to be other-than-temporarily impaired as of June&amp;nbsp;30, 2017. Marketable securities include $0.4 million and $0.6 million in accrued interest at June&amp;nbsp;30, 2017 and December&amp;nbsp;31, 2016, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
  <us-gaap:Liabilities contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">117927000</us-gaap:Liabilities>
  <us-gaap:Liabilities contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">114614000</us-gaap:Liabilities>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">383358000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesAndStockholdersEquity contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">346071000</us-gaap:LiabilitiesAndStockholdersEquity>
  <us-gaap:LiabilitiesCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">35223000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">28788000</us-gaap:LiabilitiesCurrent>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44200000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="As_Of_12_31_2016_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">44200000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByMeasurementBasisAxis_us-gaap_EstimateOfFairValueFairValueDisclosureMember_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">48600000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:LiabilitiesFairValueDisclosure contextRef="As_Of_6_30_2017_us-gaap_FairValueByFairValueHierarchyLevelAxis_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueByMeasurementFrequencyAxis_us-gaap_FairValueMeasurementsRecurringMember" unitRef="Unit1" decimals="-3">48600000</us-gaap:LiabilitiesFairValueDisclosure>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">2900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">21565000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">26206000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">58185000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-68732000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-56049000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-66625000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-31952000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-62827000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-28566000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
  <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&amp;#x2019;s financial position or results of operations upon adoption.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In May&amp;nbsp;2014, the FASB issued a new U.S GAAP accounting standard that updates guidance and disclosure requirements for recognizing revenue. The new revenue recognition standard provides a five-step model for recognizing revenue from contracts with customers. The core principle is that a company should recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard will be effective for the Company on January&amp;nbsp;1, 2018 and can be applied using one of two methods: retrospectively to each prior period presented or a modified retrospective application by recognizing a cumulative-effect adjustment as a component of equity as of the date of adoption. The Company expects to adopt the new revenue standard using the modified retrospective application method. As of June&amp;nbsp;30, 2017, the Company is still evaluating the impact the adoption of this standard will have on the Company&amp;#x2019;s financial statements and disclosure. During the second half of 2017, the Company plans to finalize its review of all applicable contracts that will be affected by the adoption of this standard.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In February&amp;nbsp;2016, the FASB issued a new U.S. GAAP accounting standard which requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for the Company on January&amp;nbsp;1, 2019. The Company is currently evaluating the potential impact that this standard may have on the Company&amp;#x2019;s financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In August&amp;nbsp;2016, the FASB issued new U.S. GAAP guidance which clarifies the classification of certain cash receipts and payments in the statement of cash flows. This standard is effective for the company on January&amp;nbsp;1, 2018. The adoption of this new guidance is not expected to have a material impact on the Company&amp;#x2019;s financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
  <us-gaap:NumberOfStatesInWhichEntityOperates contextRef="As_Of_6_30_2017" unitRef="Unit16" decimals="INF">3</us-gaap:NumberOfStatesInWhichEntityOperates>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-68070000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">-32366000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-64040000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OperatingIncomeLoss contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">-28928000</us-gaap:OperatingIncomeLoss>
  <us-gaap:OtherAssetsNoncurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">2134000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherAssetsNoncurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">1935000</us-gaap:OtherAssetsNoncurrent>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="Unit1" decimals="-3">36000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="-3">36000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">416000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">36000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">36000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">15000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
  <us-gaap:OtherLiabilities contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">87530000</us-gaap:OtherLiabilities>
  <us-gaap:OtherLiabilities contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">91364000</us-gaap:OtherLiabilities>
  <us-gaap:OtherLiabilitiesCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">4826000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">5538000</us-gaap:OtherLiabilitiesCurrent>
  <us-gaap:OtherLiabilitiesDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(6)&amp;nbsp;Other Long-Term Liabilities&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;Other long-term liabilities include the following:&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:26.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred Rent&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;398
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Net Deferred Tax Liabilities related to IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;28,054
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;28,054
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred Income from Sale of Tax Benefits&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;8,940
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9,436
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Accrued Lease Restructuring&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,150
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,154
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Long-Term Severance&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;181
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;539
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Contingent Milestones&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred Revenue&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,729
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,749
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;91,364
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,530
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Less Current Portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(5,538
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(4,826
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Long-Term Portion&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;85,826
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;82,704
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In November&amp;nbsp;2015, December&amp;nbsp;2014, January&amp;nbsp;2014 and January&amp;nbsp;2013, the Company received approval from the New Jersey Economic Development Authority and agreed to sell New Jersey tax benefits of $9.8 million, $1.9&amp;nbsp;million, $1.1&amp;nbsp;million and $0.8&amp;nbsp;million to an independent third party for $9.2 million, $1.8&amp;nbsp;million, $1.0&amp;nbsp;million and $0.8&amp;nbsp;million, respectively. Under the agreement, the Company must maintain a base of operations in New Jersey for five years or the tax benefits must be paid back on a pro-rata basis based on the number of years completed. The Company recorded $0.5 million and $0.6 million to other income related to the sale of these tax benefits during the six months ended June&amp;nbsp;30, 2017 and 2016, respectively.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In December&amp;nbsp;2016, the Company decided not to occupy the 11,500 square feet of expansion space (&amp;#x201C;Needham Expansion&amp;#x201D;) at its Needham, Massachusetts facility. The Company agreed to lease the Needham Expansion in August&amp;nbsp;2015 and the term of the lease expires in July&amp;nbsp;2020. The Company is actively trying to sublease the lease obligation. In March&amp;nbsp;2017, the Company terminated its lease in Branford, CT and consolidated its Connecticut operations in its New Haven, CT facility. The Company recorded restructuring expense of $0.2 million to general and administrative expense related to the Branford, CT lease termination. The activity related to accrued lease restructuring for the six months ended June&amp;nbsp;30, 2017 is presented below (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Accrued&amp;nbsp;Lease&lt;br /&gt;Restructuring&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,154
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;267
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Payments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(271
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,150
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:OtherLiabilitiesDisclosureTextBlock>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">82704000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:OtherLiabilitiesNoncurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">85826000</us-gaap:OtherLiabilitiesNoncurrent>
  <us-gaap:PaymentsForRestructuring contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember" unitRef="Unit1" decimals="-3">271000</us-gaap:PaymentsForRestructuring>
  <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">120053000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireMarketableSecurities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">91969000</us-gaap:PaymentsToAcquireMarketableSecurities>
  <us-gaap:PaymentsToAcquireOtherInvestments contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1801000</us-gaap:PaymentsToAcquireOtherInvestments>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1307000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">1316000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="As_Of_12_31_2016" unitRef="Unit12" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockParOrStatedValuePerShare contextRef="As_Of_6_30_2017" unitRef="Unit12" decimals="INF">0.01</us-gaap:PreferredStockParOrStatedValuePerShare>
  <us-gaap:PreferredStockSharesAuthorized contextRef="As_Of_12_31_2016" unitRef="Unit13" decimals="INF">3000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesAuthorized contextRef="As_Of_6_30_2017" unitRef="Unit13" decimals="INF">3000000</us-gaap:PreferredStockSharesAuthorized>
  <us-gaap:PreferredStockSharesIssued contextRef="As_Of_12_31_2016" unitRef="Unit13" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesIssued contextRef="As_Of_6_30_2017" unitRef="Unit13" decimals="INF">0</us-gaap:PreferredStockSharesIssued>
  <us-gaap:PreferredStockSharesOutstanding contextRef="As_Of_12_31_2016" unitRef="Unit13" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockSharesOutstanding contextRef="As_Of_6_30_2017" unitRef="Unit13" decimals="INF">0</us-gaap:PreferredStockSharesOutstanding>
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="As_Of_12_31_2016" unitRef="Unit1" />
  <us-gaap:PreferredStockValue xsi:nil="true" contextRef="As_Of_6_30_2017" unitRef="Unit1" />
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">4009000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">4709000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">2551000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">21489000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember" unitRef="Unit1" decimals="-5">21500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">149367000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">151470000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
  <us-gaap:ProceedsFromStockPlans contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">349000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:ProceedsFromStockPlans contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">76000</us-gaap:ProceedsFromStockPlans>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">13192000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:PropertyPlantAndEquipmentNet contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">12069000</us-gaap:PropertyPlantAndEquipmentNet>
  <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">53158000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">25711000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">50792000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:ResearchAndDevelopmentExpense contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">24999000</us-gaap:ResearchAndDevelopmentExpense>
  <us-gaap:RestructuringCharges contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember" unitRef="Unit1" decimals="-3">267000</us-gaap:RestructuringCharges>
  <us-gaap:RestructuringCosts contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_IncomeStatementLocationAxis_us-gaap_GeneralAndAdministrativeExpenseMember_us-gaap_RestructuringPlanAxis_cldx_BranfordCTMember" unitRef="Unit1" decimals="-5">200000</us-gaap:RestructuringCosts>
  <us-gaap:RestructuringReserve contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">1154000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="As_Of_12_31_2016_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember" unitRef="Unit1" decimals="-3">1154000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">1150000</us-gaap:RestructuringReserve>
  <us-gaap:RestructuringReserve contextRef="As_Of_6_30_2017_us-gaap_RestructuringPlanAxis_cldx_NeedhamExpansionMember" unitRef="Unit1" decimals="-3">1150000</us-gaap:RestructuringReserve>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">-719486000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">-782313000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <us-gaap:Revenues contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">2692000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">1389000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">5363000</us-gaap:Revenues>
  <us-gaap:Revenues contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">3829000</us-gaap:Revenues>
  <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Unrealized&amp;nbsp;Gain&lt;br /&gt;(Loss)&amp;nbsp;on&lt;br /&gt;Marketable&lt;br /&gt;Securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Foreign&lt;br /&gt;Currency&amp;nbsp;Items&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(55
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,596
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,541
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Other comprehensive gain&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;36
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;36
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(19
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,596
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,577
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
  <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Six&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Stock options&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;12,088,710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10,260,073
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Restricted stock&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;96,668
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;60,000
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;12,185,378
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10,320,073
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
  <us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Amortized&lt;br /&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Gross&lt;br /&gt;Unrealized&lt;br /&gt;Gains&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Gross&lt;br /&gt;Unrealized&lt;br /&gt;Losses&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Fair&amp;nbsp;Value&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:51.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;"&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,253
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,254
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,253
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;18,254
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,588
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(22
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,568
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,588
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(22
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;69,568
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,841
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(28
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,822
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;"&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;52,754
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(12
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;52,747
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;296
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;8
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;304
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total U.S. government and municipal obligations&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;53,050
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;13
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(12
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;53,051
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing in one year or less&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,320
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(56
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,264
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Maturing after one year through three years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total corporate debt securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,320
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(56
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;94,264
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total marketable securities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,370
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;13
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(68
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;147,315
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:77.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Other&amp;nbsp;Long-Term&lt;br /&gt;Liabilities:&lt;br /&gt;Contingent&lt;br /&gt;Consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Fair value adjustments included in operating expenses&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:19.04%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;4,400
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;48,600
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:17.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock>
  <us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The acquisition-date fair value of the consideration transferred consisted of the following (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Fair value of common stock issued for upfront payment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.60%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,397
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Fair value of contingent consideration&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;44,200
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Kolltan transaction expenses paid in cash by the Company&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,768
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total consideration transferred&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;121,365
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock>
  <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Three&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Six&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Research and development&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,871
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,008
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,764
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,824
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;General and administrative&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,579
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,965
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,225
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;4,089
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total stock-based compensation expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,450
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;3,973
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6,989
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,913
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
  <us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;June&amp;nbsp;30,&amp;nbsp;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;December&amp;nbsp;31,&amp;nbsp;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Estimated&lt;br /&gt;Life&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Accumulated&lt;br /&gt;Amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Cost&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Accumulated&lt;br /&gt;Amortization&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="19" valign="bottom" style="width:77.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;(In&amp;nbsp;thousands)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Intangible Assets:&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;IPR&amp;amp;D&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Indefinite&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;73,490
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Amgen Amendment&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;16 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;14,500
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,951
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,549
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;14,500
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,503
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,997
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total Intangible Assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,990
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,951
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;81,039
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;87,990
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(6,503
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;81,487
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Indefinite&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;90,976
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:07.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock>
  <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Cash&amp;nbsp;and&amp;nbsp;cash&amp;nbsp;equivalents&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.60%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;nbsp;8,160&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Other current and long-term assets&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;799
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Property and equipment, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,072
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;In-process research and development (IPR&amp;amp;D)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;61,690
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Goodwill&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;82,011
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Deferred tax liabilities, net&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(23,393
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Other assumed liabilities&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(9,974
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Total&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;121,365
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:80.62%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:03.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.26%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
  <us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The activity related to accrued lease restructuring for the six months ended June&amp;nbsp;30, 2017 is presented below (in thousands):&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Accrued&amp;nbsp;Lease&lt;br /&gt;Restructuring&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,154
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expense&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;267
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Payments&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(271
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Balance at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1,150
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:82.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.16%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock>
  <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;"&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"&gt;&lt;/font&gt;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Shares&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Weighted&lt;br /&gt;Average&lt;br /&gt;Exercise&lt;br /&gt;Price&lt;br /&gt;Per&amp;nbsp;Share&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Weighted&lt;br /&gt;Average&lt;br /&gt;Remaining&lt;br /&gt;Contractual&lt;br /&gt;Term&amp;nbsp;(In&amp;nbsp;Years)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Outstanding at December&amp;nbsp;31, 2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10,218,710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;11.14
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6.5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Granted&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2,283,100
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;2.34
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Exercised&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;&amp;#x2014;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Canceled&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;(413,100
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;)&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10.66
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Outstanding at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;12,088,710
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9.49
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6.5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;"&gt;
						&lt;font style="display:inline;font-size:1pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Vested and Expected to Vest at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;11,931,869
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;9.54
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;6.5
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Options Exercisable at June&amp;nbsp;30, 2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,085,429
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;$&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;10.93
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;4.7
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:55.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Shares Available for Grant under the 2008 Plan&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;7,292,650
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
  <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;div style="width:100%;"&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;"&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Three&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;Six&amp;nbsp;months&amp;nbsp;ended&amp;nbsp;June&amp;nbsp;30,&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="bottom" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-size:8pt;"&gt;&amp;nbsp;&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2017&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;"&gt;
						&lt;font style="display:inline;font-weight:bold;font-size:8pt;"&gt;2016&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expected stock price volatility&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;76%
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;77%
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;76 &amp;#x2013; 77%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;70 &amp;#x2013; 77%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expected option term&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;6.0 years&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Risk-free interest rate&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;2.0 &amp;#x2013; 2.1%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"&gt;&lt;div style="float:left"&gt;&lt;/div&gt;1.5%
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;2.0 &amp;#x2013; 2.3%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;1.5 &amp;#x2013; 1.6%&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
			&lt;tr&gt;
				&lt;td valign="top" style="width:41.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;Expected dividend yield&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:02.50%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:12.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&lt;font style="display:inline;"&gt;None&lt;/font&gt;&lt;/p&gt;
				&lt;/td&gt;
				&lt;td valign="bottom" style="width:01.00%;padding:0pt;"&gt;
					&lt;p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
						&amp;nbsp;&lt;/p&gt;
				&lt;/td&gt;
			&lt;/tr&gt;
		&lt;/table&gt;&lt;/div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
  <us-gaap:ShareBasedCompensation contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit1" decimals="-3">7913000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensation contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit1" decimals="-3">6989000</us-gaap:ShareBasedCompensation>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="2">0.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="2">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="2">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.77</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.7</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.76</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate contextRef="Duration_4_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="3">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.023</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="3">0.021</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="Duration_1_1_2016_To_6_30_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="INF">0.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum contextRef="Duration_4_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit14" decimals="3">0.020</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">7292650</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">7085429</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">10.93</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P4Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">413100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">2283100</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">1.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="As_Of_12_31_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">10218710</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">12088710</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="As_Of_12_31_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">11.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">9.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Duration_1_1_2016_To_12_31_2016_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
  <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1 contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit13" decimals="INF">11931869</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
  <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice contextRef="As_Of_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">9.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">10.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
  <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_AwardTypeAxis_cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" unitRef="Unit12" decimals="2">2.34</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
  <us-gaap:SharePrice contextRef="As_Of_11_29_2016_us-gaap_BusinessAcquisitionAxis_cldx_KolltanPharmaceuticalsMember" unitRef="Unit12" decimals="2">4.02</us-gaap:SharePrice>
  <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(2)&amp;nbsp; Significant Accounting Policies&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:35pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and six months ended June&amp;nbsp;30, 2017 are consistent with those discussed in Note 2 to the financial statements in our Annual Report on Form&amp;nbsp;10-K for the year ended December&amp;nbsp;31, 2016, except for the adoption of new accounting standards during the first six months of 2017 as discussed below.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Newly-Adopted Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On January&amp;nbsp;1, 2017, the Company adopted a new U.S.&amp;nbsp;GAAP accounting standard which involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company elected to continue to estimate forfeitures expected to occur to determine stock-based compensation expense. Upon adoption, the Company&amp;#x2019;s gross deferred tax assets and corresponding valuation allowance each increased by $17.7 million related to tax deductions from the exercise of stock options that previously would have been credited to additional paid-in-capital when realized.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;On January&amp;nbsp;1, 2017, the Company adopted a new U.S.&amp;nbsp;GAAP accounting standard which simplifies how an entity is required to test goodwill for impairment. A goodwill impairment will be measured by the amount by which a reporting unit&amp;#x2019;s carrying value exceeds its fair value, with the amount of impairment not to exceed the carrying amount of goodwill.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&amp;#x2019;s financial position or results of operations upon adoption.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In May&amp;nbsp;2014, the FASB issued a new U.S GAAP accounting standard that updates guidance and disclosure requirements for recognizing revenue. The new revenue recognition standard provides a five-step model for recognizing revenue from contracts with customers. The core principle is that a company should recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard will be effective for the Company on January&amp;nbsp;1, 2018 and can be applied using one of two methods: retrospectively to each prior period presented or a modified retrospective application by recognizing a cumulative-effect adjustment as a component of equity as of the date of adoption. The Company expects to adopt the new revenue standard using the modified retrospective application method. As of June&amp;nbsp;30, 2017, the Company is still evaluating the impact the adoption of this standard will have on the Company&amp;#x2019;s financial statements and disclosure. During the second half of 2017, the Company plans to finalize its review of all applicable contracts that will be affected by the adoption of this standard.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In February&amp;nbsp;2016, the FASB issued a new U.S. GAAP accounting standard which requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for the Company on January&amp;nbsp;1, 2019. The Company is currently evaluating the potential impact that this standard may have on the Company&amp;#x2019;s financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In August&amp;nbsp;2016, the FASB issued new U.S. GAAP guidance which clarifies the classification of certain cash receipts and payments in the statement of cash flows. This standard is effective for the company on January&amp;nbsp;1, 2018. The adoption of this new guidance is not expected to have a material impact on the Company&amp;#x2019;s financial statements.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
  <us-gaap:StockholdersEquity contextRef="As_Of_12_31_2016" unitRef="Unit1" decimals="-3">265431000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_12_31_2016_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="Unit1" decimals="-3">-55000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_12_31_2016_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="-3">2541000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_12_31_2016_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="Unit1" decimals="-3">2596000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_6_30_2017" unitRef="Unit1" decimals="-3">231457000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" unitRef="Unit1" decimals="-3">-19000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember" unitRef="Unit1" decimals="-3">2577000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquity contextRef="As_Of_6_30_2017_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedTranslationAdjustmentMember" unitRef="Unit1" decimals="-3">2596000</us-gaap:StockholdersEquity>
  <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="Duration_1_1_2017_To_6_30_2017">&lt;div&gt; &lt;div&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;font-weight:bold;"&gt;(7)&amp;nbsp;Stockholders&amp;#x2019; Equity&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;In May&amp;nbsp;2016, the Company entered into an agreement with Cantor Fitzgerald&amp;nbsp;&amp;amp;&amp;nbsp;Co. (&amp;#x201C;Cantor&amp;#x201D;) to allow the Company to issue and sell shares of its common stock having an aggregate offering price of up to $60.0&amp;nbsp;million from time to time through Cantor, acting as agent. During the six months ended June&amp;nbsp;30, 2017, Company issued 6,731,066 shares of its common stock under this controlled equity offering sales agreement with Cantor resulting in net proceeds to the Company of $21.5 million, after deducting commission and offering expenses. At June&amp;nbsp;30, 2017, the Company had $23.1 million remaining in aggregate gross offering price available under the agreement.&lt;/font&gt;
		&lt;/p&gt;
		&lt;p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;"&gt;
			&lt;font style="display:inline;"&gt;&amp;nbsp;&lt;/font&gt;
		&lt;/p&gt;&lt;div /&gt;&lt;/div&gt; &lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
  <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="Duration_1_1_2017_To_6_30_2017_us-gaap_CounterpartyNameAxis_cldx_CantorFitzgeraldAndCompanyAgreementMember" unitRef="Unit13" decimals="INF">6731066</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Duration_1_1_2016_To_6_30_2016" unitRef="Unit13" decimals="-3">98753000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Duration_4_1_2016_To_6_30_2016" unitRef="Unit13" decimals="-3">98817000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Duration_1_1_2017_To_6_30_2017" unitRef="Unit13" decimals="-3">123932000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted contextRef="Duration_4_1_2017_To_6_30_2017" unitRef="Unit13" decimals="-3">125202000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
  <!--Footnote Section-->
</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cldx-20170630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--XBRL document created with Merrill Bridge  7.2.100.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2017 7:43:03 PM-->
<!--Modified on: 8/3/2017 7:43:03 PM-->
<xsd:schema targetNamespace="http://www.celldextherapeutics.com/20170630" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:cldx="http://www.celldextherapeutics.com/20170630" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2014-01-31" xmlns:attributeFormDefault="unqualified" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2016-01-31" xmlns:us-types="http://fasb.org/us-types/2016-01-31" xmlns:us-roles="http://fasb.org/us-roles/2016-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated">
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets" id="StatementCondensedConsolidatedBalanceSheets">
        <link:definition>00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" id="StatementCondensedConsolidatedStatementsOfCashFlows">
        <link:definition>00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" id="DisclosureFairValueMeasurementsDetails">
        <link:definition>40301 - Disclosure - Fair Value Measurements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" id="DisclosureMarketableSecuritiesDetails">
        <link:definition>40401 - Disclosure - Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" id="DisclosureIntangibleAssetsAndGoodwillDetails">
        <link:definition>40501 - Disclosure - Intangible Assets and Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" id="DisclosureOtherLongTermLiabilitiesDetails">
        <link:definition>40601 - Disclosure - Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetailss" id="DisclosureIntangibleAssetsAndGoodwillDetailss">
        <link:definition>40702 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetailsCalc2" id="DisclosureOtherLongTermLiabilitiesDetailsCalc2">
        <link:definition>40802 - Disclosure - Other Long-Term Liabilities (Details) (Calc 2)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" id="DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails">
        <link:definition>41102 - Disclosure - Kolltan Acquisition - Allocations of Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DocumentDocumentAndEntityInformation" id="DocumentDocumentAndEntityInformation">
        <link:definition>00090 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" id="StatementCondensedConsolidatedBalanceSheetsParenthetical">
        <link:definition>00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation" id="DisclosureBasisOfPresentation">
        <link:definition>10101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies" id="DisclosureSignificantAccountingPolicies">
        <link:definition>10201 - Disclosure - Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements" id="DisclosureFairValueMeasurements">
        <link:definition>10301 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities" id="DisclosureMarketableSecurities">
        <link:definition>10401 - Disclosure - Marketable Securities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill" id="DisclosureIntangibleAssetsAndGoodwill">
        <link:definition>10501 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities" id="DisclosureOtherLongTermLiabilities">
        <link:definition>10601 - Disclosure - Other Long-Term Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
        <link:definition>10701 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation" id="DisclosureStockBasedCompensation">
        <link:definition>10801 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome" id="DisclosureAccumulatedOtherComprehensiveIncome">
        <link:definition>10901 - Disclosure - Accumulated Other Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenue" id="DisclosureRevenue">
        <link:definition>11001 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition" id="DisclosureKolltanAcquisition">
        <link:definition>11101 - Disclosure - Kolltan Acquisition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes" id="DisclosureIncomeTaxes">
        <link:definition>11201 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare" id="DisclosureNetLossPerShare">
        <link:definition>11301 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies" id="DisclosureSignificantAccountingPoliciesPolicies">
        <link:definition>20202 - Disclosure - Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables" id="DisclosureFairValueMeasurementsTables">
        <link:definition>30303 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables" id="DisclosureMarketableSecuritiesTables">
        <link:definition>30403 - Disclosure - Marketable Securities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables" id="DisclosureIntangibleAssetsAndGoodwillTables">
        <link:definition>30503 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables" id="DisclosureOtherLongTermLiabilitiesTables">
        <link:definition>30603 - Disclosure - Other Long-Term Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables" id="DisclosureStockBasedCompensationTables">
        <link:definition>30803 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables" id="DisclosureAccumulatedOtherComprehensiveIncomeTables">
        <link:definition>30903 - Disclosure - Accumulated Other Comprehensive Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionTables" id="DisclosureKolltanAcquisitionTables">
        <link:definition>31103 - Disclosure - Kolltan Acquisition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables" id="DisclosureNetLossPerShareTables">
        <link:definition>31303 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentationDetails" id="DisclosureBasisOfPresentationDetails">
        <link:definition>40101 - Disclosure - Basis of Presentation - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesDetails" id="DisclosureSignificantAccountingPoliciesDetails">
        <link:definition>40201 - Disclosure - Significant Accounting Policies - (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" id="DisclosureStockholdersEquityDetails">
        <link:definition>40701 - Disclosure - Stockholders' Equity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationSummaryOfPlansDetails" id="DisclosureStockBasedCompensationSummaryOfPlansDetails">
        <link:definition>40801 - Disclosure - Stock-Based Compensation - Summary of Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" id="DisclosureStockBasedCompensationValuationAndExpensesInformationDetails">
        <link:definition>40802 - Disclosure - Stock-Based Compensation - Valuation and Expenses Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails" id="DisclosureAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>40901 - Disclosure - Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" id="DisclosureRevenueDetails">
        <link:definition>41001 - Disclosure - Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionPurchasePriceDetails" id="DisclosureKolltanAcquisitionPurchasePriceDetails">
        <link:definition>41101 - Disclosure - Kolltan Acquisition- Purchase Price (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails" id="DisclosureIncomeTaxesDetails">
        <link:definition>41201 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" id="DisclosureNetLossPerShareDetails">
        <link:definition>41301 - Disclosure - Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20170630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20170630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20170630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cldx-20170630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xsd:import namespace="http://xbrl.sec.gov/dei/2014-01-31" schemaLocation="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd" />
  <xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xsd:import namespace="http://fasb.org/us-gaap/2016-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd" />
  <xsd:element name="RockefellerUniversityMember" id="cldx_RockefellerUniversityMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="CuraGenCorporationMember" id="cldx_CuraGenCorporationMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DocumentAndEntityInformationAbstract" id="cldx_DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element id="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" name="RevenueFromProductDevelopmentAndLicensingAgreements" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_RevenueFromContractsAndGrants" name="RevenueFromContractsAndGrants" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <xsd:element name="SignificantRevenueArrangementsDisclosureAbstract" id="cldx_SignificantRevenueArrangementsDisclosureAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element id="cldx_SignificantRevenueArrangementsDisclosureTextBlock" name="SignificantRevenueArrangementsDisclosureTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <xsd:element name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" id="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AmgenAmendmentMember" id="cldx_AmgenAmendmentMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" id="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="DeferredIncomeFromSaleOfTaxBenefits" id="cldx_DeferredIncomeFromSaleOfTaxBenefits" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <xsd:element name="ValueOfTaxBenefitsAgreedToBeSold" id="cldx_ValueOfTaxBenefitsAgreedToBeSold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="PeriodForWhichBaseOfOperationsMustBeMaintained" id="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" type="xbrli:durationItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" id="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockholdersEquityTable" id="cldx_StockholdersEquityTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="StockholdersEquityLineItems" id="cldx_StockholdersEquityLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="USGovernmentAndMunicipalObligationsMember" id="cldx_USGovernmentAndMunicipalObligationsMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <element id="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <xsd:element name="AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" id="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element id="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" name="AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <xsd:element name="AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" id="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" id="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration" />
  <element id="cldx_CollaborativeArrangementAgreementTerm" name="CollaborativeArrangementAgreementTerm" nillable="true" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <xsd:element name="ValueAtWhichTaxBenefitsSold" id="cldx_ValueAtWhichTaxBenefitsSold" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="duration" />
  <xsd:element name="FairValueAssetsAmountTransfersBetweenMeasurementLevels" id="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="instant" />
  <xsd:element name="FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" id="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="credit" xbrli:periodType="instant" />
  <element id="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" name="AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" name="AccumulatedOtherComprehensiveIncomeLossRollForward" nillable="true" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_ReimbursementOfExternalCostsIncurredPercentage" name="ReimbursementOfExternalCostsIncurredPercentage" nillable="true" type="num:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" name="ScheduleOfOtherLongTermLiabilitiesTableTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BristolMeyersSquibbCompanyMember" name="BristolMeyersSquibbCompanyMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_CantorFitzgeraldAndCompanyAgreementMember" name="CantorFitzgeraldAndCompanyAgreementMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_StockIssuedAuthorizedAmount" name="StockIssuedAuthorizedAmount" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_StockIssuedRemainingAuthorizedAmount" name="StockIssuedRemainingAuthorizedAmount" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_KolltanPharmaceuticalsMember" name="KolltanPharmaceuticalsMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" name="BusinessAcquisitionStockIssuedInLieuOfSeverance" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessAcquisitionMileStonePayments" name="BusinessAcquisitionMileStonePayments" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_NeedhamExpansionMember" name="NeedhamExpansionMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_LongTermSeveranceLiability" name="LongTermSeveranceLiability" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" name="BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" nillable="true" type="num:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" name="BusinessAcquisitionStockIssuableInLieuOfSeverance" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance" name="SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="credit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_CDX1058Member" name="CDX1058Member" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_CDX3379Member" name="CDX3379Member" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_TMProgramMember" name="TMProgramMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BranfordCTMember" name="BranfordCTMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_AccountingStandardsUpdateMember" name="AccountingStandardsUpdateMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" name="GrossDeferredTaxAssetsAndCorrespondingValuation" nillable="true" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xbrli:balance="debit" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_BusinessAcquisitionRemainingStockObligation" name="BusinessAcquisitionRemainingStockObligation" nillable="true" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" name="NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" nillable="true" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
  <element id="cldx_InternationalAidsVaccineInitiativeMember" name="InternationalAidsVaccineInitiativeMember" nillable="true" type="nonnum:domainItemType" substitutionGroup="xbrli:item" abstract="true" xbrli:periodType="duration" xmlns="http://www.w3.org/2001/XMLSchema" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>cldx-20170630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--XBRL document created with Merrill Bridge  7.2.100.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2017 7:43:03 PM-->
<!--Modified on: 8/3/2017 7:43:03 PM-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureMarketableSecuritiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIntangibleAssetsAndGoodwillDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureOtherLongTermLiabilitiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIntangibleAssetsAndGoodwillDetailss" roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetailss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureOtherLongTermLiabilitiesDetailsCalc2" roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetailsCalc2" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_636373861819150247" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent_636373861819150247" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_636373861819150247" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_636373861819150247" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_636373861819150247" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_636373861819150247" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_636373861819150247" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_636373861819150247" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_636373861819150247" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_636373861819150247" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_636373861819150247" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_636373861819150247" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent_636373861819150247" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_636373861819150247" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_636373861819150247" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_636373861819150247" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_636373861819160248" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent_636373861819160248" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Goodwill_636373861819160248" order="5" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities_636373861819160248" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_636373861819160248" xlink:to="us-gaap_LiabilitiesCurrent_636373861819160248" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_636373861819160248" xlink:to="us-gaap_AccountsPayableCurrent_636373861819160248" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_636373861819160248" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_636373861819160248" xlink:to="us-gaap_AccruedLiabilitiesCurrent_636373861819160248" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent_636373861819160248" xlink:to="us-gaap_OtherLiabilitiesCurrent_636373861819170249" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities_636373861819160248" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_636373861819170249" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity_636373861819170249" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_636373861819170249" xlink:to="us-gaap_PreferredStockValue_636373861819170249" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_636373861819170249" xlink:to="us-gaap_CommonStockValue_636373861819170249" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_636373861819170249" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_636373861819170249" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_636373861819170249" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_636373861819170249" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_636373861819170249" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_636373861819180250" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity_636373861819170249" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_636373861819180250" order="5" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended" xlink:title="00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819180250" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819180250" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_636373861819180250" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819180250" xlink:to="us-gaap_OperatingIncomeLoss_636373861819180250" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_636373861819180250" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_636373861819180250" xlink:to="us-gaap_Revenues_636373861819180250" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_636373861819180250" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues_636373861819180250" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_636373861819180250" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants_636373861819180250" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Revenues_636373861819180250" xlink:to="cldx_RevenueFromContractsAndGrants_636373861819180250" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss_636373861819180250" xlink:to="us-gaap_CostsAndExpenses_636373861819190251" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_636373861819190251" xlink:to="us-gaap_ResearchAndDevelopmentExpense_636373861819190251" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_636373861819190251" xlink:to="us-gaap_GeneralAndAdministrativeExpense_636373861819190251" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_636373861819190251" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819190251" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CostsAndExpenses_636373861819190251" xlink:to="us-gaap_AmortizationOfIntangibleAssets_636373861819190251" order="4" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819180250" xlink:to="us-gaap_InterestAndOtherIncome_636373861819190251" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_636373861819190251" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_636373861819190251" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" order="1" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819200252" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_DepreciationDepletionAndAmortization_636373861819200252" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_AmortizationOfIntangibleAssets_636373861819200252" order="3" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_636373861819200252" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_636373861819200252" order="5" use="optional" weight="-1" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819200252" order="6" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_ShareBasedCompensation_636373861819200252" order="7" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_636373861819200252" order="8" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_636373861819200252" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_636373861819200252" order="9" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_636373861819210253" order="10" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_636373861819210253" order="11" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636373861819210253" order="12" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819200252" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_636373861819210253" order="13" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819210253" order="2" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819210253" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_636373861819210253" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819210253" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_636373861819210253" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_636373861819210253" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819210253" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_636373861819210253" order="3" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_636373861819220254" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819210253" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_636373861819220254" order="4" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_636373861819220254" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_636373861819220254" order="3" use="optional" weight="1" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_636373861819220254" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_636373861819220254" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_636373861819220254" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans_636373861819220254" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities_636373861819220254" xlink:to="us-gaap_ProceedsFromStockPlans_636373861819220254" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Fair Value Measurements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_636373861819230255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_636373861819230255" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities_636373861819230255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AvailableForSaleSecurities_636373861819230255" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_636373861819230255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_636373861819230255" order="1" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Marketable Securities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_636373861819230255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_636373861819230255" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_636373861819230255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_636373861819230255" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_636373861819230255" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_636373861819230255" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_636373861819240256" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_636373861819240256" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_636373861819240256" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_636373861819240256" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_636373861819240256" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_636373861819240256" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_636373861819240256" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_636373861819240256" order="1" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Intangible Assets and Goodwill (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_636373861819250257" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_636373861819250257" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_636373861819250257" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_636373861819250257" order="2" use="optional" weight="-1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_636373861819250257" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_636373861819250257" order="1" use="optional" weight="1" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_636373861819250257" order="2" use="optional" weight="-1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Other Long-Term Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_636373861819250257" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_636373861819250257" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits_636373861819250257" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="cldx_DeferredIncomeFromSaleOfTaxBenefits_636373861819250257" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DeferredRentCredit_636373861819260258" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DeferredRevenue_636373861819260258" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_636373861819260258" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_LongTermSeveranceLiability" xlink:label="cldx_LongTermSeveranceLiability_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="cldx_LongTermSeveranceLiability_636373861819260258" order="6" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_RestructuringReserve_636373861819260258" order="7" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetailss" xlink:type="extended" xlink:title="40702 - Disclosure - INTANGIBLE ASSETS AND GOODWILL (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_636373861819260258" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_636373861819260258" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_636373861819260258" order="2" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_636373861819270259" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_636373861819270259" order="1" use="optional" weight="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_636373861819270259" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_636373861819270259" order="2" use="optional" weight="1" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetailsCalc2" xlink:type="extended" xlink:title="40802 - Disclosure - Other Long-Term Liabilities (Details) (Calc 2)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_636373861819270259" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilitiesCurrent_636373861819270259" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_636373861819270259" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_636373861819270259" order="2" use="optional" weight="1" priority="2" />
  </calculationLink>
  <calculationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Kolltan Acquisition - Allocations of Assets and Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_636373861819270259" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_636373861819270259" order="1" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_636373861819270259" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_636373861819270259" order="2" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_636373861819280260" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_636373861819280260" order="3" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_636373861819280260" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_636373861819280260" order="4" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_636373861819280260" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_Goodwill_636373861819280260" order="5" use="optional" weight="1" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_636373861819280260" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_636373861819280260" order="6" use="optional" weight="-1" priority="2" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_636373861819280260" />
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_636373861819280260" order="7" use="optional" weight="-1" priority="2" />
  </calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>cldx-20170630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--XBRL document created with Merrill Bridge  7.2.100.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2017 7:43:03 PM-->
<!--Modified on: 8/3/2017 7:43:03 PM-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_DocumentAndEntityInformationAbstract" xlink:label="cldx_DocumentAndEntityInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="cldx_DocumentAndEntityInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_DocumentAndEntityInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document and Entity Information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Statement [Line Items]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Registrant Name</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Central Index Key</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Type</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Period End Date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amendment Flag</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Fiscal Year End Date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Current Reporting Status</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Filer Category</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Entity Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Year Focus</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Document Fiscal Period Focus</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED BALANCE SHEETS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">ASSETS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, at Carrying Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents at End of Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents at Beginning of Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities, Debt Securities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts and Other Receivables, Net, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts and Other Receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid Expense and Other Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid and Other Current Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Current Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property, Plant and Equipment, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and Equipment, Net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Net (Excluding Goodwill)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Goodwill" xlink:to="us-gaap_Goodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_Goodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Assets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">LIABILITIES AND STOCKHOLDERS' EQUITY</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Less Current Portion</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Current Portion of Long-Term Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities, Current</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Current Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-Term Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-Term Portion</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Liabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingencies" xlink:to="us-gaap_CommitmentsAndContingencies_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingencies.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommitmentsAndContingencies_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Commitments and Contingent Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_PreferredStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2017 and December 31, 2016</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Value, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CommonStockValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 127,411,975 and 120,516,654 Shares Issued and Outstanding at June 30, 2017 and December 31, 2016, respectively</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid in Capital, Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional Paid-In Capital</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Retained Earnings (Accumulated Deficit)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Deficit</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">StockholdersEquity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at June 30, 2017</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at December 31, 2016</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_StockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities and Equity</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Liabilities and Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Preferred Stock, Par Value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Preferred Stock, Shares Authorized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Preferred Stock, Shares Issued</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Preferred Stock, Shares Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Convertible Preferred Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Par or Stated Value Per Share</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Par Value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Authorized</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Authorized</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Issued</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Issued</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares, Outstanding</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common Stock, Shares Outstanding</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RevenuesAbstract" xlink:to="us-gaap_RevenuesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RevenuesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">REVENUE:</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element represents revenue from product development and licensing agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Product Development and Licensing Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Product Development and Licensing Agreements</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Product development and licensing agreements revenue</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RevenueFromContractsAndGrants" xlink:to="cldx_RevenueFromContractsAndGrants_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_RevenueFromContractsAndGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element represents revenue earned during the period arising from products sold or services provided under the terms of a contract. Also include revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_RevenueFromContractsAndGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue from Contracts and Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_RevenueFromContractsAndGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contracts and Grants</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cldx_RevenueFromContractsAndGrants_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contracts and grants revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Revenues" xlink:to="us-gaap_Revenues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_Revenues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpensesAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Costs and Expenses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CostsAndExpensesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">OPERATING EXPENSE:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and Development</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and Administrative Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and Administrative</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss on Fair Value Remeasurement of Contingent Consideration</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value adjustments included in operating expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfIntangibleAssets" xlink:to="us-gaap_AmortizationOfIntangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/positiveLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization expense for intangible assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Acquired Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_AmortizationOfIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CostsAndExpenses" xlink:to="us-gaap_CostsAndExpenses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Costs and Expenses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CostsAndExpenses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Operating Expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Operating Loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestAndOtherIncome" xlink:to="us-gaap_InterestAndOtherIncome_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest and Other Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestAndOtherIncome_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment and Other Income, Net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Income (Loss) Available to Common Stockholders, Basic</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Loss</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share, Basic and Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic and Diluted Net Loss Per Common Share (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Number of Shares Outstanding, Basic and Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">COMPREHENSIVE LOSS:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized Gain on Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Loss</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flows from Operating Activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DepreciationDepletionAndAmortization" xlink:to="us-gaap_DepreciationDepletionAndAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation, Depletion and Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DepreciationDepletionAndAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Depreciation and Amortization</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accretion (Amortization) of Discounts and Premiums, Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization and Premium of Marketable Securities, Net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (Loss) on Disposition of Property Plant Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Loss on Sale or Disposal of Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation Expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AmortizationOfDebtDiscountPremium" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortization of Debt Discount (Premium)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-Cash Expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Operating Capital [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in Operating Assets and Liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts and Other Receivables</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts and Other Receivables</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Prepaid Expense and Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Prepaid and Other Current Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Other Operating Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Accounts Payable and Accrued Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounts Payable and Accrued Expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase (Decrease) in Other Operating Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Operating Activities, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net cash used in operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Used in Operating Activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flows from Investing Activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Sale and Maturity of Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Sales and Maturities of Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Marketable Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Purchases of Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Other Investments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investment in Other</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments to Acquire Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition of Property and Equipment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Investing Activities, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by Investing Activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flows from Financing Activities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Common Stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net proceeds from sale of common stock</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Proceeds from Stock Issuances</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockPlans" xlink:to="us-gaap_ProceedsFromStockPlans_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Stock Plans</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProceedsFromStockPlans_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Proceeds from Issuance of Stock from Employee Benefit Plans</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by (Used in) Financing Activities, Continuing Operations</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Cash Provided by Financing Activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, Period Increase (Decrease)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Increase (Decrease) in Cash and Cash Equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-cash Investing Activities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Capital Expenditures Incurred but Not yet Paid</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Supplemental Cash Flow Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Non-cash Supplemental Disclosure</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance" xlink:label="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance" xlink:to="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the value of shares issued to certain executive for settlement in lieu of cash payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Issued To Former Kolltan Executive For Settlement of Severance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued to former Kolltan executive for settlement of severance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Presentation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccounting" xlink:to="us-gaap_BasisOfAccounting_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Accounting [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BasisOfAccounting_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basis of Presentation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Accounting Policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Accounting Policies [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Accounting Policies</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Disclosures [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets and Goodwill</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill and Intangible Assets Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets and Goodwill</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-Term Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-Term Liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity Note Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Comprehensive Income (Loss) Note [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:to="cldx_SignificantRevenueArrangementsDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:to="cldx_SignificantRevenueArrangementsDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">This element may be used to capture the complete disclosure pertaining to an entity's significant revenue contracts and arrangements.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Significant Revenue Arrangements Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationsAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationsAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan Acquisition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan Acquisition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Tax Disclosure [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Taxes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Earnings Per Share [Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Loss Per Share</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of accounting policy pertaining to newly-adopted accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Newly Adopted Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Newly-Adopted Accounting Pronouncements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements, Policy [Policy Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Recent Accounting Pronouncements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of financial assets and liabilities subject to fair value measurements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of the activity for the Company's contingent consideration liabilities measured at fair value using Level 3 inputs</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Available-for-sale Securities Reconciliation [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of marketable securities, classified as available-for-sale</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Intangible Assets and Goodwill [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of intangible assets, net of accumulated amortization, and goodwill</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:to="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Tabular disclosure of other long-term liabilities, not separately disclosed on the balance sheet.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Other Long Term Liabilities [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of other long-term liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:to="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Restructuring Reserve by Type of Cost [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of activity related to accrued lease restructuring</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of stock option activity</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of assumptions used for the fair value of employee and director stock options granted</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of changes in accumulated other comprehensive income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Business Acquisitions, by Acquisition [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of acquisition-date fair value of the consideration transferred</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of fair values of the assets acquired and liabilities assumed at the acquisition date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsAndCash" xlink:to="us-gaap_InvestmentsAndCash_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InvestmentsAndCash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Investments and Cash</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InvestmentsAndCash_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash, cash equivalents and marketable securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements or Change in Accounting Principle [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Newly-Adopted Accounting Pronouncements</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" xlink:label="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" xlink:to="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross deferred tax assets and valuation allowance related to tax deductions from the exercise of stock options that would have been credited to additional paid-in-capital when realized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross deferred tax assets and corresponding valuation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Increase in deferred tax and valuation allowance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements, Recurring and Nonrecurring [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Frequency [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurement Frequency [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Measurement Frequency [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements Recurring [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Hierarchy [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Measurements Fair Value Hierarchy [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Hierarchy [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Inputs Level2 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Level 2</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value measurements</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and Cash Equivalents, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Money market funds and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecurities" xlink:to="us-gaap_AvailableForSaleSecurities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecurities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total financial assets at fair value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Consideration Classified as Equity, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at end of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance at beginning of period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan acquisition contingent consideration</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesFairValueDisclosure" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Financial and Nonfinancial Liabilities, Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total financial liabilities at fair value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Roll-forward of acquisition-related contingent consideration</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:to="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of transfer of assets measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Assets Amount Transfers between Measurement Levels</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assets transferred between the fair value measurement classifications</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:to="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of transfer of liabilities measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Liabilities Amount Transfers between Measurement Levels</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Liabilities transferred between the fair value measurement classifications</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionMileStonePayments" xlink:label="cldx_BusinessAcquisitionMileStonePayments" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessAcquisitionMileStonePayments" xlink:to="cldx_BusinessAcquisitionMileStonePayments_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessAcquisitionMileStonePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the maximum amount of milestone payments to Kolltan Stockholders pending certain commercial and product milestones.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessAcquisitionMileStonePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition Mile Stone Payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BusinessAcquisitionMileStonePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum amount of milestone payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="cldx_BusinessAcquisitionMileStonePayments_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum amount of future consideration payable</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Available-for-sale Securities [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Major Types of Debt and Equity Securities [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Major Types Of Debt And Equity Securities [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Major Types of Debt and Equity Securities [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_USGovernmentAndMunicipalObligationsMember" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_USGovernmentAndMunicipalObligationsMember" xlink:to="cldx_USGovernmentAndMunicipalObligationsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents securities issued by US government agencies and municipal governments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U S Government And Municipal Obligations [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">U.S. government and municipal obligations</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate Debt Securities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Corporate debt securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Available-for-sale Securities [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities, Debt Maturities, Amortized Cost Basis, Fiscal Year Maturity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortized Cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities, Debt Maturities, Next Twelve Months, Amortized Cost Basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing in one year or less</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Debt Maturities after One Through Three Years, Amortized Cost</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing after one year through three years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Debt Securities, Amortized Cost Basis</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amortized cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities, Gross Unrealized Gain [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Unrealized Gains</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Debt Maturities within One Year Gross Unrealized Gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing in one year or less</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature after one year and through three years from the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Debt Maturities after One Through Three Years, Gross Unrealized Gain</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing after one year through three years</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Unrealized Gains</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Gross Unrealized Losses [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Unrealized Losses</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the gross unrealized losses on securities, at a point in time, which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Debt Maturities within One Year, Gross Unrealized Losses</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing in one year or less</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gross Unrealized Losses</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities, Debt Maturities, Fair Value, Fiscal Year Maturity [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available-for-sale Securities, Debt Maturities, Next Twelve Months, Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing in one year or less</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Debt Maturities after One Through Three Years, Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maturing after one year through three years</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:to="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the amount of investment in debt and equity securities considered to be other-than-temporarily impaired, categorized neither as held-to-maturity nor trading.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Available For Sale Securities, Considered to be Other than Temporarily Impaired</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Marketable securities considered to be other-than-temporarily impaired</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InterestReceivable" xlink:to="us-gaap_InterestReceivable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InterestReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Interest Receivable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InterestReceivable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued interest included in marketable securities</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of the carrying value of purchased amortizable finite-lived intangible assets, including disclosure of the carrying value of indefinite-lived intangible assets not subject to amortization, excluding goodwill, in total and by major class.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite Lived and Indefinite Lived Intangible Assets by Major Class [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-lived Intangible Assets [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite Lived Intangible Assets Major Class Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-lived Intangible Assets, Major Class Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">In Process Research And Development [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IPR&amp;D</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets by Major Class [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite Lived Intangible Assets Major Class Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Major Class Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AmgenAmendmentMember" xlink:label="cldx_AmgenAmendmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AmgenAmendmentMember" xlink:to="cldx_AmgenAmendmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AmgenAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to an amendment to the license agreement, Amgen Amendment.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AmgenAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amgen Amendment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AmgenAmendmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amgen Amendment</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite Lived and Indefinite Lived Intangible Assets by Major Class [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets and Goodwill</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-lived intangible assets:</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-Lived Intangible Assets (Excluding Goodwill)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-lived intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Indefinite-lived Intangible Assets (Excluding Goodwill), Fair Value Disclosure</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of Intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-lived intangible asset</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Asset, Useful Life</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimated Life</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Accumulated Amortization</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Amortization</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Finite-Lived Intangible Assets, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Net (Excluding Goodwill) [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total Intangible Assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Intangible Assets, Gross (Excluding Goodwill)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cost of total intangible assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRentCredit" xlink:to="us-gaap_DeferredRentCredit_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRentCredit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Rent Credit</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRentCredit_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Rent</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Tax Liabilities, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net Deferred Tax Liabilities related to IPR&amp;D</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:to="cldx_DeferredIncomeFromSaleOfTaxBenefits_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the deferred income from the sale of tax benefit.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Income from Sale of Tax Benefits</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Income from Sale of Tax Benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserve" xlink:to="us-gaap_RestructuringReserve_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Reserve</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Ending Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Beginning Balance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringReserve_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Lease Restructuring</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_LongTermSeveranceLiability" xlink:label="cldx_LongTermSeveranceLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_LongTermSeveranceLiability" xlink:to="cldx_LongTermSeveranceLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_LongTermSeveranceLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of long term severance liability.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_LongTermSeveranceLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long Term Severance Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_LongTermSeveranceLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Long-Term Severance</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration, Liability</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent Milestones</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of contingent consideration</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredRevenue" xlink:to="us-gaap_DeferredRevenue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred Revenue</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_DeferredRevenue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred revenue</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilities" xlink:to="us-gaap_OtherLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_OtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:to="cldx_ValueOfTaxBenefitsAgreedToBeSold_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the value of tax benefits agreed to be sold by the entity during the reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value of Tax Benefits Agreed to be Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount at which New Jersey tax benefit agreed to be sold</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ValueAtWhichTaxBenefitsSold" xlink:label="cldx_ValueAtWhichTaxBenefitsSold" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ValueAtWhichTaxBenefitsSold" xlink:to="cldx_ValueAtWhichTaxBenefitsSold_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_ValueAtWhichTaxBenefitsSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the value at which tax benefit sold by the entity during the reporting period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_ValueAtWhichTaxBenefitsSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Value at which Tax Benefits Sold</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_ValueAtWhichTaxBenefitsSold_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of sale of New Jersey tax benefit</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:to="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents period for which base of operations must be maintained in New Jersey.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period for which Base of Operations Must be Maintained</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Period for which base of operations must be maintained</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GainLossOnSaleOfOtherAssets" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Gain (Loss) on Disposition of Other Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other income related to sale of tax benefits</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AreaOfLand" xlink:to="us-gaap_AreaOfLand_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Area of Land</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AreaOfLand_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expansion space (in square feet)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="us-gaap_RestructuringCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCosts" xlink:to="us-gaap_RestructuringCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_RestructuringReserveAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringReserveAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Reserve [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringReserveAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accrued Lease Restructuring</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringCharges" xlink:to="us-gaap_RestructuringCharges_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Charges</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringCharges_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRestructuring" xlink:to="us-gaap_PaymentsForRestructuring_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments for Restructuring</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_PaymentsForRestructuring_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Payments</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockholdersEquityTable" xlink:label="cldx_StockholdersEquityTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityTable" xlink:to="cldx_StockholdersEquityTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_StockholdersEquityTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Disclosure of information pertaining to changes in stockholders' equity during the period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_StockholdersEquityTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders Equity [Table]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockholdersEquityLineItems" xlink:label="cldx_StockholdersEquityLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_StockholdersEquityLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_StockholdersEquityLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_StockholdersEquityLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders Equity [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_StockholdersEquityLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stockholders' Equity</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockIssuedAuthorizedAmount" xlink:label="cldx_StockIssuedAuthorizedAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedAuthorizedAmount" xlink:to="cldx_StockIssuedAuthorizedAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_StockIssuedAuthorizedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The maximum amount of stock issued authorized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_StockIssuedAuthorizedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued, Authorized Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_StockIssuedAuthorizedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate offering price of common stock</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued During Period, Shares, New Issues</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Common stock issued (in shares)</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockIssuedRemainingAuthorizedAmount" xlink:label="cldx_StockIssuedRemainingAuthorizedAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_StockIssuedRemainingAuthorizedAmount" xlink:to="cldx_StockIssuedRemainingAuthorizedAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_StockIssuedRemainingAuthorizedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount remaining of stock issued authorized.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_StockIssuedRemainingAuthorizedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock Issued, Remaining Authorized Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_StockIssuedRemainingAuthorizedAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Aggregate gross offering price available</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Award Type [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangements By Share Based Payment Award Award Type And Plan Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Award [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">An arrangement whereby an employee, consultant or non-employee director is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the holder pays the strike value in cash to the issuing entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize recipients, in addition to other compensation and other benefits, if any.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Consultant And Non Employee Director Stock Option [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock options</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Stock-Based Compensation</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Outstanding at the end of the period (in shares)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Outstanding at beginning of the period (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canceled (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Vested and Expected to Vest at the end of the period (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Exercisable at the end of the period (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares Available for Grant under the 2008 Plan</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Exercise Price Per Share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Outstanding at the end of the period (in dollars per share)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Outstanding at beginning of the period (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Granted (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Canceled (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Vested and Expected to Vest at the end of the period (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Exercisable at the end of the period (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Based Compensation Arrangement by Share Based Payment Award, Options, Weighted Average Remaining Contractual Term [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted Average Remaining Contractual Term (In Years)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Outstanding at the end of the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Vested and Expected to Vest at the end of the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Options Exercisable at the end of the period</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Additional information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Weighted average grant-date fair value (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Income Statement Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research And Development Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Research and development</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General And Administrative Expense [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">General and administrative</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Valuation and Expenses Information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Allocated Share-based Compensation Expense</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total stock-based compensation expense</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Assumptions used for fair value of employee and director stock options granted</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected stock price volatility (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected stock price volatility, minimum (as a percent)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected stock price volatility, minimum (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected stock price volatility, maximum (as a perecnt)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected stock price volatility, maximum (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected option term</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate, minimum (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Risk-free interest rate, maximum (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Expected dividend yield (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss) [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Components [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EquityComponentDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Equity Component [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:to="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Net Unrealized Investment Gain Loss [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Unrealized Gain (Loss) on Marketable Securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Translation Adjustment [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Foreign Currency Items</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss) [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">na</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income (Loss) [Roll Forward]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Changes in accumulated other comprehensive income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amounts reclassified from other comprehensive income</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Comprehensive Income (Loss), Net of Tax</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other comprehensive gain</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Collaborative Arrangements and Non-collaborative Arrangement Transactions [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Revenue</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="cldx_CollaborativeArrangementAgreementTerm" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CollaborativeArrangementAgreementTerm" xlink:to="cldx_CollaborativeArrangementAgreementTerm_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_CollaborativeArrangementAgreementTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the term of the collaborative arrangement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_CollaborativeArrangementAgreementTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Collaborative Arrangement Agreement Term</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_CollaborativeArrangementAgreementTerm_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Term of the agreement</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ReimbursementOfExternalCostsIncurredPercentage" xlink:label="cldx_ReimbursementOfExternalCostsIncurredPercentage" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_ReimbursementOfExternalCostsIncurredPercentage" xlink:to="cldx_ReimbursementOfExternalCostsIncurredPercentage_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_ReimbursementOfExternalCostsIncurredPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents percentage of reimbursement of external costs incurred by the company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_ReimbursementOfExternalCostsIncurredPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reimbursement of external costs incurred percentage</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_ReimbursementOfExternalCostsIncurredPercentage_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Reimbursement of external costs incurred by the company (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Business Acquisitions, by Acquisition [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan Acquisition</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Equity Interest Issued or Issuable, Number of Shares</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued as part of consideration (in shares)</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" xlink:label="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" xlink:to="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of shares issuable to certain officers in lieu of cash payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition Stock Issuable, In Lieu Of Severance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issuable in lieu of cash severance obligations (in shares)</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" xlink:label="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" xlink:to="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the number of shares issued to certain officers in lieu of cash payments</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition stock issued in lieu of severance</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Shares issued in lieu of cash severance obligations (in shares)</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionRemainingStockObligation" xlink:label="cldx_BusinessAcquisitionRemainingStockObligation" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessAcquisitionRemainingStockObligation" xlink:to="cldx_BusinessAcquisitionRemainingStockObligation_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessAcquisitionRemainingStockObligation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the remaining number of shares which are to be issued to certain officers in lieu of cash payments.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessAcquisitionRemainingStockObligation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business acquisition remaining stock obligation</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BusinessAcquisitionRemainingStockObligation_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Remaining obligation (in shares)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Share Price</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_SharePrice_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Closing price of common stock (in dollars per share)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Consideration Transferred [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Acquisition-date fair value of consideration transferred</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Consideration Transferred, Equity Interests Issued and Issuable</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value of common stock issued for upfront payment</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Acquisition Related Costs</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan transaction expenses paid in cash by the Company</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Consideration Transferred</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total consideration transferred</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration, Liability, Noncurrent</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Contingent consideration, noncurrent</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsDiscountRate" xlink:to="us-gaap_FairValueInputsDiscountRate_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Inputs, Discount Rate</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsDiscountRate_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Discount rate (as a percent)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, Low</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range of estimated milestone payment, minimum</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Contingent Consideration Arrangements, Change in Range of Outcomes, Contingent Consideration, Liability, Value, High</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range of estimated milestone payment, maximum</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Goodwill, Expected Tax Deductible Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Goodwill expected to be deductible for income tax purposes</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Summary of fair values of assets acquired and liabilities assumed at acquisition date</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cash and cash equivalents</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of other and long-term assets acquired at the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Current and Long-term Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other current and long-term assets</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Property and equipment, net</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">In-process research and development (IPR&amp;D)</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Deferred tax liabilities, net</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Amount of other liabilities assumed at the acquisition date.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other assumed liabilities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Total</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationAbstract_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Pro Forma Information [Abstract]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Pro Forma Financial Information</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Pro Forma Net Income (Loss)</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Net loss</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" xlink:label="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" xlink:to="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Pro Forma Earnings Per Share, Basic And Diluted</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Basic and Diluted Net Loss Per Common Share</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfStatesInWhichEntityOperates" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of States in which Entity Operates</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Number of states in which the entity primarily operates or has operated and has income tax nexus</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities, Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedStockMember" xlink:to="us-gaap_RestrictedStockMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted Stock [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestrictedStockMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restricted stock</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Anti-dilutive securities</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for New Accounting Pronouncements [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_TypeOfAdoptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Type Of Adoption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_TypeOfAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Type of Adoption [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AccountingStandardsUpdateMember" xlink:label="cldx_AccountingStandardsUpdateMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_AccountingStandardsUpdateMember" xlink:to="cldx_AccountingStandardsUpdateMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_AccountingStandardsUpdateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to the Accounting Standards Update which involves several aspects of the accounting for share-based payment transactions.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_AccountingStandardsUpdateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Standards Update [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_AccountingStandardsUpdateMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accounting Standards Update</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:to="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Pronouncement, Early Adoption [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:to="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Principles Early Adoption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">New Accounting Principles, Early Adoption [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" xlink:label="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" xlink:to="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments For New Accounting Principle Early Adoption [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Adjustments for New Accounting Principle, Early Adoption</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Measurement Basis [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Portion At Fair Value Fair Value Disclosure [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Portion at Fair Value Measurement [Member]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Estimate Of Fair Value Fair Value Disclosure [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair value</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Fair Value Inputs Level3 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Level 3</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition Acquiree [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Business Acquisition, Acquiree [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_KolltanPharmaceuticalsMember" xlink:to="cldx_KolltanPharmaceuticalsMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_KolltanPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to Kolltan, a privately-held, clinical-stage biopharmaceutical company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_KolltanPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan Pharmaceuticals [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_KolltanPharmaceuticalsMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Kolltan</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance Sheet Location [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance Sheet Location [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Balance Sheet Location [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Noncurrent Liabilities [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Other Long-Term Liabilities</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CuraGenCorporationMember" xlink:to="cldx_CuraGenCorporationMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_CuraGenCorporationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to CuraGen Corporation.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_CuraGenCorporationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cura Gen Corporation [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_CuraGenCorporationMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CuraGen</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductOrServiceAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductOrServiceAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products and Services [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="us-gaap_ProductsAndServicesDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_ProductsAndServicesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products And Services [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_ProductsAndServicesDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Products and Services [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CDX1058Member" xlink:label="cldx_CDX1058Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CDX1058Member" xlink:to="cldx_CDX1058Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_CDX1058Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information pertaining to CDX-0158.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_CDX1058Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">C D X1058 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_CDX1058Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CDX-0158</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CDX3379Member" xlink:label="cldx_CDX3379Member" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CDX3379Member" xlink:to="cldx_CDX3379Member_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_CDX3379Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to CDX-3379.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_CDX3379Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">C D X3379 [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_CDX3379Member_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">CDX-3379</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_TMProgramMember" xlink:label="cldx_TMProgramMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_TMProgramMember" xlink:to="cldx_TMProgramMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_TMProgramMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to TAM program.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_TMProgramMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">T M Program [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_TMProgramMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">TAM</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringPlanAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Plan [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="us-gaap_RestructuringPlanDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RestructuringPlanDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Plan [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RestructuringPlanDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Restructuring Plan [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_NeedhamExpansionMember" xlink:label="cldx_NeedhamExpansionMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_NeedhamExpansionMember" xlink:to="cldx_NeedhamExpansionMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_NeedhamExpansionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information pertaining to Needham Expansion.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_NeedhamExpansionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Needham Expansion [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_NeedhamExpansionMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Needham Expansion</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BranfordCTMember" xlink:label="cldx_BranfordCTMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BranfordCTMember" xlink:to="cldx_BranfordCTMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BranfordCTMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents the information about the branford lease termination.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BranfordCTMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Branford C T [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BranfordCTMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Branford, CT lease termination</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="us-gaap_CounterpartyNameAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_CounterpartyNameAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparty Name [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Repurchase Agreement Counterparty Name [Domain]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Counterparty Name [Domain]</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CantorFitzgeraldAndCompanyAgreementMember" xlink:label="cldx_CantorFitzgeraldAndCompanyAgreementMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_CantorFitzgeraldAndCompanyAgreementMember" xlink:to="cldx_CantorFitzgeraldAndCompanyAgreementMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_CantorFitzgeraldAndCompanyAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents details about the Cantor Fitzgerald &amp; Co. agreement.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_CantorFitzgeraldAndCompanyAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cantor Fitzgerald And Company Agreement [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_CantorFitzgeraldAndCompanyAgreementMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Cantor agreement</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeAxis_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeAxis_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [Axis]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_RangeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_RangeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Range [Domain]</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MaximumMember" xlink:to="us-gaap_MaximumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MaximumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Maximum</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Accumulated Other Comprehensive Income</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BristolMeyersSquibbCompanyMember" xlink:label="cldx_BristolMeyersSquibbCompanyMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_BristolMeyersSquibbCompanyMember" xlink:to="cldx_BristolMeyersSquibbCompanyMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_BristolMeyersSquibbCompanyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to Bristol Meyers Squibb Company.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_BristolMeyersSquibbCompanyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Bristol Meyers Squibb Company [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_BristolMeyersSquibbCompanyMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">BMS</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RockefellerUniversityMember" xlink:label="cldx_RockefellerUniversityMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_RockefellerUniversityMember" xlink:to="cldx_RockefellerUniversityMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_RockefellerUniversityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to Rockefeller University.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_RockefellerUniversityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rockefeller University [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_RockefellerUniversityMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Rockefeller</label>
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_InternationalAidsVaccineInitiativeMember" xlink:label="cldx_InternationalAidsVaccineInitiativeMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="cldx_InternationalAidsVaccineInitiativeMember" xlink:to="cldx_InternationalAidsVaccineInitiativeMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="cldx_InternationalAidsVaccineInitiativeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Represents information related to International AIDS Vaccine Initiative.</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="cldx_InternationalAidsVaccineInitiativeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">International Aids Vaccine Initiative [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="cldx_InternationalAidsVaccineInitiativeMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">IAVI</label>
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" xmlns="http://www.xbrl.org/2003/linkbase" />
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MinimumMember" xlink:to="us-gaap_MinimumMember_lbl" xmlns="http://www.xbrl.org/2003/linkbase" />
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum [Member]</label>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="us-gaap_MinimumMember_lbl" xml:lang="en-US" xmlns="http://www.xbrl.org/2003/linkbase">Minimum</label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>cldx-20170630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--XBRL document created with Merrill Bridge  7.2.100.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2017 7:43:03 PM-->
<!--Modified on: 8/3/2017 7:43:03 PM-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DocumentDocumentAndEntityInformation" roleURI="http://www.celldextherapeutics.com/role/DocumentDocumentAndEntityInformation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedBalanceSheets" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedBalanceSheetsParenthetical" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#StatementCondensedConsolidatedStatementsOfCashFlows" roleURI="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureBasisOfPresentation" roleURI="http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureSignificantAccountingPolicies" roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureFairValueMeasurements" roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureMarketableSecurities" roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIntangibleAssetsAndGoodwill" roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureOtherLongTermLiabilities" roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockholdersEquity" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockBasedCompensation" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureAccumulatedOtherComprehensiveIncome" roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureRevenue" roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenue" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisition" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIncomeTaxes" roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureNetLossPerShare" roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureSignificantAccountingPoliciesPolicies" roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureFairValueMeasurementsTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureMarketableSecuritiesTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIntangibleAssetsAndGoodwillTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureOtherLongTermLiabilitiesTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockBasedCompensationTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureAccumulatedOtherComprehensiveIncomeTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisitionTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureNetLossPerShareTables" roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureBasisOfPresentationDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureSignificantAccountingPoliciesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureMarketableSecuritiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIntangibleAssetsAndGoodwillDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureOtherLongTermLiabilitiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockholdersEquityDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockBasedCompensationSummaryOfPlansDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationSummaryOfPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureRevenueDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisitionPurchasePriceDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionPurchasePriceDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIncomeTaxesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureNetLossPerShareDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DocumentDocumentAndEntityInformation" xlink:type="extended" xlink:title="00090 - Document - Document and Entity Information" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_DocumentAndEntityInformationAbstract" xlink:label="cldx_DocumentAndEntityInformationAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName_636373861819620294" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityRegistrantName_636373861819620294" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey_636373861819620294" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCentralIndexKey_636373861819620294" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType_636373861819620294" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentType_636373861819620294" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate_636373861819620294" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentPeriodEndDate_636373861819620294" order="4" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag_636373861819620294" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_AmendmentFlag_636373861819620294" order="5" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_CurrentFiscalYearEndDate_636373861819630295" order="6" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCurrentReportingStatus_636373861819630295" order="7" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityFilerCategory_636373861819630295" order="8" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding_636373861819630295" order="9" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalYearFocus_636373861819630295" order="10" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.sec.gov/dei/2014/dei-2014-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentFiscalPeriodFocus_636373861819630295" order="11" use="optional" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets" xlink:type="extended" xlink:title="00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_AssetsAbstract_636373861819630295" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_636373861819630295" xlink:to="us-gaap_AssetsCurrentAbstract_636373861819630295" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_636373861819630295" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_636373861819630295" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_636373861819630295" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_636373861819630295" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsAndOtherReceivablesNetCurrent" xlink:label="us-gaap_AccountsAndOtherReceivablesNetCurrent_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_636373861819630295" xlink:to="us-gaap_AccountsAndOtherReceivablesNetCurrent_636373861819630295" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_636373861819630295" xlink:to="us-gaap_PrepaidExpenseAndOtherAssetsCurrent_636373861819630295" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract_636373861819630295" xlink:to="us-gaap_AssetsCurrent_636373861819630295" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_636373861819630295" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_636373861819630295" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_636373861819630295" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_636373861819630295" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_636373861819640296" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_636373861819630295" xlink:to="us-gaap_OtherAssetsNoncurrent_636373861819640296" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_636373861819630295" xlink:to="us-gaap_Goodwill_636373861819640296" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract_636373861819630295" xlink:to="us-gaap_Assets_636373861819640296" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" xlink:to="us-gaap_AccountsPayableCurrent_636373861819640296" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" xlink:to="us-gaap_AccruedLiabilitiesCurrent_636373861819640296" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" xlink:to="us-gaap_OtherLiabilitiesCurrent_636373861819640296" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" xlink:to="us-gaap_LiabilitiesCurrent_636373861819640296" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract_636373861819640296" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_636373861819640296" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_Liabilities_636373861819640296" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="us-gaap_CommitmentsAndContingencies_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_CommitmentsAndContingencies_636373861819640296" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_StockholdersEquityAbstract_636373861819640296" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue_636373861819640296" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_PreferredStockValue_636373861819640296" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_CommonStockValue_636373861819650297" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_636373861819650297" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_636373861819650297" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_636373861819650297" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_StockholdersEquity_636373861819650297" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract_636373861819640296" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_636373861819650297" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" xlink:type="extended" xlink:title="00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_636373861819650297" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized_636373861819650297" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued_636373861819650297" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesIssued_636373861819650297" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding_636373861819820314" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding_636373861819820314" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_636373861819820314" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_636373861819820314" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized_636373861819820314" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized_636373861819820314" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued_636373861819820314" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesIssued_636373861819820314" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_CommonStockSharesOutstanding_636373861819830315" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="extended" xlink:title="00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RevenuesAbstract" xlink:label="us-gaap_RevenuesAbstract_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RevenuesAbstract_636373861819830315" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_636373861819830315" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_636373861819830315" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_636373861819830315" xlink:to="cldx_RevenueFromContractsAndGrants_636373861819830315" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Revenues" xlink:label="us-gaap_Revenues_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RevenuesAbstract_636373861819830315" xlink:to="us-gaap_Revenues_636373861819830315" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpensesAbstract" xlink:label="us-gaap_CostsAndExpensesAbstract_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_CostsAndExpensesAbstract_636373861819830315" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_636373861819830315" xlink:to="us-gaap_ResearchAndDevelopmentExpense_636373861819830315" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_636373861819830315" xlink:to="us-gaap_GeneralAndAdministrativeExpense_636373861819830315" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_636373861819830315" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819830315" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_636373861819830315" xlink:to="us-gaap_AmortizationOfIntangibleAssets_636373861819830315" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CostsAndExpenses" xlink:label="us-gaap_CostsAndExpenses_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CostsAndExpensesAbstract_636373861819830315" xlink:to="us-gaap_CostsAndExpenses_636373861819830315" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss_636373861819830315" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestAndOtherIncome" xlink:label="us-gaap_InterestAndOtherIncome_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_InterestAndOtherIncome_636373861819830315" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819830315" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_636373861819830315" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_636373861819830315" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_636373861819830315" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_636373861819830315" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_636373861819830315" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819840316" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_636373861819830315" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_636373861819840316" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract_636373861819840316" xlink:to="us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_636373861819840316" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax" xlink:label="us-gaap_ComprehensiveIncomeNetOfTax_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract_636373861819830315" xlink:to="us-gaap_ComprehensiveIncomeNetOfTax_636373861819840316" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows" xlink:type="extended" xlink:title="00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_636373861819840316" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_636373861819840316" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819840316" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_636373861819840316" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="us-gaap_DepreciationDepletionAndAmortization_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_DepreciationDepletionAndAmortization_636373861819840316" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_AmortizationOfIntangibleAssets_636373861819840316" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments" xlink:label="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_636373861819840316" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:label="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_GainLossOnSaleOfPropertyPlantEquipment_636373861819840316" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819840316" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_ShareBasedCompensation_636373861819840316" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfDebtDiscountPremium" xlink:label="us-gaap_AmortizationOfDebtDiscountPremium_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_AmortizationOfDebtDiscountPremium_636373861819840316" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_636373861819840316" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables" xlink:label="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_636373861819840316" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" xlink:to="us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables_636373861819840316" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_636373861819850317" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_636373861819850317" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_636373861819850317" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_636373861819840316" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_636373861819850317" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract_636373861819840316" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819850317" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:label="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_636373861819850317" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities" xlink:label="us-gaap_PaymentsToAcquireMarketableSecurities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_PaymentsToAcquireMarketableSecurities_636373861819850317" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments" xlink:label="us-gaap_PaymentsToAcquireOtherInvestments_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_PaymentsToAcquireOtherInvestments_636373861819850317" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_636373861819850317" order="4" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_636373861819850317" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_636373861819850317" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_636373861819850317" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromStockPlans" xlink:label="us-gaap_ProceedsFromStockPlans_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_ProceedsFromStockPlans_636373861819850317" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_636373861819850317" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract_636373861819850317" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_636373861819850317" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_636373861819860318" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_636373861819860318" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_6363738618198603181" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_6363738618198603181" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:label="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_636373861819860318" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_636373861819860318" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_636373861819860318" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract" xlink:label="us-gaap_SupplementalCashFlowInformationAbstract_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract_635475916101371870" xlink:to="us-gaap_SupplementalCashFlowInformationAbstract_636373861819860318" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance" xlink:label="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowInformationAbstract_636373861819860318" xlink:to="cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance_636373861819860318" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation" xlink:type="extended" xlink:title="10101 - Disclosure - Basis of Presentation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BasisOfAccounting" xlink:label="us-gaap_BasisOfAccounting_636373861819860318" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_BasisOfAccounting_636373861819860318" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies" xlink:type="extended" xlink:title="10201 - Disclosure - Significant Accounting Policies" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements" xlink:type="extended" xlink:title="10301 - Disclosure - Fair Value Measurements" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities" xlink:type="extended" xlink:title="10401 - Disclosure - Marketable Securities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill" xlink:type="extended" xlink:title="10501 - Disclosure - Intangible Assets and Goodwill" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities" xlink:type="extended" xlink:title="10601 - Disclosure - Other Long-Term Liabilities" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:label="us-gaap_OtherLiabilitiesDisclosureTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_OtherLiabilitiesDisclosureTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity" xlink:type="extended" xlink:title="10701 - Disclosure - Stockholders' Equity" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation" xlink:type="extended" xlink:title="10801 - Disclosure - Stock-Based Compensation" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome" xlink:type="extended" xlink:title="10901 - Disclosure - Accumulated Other Comprehensive Income" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:label="us-gaap_ComprehensiveIncomeNoteTextBlock_636373861819870319" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ComprehensiveIncomeNoteTextBlock_636373861819870319" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureRevenue" xlink:type="extended" xlink:title="11001 - Disclosure - Revenue" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SignificantRevenueArrangementsDisclosureTextBlock" xlink:label="cldx_SignificantRevenueArrangementsDisclosureTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:to="cldx_SignificantRevenueArrangementsDisclosureTextBlock_636373861819880320" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition" xlink:type="extended" xlink:title="11101 - Disclosure - Kolltan Acquisition" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock" xlink:label="us-gaap_BusinessCombinationDisclosureTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_BusinessCombinationDisclosureTextBlock_636373861819880320" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes" xlink:type="extended" xlink:title="11201 - Disclosure - Income Taxes" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_636373861819880320" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare" xlink:type="extended" xlink:title="11301 - Disclosure - Net Loss Per Share" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock_636373861819880320" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies" xlink:type="extended" xlink:title="20202 - Disclosure - Significant Accounting Policies (Policies)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock_636373861819880320" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_636373861819880320" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables" xlink:type="extended" xlink:title="30303 - Disclosure - Fair Value Measurements (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_636373861819880320" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_636373861819880320" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_636373861819880320" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables" xlink:type="extended" xlink:title="30403 - Disclosure - Marketable Securities (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock_636373861819890321" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables" xlink:type="extended" xlink:title="30503 - Disclosure - Intangible Assets and Goodwill (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock" xlink:label="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock_636373861819890321" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables" xlink:type="extended" xlink:title="30603 - Disclosure - Other Long-Term Liabilities (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock" xlink:label="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock_636373861819890321" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock" xlink:label="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:to="us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock_636373861819890321" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables" xlink:type="extended" xlink:title="30803 - Disclosure - Stock-Based Compensation (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_636373861819890321" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_636373861819890321" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_636373861819890321" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables" xlink:type="extended" xlink:title="30903 - Disclosure - Accumulated Other Comprehensive Income (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:label="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_636373861819890321" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionTables" xlink:type="extended" xlink:title="31103 - Disclosure - Kolltan Acquisition (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_636373861819890321" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:label="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_636373861819890321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_636373861819890321" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables" xlink:type="extended" xlink:title="31303 - Disclosure - Net Loss Per Share (Tables)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentationDetails" xlink:type="extended" xlink:title="40101 - Disclosure - Basis of Presentation - (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsAndCash" xlink:label="us-gaap_InvestmentsAndCash_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_InvestmentsAndCash_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_636373861819900322" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_636373861819900322" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Significant Accounting Policies - (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_636373861819900322" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_636373861819900322" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_636373861819900322" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_636373861819900322" xlink:to="us-gaap_TypeOfAdoptionMember_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AccountingStandardsUpdateMember" xlink:label="cldx_AccountingStandardsUpdateMember_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfAdoptionMember_636373861819900322" xlink:to="cldx_AccountingStandardsUpdateMember_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_636373861819900322" xlink:to="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_636373861819900322" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis_636373861819900322" xlink:to="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" xlink:label="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_636373861819900322" xlink:to="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_636373861819900322" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_636373861819900322" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" xlink:label="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation_636373861819900322" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_636373861819900322" xlink:to="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation_636373861819900322" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Fair Value Measurements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_636373861819910323" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis_636373861819910323" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain_636373861819910323" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" xlink:to="us-gaap_FairValueByMeasurementBasisAxis_636373861819910323" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementBasisAxis_636373861819910323" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember_636373861819910323" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_636373861819910323" order="3" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_636373861819910323" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861819910323" xlink:to="us-gaap_FairValueInputsLevel2Member_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861819910323" xlink:to="us-gaap_FairValueInputsLevel3Member_636373861819910323" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" xlink:to="us-gaap_BusinessAcquisitionAxis_636373861819910323" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_636373861819910323" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819910323" xlink:to="cldx_KolltanPharmaceuticalsMember_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" xlink:to="us-gaap_BalanceSheetLocationAxis_636373861819910323" order="5" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis_636373861819910323" xlink:to="us-gaap_BalanceSheetLocationDomain_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain_636373861819910323" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_636373861819910323" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract_636373861819910323" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure_636373861819910323" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract_636373861819910323" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure_636373861819910323" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract_636373861819910323" xlink:to="us-gaap_AvailableForSaleSecurities_636373861819920324" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract_636373861819910323" xlink:to="us-gaap_AssetsFairValueDisclosure_636373861819920324" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract_636373861819920324" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract_636373861819920324" xlink:to="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_636373861819920324" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract_636373861819920324" xlink:to="us-gaap_LiabilitiesFairValueDisclosure_636373861819920324" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_636373861819920324" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_6363738618199203241" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_636373861819920324" xlink:to="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_6363738618199203241" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_636373861819920324" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_636373861819920324" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_63637386181992032412" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_636373861819920324" xlink:to="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_63637386181992032412" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" xlink:to="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels_636373861819920324" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_636373861819920324" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" xlink:to="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels_636373861819920324" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionMileStonePayments" xlink:label="cldx_BusinessAcquisitionMileStonePayments_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_636373861819910323" xlink:to="cldx_BusinessAcquisitionMileStonePayments_636373861819930325" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Marketable Securities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_636373861819930325" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_636373861819930325" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_636373861819930325" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis_636373861819930325" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_636373861819930325" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_USGovernmentAndMunicipalObligationsMember" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_636373861819930325" xlink:to="cldx_USGovernmentAndMunicipalObligationsMember_636373861819930325" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_636373861819930325" xlink:to="us-gaap_CorporateDebtSecuritiesMember_636373861819930325" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable_636373861819930325" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_636373861819930325" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_636373861819930325" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_636373861819930325" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_636373861819930325" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost_636373861819930325" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract_636373861819930325" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_636373861819930325" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_636373861819930325" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_636373861819930325" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain_636373861819930325" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_636373861819930325" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain_636373861819930325" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract_636373861819930325" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_636373861819930325" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_636373861819930325" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_636373861819930325" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_636373861819930325" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses_636373861819940326" order="1" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract_636373861819930325" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_636373861819940326" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_636373861819940326" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_636373861819940326" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_636373861819940326" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_636373861819940326" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue_636373861819940326" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract_636373861819940326" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_636373861819940326" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" xlink:to="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired_636373861819940326" order="5" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_636373861819930325" xlink:to="us-gaap_InterestReceivable_636373861819940326" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Intangible Assets and Goodwill (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:label="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_636373861819940326" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_636373861819940326" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819940326" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819940326" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember_636373861819940326" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_636373861819940326" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_636373861819940326" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819940326" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AmgenAmendmentMember" xlink:label="cldx_AmgenAmendmentMember_636373861819940326" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819940326" xlink:to="cldx_AmgenAmendmentMember_636373861819940326" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" xlink:to="us-gaap_BusinessAcquisitionAxis_636373861819950327" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_636373861819950327" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819950327" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819950327" xlink:to="cldx_CuraGenCorporationMember_636373861819950327" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819950327" xlink:to="cldx_KolltanPharmaceuticalsMember_636373861819950327" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" xlink:to="us-gaap_ProductOrServiceAxis_636373861819950327" order="4" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductOrServiceAxis_636373861819950327" xlink:to="us-gaap_ProductsAndServicesDomain_636373861819950327" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CDX1058Member" xlink:label="cldx_CDX1058Member_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductsAndServicesDomain_636373861819950327" xlink:to="cldx_CDX1058Member_636373861819950327" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CDX3379Member" xlink:label="cldx_CDX3379Member_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductsAndServicesDomain_636373861819950327" xlink:to="cldx_CDX3379Member_636373861819950327" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_TMProgramMember" xlink:label="cldx_TMProgramMember_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ProductsAndServicesDomain_636373861819950327" xlink:to="cldx_TMProgramMember_636373861819950327" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable_636373861819940326" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_636373861819950327" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_636373861819950327" xlink:to="us-gaap_Goodwill_636373861819950327" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_636373861819950327" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_636373861819950327" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_636373861819950327" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_636373861819950327" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_636373861819950327" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure_636373861819950327" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_636373861819950327" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_636373861819950327" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_636373861819950327" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_636373861819950327" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife_636373861819960328" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_636373861819950327" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross_636373861819960328" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_636373861819950327" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_636373861819960328" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract_636373861819950327" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet_636373861819960328" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems_636373861819950327" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_636373861819960328" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_636373861819960328" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill_636373861819960328" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_636373861819960328" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill_636373861819960328" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_636373861819960328" xlink:to="us-gaap_AmortizationOfIntangibleAssets_636373861819960328" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/positiveLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Other Long-Term Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract" xlink:label="us-gaap_OtherLiabilitiesDisclosureAbstract_636273890092090904" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherLiabilitiesDisclosureAbstract_636273890092090904" xlink:to="us-gaap_StatementTable_636373861819960328" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_636373861819960328" xlink:to="us-gaap_IncomeStatementLocationAxis_636373861819960328" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_636373861819960328" xlink:to="us-gaap_IncomeStatementLocationDomain_636373861819960328" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_636373861819960328" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_636373861819960328" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_636373861819960328" xlink:to="us-gaap_RestructuringPlanAxis_636373861819960328" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain_636373861819960328" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanAxis_636373861819960328" xlink:to="us-gaap_RestructuringPlanDomain_636373861819960328" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_NeedhamExpansionMember" xlink:label="cldx_NeedhamExpansionMember_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanDomain_636373861819960328" xlink:to="cldx_NeedhamExpansionMember_636373861819970329" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BranfordCTMember" xlink:label="cldx_BranfordCTMember_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringPlanDomain_636373861819960328" xlink:to="cldx_BranfordCTMember_636373861819970329" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable_636373861819960328" xlink:to="us-gaap_StatementLineItems_636373861819970329" order="3" use="optional" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_DeferredRentCredit_636373861819970329" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_DeferredTaxLiabilities_636373861819970329" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="cldx_DeferredIncomeFromSaleOfTaxBenefits_636373861819970329" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_RestructuringReserve_636373861819970329" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_LongTermSeveranceLiability" xlink:label="cldx_LongTermSeveranceLiability_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="cldx_LongTermSeveranceLiability_636373861819970329" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_636373861819970329" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_DeferredRevenue_636373861819970329" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_OtherLiabilities_636373861819970329" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_OtherLiabilitiesCurrent_636373861819970329" order="9" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_OtherLiabilitiesNoncurrent_636373861819970329" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="cldx_ValueOfTaxBenefitsAgreedToBeSold_636373861819970329" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ValueAtWhichTaxBenefitsSold" xlink:label="cldx_ValueAtWhichTaxBenefitsSold_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="cldx_ValueAtWhichTaxBenefitsSold_636373861819970329" order="12" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained_636373861819970329" order="13" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets_636373861819970329" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets_636373861819970329" order="14" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_AreaOfLand_636373861819980330" order="15" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="us-gaap_RestructuringCosts_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_RestructuringCosts_636373861819980330" order="16" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems_636373861819970329" xlink:to="us-gaap_RestructuringReserveAbstract_636373861819980330" order="17" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract_636373861819980330" xlink:to="us-gaap_RestructuringReserve_636373861819980330" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract_636373861819980330" xlink:to="us-gaap_RestructuringCharges_636373861819980330" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract_636373861819980330" xlink:to="us-gaap_PaymentsForRestructuring_636373861819980330" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve_6363738618199803301" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RestructuringReserveAbstract_636373861819980330" xlink:to="us-gaap_RestructuringReserve_6363738618199803301" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Stockholders' Equity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract" xlink:label="us-gaap_StockholdersEquityNoteAbstract_635941527943738283" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockholdersEquityTable" xlink:label="cldx_StockholdersEquityTable_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityNoteAbstract_635941527943738283" xlink:to="cldx_StockholdersEquityTable_636373861819980330" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable_636373861819980330" xlink:to="us-gaap_CounterpartyNameAxis_636373861819980330" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CounterpartyNameAxis_636373861819980330" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861819980330" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CantorFitzgeraldAndCompanyAgreementMember" xlink:label="cldx_CantorFitzgeraldAndCompanyAgreementMember_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861819980330" xlink:to="cldx_CantorFitzgeraldAndCompanyAgreementMember_636373861819980330" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable_636373861819980330" xlink:to="us-gaap_RangeAxis_636373861819980330" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_636373861819980330" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis_636373861819980330" xlink:to="us-gaap_RangeMember_636373861819980330" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember_636373861819980330" xlink:to="us-gaap_MaximumMember_636373861819990331" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockholdersEquityLineItems" xlink:label="cldx_StockholdersEquityLineItems_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityTable_636373861819980330" xlink:to="cldx_StockholdersEquityLineItems_636373861819990331" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockIssuedAuthorizedAmount" xlink:label="cldx_StockIssuedAuthorizedAmount_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems_636373861819990331" xlink:to="cldx_StockIssuedAuthorizedAmount_636373861819990331" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems_636373861819990331" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_636373861819990331" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems_636373861819990331" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock_636373861819990331" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockIssuedRemainingAuthorizedAmount" xlink:label="cldx_StockIssuedRemainingAuthorizedAmount_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_StockholdersEquityLineItems_636373861819990331" xlink:to="cldx_StockIssuedRemainingAuthorizedAmount_636373861819990331" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationSummaryOfPlansDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Stock-Based Compensation - Summary of Plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_636373861819990331" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_636373861819990331" xlink:to="us-gaap_AwardTypeAxis_636373861819990331" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861819990331" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861819990331" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_636373861819990331" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636373861819990331" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_636373861819990331" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_636373861819990331" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_636373861819990331" order="3" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6363738618199903311" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6363738618199903311" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_636373861819990331" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_636373861819990331" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_636373861820000332" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_636373861820000332" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_636373861820000332" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_636373861820000332" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_636373861820000332" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6363738618200003321" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_6363738618200003321" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_636373861820000332" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_636373861820000332" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636373861819990331" xlink:to="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_636373861820000332" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_636373861820000332" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_636373861820000332" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="9" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_636373861820000332" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_636373861820000332" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract_636373861820000332" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_636373861820000332" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636373861819990331" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_636373861820000332" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_636373861820000332" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract_636373861820000332" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_636373861820000332" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Stock-Based Compensation - Valuation and Expenses Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_636373861820010333" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_636373861820010333" xlink:to="us-gaap_IncomeStatementLocationAxis_636373861820010333" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis_636373861820010333" xlink:to="us-gaap_IncomeStatementLocationDomain_636373861820010333" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_636373861820010333" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_636373861820010333" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain_636373861820010333" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_636373861820010333" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_636373861820010333" xlink:to="us-gaap_AwardTypeAxis_636373861820010333" order="2" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861820010333" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861820010333" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_636373861820010333" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_636373861820010333" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_636373861820010333" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_636373861820010333" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_636373861820010333" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_636373861820010333" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_636373861820010333" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_636373861820010333" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_636373861820010333" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_636373861820010333" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_636373861820010333" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_636373861820010333" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_636373861820010333" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract_636373861820010333" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_636373861820010333" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Accumulated Other Comprehensive Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:label="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComprehensiveIncomeNetOfTaxAbstract" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_636373861820020334" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_636373861820020334" xlink:to="us-gaap_StatementEquityComponentsAxis_636373861820020334" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis_636373861820020334" xlink:to="us-gaap_EquityComponentDomain_636373861820020334" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_636373861820020334" xlink:to="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember_636373861820020334" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_636373861820020334" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember_636373861820020334" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain_636373861820020334" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember_636373861820020334" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_636373861820020334" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_636373861820020334" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_636373861820020334" xlink:to="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_636373861820020334" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_636373861820020334" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_636373861820020334" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_636373861820020334" xlink:to="us-gaap_StockholdersEquity_636373861820020334" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax_636373861820020334" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_636373861820020334" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax_636373861820020334" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_6363738618200203341" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward_636373861820020334" xlink:to="us-gaap_StockholdersEquity_6363738618200203341" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Revenue (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:label="cldx_SignificantRevenueArrangementsDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="cldx_SignificantRevenueArrangementsDisclosureAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_636373861820040336" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_636373861820040336" xlink:to="us-gaap_CounterpartyNameAxis_636373861820040336" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CounterpartyNameAxis_636373861820040336" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861820040336" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BristolMeyersSquibbCompanyMember" xlink:label="cldx_BristolMeyersSquibbCompanyMember_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861820040336" xlink:to="cldx_BristolMeyersSquibbCompanyMember_636373861820040336" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RockefellerUniversityMember" xlink:label="cldx_RockefellerUniversityMember_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861820040336" xlink:to="cldx_RockefellerUniversityMember_636373861820040336" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_InternationalAidsVaccineInitiativeMember" xlink:label="cldx_InternationalAidsVaccineInitiativeMember_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861820040336" xlink:to="cldx_InternationalAidsVaccineInitiativeMember_636373861820040336" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_636373861820040336" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" xlink:to="us-gaap_DeferredRevenue_636373861820040336" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="cldx_CollaborativeArrangementAgreementTerm_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" xlink:to="cldx_CollaborativeArrangementAgreementTerm_636373861820040336" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ReimbursementOfExternalCostsIncurredPercentage" xlink:label="cldx_ReimbursementOfExternalCostsIncurredPercentage_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" xlink:to="cldx_ReimbursementOfExternalCostsIncurredPercentage_636373861820040336" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_636373861820040336" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements_636373861820040336" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_636373861820040336" xlink:to="cldx_RevenueFromContractsAndGrants_636373861820050337" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionPurchasePriceDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Kolltan Acquisition- Purchase Price (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820050337" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820050337" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_636373861820050337" order="1" use="optional" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis_636373861820050337" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861820050337" xlink:to="us-gaap_FairValueInputsLevel3Member_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820050337" xlink:to="us-gaap_BusinessAcquisitionAxis_636373861820050337" order="2" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_636373861820050337" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_636373861820050337" xlink:to="cldx_KolltanPharmaceuticalsMember_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820050337" xlink:to="us-gaap_RangeAxis_636373861820050337" order="3" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeAxis_636373861820050337" xlink:to="us-gaap_RangeMember_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember_636373861820050337" xlink:to="us-gaap_MinimumMember_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_RangeMember_636373861820050337" xlink:to="us-gaap_MaximumMember_636373861820050337" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820050337" xlink:to="us-gaap_BusinessAcquisitionLineItems_636373861820050337" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_636373861820050337" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" xlink:label="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance_636373861820050337" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" xlink:label="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance_636373861820050337" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionRemainingStockObligation" xlink:label="cldx_BusinessAcquisitionRemainingStockObligation_636373861820050337" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="cldx_BusinessAcquisitionRemainingStockObligation_636373861820050337" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionMileStonePayments" xlink:label="cldx_BusinessAcquisitionMileStonePayments_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="cldx_BusinessAcquisitionMileStonePayments_636373861820060338" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_SharePrice_636373861820060338" order="6" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredAbstract_636373861820060338" order="7" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract_636373861820060338" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_636373861820060338" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract_636373861820060338" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability_636373861820060338" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract_636373861820060338" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts_636373861820060338" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract_636373861820060338" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1_636373861820060338" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="7" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_636373861820060338" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_FairValueInputsDiscountRate_636373861820060338" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow_636373861820060338" order="10" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="5" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820050337" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh_636373861820060338" order="11" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Kolltan Acquisition - Allocations of Assets and Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationsAbstract" xlink:label="us-gaap_BusinessCombinationsAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationsAbstract" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820060338" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis_636373861820060338" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820060338" xlink:to="us-gaap_BusinessAcquisitionAxis_636373861820060338" order="1" use="optional" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAxis_636373861820060338" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_636373861820070339" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain_636373861820070339" xlink:to="cldx_KolltanPharmaceuticalsMember_636373861820070339" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_636373861820060338" xlink:to="us-gaap_BusinessAcquisitionLineItems_636373861820070339" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="2" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820070339" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount_636373861820070339" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionLineItems_636373861820070339" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_636373861820070339" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets_636373861820070339" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="1" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_636373861820070339" order="3" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_636373861820070339" order="4" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_Goodwill_636373861820070339" order="5" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_636373861820070339" order="6" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="6" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities_636373861820070339" order="7" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_636373861820070339" order="8" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" priority="3" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_636373861820070339" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationAbstract_636373861820070339" order="9" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="4" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract_636373861820070339" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss_636373861820070339" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" priority="8" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" xlink:label="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted_636373861820070339" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract_636373861820070339" xlink:to="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted_636373861820070339" order="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" priority="3" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails" xlink:type="extended" xlink:title="41201 - Disclosure - Income Taxes (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NumberOfStatesInWhichEntityOperates" xlink:label="us-gaap_NumberOfStatesInWhichEntityOperates_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_NumberOfStatesInWhichEntityOperates_636373861820080340" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
  <presentationLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Net Loss Per Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_636373861820080340" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_636373861820080340" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_636373861820080340" order="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_636373861820080340" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_636373861820080340" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_636373861820080340" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember_636373861820080340" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain_636373861820080340" xlink:to="us-gaap_RestrictedStockMember_636373861820080340" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_636373861820080340" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_636373861820080340" order="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_636373861820080340" />
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_636373861820080340" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_636373861820080340" order="1" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>cldx-20170630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- Created by Merrill Corporation -->
<!--XBRL document created with Merrill Bridge  7.2.100.0 -->
<!--Based on XBRL 2.1-->
<!--Created on: 8/3/2017 7:43:03 PM-->
<!--Modified on: 8/3/2017 7:43:03 PM-->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureSignificantAccountingPoliciesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureFairValueMeasurementsDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureMarketableSecuritiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureIntangibleAssetsAndGoodwillDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureOtherLongTermLiabilitiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockholdersEquityDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockBasedCompensationSummaryOfPlansDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationSummaryOfPlansDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureRevenueDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisitionPurchasePriceDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionPurchasePriceDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <roleRef xlink:type="simple" xlink:href="cldx-20170630.xsd#DisclosureNetLossPerShareDetails" roleURI="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" xmlns="http://www.xbrl.org/2003/linkbase" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesDetails" xlink:type="extended" xlink:title="40201 - Disclosure - Significant Accounting Policies - (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:label="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember_636373861819310263" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="us-gaap_TypeOfAdoptionMember_636373861819310263" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AccountingStandardsUpdateMember" xlink:label="cldx_AccountingStandardsUpdateMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="cldx_AccountingStandardsUpdateMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:label="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:to="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:label="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_636373861819310263" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_NewAccountingPronouncementEarlyAdoptionAxis" xlink:to="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember_636373861819310263" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" xlink:label="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_NewAccountingPrinciplesEarlyAdoptionMember" xlink:to="us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" xlink:label="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="cldx_GrossDeferredTaxAssetsAndCorrespondingValuation" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails" xlink:type="extended" xlink:title="40301 - Disclosure - Fair Value Measurements (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_636373861819320264" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_636373861819320264" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByMeasurementBasisAxis" xlink:label="us-gaap_FairValueByMeasurementBasisAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementBasisAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:label="us-gaap_PortionAtFairValueFairValueDisclosureMember_636373861819330265" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FairValueByMeasurementBasisAxis" xlink:to="us-gaap_PortionAtFairValueFairValueDisclosureMember_636373861819330265" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EstimateOfFairValueFairValueDisclosureMember" xlink:label="us-gaap_EstimateOfFairValueFairValueDisclosureMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_PortionAtFairValueFairValueDisclosureMember" xlink:to="us-gaap_EstimateOfFairValueFairValueDisclosureMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861819330265" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_636373861819330265" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819330265" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain_636373861819330265" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_KolltanPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_BalanceSheetLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_636373861819340266" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_636373861819340266" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember" xlink:label="us-gaap_OtherNoncurrentLiabilitiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherNoncurrentLiabilitiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract" xlink:label="us-gaap_AssetsFairValueDisclosureAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosureAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:label="us-gaap_CashAndCashEquivalentsFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_CashAndCashEquivalentsFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecurities" xlink:label="us-gaap_AvailableForSaleSecurities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AvailableForSaleSecurities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:label="us-gaap_LiabilitiesFairValueDisclosureAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_LiabilitiesFairValueDisclosureAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:label="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure" xlink:label="us-gaap_LiabilitiesFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="us-gaap_LiabilitiesFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:label="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" xlink:label="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionMileStonePayments" xlink:label="cldx_BusinessAcquisitionMileStonePayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="cldx_BusinessAcquisitionMileStonePayments" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails" xlink:type="extended" xlink:title="40401 - Disclosure - Marketable Securities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:label="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_636373861819360268" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis" xlink:to="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain_636373861819360268" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_USGovernmentAndMunicipalObligationsMember" xlink:label="cldx_USGovernmentAndMunicipalObligationsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="cldx_USGovernmentAndMunicipalObligationsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_MajorTypesOfDebtAndEquitySecuritiesDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:label="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" xlink:label="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" xlink:label="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InterestReceivable" xlink:label="us-gaap_InterestReceivable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_InterestReceivable" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails" xlink:type="extended" xlink:title="40501 - Disclosure - Intangible Assets and Goodwill (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819380270" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819380270" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember" xlink:label="us-gaap_InProcessResearchAndDevelopmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="us-gaap_InProcessResearchAndDevelopmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:label="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:label="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819390271" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_636373861819390271" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AmgenAmendmentMember" xlink:label="cldx_AmgenAmendmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="cldx_AmgenAmendmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CuraGenCorporationMember" xlink:label="cldx_CuraGenCorporationMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_CuraGenCorporationMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_KolltanPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductOrServiceAxis" xlink:label="us-gaap_ProductOrServiceAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="4" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" xlink:to="us-gaap_ProductOrServiceAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProductsAndServicesDomain" xlink:label="us-gaap_ProductsAndServicesDomain_636373861819390271" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_ProductOrServiceAxis" xlink:to="us-gaap_ProductsAndServicesDomain_636373861819390271" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CDX1058Member" xlink:label="cldx_CDX1058Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="cldx_CDX1058Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CDX3379Member" xlink:label="cldx_CDX3379Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="cldx_CDX3379Member" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_TMProgramMember" xlink:label="cldx_TMProgramMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ProductsAndServicesDomain" xlink:to="cldx_TMProgramMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:label="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_Goodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" xlink:label="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:label="us-gaap_FiniteLivedIntangibleAssetUsefulLife" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetUsefulLife" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross" xlink:label="us-gaap_FiniteLivedIntangibleAssetsGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:label="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet" xlink:label="us-gaap_FiniteLivedIntangibleAssetsNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="us-gaap_FiniteLivedIntangibleAssetsNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsGrossExcludingGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsGrossExcludingGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_IntangibleAssetsNetExcludingGoodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_IntangibleAssetsNetExcludingGoodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_AmortizationOfIntangibleAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="us-gaap_AmortizationOfIntangibleAssets" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails" xlink:type="extended" xlink:title="40601 - Disclosure - Other Long-Term Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_636373861819450277" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_636373861819450277" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanAxis" xlink:label="us-gaap_RestructuringPlanAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_RestructuringPlanAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringPlanDomain" xlink:label="us-gaap_RestructuringPlanDomain_636373861819450277" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RestructuringPlanAxis" xlink:to="us-gaap_RestructuringPlanDomain_636373861819450277" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_NeedhamExpansionMember" xlink:label="cldx_NeedhamExpansionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="cldx_NeedhamExpansionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BranfordCTMember" xlink:label="cldx_BranfordCTMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RestructuringPlanDomain" xlink:to="cldx_BranfordCTMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRentCredit" xlink:label="us-gaap_DeferredRentCredit" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRentCredit" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredTaxLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_DeferredIncomeFromSaleOfTaxBenefits" xlink:label="cldx_DeferredIncomeFromSaleOfTaxBenefits" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_StatementLineItems" xlink:to="cldx_DeferredIncomeFromSaleOfTaxBenefits" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserve" xlink:label="us-gaap_RestructuringReserve" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestructuringReserve" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_LongTermSeveranceLiability" xlink:label="cldx_LongTermSeveranceLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_StatementLineItems" xlink:to="cldx_LongTermSeveranceLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_DeferredRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilities" xlink:label="us-gaap_OtherLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_OtherLiabilitiesNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_OtherLiabilitiesNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ValueOfTaxBenefitsAgreedToBeSold" xlink:label="cldx_ValueOfTaxBenefitsAgreedToBeSold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_StatementLineItems" xlink:to="cldx_ValueOfTaxBenefitsAgreedToBeSold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ValueAtWhichTaxBenefitsSold" xlink:label="cldx_ValueAtWhichTaxBenefitsSold" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="13" xlink:from="us-gaap_StatementLineItems" xlink:to="cldx_ValueAtWhichTaxBenefitsSold" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" xlink:label="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="14" xlink:from="us-gaap_StatementLineItems" xlink:to="cldx_PeriodForWhichBaseOfOperationsMustBeMaintained" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GainLossOnSaleOfOtherAssets" xlink:label="us-gaap_GainLossOnSaleOfOtherAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="15" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_GainLossOnSaleOfOtherAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AreaOfLand" xlink:label="us-gaap_AreaOfLand" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="16" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AreaOfLand" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCosts" xlink:label="us-gaap_RestructuringCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="17" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestructuringCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringReserveAbstract" xlink:label="us-gaap_RestructuringReserveAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="18" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_RestructuringReserveAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestructuringCharges" xlink:label="us-gaap_RestructuringCharges" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_RestructuringCharges" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_PaymentsForRestructuring" xlink:label="us-gaap_PaymentsForRestructuring" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RestructuringReserveAbstract" xlink:to="us-gaap_PaymentsForRestructuring" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails" xlink:type="extended" xlink:title="40701 - Disclosure - Stockholders' Equity (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockholdersEquityTable" xlink:label="cldx_StockholdersEquityTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="cldx_StockholdersEquityTable" xlink:to="us-gaap_CounterpartyNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861819480280" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain_636373861819480280" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CantorFitzgeraldAndCompanyAgreementMember" xlink:label="cldx_CantorFitzgeraldAndCompanyAgreementMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_CantorFitzgeraldAndCompanyAgreementMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="cldx_StockholdersEquityTable" xlink:to="us-gaap_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember_636373861819480280" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember_636373861819480280" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockholdersEquityLineItems" xlink:label="cldx_StockholdersEquityLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_StockholdersEquityTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockIssuedAuthorizedAmount" xlink:label="cldx_StockIssuedAuthorizedAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_StockIssuedAuthorizedAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="us-gaap_ProceedsFromIssuanceOfCommonStock" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfCommonStock" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_StockIssuedRemainingAuthorizedAmount" xlink:label="cldx_StockIssuedRemainingAuthorizedAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="cldx_StockholdersEquityLineItems" xlink:to="cldx_StockIssuedRemainingAuthorizedAmount" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationSummaryOfPlansDetails" xlink:type="extended" xlink:title="40801 - Disclosure - Stock-Based Compensation - Summary of Plans (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861819490281" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_636373861819490281" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:label="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationAndExpensesInformationDetails" xlink:type="extended" xlink:title="40802 - Disclosure - Stock-Based Compensation - Valuation and Expenses Information (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_AwardTypeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" xlink:title="40901 - Disclosure - Accumulated Other Comprehensive Income (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="us-gaap_StatementEquityComponentsAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_636373861819540286" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_636373861819540286" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" xlink:label="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember" xlink:label="us-gaap_AccumulatedTranslationAdjustmentMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedTranslationAdjustmentMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:label="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:label="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:label="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="us-gaap_StockholdersEquity" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_OtherComprehensiveIncomeLossNetOfTax" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="cldx_AccumulatedOtherComprehensiveIncomeLossRollForward" xlink:to="us-gaap_OtherComprehensiveIncomeLossNetOfTax" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureRevenueDetails" xlink:type="extended" xlink:title="41001 - Disclosure - Revenue (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CounterpartyNameAxis" xlink:label="us-gaap_CounterpartyNameAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CounterpartyNameAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:label="us-gaap_RepurchaseAgreementCounterpartyNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_CounterpartyNameAxis" xlink:to="us-gaap_RepurchaseAgreementCounterpartyNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BristolMeyersSquibbCompanyMember" xlink:label="cldx_BristolMeyersSquibbCompanyMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_BristolMeyersSquibbCompanyMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RockefellerUniversityMember" xlink:label="cldx_RockefellerUniversityMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_RockefellerUniversityMember" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_InternationalAidsVaccineInitiativeMember" xlink:label="cldx_InternationalAidsVaccineInitiativeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_RepurchaseAgreementCounterpartyNameDomain" xlink:to="cldx_InternationalAidsVaccineInitiativeMember" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_DeferredRevenue" xlink:label="us-gaap_DeferredRevenue" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_DeferredRevenue" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_CollaborativeArrangementAgreementTerm" xlink:label="cldx_CollaborativeArrangementAgreementTerm" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_CollaborativeArrangementAgreementTerm" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_ReimbursementOfExternalCostsIncurredPercentage" xlink:label="cldx_ReimbursementOfExternalCostsIncurredPercentage" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_ReimbursementOfExternalCostsIncurredPercentage" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromProductDevelopmentAndLicensingAgreements" xlink:label="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_RevenueFromProductDevelopmentAndLicensingAgreements" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_RevenueFromContractsAndGrants" xlink:label="cldx_RevenueFromContractsAndGrants" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="cldx_RevenueFromContractsAndGrants" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionPurchasePriceDetails" xlink:type="extended" xlink:title="41101 - Disclosure - Kolltan Acquisition- Purchase Price (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_KolltanPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="2" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeAxis" xlink:label="us-gaap_RangeAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="3" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_RangeAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RangeMember" xlink:label="us-gaap_RangeMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_RangeAxis" xlink:to="us-gaap_RangeMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MinimumMember" xlink:label="us-gaap_MinimumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MinimumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_MaximumMember" xlink:label="us-gaap_MaximumMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_RangeMember" xlink:to="us-gaap_MaximumMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" xlink:label="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" xlink:label="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" xlink:label="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionRemainingStockObligation" xlink:label="cldx_BusinessAcquisitionRemainingStockObligation" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="cldx_BusinessAcquisitionRemainingStockObligation" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionMileStonePayments" xlink:label="cldx_BusinessAcquisitionMileStonePayments" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="cldx_BusinessAcquisitionMileStonePayments" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_SharePrice" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" xlink:label="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiability" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiability" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:label="us-gaap_BusinessCombinationAcquisitionRelatedCosts" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationAcquisitionRelatedCosts" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1" xlink:label="us-gaap_BusinessCombinationConsiderationTransferred1" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessCombinationConsiderationTransferredAbstract" xlink:to="us-gaap_BusinessCombinationConsiderationTransferred1" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" xlink:label="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_FairValueInputsDiscountRate" xlink:label="us-gaap_FairValueInputsDiscountRate" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="10" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_FairValueInputsDiscountRate" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="11" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" xlink:label="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="12" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails" xlink:type="extended" xlink:title="41102 - Disclosure - Kolltan Acquisition - Allocations of Assets and Liabilities (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:label="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAxis" xlink:label="us-gaap_BusinessAcquisitionAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="us-gaap_BusinessAcquisitionAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain" xlink:label="us-gaap_BusinessAcquisitionAcquireeDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_BusinessAcquisitionAxis" xlink:to="us-gaap_BusinessAcquisitionAcquireeDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_KolltanPharmaceuticalsMember" xlink:label="cldx_KolltanPharmaceuticalsMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="cldx_KolltanPharmaceuticalsMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionLineItems" xlink:label="us-gaap_BusinessAcquisitionLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" xlink:label="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessAcquisitionLineItems" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="3" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="4" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_Goodwill" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="5" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_Goodwill" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="6" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" xlink:label="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="7" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:label="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="8" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:label="us-gaap_BusinessAcquisitionProFormaInformationAbstract" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="9" xlink:from="us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract" xlink:to="us-gaap_BusinessAcquisitionProFormaInformationAbstract" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" xlink:label="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss" priority="1" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" xlink:label="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_BusinessAcquisitionProFormaInformationAbstract" xlink:to="cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted" priority="1" use="optional" />
  </definitionLink>
  <definitionLink xlink:role="http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails" xlink:type="extended" xlink:title="41301 - Disclosure - Net Loss Per Share (Details)" xmlns="http://www.xbrl.org/2003/linkbase">
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" order="1" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_636373861819600292" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_636373861819600292" use="optional" />
    <loc xlink:type="locator" xlink:href="cldx-20170630.xsd#cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" xlink:label="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_RestrictedStockMember" xlink:label="us-gaap_RestrictedStockMember" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_RestrictedStockMember" use="optional" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" order="1" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2016/elts/us-gaap-2016-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" order="2" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="1" use="optional" />
  </definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g133771kk03i001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g133771kk03i001.gif
M1TE&.#=AIP,#!G<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M=^_]]^"'+_[XY)=O_OGHIZ_^^NRW[_[[\,<O__STUV___?CGK__^_/?O__\
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MV @QP"(0;I%"/[G-15 "!QY \9 8P 1^F,"E'?"0/M3A N[_Y@@I0'&&E .
M%&CH-A"&0'*!$"($$*<(S$5 "IR_@^4<B #.&4**.J2;(I">0*PA+0(;'UW>
M2GAZ21IP!%I7A!2'L'I$I'R!.&2]WPN1<I<-H@ Q_"$.  >[3"0>@R@LG X+
MKSE'  &#0\C=XKDV@ YZ( 27$YK9,'!V4 @@86D;(". *,09! )I:1P#Y_U5
MP V"P(1Q&^ )7Z" TB5/^?YR^A$=V/SD*R]Q#A!  8L@ P B8 X/",(#'_@
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M$J#>_, "GM"$WX:H=BAO.68*8ET$2! *_' %JQJZ3N=53 < ;TW6DC7F! H
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MC(]&X*.3&2AA>B%LENZ($B Z5DBNL768081(.(9HH%*N$"%)N1PJT@\?-.!
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M*$A6@L<%8V2!F(YSV2GZ( &Q(J.8VG(TL02!!&QU @ZB8(A)G,$K;[$J,IW
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M*#1*CAQ##PA:TD0T@ P4T#<54?IJ@*CT#ZE A\'4F<OAX32<1A#?\9%Z10;
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MF2&(/^  L,H*%?B#,4"$K- < 0@#XPB>OV 8*N$(SX$+'O"!3NB G:F<P6B
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M3 D=B(<490<;D ;S0;+D(X#H.(.2, <Y@%52(9\X"*;_V0$4. $/,#!IT
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M-N2TA3W:Q&<;P<$!: G?$X0X$,#_*;@!0;@]D'*",RD5R D/BSB!&<P",.
M.OF#&30PKKP#O((*]92$5N8QW4MH%TF^?*,(+"[H!%&9B;@*!P""2> 0G!X"
M.LAE&4(#11"$ 9 &Z/.R,6"E&<0"K0$I2A!JHAX 09 &&H2 02B#*1"$0M/F
MKU$>:\"K=P %4NF#05#GU9&%JK*#)ABJ%AN#&1 ".H@#,[":11"$)W ?K?:8
MLJ.32_V CZ;I%MG.@':+5!"$X"OH;T5DF,MC?=L*]B"(S?G08[G$C(Y& &B
MS='.'O"!.]$LK7"9[L&GP#$X1]KK%>% #]0Y_AN_%C,6SOB^%:2ZU/P _GNR
MU+[M&;1M_Q54CA?P )Z3!DBC@A&. @VH[2C%WRWLFZ$[!BU.S448@"C][=L;
M;NB6[A7X8AS$OPG(WR_L9X],&9])@)NYGD'X@C>PP"<8 H@>YJ*Z;)5PYI7"
M[#;PA ?P*P!P9O:-;/E&"1DP!0GX@G,V@8)J@20A%14P;ZL)T[-N,4- A#9
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M"GQPZR,%-)"KH]?HTT":-26B0@<_1!@(.# . &*2#EK#C=$^ZL#!#C04$60
M:=P<* $-IH#@#@H$$42'+X0PQX,5S'@C 1,F^6/& 3H%@ KO9J#D,FNN: &
M(EM089#W#'#A/8*HL*.)*U(8R( Q9F#"@SATS.'&%08!0Y 05211I>["^..#
M#[( H]:%2#EB+X7Z.*2%!F@D5"%24/$!3(*\/$"!16[(_^""F@PH(@C;O"VX
MQ)V&VB@E ]Y!8Z_XSGC*($ *.0,P4I*X(,(&>O@"D0D ,"6N2$:* H9C3OC+
M@ A6".(%/6W]P"TJ;@@"2@*HT" ',3]XA$(=DMCBA00##OJ%*#0XADJN!/E@
M!0H!4^"&8RB,8MRG8W@U"11>\$"'#*2!V0 -S-%7 P05^, #<^B(XP@4IK A
M@RDL>$%B6V_$0!JV9[-Y3#S$V*)FNR-H0PDF),L9 PHCB:"&,#I4M.80R,C9
M32H\$.33 :8(0AJ!J(B@:3)IQ#N&'!Y8_/((.)?&@ZE#<,"T+3[P_("^!,F\
M9FFZ?<@ .Q!5= Q9<G#TBS-PSO_-@>&*\Z/9>>OPU0!*"2Z6CPDHU14A.R3X
MHKSK)M'"UU0*\418+<"8R]@Z 3# $$3:>&,N%=#0'@ 5PD@4@/@\,<!@E]*5
MF5\=@0E1$$24Q$0'#SSA#[P+V!(R8#>!+0T )K, !%#@@P1\@ -2HYJ;>.8S
M! 5F!!28 !4X2 ">-0UKKWJ;W3X0AT-$SE-%^"!@^B:-,7T*1#7J""!0D8%[
M_8^()SG14/CAOY2H@#ASH9@G2':0^"SF5ST0@HK2A0$T:$5)3!()*=K0 0%D
MH0,IZ$,%&&"$, A0!8<00A1J4(%9),%<[1+" SH&A21(P09+Z,"@G#4"-.Q
M&EC@(PG_.B "%83""7KL  X:4 ,ES+$#0>A!(Y/0 2;<H =2" (14!"/)5 @
M-E1P 0-B8((>F' $L_""8FZ0A3 $(0E.V$$2=L >@CR@!BSHP 9L\ <(R#$4
M,Z! '&I@2Q)(X0*TZ8!6HN:"4'2 !#L00A&2L$;K " "8JA !C+Y 0B,9DY;
MD ,6^!&&"DBA/+P\ P2V@,QVUN ,G>@!-8EP@2@8(ITV$, L,QF#,?"#CQ4X
M@VDZ@ 5?'H,(R)N(H7KP/ 48 @PY*((?'G$DX,B" ,,1 A"6H#^$?(8X P&"
M'[0'FB$<0#WV,\@(9C *1AE #S2H QQ^A1X5^.$:O3% *;C _SX6X6 $0P 9
M4!VPIG> PE=%7(D=E."#)JF :P10@1($((4,G,(/)\C!$P;)A,?-D0832$4-
M=C +,PSA J0XA 62@-5,^@"/7W DP2XCALBT\2[IL@$C'>D&&"Q!"B_0P"$$
M "%\/2X#RWSC&-#8 PE0  M$N*M'NI,!D3J5LR=A"E&<HI)WU&$O@!#%&6!6
M$(J=82LL @M8>I4NHO+ !W#Q4T@>0+E?*>$"(\C@9\R1(*KZ  @=D&H#VG "
M#=B@!0^H@%;J,HI#<$E12 C!#6QP7#.Y+3(!S!S(_$J$T00P%:@X$X<($(&R
M$00(LQ""#NXP!#<P\ .H.($"S.L!)/^0DC(4D--^'=" 8^P "AHCQ7[E$#@'
M*$ ,99##"@XAF0=L 'D&>((-8G!AD V$%$9@;=H\@ K_,G@+=% P($Y#AB(0
M\ EE($.*5\P$(Y2!  : @1(^\01(I0(+HZ'"(NB@8P=080Q;R/ 6(  I*@!!
M"9OUW4FUAV(>Y  ;2A H#R8PA@[D@'G&,<L^G#"'@S!1>B88!#_\P0]^(")1
M9@9+@;X' !F8@@O7J ,E*"8-,XAYM"T@!1HFH(?MC.!8[2-T@-$#@/4EY!V)
M[BQ*@, #)!5DN%:M0 6,&PFR$> =BK$#"OQSI0MT8@L^N$X&^X "FU4I71=X
M !&Z:P,!_NK_$&HBQ08,?(0-=*"[1S@!X+YTZUG,4#*$$ 1X:WT#*/3U"$1X
M)@$ (88,L(\B.HA'4Q^=;9&8J"@I4@F9YP(QI1:B0RQ:%X?5!8@:4'9)2I2(
MA?=(@2JU[P%(Z($D>@5'"3A!WGBA*A-<8$(  *(-?\#N'6W@GW0-F[KF0<(?
MX!N  .S#0!]P(P'JXM4'B"$46KC"+%#0UPV<P -F2O =KG @B5$F \=( @V"
MD($33%B?VTT3 3!3)U*@#$-(6 (#;!/M/]!!,0?HKQR">!@#F& #TKOP"YYP
MB*0JR@5W\.716HSSP"5X- ;0 1*8  $*/'@+%DW"?"GP@1KXQNL$_UP!:NKC
M2QS,S@%2?G 'X+D5VCPO(A#=<)D@X0 @1&,"#\@"9<&PO$J=U,F!>8 9",8;
M(7Q@#$H@F GJ-](1<"$&;? $$$IL!E\!JP]^6'"YQ@ >@@#"&DZ00@4DP2BD
M*I6I\M)V1J"*5X)052Y7A>N^*4 &&;@U!&,0." ,D0$L"-RM=,UN'" 0"@ED
MY4%]?>Y_^@ AO6#<!C8(.?=/((>'8SP#B3TW !X @7M? 01/ /K^Q+ $2? #
M+"P PX8QLG0.W9[_LD&84!2F)&R,"2)AM*YHX"HFM58O ?>G!S1&2XY JECD
M#OA@TB9" VY $,)F((I CE[ ;1ZP 6Y 1_\VK"Y\H!,H(%'<YY@.@:XNKBXR
MX AHB"NLJQ-VX 0^P!PXB.8PSM>*@ @H0!HFS/N@R]>0[@\ (PJ  )?P"MZV
MP *.H0> KKQ.H$S^(,0BH[_JI 'L"^>.00J@P#?> 14.P<2R4 PH8%6FC2!,
MX-K:!P9L0!J>  6<#&EJ@)D:3%^*C Y6P+\ @!". 0KB80Y68S04  LZ(!Y<
MC03*H^V8H,64K@@,Z03>[@"H0,<X0,<P #:6[@AT[\F<YS+&H*),@ <<P.ON
M( R4@\Q\Q*4.(BH:L:7:QQ"&0 2FY\X2 @C"P '<HP;>H,_,0_3^+%&P81*6
MH-#4 P2V!5HH007_<F7W>F,@ ,'1^B\D N@P,.8,B@#4[H>W"" 58*!<)N!*
MA* 3&"!1"$Z8SO%7LNL!4""K*. %BF"&9$BJVHB&W,K 7O (X@$%<NT$(@ 5
M0B1#AHV&'B )XC$.-H ";F 6;(,R_$@1V$95>B<B9* -=:D:-1(B9."(A.+_
M1H*F[D\7O8A_[H8@IJBUK B+HD&JDN0.N. %1*)8ML 670!R7( &4J!8RFH@
MABL.T,L$9% #4"V#K.H(9D$&5:0!C$&Y\FGX'JX>P:\30,WKEL &&$#D2$[:
ME$VJ1N#]V,L,$,$-JD[>&@#7K/ #%$,&6$XR;BTR" $5&& A<T 'V +I_VB,
M,LJ@Y*2.(!)CVLI)#C2,#7&- )@.!.")# ZRQ,QD*\0##2"E3$8#Q>X@,HLL
MP,0 !8[L -R),VM $4[C *3LQ;8 "Y;D-:CM(4"#40QE"?I'!Y2@-2;*_EC*
MBD"J\0B"I"(/#?0G%<JE48+',S9O>>X@5X E&#V!%$RO?4I!.[A#T,*C$, @
M$D3A8[A"%(YEJ7Q#(<;&A]I' Z(D-\'S/\8F/+_3/,^3/,=3/-&S//'"/=E3
M/=MS/9V%/L<F!V3@631)A;3L!?I "80@ 5Q@"98 $79R#,KJP*Y+!H^RF79
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MWW+ #A;YKYW*QE#! 0BA!HPIP,;@"XSL P0!39!@%IHE IZ !/Y@ CQH T(
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M2YCN# #]&/:;OP+'Q&B,Q!*]Y\U785NC 3)F*T9 "5(@0OV^!WQ@##1FIR
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M$),*,W8R2%9?%==$ /[L$P +%Y#HDP$CW,$'#AC2U!D=T\%$2@].^. 5$'>
M$<<A%TQ)X!@=C!E39R/""-.5;++7&'\2N/EFG7;>B2=Z=@RQTDTJH"$> $[R
MN1\I(4P%0E=#QB'((SUTX 43'-"94P.%4! #%3V1<L1Q-/71PQ5+ @"((5]^
M(,B&9)'2!@LG]/E2 V(<F&>MY)TXGWJV[LIKK[X2PH0,!! BB /$?@#!"3G
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M,SRC+C=P#"#S &+"'(?UDEU!8K.  5[P3H<P"SM3< KP 0,P!1KY-'2@2(*
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M&Z .BO0$%3 )5U &<H *?V" )Z #,@IN-B -:#<L2) !GE,0I@E0\7<YIP4
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M R$P!0:J+",PD7Z4K-M!8N)36R1V*'+X!!@C*)!U QDZ62=0!$1  4IL P*
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MV2:7H(!.!58(X08AHKCA @*H*.*"2+0,@P(X 7B67',OB$*'%CHMXH0G,G
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M@3L\4;)#?*(3+@0 'D;ZEDZ4@5.>4BD 4E$#'+C@#7/1*!B.(()2S-0 -YA
M3BUV P[H  R1,"*G$O $=_80"&#(@4SA J.9<E&J4T5,'!W0@!I<H!-!HQ$-
M+# %09!ADD(8@XR0V $+P&D$-/#"%$*0 T[546<DN,#D>H8G.#'MJV\= 0.^
M6@,*B)4=.((+X? TP@M<"@ N ,$QO*#8MVCM!4_P0B<NP('$#1)8;9 "M1H&
MA3^XU0,ZH"9<^@""FI$B S@8'?\%I@!8:[5@FA5[0#RDH,BWZ" (@P1"$+P0
M#PK<P&Z+TRUO;RE,!SR !#0XQ@9V, O@@C4&UJ/  ,0'/'+FKIN 6 $1HAL"
M_/V N=+HG@RL6;-N4> 4KI4&!Q2 A0[H"X*I@,!XGT"#'P O+@WH! V0\ *
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M&""8A1> $0M8 5DI+%20D=&Q &<B "#(@ GH \[+O S8/-F"@5)#G-)Z"T!
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M" 6!0(01FZ1]Y ,< ()0",< L"(3Z(&(Q!$=V$<GJ)=&&Q,Q$  *_^BE%<
MG>NM57L+4FB#)G "BE&!;B($,D25!V@#"6 !BK$8'3"]!^ \:)J%4.!&?A@"
M0=08"* =:)J#.*B!?>"',&B!5,@"?^"'J!0\/20!A#*!X'.7;1I$0A0#Y'L$
M2KPWY8J@,9"$ '"".=BP)VB!2# 9A'H 981'.1BI(CB"3X !,- #@G "B:H!
M@;A+^-,I&+#%5!D#>)" ? 2$3E! BWF (W" <J$_,]B'*Z"  WB *@@ %BB#
M'%BJ<AF!02#-[ILI_1NJ,0A+U6R!V^2' +@"=K)&X Q.NH@"N H,XLPAP3A.
MN,"#2(@+ U@ Y.R+*%@  [ + \ #,Z("//^(SL$P@ 1( +WPSBR2B^J<#1G8
MSKC@3GW"SL9XSK]@S^74.>?$ ^&L3VMD,I53.:@,@/SD3]P4B,<<"/T<"''\
M3Y@ 4&Y,4 3E3=PD"'YP4 BE"8%XT 3=2@1%4)'\3_T,T,<,QP[USP(5QW#T
MT 0E4 D-T<<\T0J%RA$ET*VTT -U41%]T =-4=[LSP85T01ET!O54!;MSP$U
M41IMT0DE40$UTA,E49',4)@04A_%40H%4-XDT1--4AT-R[!T4"G=2@+E3R(U
M4?_L41YE4?ZT3S.ED"\0RQM54S9M4S==TP"0@#?E3SJ]47'DS3I]4SUE4_X4
M2WB TSD-5#VMTS[_[5,U%4<)R-,]=5-"!52Q]$\YY<U(950^G=0X-=1'G5-+
M7=1!S=0UK=1/Q51/[51.;51.Y=,VS5-,5=1#I=14==5"1=5%[5.W.%-;?9 T
MI<];31 96+E=_54%^8( \ !@11!^J-5B358!^0)_.!%E'9 $\ =D?59JW0]A
M)=9J!1 9.-9L[5;\2%-L]5;^B-9I%5=S=8]K/=?]V-9R55=W/0]P?5?\B%8M
M0 U2  4 W8<\0@QL<"#U? P50 %SY(N ;1;@]!+U"PP825C#\*4.R $8Z  C
M$PPJ  (>D,_%P(8AD,]$Q-C * 4)X ,0) P-&%F]2%=YM0]V10T50 -%_P@!
M01@ 09C8P>A7S9H,0G@KOPC8@:U&A*79O?C9P] H2"@B2/#8P)"3?QU:.^ "
M^6Q9T"0,4J@#(CD,%:B#%%A:NV#6!4A9^R!7ED4#69,+!8"!##@56O$6MEN$
M"1"38#F1;A$ 2U$!!XH"03B1MRT7&#B&4(D+!>"9M'H6OG56/AM< $B !.K;
M5\H!#3B[P^, Q#5<?//")^"!GG5 A/V ("BR3HD )D03*HB  1@ )L@!SPVW
M*(C89=J4*%@$ME.H@EP$"""21UR!8I*FB,T!E_/81\P7W,J2("@TX"TU0F"3
M",  "_B NU4H#3@&/8N+V9/; T"4YM4S9,&7C?]]*A>8@1-07F]Q $)8 >G%
M%&DXGC_IE >HRD9R 91YH $( K0-%F^!K&"9D6"Y*D&HWL'T W9QEU\J7;R(
M5Z^ECY4]C98MOC')@@Z(AQXH(R"0!"?H  TR $-@*J9SL@=(FF/HLAMP(!/P
M5VPPG(;ZMAX(++C ACNX AA3'P$H83(PK" H83HP!!+>%A50@A> I/5%QRE+
M@FTAG.<*!2ZXW ;<F*@D@0K8GR.!@@VH 'D9 WYP@@RX 06.AR0> Q:(MB1^
MJ0 DA ^#N"<(@R @ 26@!&Q(@F +A3,XJJ(=@:.5OQ1C@%$(!:8: 3'VLV*\
MXS"8E1$8@@\P@U\;A#S_&@$)D()9Z"#D-  7VX)C, -9L(-"G@4S*".D4:])
MR%XQ-(09H(!.\(<(OH$7"P)'/@!3>#=)+B,["(-9J($9<(.#I %I:(-O,X,W
MR %3:$BE016-79H9$($'5N4>R+$OV):O).$RNHLT[=H!G@]Z18UW, .:\(1H
M%%D >(<ZP($0+CX5\ ,1B()"^"@5^)5^/08>$ &Z]:-M+D8)_I$>: %448$P
MD#4[Z( 1(X5V'H&.B9-KZ8!/2),>$ (3$-@^4*,HJ($3<#D<2),8ZH2.(0!3
M:!&M1;(H>((.< ""H></ [S)1)B*?B_3S#PT@+:(@0$E.$PEF( '2 +]"I0R
M_VI=<\AHQ/$#. (#,G YFBV"$)"F$>"!&,CH1#2X,C( 05"K(:B!H!X!+K C
M+G@BIX6+DLEIQ F#1W B &C:"7 !/C@ &1@!/I!/4D #$<"&7C:D9PKAL)X!
M2C"D7N;J?2D"!_CJ8J1FN!9K!-;8?>E7;.:!PPEA:4 #1.KC1K)F=][:85WF
M^2A@TSA@YS2$-VC.=_AF.[A8Y'R'-O"$R,:S(JB!4."'*R!GJ8,$/PKA'):$
M++T"PC(DT.8Q=^0'>/RP.:K+/H7'(MB"%P $@RZ"1G$!21!+?VCM;?F10R#B
MGOM9+^F #V@#&#6<)U"_"!"% N6'+]@!]5/D'L"!E/]N 3?6N<PS@W5D CEP
M;I%T@F+D@0/([KF8%Q+8QWSL _4>.Q?#Q[%KNS @ IT" IF.['VQXYOTW_3F
M!RZ @"&8$:3^!#U0A3/B B-KV;#NZK> M)!,! >P@^S%AJ5&FBC.&C3  3U0
MQ[!D@1;X8(PUA7Q4:U^6; I_!&XV #WHH6K^YD@HS[G@6L.6#[ UX R7BRHZ
MD<<^ Q,8<9^C :,6\# X@1@P 3_X@7SLUYK!!C]P@S$8 J(QAP\H3D,B% )P
M@0Y@ @TXGQP8 Z4A $#8E2R7<G,@@X'>%#M@ !*@@$_ Y\J9HAKZ;9Z-Z"/S
MDC)P (25!L"ZG_.9:/5[*3#_X/,/@( M<(",J^Z-Z8 6HHLX, (IN*A )W.S
M:6,G<\Y(N,3+ZN-]R;AC6((SZ,PR040=" ,28''[=@"+W1<1OTE0Y!+,"@,,
MF/ PF( 5YY1^?5INMFL & 'NY0"Q#NL)'VN76@$[ZX,,+P4^()LI.@!=CPM=
M[U<S+F>UO@8_> $9J*)]>>S3I@L!GO'W0.S2..#HW&D1B(143@&;E0L5, /Q
MEB9LGZ090'(',($P$,A2&&([4()ZV6:#-20'BNJ$OMH/5R.7B3;#B80^^.?9
M_IP&R((OR,MC; $"4(%_CH,LOW*"QP,/&,^=^UF"X8%/\'('F&@40!CU P21
MG^@E_]B <O[9S!N$#DAK$JN!86P#1>B$BVT[/SA,B5UN,O  9QT3HW:6&H#R
MH2<<1. X HB"-NBAG7Z$S&R#(9"9 -_UIDX5/=@# ##(*X#Z?;%J"8\80V!P
M.@)K4W!:%8=&%8?PIE7U*W" %0>\%7^ #+>#L4ZQC]S8Z 2"I8X"/>CE5">
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M P,( @:/R( %.  L*BPBRX18 :5C$ %.^Y@ FSY&!J1Q "^)*01TB$ Q8P
M,(? U41IP <$(0@.&$ #UZ%"G*5!AT60X3X?P+4&!+$" 80Z"HNP-:X]8 4"
M""O&S&D,#$;Q!VD0( %%B/$!#( ')L=  V(@M8]S+0@"*'O: (@"#%+]@5K?
M@-38ALRVC03C$)!!_UC'N/8!A"6F()SX,AJ0MK^17:Q!'Y/=UT:W#C+P FVG
M@ H\]C'$&R.(')@ 31GP01'^[8-%#*G#(M<6*0YQ@!&4X0-/ $,-L'(0"GS
M'-,>P20\D8!2I!P+8'"!(NH#G!' _ D4& /,;Z"$&KPA!WH(@P^B8 PFZ  %
MTJ .-E# A#@<P0= _X .E+ L/$1=&AQ .1V><((G@$ :,*  %GK^ 0^(01H/
M6 (%Z("$%^A@%M*XP2%J  8.@-T&0AA#S\U!A\?H) P7B (JS@T$ND]@!$NX
MLPO"8 ,0,.$#"^ .$'KP]X-,7@[9.,8LH+[QPW0>#!- ENGC$033^V#@F?]'
MPA\T<(S,<T 'QP@!VL]Y ;3CAC6CB$<2*$"&%30CQ2?X@!AZ0 &%O'H**3
M#) PB@O<  D7>, HM%%\,L#@#U& 0 8^P.FA1  "%^CX'TC] 0QD0!!8N( .
MXG$!VV=@ @<@1 V&@(/6!!\ ),8-B$$'2 ,$*,(37 #S,4EC"!T=K, 1C +,
MK< A2,,3G$$<B,$)>$ GG(&N)8<"")WY'<(GC,$9Q)RB&8(3X( "$%T<U, 9
M$-T'8,$9=,(;1-T'+ (),$$;",4#1$,.N  *>H '#&',Y0 0E %VC%P37HD!
MC !51"$!J  #U,!/0&'*?8!E&$ ;0, 6., (T(#_$,B!#-B!%JK;"&"%"E
M!+2 #/1!WX&!$%8 &-#!(4Q  V0 !U#9&*P8 -C!&3Q!"^1 R;W 8>CA4 ""
M&,0#!0S$!3@ *60 %J2=.2R &CY!/&S!#?P!!P#!G9$"$I" (@Q% _R!.0#!
MM6D>0XP "1@@ED7"$Q@!!;S "-R!'6*!'\0#YEDBE3V!&%" #QR$*TH#*FB?
M T1!-AP3]1F!P\5!"$R D;4!*1H9!L2!%^0A*H1 '/C*V]G>"=#! J28!6RA
M5I#"*,R"*PK!"H3 #3S"4$2"#OQ P#W "H@ IB$!!F#$(J#"!SS"++1!!YP
M/[[?B1E %&0%*=P #@#"_PH0P2@H1 -   A  ,SE@ P PB)@Q8_(UPG$ 00$
M((J) 0XTP!,HP@K@ *^=0%8L&6Y0@;B=6 /<0 +BA@8@00Q@(!(212I@ 6X
M@@<.H3G8QZO)5QG(02?08@YT(,QY@!R, 1B,0? EAA[DB1P< AF<H#ELX1%N
MH0*( ?0Y85ANB0%$)0&4@@0$0 >\@![,05:,P)HX'!4J@1?T &X\@!A,G@M
M@0#$Y7!( @OXWPCL !',0 N,@"(<0"E<@"& P"'002KLH6T80@MD!1MV A14
M@!-< %&00B<N!"D<@1!$@BWRPQ (@1UH$\<I A)( Q)H'QD @0U4@.+IP!D,
M!?\I^%AL,H"O=,8(> $$C,(A"$')@=/9D4 ;SID80,%>,D%@D,(&!,$&6$ 8
M>L$Q!*<18*,!/,$Q/6<&;, ?Z$!VPD 2G$ TPD [TDH84, !F$ \3(H0+$ 4
M/ $1Y!\>.&3^$06RS,(/N(,1'$((Q-FT 8$^?N8C3-\*(($73-^V?< Q,, /
M6  64$ (:  &3, 3#((3M,"KM4$ .,$?/ (J.("6/<(<1($.D  *B !^_$%C
MK  *'(,%@B110-D< (!$GH$>[(,$#46N&8%"Y-I7-H8.4,!"OIH8O, 8["6Q
M,(0!W*5"*( .* (6[, H'!,5C  */$(%3("PD$ %4 +_%61?!;0 ST7E X#"
M.4"E)QB"(A@#5CJ3LHQ!!\Q("BB (02<6.IIE1@";HS ABY$*3 )%#9@H$ZH
MW[4!;ECF3VB%';0E $!A"T1"*=@@&#B H*9"&\!$9ZH;I3X:SRG@:):!NNGA
MM $"E@'%G2T$-D!B4;0!#\1 Y=W89N0 T)ED*?[!0# !< R'!=!!+OI )\R"
M%TCH*5@ $E2 %V2 &+0J0P#!+%@ ,.*=KZ:0_4W J1X3$ @ L6(*-)[J$8#
MM:+"'Q3!% S$QI%"K$%J$6"  RA $-B %Y"! F# 'RY$'UC +"@+0EP -^(
M]=T!#= C!K1@!%K /:[ '\0!_P:PR2=T AJ4P4=NZ#M,@5T:Z:L=PX::P#&
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MD08<04Q1]>I(%" (#A!("#*(*EH%TEL.-%8@0*@ !5Z@@39TX 44:0 2_G"
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M9 <).*$#$P@5*GL !I\/P0)9H( #L/'S#J0@5#L00-%S (0ES,((,VA! VI
M)*IC8Q).H!$8(!X&&DBCZU.G !FB'H\[#$'" ,#&'<(PB_A,@-TD&@$%:FN
M)U3M!7T I U"T0%I8&%&2B=P@_\,L7:KGR$'8Z# #6S@@Q4 W@2AN (#AI2"
M/AQB%*$ HP+QG=PCS &O!AA#!1A0OQ20(A0L"(,4OJ $-[3Y!#KH01@$T($0
MY, 04K !$5" ]@K,@@0=N(#NI>"#'+B ]:176/ S0 (IS"$"-?C"#HB@?+_W
MH/5?8+5  /$$\"?A"V6(A N6P  2[* % R$$%EBP ^O/(0&ZI\$&B""$*-1
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M'_B!!8ZP3.0N7E2@!UY@#-8J /;A"LY #SXEJPXA[F"+6PKA N3 $,X@#I2
MN/8%MW01!7"  %1@":1  @( .5G@#';./[V DK8  Q"M#](Q%0J2#A%M0)7@
M&6T@"-)1K.YQ((# (5-K! HE02G )!^2NF2 %$ZR))% "'2  ?:R00C!;/"E
M#%(!O X "1W_Q1]8@#P2PD&>H (DX0K*P ..P:^F:_+B04 #Z[ &P@0$(/X
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MT\1+0!,SC54/9&%,#($+.L%7K\ !8A%:%LP ZG=,] !8L0%25K%,3*%)" !
M1&!:2,0.7O-5H%,7X?5;F3F GV2T"&S=)$ "VA,(ON +?HY8)GH@7$ 26$!!
M$Z !1($%^,$)<&#])$$"%/0 L*$8!]2' :$-). ,QK&EV=0%"N4+>  926$)
M)L%(>S:+4\"MGD42SJ ( C1#A0 &"H4%**!CLPJ0[T-#">#S5-@0)@%%J99
M'- &?@ %Q(1G(TM8[F ? B ,.!.:^($\&H AQX0=N'HA+R *.K*N(Z$(H.D*
MY..-OD *PB #C'D0VBT.H&E14\  Q&#->'<2 /];"J V"/Z,$!Z9KNZ%!ZC1
M+[/@7@2P5+-S41=/O=A+)QT@#MJ '[3@@FT-O@:DIOF!!RY@#"3@"Q)[Q9(
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M3PMZO>03]( /3)8.7*04^, '.UWM#Q_QI3$(L1,FK?_9+_T@!CHA66 D#":
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MV0#M[H<$R#$,$&*P(-Q>)X8,.* !8CB#[@I&!0V\0 $K.(0#%""&U'6FA4S
MV>=:YQD%;(4)'UA!*"RG,@.8P \3(,4%+T:*$!#@?2(P!1>"!YKYG6$!H9&B
M TP!O)V1H@>*X  &/8,-Z-G/?Q<D!!,60 HEO(!D#3A"&@]8P! @L#1Q%$(
M4?# F"E _Q Q:)\@!VDP W0"#2= H )@$ 0F@,R0B/R -& 0 C)$ 08"J.3K
M!*$!"&@2  _ @ 7VE[8[4. %5+C!,?2X24K>T0 Z0 ,%)H -%'@! W:\81%6
MZ3H#1& %%GAC9Q2@RD1N,@>7M, *>"!,S_PR"&_LPR&(8@$.0"R5QPA!(/]X
M VT2P "+P"4""3$ :)*,"D409PL_,(!1(LZ(1YA;!#;PARFX$P M%"=H"+&!
M#-BS;0;0@#X!$%!]*@YR$: C,1NI.RJ$LIJ^;(,4+C P4B#!C7(0PQ9N8$Y\
M1@"7@>R,]@1Q@!;NCPH>,(<&/N"!&BB!"1YXPD;-:8"4>D 0-_^P@#0BYTN<
MZO2:,?V#-!*0T)S&0 XPL$#T? G,D!H@E%Z  "0&EC8_*(R@.H > 'X9S)(U
M( 0P$,(!"(%3:/8-AF8EZP $MM45\%(!8T##!3X@"+RA%7 &U  O/Z. L0&
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M@(J=,4&$W7T&R$K "1F(P0B&36/+*5S"9>B$/R ^ 2#<80O', ,8Y)"164
M> ^(L !Z4 8"C"  0X 3&!"7BD)XP@!CN (.#""*-TA1#@RF0"<"P ?B$'S6
MAI  !8R@65-<H>/ ,P'P$(<->#C!"UD('80E//(V6*X4.D^ (< 0A?\VCV+"
M!S#%PSMPZ0;T9L)R&,,DV$[&,&2@!F' M1FQX0<<>'P(*Y^E"51LA-F-X0M;
M>$$?>$"'PS,  CRHGPK"P(0G?&%N6'Y!*B0ZBR1L80(JJ#<#0@&&D((9\SUP
MPJ$[$#^1C@ -"^Q#ZB&]P"B,00HV2 (%+AUG)\R"!*R7O19XX 4Q5)H&*2"%
MHZ%0Z!V08 DFK. %'D "%,0#^AR@M* 7V.H9+X$""$^P^*VF C_D>P1\4,T[
MZM "Q)4_!2J8 0X T$3.E)$29<0! 4P1^1$,80(!)49?) 1VT &!M'XM<$1?
M!@#O$ WZAPU*T'ZWY0- T &?0']'L$$ , +_"T0 BR!&#Q "JG%;%] '2A /
M'3!_9?1E=K %/@!*'/  4"8#_C-]N:0"&?@ %7 !"0  ?6 #[1=!1-9^*P4R
M0 "$!(!"1R %*N0_J]9#8C!!_A,Z3A@'-G X-&1"GA%'%'  ('0'0W X()0!
M-W"%!#"&'Q N4/"$*K !EH,''W V#Z!!9UA",? $-A \,'0(!X!"X$=#6T '
M1F Y!O $AQ ]#S"(<6 &3B $.G ('R!3.0 #,@176S!#8Q"(,#!CE[A#?_8$
M!_<Y'2 'BW!!@/ $81 /J:$ -3!SDQ-J8D!A!@ #2O )8U<Z!]<9M@<)" =7
MLCAX+^ "/! _:=-%_T#@![;XBVB@BJUG DOD?PY0?BC& V0P!K+8!VA "2,0
M!O%C!YKE&:6P!U$@"OSP!C7G=\!3?B* #3/0C5S0>IU!"FB  ]B0?F#VCL=C
M"O9(1NT8-_-8"O:X?C@0CCF0="-7"#A@!_]G  *)#6$P?X_E?VWS12TP/RW
M,1P8/XL >GO7=Y/7?E_$!)W =J'E/WPC-RF0"M'@ R;0@;?5 BJY4W*# R.P
M!0I3@T60@4^D!!05C^6C@X?3!QEX-A%T0:2P@P?P !E8!"B@?PK0!A,4CS:P
M:A%D9E.9 RJ A"CT!]FV:G9 :@3P!+,P 0]@.%9X =<3 T5@AF-XE@00 ?]6
ML$+C-Y=1,S_YI@<SQX V]QDJ4 ?4EAK?5 0;$ K^< 4I4$8#Y) XX';\X 0G
M #=?= 'GY@_\X \LX EV8$;]TP-O)$ $P'<M, :2$ #[P \!H$*85@,/!P+6
M]%1($ H2< 4^8((DH @3:0-TLX6JZ004P $F< CZ1X($\ !B )M7, </4#YX
MXP)W4)D!$  =D 22T!034%TCX& \9@A+P -&.91;B 0"0PH;8)2G]@2$69DL
M  9W1']((%: P Z2, 1N0%#L "&S,'\X=PC24 ,!X 1S8%=C< <L<$H6 TL;
M@)]X* TR%3T\A@H9,%8IE(1B0 $WD 7^0)K\P'K_P_0$&1 $1\  %'!M<K "
M93"BE7AMHJ-1= "*$- Z(+0%'U #4H "=293I;.*3T B+, #Q] ZK68Y#Y $
M.! !Y!@ %SH[6. )!#4"4U5P7?09/YIP=4"3'< 9:9,:H-0#%U #;] 9?6 &
M4M"D^ 0#)$)T$W!$$Z #0T &8Q>/9M "O\,9(_".CW6,=% 'QP &G9 :7!2-
M:.  "JD:IM"/"32/?0H @[J.4Y195'2H@% (+: ';X W[V &GE!^'] #1K '
MN#,!>B !E+D/+- "O/-.>$FI-A=G7T8*Y.B89("8G_F0SR-&C^H)$= &_A &
MBK  2GE!B*F4+%D]8*8$_SX K 'D1F.@9(  E7&P0'&C!$L4-[%W-\*YA4<0
M C1H0823@4_0G)29GF23E>:S8%RIK6I#F98Y68=P."/  #Y0B$I%"!9D9QHV
M63I F$::GA\@FKRY/W3YKU.CC@: EYP!"-;@;Y[Q#N8G0!NX$#%0?CA@ L,(
M9GW7&1'P6F"0 PBH!QW !.9 !^: E9$'&@UXDAU("DO@!@;GL1\0LJ"A )TP
M839&8C%@@D) FX@PD<H)&A&@ R)W WRTK1>@ Q5  =*@ 1D8!S2*-R.P Q=@
M#N;P 8-#3,%Q:1O( /,'0CW  X?CA$2)"JM&"AEP.''T!S>P Z@&M73 ,0TP
MMO]G. :#P 8(N@&[T6R%: ,?T$_'8 .7EDI(]H()%P__.8M'@ .&R*![Z "
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MD!!(Y4>!+_5$/2!6!&7!$Q )R1H#G?!YD8"]+8!EQ] !/I #(^!E?0-9- "
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MP(94H""%AX"X0,&!&D#EA8)&@.*"#\9@H$6,2,G !QH5(O"/-P%0(90A1%0
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M,(KG_94]'<! $": /ZDMX0HGB,,HO' ,$!R# :@89Q&.(8U2XJ]YWR2 !IY
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M@GR*H@X8''T* UFK >F3@C+0@$%+!4.0OC!PH&M:@6>0 Q=8@C-H$!8( QP
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M14B7!Q#_! ?0(4?930JJS.!L+^T4!/A<FMRJS>!<A$M:!&G D-44A$CX&@X
M$"N($&>I3 L0A ^HQ%00ITDA >0,)VE8 >V, 3E8! 6) IP3T8Q[ AN8A:L2
MI]P2A 0834@*4??R#V1A@@-(!4&( 0 1@\H4@$2B N.,'B.JS(!!Q02]@12
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M"(B9&O"$.#B&+8@0?P2#E-* 0] ?QFN!.," +4"I-XB#%=@".O@ 0Z $*GB
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M<.5C, -^0(3*;%X-3F++1.9@UN!+/H9FMLQ1L 9_*&8=CN!+7F9!M@"_)(\
MB *'<"H?*05/( #%&0-R+HA22#0%2$?)<P'1>P!1^ (P\( "D2JBF8 &R !>
M*86> @1C" 5_/H1]$ST X)(Q4 0RH (ZJ&?/@1OD5  Z<($34&@Q8"G_L ,0
M,(+UHZL8Z(1LX2,RH*L<):3UTP$O> 0F8#^#7K][D@/]&J=L"($5()I^8]L_
M^;$:2!,@*-87D&EU"8$7> "V'8@^"(%$ ?\"R7(T"DSJ">@##/B$)T""#( ?
M#RD"&PO?+.@ '("!9O 14IB"03(!TATZ\F&1>_H \9T%"&"V1[" 1^@00AB
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M@[>!;2W(61>0!'[PARM ;'P\ :4E P*) :M=L!'H(D>K$@_Y[WU8*R"X ]D
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M,( =Q96R#LB Q6YL1P< 0FAU7:LTV[78,7 #=#L$,N#%M5/+(E"'ESX# _@
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M [3!$T\$'B#Q,H8J!$\?4W4"\R1O#S!S<1CH=,9 G#]1.KTQ4.3/ 05C/!F
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M\LDKOSSSV$F@<W<%$R&J DU+5\0$*A5QH\_8X[V=PS;\0>!U#\1PN7@*"+)
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MQPC%%VB0A!F 8 7'(,$2RK#/(G%@M3L*"D>+- $=U, )%'CI$H;@@X\ X28
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M+,P"LAC)E[ #$T3 +#A?'&3 $3"!!F2 ,I6&*V$CW?5 "[ *"3R?*GW$"%S
M JB (@1!#  !!1A3)\S"$0B!!\3?N'1?*)0!'00!4TR '=P!H*$"$7B!!X0
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MJ6Z'"RR) M#!@HR&2I#"!)B5'!@#G+ #3#E  V0 ^YC( 0 "$F2!)]SO7^G
ME'2%_5Y7#+@ ]=C($Y! HT$S,L= )#P!3$U _DFQC4Q?]F"#CWR$.#O*9K&P
M'+1!:HXS*R5$ Z""$$0"#-#1"^A "+ /$+B2"6PCV@*!M?4 (GQ"-O22#B3$
M.V" +A[)5.XJ !1!$+01NAP0#*"7 5#P"F !#>  %2^<&.2KU 3<""[Q*(@
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M*9H *GC$5Q09M\Z- !09-2D32(B@DGE UJC4":Q !E2U4W:=5?NNM).1C1U
M5!9%'0K="8C!!!2!% P"68W8!O7!U:6.#!S>CM\[OJM.SD15G+2 # !!&7#&
M@D10CUQ2%(C"$,2 )=J!9!P-*R$P-M! #7A")("2=+9  =F!D;POCYQ!03!
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M)(@#0L=.A!44@H!2!8O8 C!!XDN'%FT5C%DB9<L'"(IJ!/#GA,:/"T6R2.F
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MS]_,:XE4 8TR/M:'.GCD6)W@ 0X ,88K_XA.< !0P0S<, :?&< %,Z $*>J
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MJKI][E7C6MVH&G>[3_]=9GBK2MCS=G6;[9VJ9.OH 6WP!S^&\(+\Y&UP_M$
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M0$=B= S41]Q/.,^DU%QE<>Y  .-F;A3@!H* "60 )-#@#T0@"@2&"FX %9C
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M!)2 !!#!4?M2*(X =; !!8Q@,<+E6CL .!K@""Z@O]+W!!)&!2K@A%1 "2X
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MXLX$[M8J?%D,E."*#R .:@"S<: !Q "37[L";" G\J*3GP %OO.U6SD54IL
MX%X(2G<"(N!@HZ8,ICKN84 )LKQS,=9D@Z8#R& J!">X;5/SKTB;IT()H@;Z
MS.8,D)<2J !Q)B#_FR&7Y8]!E<MY @PH8]5YG?GA#5+!B/+%\#8B=,H' .R
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M(;H]X4 C,M7-AHOI3(/(E9JND>W$$(K\"&$Z$I#J RO4@"-X 0DD  ,&I/2
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M@ 6(@@7 /1DH/W- OR+4@&=KP()8 !X$P0_P@!PP!R0$  -00.++/Y=30@(
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MMM1(L4Z(-;1L"FW X$Y% 3PT >Q(! ;N]G.VL6Y-+$S%L78_Z8;7553"!"A
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M1A]RR;],G8]S\:O]P[9(\^L^- WN1CQ,ES-L+*<)T59=6V;OK.Y#C#AV@KA
M5Y<\'(^_QP_&3B?W;5]1"4SS*91PCJA>\RT)!T9E#>C-N_0SD!/%]#/$)9(!
M)-@ &]B >*C_?]\ ^@\X"9 "&Q  @-A@(YX,  8/(DRH<"'#A@X+_QJD(@<
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D+N<V[NJZ[NL:A^?"[NS2[D*,;NWB+NQZ;M241>[ZKN4&!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g133771kk01i001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g133771kk01i001.gif
M1TE&.#=AXP62 W<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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M^H+)58Y;2THCB\X)P/39X ?[N*"(225DMVY,#[,SL&O'3.;UP/8DXC5N+^+
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M:U QVQ 8*[,M^[,4 [)"*[(]2[0V6UTC&T4S:[1%V[%KF"=)6[/(-!"SM+-
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M4:2^[2L0X'N^ZPNV=TNU]KN^X:NV\*N^Z%N^8+N] ,P?4WN[^'L5Z3L0MSO
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MPM:\P S<OQFCOBU<L01,MD_J%SL0!C*  J-0 &#P!F_0!W80!J,@ ED0!B*
M!"B !(L !DBP RBP S&0 RC@ACOP!BC  @!]S^^\SP<= EE@!_M\!SO  OLL
M _3<!Z.P W8P"J.  F\P"F$@T4C@SPK]!@"] QZ=!4B T!@= 5XP"F PTPC_
MK=%@( (ND 5W$ 8C;0?P_ 990,PX3 ,%4 !$;=1%G=1*O=1,W=1._=10'=52
M/=547=56?=58G=5:O=5<W=5>_=5@'=9B/=9D7=9F?=9HG=9JO=9LW=9N_=9P
M7=1$3<P''<^C$ (BS0)OL A* -)WT =]L -@L ,DX !]( ,.T-)9<,_LK,]
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M E3P!JP@!V\P :/0#?3=#27  B%0 OP !A+  A/@ZR$ !LJ  E(0WW* !1;
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M"Q*Y*!Q,W>%!@@</6WT2&F)5QI$8(EB]>7,'!0LI@WM:"+&)18D>!0HX* "
M7X'1I$V/1NVY=.K4ID^_=LTZMO_JUZMIRYZ-V[;NV[!W^^[=^K?PX+-K&Y=M
M^[CRY+27.V^>&_ASZ<2I#T=^O'IVWM>+,]>.'7SWZ.*AA_]^GCQZ[^W+I]\^
M?OI[]^SIW[>??_W^^?K[\[<./P"Y^Z_  /T[<$#Y$C200 8?Y XW,DH+K0 :
MCG#@ 1DDB"(*+"R@RP464'#*(13XL:H$$1P(@3!E)K!$L#=D(*,$&1P!HQLP
M7)  !0]$%(R%MS8I08*))G!!BA TQ,(!">PH()0C?"1LL! :F("?!U@(P0$
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ME26&V6"9#X;8XW0QUMCBH&T.F>!R2P,@BS>D<,$%&\'P8!0/_UB(0H:H;"P
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M#%W8!"'XL0-/.80HFZ #"\('M>T9"06BV0$*%(6"* 3B5!-0A@=>%(4W4*X
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M 09GQH $)(!?3\["K.5=I&D]T9U33NX!)?3 !1C!2[-L_J-3"6X'=HBQWDI
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MI:A@FN%I'@E\DQY8MS>@ Y%#P114P15D"9)CB<U! 0NP@$+J 1D@GPFP$LQ
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M+;D4 0E@MZ:1 "G80BY8E*3=@C=P@$5(#'^4&[6A F6( CIPA+"DG!YPA%B
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MZ@9TA IQ[)W9ND@)N(,.X)OV6E:L.4L)+  94!TPD(&F*P"Q$, 24YM:H8M
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M 27XR&-2L#5@ 2@ PC2H"GY8@R'L@9/M EE! 3M(:7@R(R5HW[3 P'8+@4)
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M\:DI@(L$ Q)A!3K@B:;8[MP*BCX(8<9P\9YHHRAHD>1W :^TBSYXN6Z0 2K
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MQ00.2&<)<A9MT0<_)3@PGR5OA#!!%!,H4T(($J!P!"L2[-"#!QY(P8(+_$E
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M1XS-ZB+\  /8;O"&Z&"!9E@( 1(*<#_-.8!IYW2;!.[G !+T0'IR0 $+KE.
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MS2_\UGO?^-!75?61WW[:CX3^JK(_^>'?>_G7'U;[5W[W35_Y<=_[O1_Y@=\
M.A]OI!\ OA_[%1_[*>#_]00$WI_^;1_S$6#_ > "YDOM31]=[%Y---@U8<0&
MQM[ I(9\I88R0=D=P!FEY9DL5$(I#%<!;% DJ$)I10(B;0'9D8)WB<"8E0+[
M_&";H?_99U%"#083UJ&9'V!#,7'9$J #GO4,1JQ ';C"*023+)B7)43 !C!!
M^MP6">Q!"$70*.@6*40"$M[9(62! \09(["#&3 !I;7"='4=&Y /R"@=;^@$
M(%)?":[>'>'$;H3$-$',1M  C'3 #FR"Y9!)J#P "V#!<;A  1S30&!!WGB
M!30 2I4 SH@ "EB"4LF!=KQ!&M3--XW3PT$'%K  LST-/[Q!(70< +#5F50!
M"F <?SP-%'2! SA"-^2-!72(!,B!0S2' V !%8A56'T'E@04#0@("TA!!\F(
M2^4;-W:C-WXC..K(O@U)!ZP<"C3 &^A)#SPB8)F)YW0((8#_P88@0<T,!,91
M3P/LF@.$0!:$P#R4B!U 30F8% ETG /T $5)0#?,QQ]@P1LXR,[XCXP<P0ZP
M0 DH8U@MPM.T"3TY #UZH@N 53= 21_$P 10 4:%P!",B91\2$;$2(X9S$B\
MSU*P'QPA1DGDI!^$5N)I1#:8 A) @OQ@02C$2B\%GC)IF0400B]% N?MP6J]
M R-T P30%FR9P0Q&0FS%"M<%GBQ-UG<%UR&T@BI]5FAY@!G8&23LP)U41'D-
MUU#,8#B,'47( ]>=0ABLX59^5B+T@1GDP-]-P1K(CP3<P4JTGN]QQ#]@S#9I
MA:LX#/QQ7Z=1WU&\'B%2)M3)RKWT_T4<\8MB<9,<>68U55&R--VW"(P834MG
MCB9CDA&\2,O"+,M1/-%D/!9E; L9B=$@WHK 1,QJ2!U(6*9'$(M,2""G=0Q/
MJ)_Y'69'F,"8T0(T6= JH(#EL6$P91+F58$81 ($'<(=.%H$M<&8=:<<.!H#
MS($VG,!VGL(#\$8.!!J>31IEG0(71  <P)87((5S1H(PB(!.:()3I<02<,([
M?(,#9-D6>@1\YMF8S<&F18#EK<*&3!HCM,*755J[S>;&3 ROI(MH$&?#3$6'
M.A8?'0$-E,GR1 ')#80E($$MDD ).$) C8>63(T'; @='-/4L("7_ $=.( <
M%,+>(%8/L/_ '_S!0(3 &3A(S;0.U@! NR%!**A "43!K8'('^R''/!##VR!
M='0#L[5DJ.23?'@ V !-VTP*G=B-([Q!+'B  VQC.,XIG=:IG;[4.!8)5]5,
MD::CAZ@DR81*Z< -5ZU4ED0!"T@;&/2C"]@!?P1/L;T,G,Q(!.R PNU !#!B
M!,BC/%[-C)" PLD *5:*'3S'(N!3#X3"F(!( WS.F0 ;*^Q [<2'#"Q5AZ2-
M1ZQ<%]V$-E$3:HH$8VF3+&0"(^PA1VB.::'=:YB6W.TD(R##'"C"'E"7(: !
M.S"!)SQKM.X!)<P!&J !>L40(X3 ^S K&P F=T:0"&B"(1P")@C_RS[8)=M%
MD!*0 /EP@R&<@@CT#+,B4$8PZRH@ R-80)UI1 ?0P-3]W2FPG;Z""PH&!K#
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M)A$.0H#ATL<!"K+=/&!Q\,>%'0\H)+"@XTB.E#=5);Q!T8%&B"@-WM !L!M
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M!!>V6(.&?=H.Y37 /+!'P<!>:__PCB-ZZ((,!Y!0@@X9SGACD0RYL".*$E@
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M!!Z!=(^)Y7/YI6[K+LI:\$>2R4*9+"=JRJ'ZUNU02D8="T8;.7'6%&/[6-6
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M0!9$P()->  +(FA)"#P@ CHD*PHI*0$ 2E  "70#"]VPA 1V   'L,!77)B
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M+=S5FQ-)J$02DMQ/<WS")4TQ>^C#IDZMI0D19G#T'ROK)4E2<9-=FN.X5 .
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M!2@@![S8$BBF!%QP$C747OFYOU& 779@8 <1<T*41B6 2]08O?]\I$LP#0E
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MJ,09=H .+;#!BF!80T$)(09A@ $/B<C$&]: ATJ<<P^$J(,S[H"(4RAT#9"
MQ"U"X0=2G.&AF6A#4_@YAS;( P_IB"@ZT9%0/&QT+P601S;J$0HQ2 ()&Y3
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M@LR2?8@ )I@G3?",/F"!KXR 2V '?^P"*__"A#T0@TR8AR40@RD83G4P(0E
M!TLP@^L4O688(H0A ['2J"ZH Y@JJ"IJ32;8A>^\#GCR TG@@@+@AD/@A85Z
M QKHO"H "FX8*X+*HE[:R7TS(*<,BBWZ$4+: *"A R8K 1:H'9=1'8B! A:P
M "F0  EH'1DX@M%A 8AXF!U@00?P@)FP!Y-9!!:PH%]A09V9'!;< 0?) M;:
MA,VZK,SR #D(FAYXF9>1 _(#@ KL !-M "D(@=:9@ >P@Y<9 @E0ABJ0 "Q
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MHDE@EMYIW638EH*&$/8/#?1 :90&BEJ+"_S5&T1!#,2 93F "PQ69"D!*\E
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MM)Z3[UW3Q>7R/)Y3IEA 6Q$(*Q7+&CQ N<E!#'05IN-B-TY //: 7S%*;CB
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MS2#>(7'G'Z&NW_\YA?AZCB<V!7"/3FLSX6KGZ"I$0/6 &777CCSD >DP@"Z
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MQ9 U%-X7Z&_#G2QAHD?#;.UU(]!E;L'U-45K-/I(F*YQTR5:LLC6]G8-K>?
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M:UL]( ,8I#,!+I#@!D-X RL*\ ;[3. -*'" ;.CH !)080=4H$,)4- '!Y0
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MMA]VDCCP>4 K7*F#!*Q"B$LL0S$;!(D#ERT8TW#.9YT15>JVO#S'HC%Z!BN
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M6-Y*J-Y &9 O!$:)$.@@K^2*]Q9IJ^C*5BIIXU0P+P4#  SFF"* !'J $+K
M ;)@%."J-8*#D5" !%2 ! B!'V:J 5)%*CN%1+$O! BA UR %5+%!<# 4X8+
M *:-WF@,8%C_ZRCC+<SJ(GKNJW=>9F&\[+N0K M'0P4[PP%>JUO,+-YF*Q<!
M!HF")P&/4GDT,(VTZ[$ZQF+T+0(M9F92)JUPH@$!YK;RQ4A3T;0>:[+<-$UQ
M\,&0C -[L+D\,'%H1U]V$5Y"(@R+9[*6DC+6JW<&]?Z$#$A[!F6Z !D ;&P
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M!R"D4'4# ""@!]:@ TK4 =;@KMJ!<L%@,<$@Z2 S FA@$V(/Z!PA!HH.5%S
M$G[V"*C $D(@-%T KXZ $&XC.[J 1=3SF6! [Y[7!*+$%^2.G7Q!#^Y)0GQ!
M#>8N0JR7>R%D>K$7?*^W>NVI>LG7G\P7!JX  %[@>I?7[XISG'K!20K "%AJ
M\Y)@.A-@\"C*HIPSHY) !Y*@3+J3#-CI!'Y@/,US@=_D"32/>=43# [$'BS
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MR?@!#/QH$6JW$$J !1QA AQAJNZ 'SJE"KC !:K@#1;A<U/[#_KJ./H ,&]
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M=*7#$;H!#+8@J,@O!.Y  FKT#T(@!#:3!;R#!8Y@JUB %>;RET@X/_-R0H^
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M&3=E8U<C S4T!"0@,EU0"&^  AZP"2.T RZ@!#W@ 2%0 @5V V^08H6P __
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MB),*+%2D'92HJ9\T:2>'J;[R<P'B' VR+26CJW.$J9,44FT4<F*@"TC0>@[
M!&*P"JNP"-*A"7VW+V3 KP02 4Q@"GFP"GG0!S>U!/&:!F! 5YI L 3;!V:@
M+/+PL&FP R7@!XE@"@2["A*[ IJ L;* " 8;L7N0#E4@+V) ":LP"OLZ>04@
M#TR  D/#!(A@"OC*L7VP ]PA#W6@KYY6 .^:B_K!14#:I?C1,\/2=3YE(#\3
M:>A66S* !78%85L0 A. EA*P"N"B-PX !IL@ 5A@>!)P!YF#@0S#'RP0 V0
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M@P0 .D#" 10 H($*.3RPP $/L)"B6W[ND,"#$!SQ0 YERK##JQ)LIB&+$@
M(ZX_\C*;A3LFX$@"%FZ^J!L)Y(BH<,,/3PB&&69(@''$%>J #%EFX('_C!/(
M: PA68Q(((X3'FDBB8.6F&$@ 'J))H$K;'X<@!742*(#/6)? O:#.N@E"3(
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M(5A #B=[PR9"087;NB &:SA""=X0M#?,K0/S W!$+'<" IL@P 1QGX ADN
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MDP0M,"53T@5#J-<P<H^,*P4MP,/*NI%.\AC#X,E\D#F4>Q(TR , T$";40L
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M Q;H<!YJP_)S@6ZP 'O0'^U*ST7S@$#@B$ 8KY:A@J 9PZL@BM**0SQE!21
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MV8D%Q(($Q$ H_[# $?!#%O0 "M#:4[V*"X !/_2!S\G4'@# H!U!HHD %LB
M'804&+S!<QR"G3B""!!2U97 $:Q!%?R!+KW!!"B,&6R"*I5 "%2, [R!/0A5
M*#A;OV&3$,  #/C +O8B+_YB/]VBNBV!$?@ #Y33L3R"$4S##US /PACOY&!
MO9T+#M ;O>$ 0H&+O'E+',3+$^B -^K %_33/H0;-/;+O_7+S_S44"&!U.@2
MP[@ %;  %:04"5"!QQ4 '=!4%K@*"P2"S[$ "?!,"("!',P,,'5!"9  3[E
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MNQ!40\D;0H7+I7(C#CPJI*(CP 2,"RS53WU*"?PA"VP"$E#!1TH "Y *"^P
M$O1!TO&# ]#!(D2)G'1#%'C PVR" R2$4\G!&I2 2K%J%60,'?9 "?"#I,6
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MU-,]Y=,*..JU]4("X( YOO"[(%0W?N.WL(LW?F-!^8!"><M"X4 PQK PT@
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M@>VYL<W1 8VWU ;L>$OU@ JT5(K'=DNE>@P@?8IG00F@?8HG/=>G> S "12
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M@Y>^ )8/OO L4_;*"89-Y8^+=8(D)$$'0LA6M820A"_ $LH_YB:Y^+&#;KC
M G;H 1B4$ (J@&$'=PC!)KKQ "2@H$CI*0!S".1AB1:8Q'<>RP5!;.(]\_G
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M!<J1&T54TX:'[Q9/_IPRHDST+.(1'(VR*R-B[AQP[?Z.MVJ#'ET 7F3  QY
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M*V3!$PHA%.8[;./6O]A6:VF =W-7OT,M;H\@54$Y41]JPDEZT%842ZA #MY
M&5A!!EC@!EB@!-X@!#:/\P! #AP!E"8 "GI/F6^%61* G,W%%Y!%QD-RFP%
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MC>JX- K6)DTGC N9'QX!8&$3$]'QCL9802RAC2JB8&1@7&C0!Q!I>'*Q 6D
M/Y;%+UN!/LC0!?.3!I35%A%@"EPQ!U]G8 5P67A0$:S#&_S !( A/&3U<WA@
M$!_)#X!W$GN !K=#$B&)#"0P/;SQC>YA K(%6IHA4J-#C FQ$G*1%@=2$6_Q
M?4,C'N(55=,XCFB3$ 5RBR?!$=]X;SFQ';?(($XCEV.S%^]A(B-'4WGC$<,H
M4E#5<DJE-G9S$16AC F4$ BD(G=Q>BK_41'9L5(TL2$>D4,0LHH*!V$^I3>'
MB1$.0$!0U1$"80*$8 )\02.HV$T6""9Z)PMBH L%DV-1HB0LI@X L 1X<$81
MTP:R"0#RP GQ8@I<-&,EQ@#YP A_< <95HJH:8I(!",00 A4( $2< 1R@ )*
M0 =1P )8$ I1, $D@ ):-@$B( 43$$F<0H69<@$PX ,P  --T(+G66A.( K_
ML"B]H ,Z* HWB$D=\ 4V  ,_\"NB I^10@9/D !-^"HU\ 0X@ -"D 0/F@0_
M@ JWI&A/H)\#RBC")"PH@)V;@ 0]P (EH RA  94]@9G\ 8L8$T10 B-@26F
MR4U+D FEP 83_Y@-67$Q+>95Q( %U)8)PA &F$9. O-KY\0&B ANH3 N B,&
MR* *LU8C3((DJW!.[% "*T N;."))T8,./<&;O2&*7-A8YI-F,$3U/>9[S$A
MZ/&-\"83I]<W"0>.0/1[.K,>3'5ZX(%!*I(Z>],0[E8= A15&U<7<MH0UP07
M^=91_F-2L0= (6%";K->Z;@U!1(!?VB-.:0S? D=[N$>'!%"';=>1C58G-,W
M!'&5,X40&Y '6K '[(-6IT!:L88,I5!S4L&3C+,&D "0L!>/%B) #Z8_8<DV
M(=<6&C>L2+<3/V,7W768.M$%BV,\/\,^AZ>1JX &IL /\M '4+$X5/]!#)%W
M;M@:/3%Q!)  +\*3!U21DBG1!\73$HDG&R1PDCNW<\C 63U0DP81DM_3$G-G
M")JCD;HP!^JC=8<756JR#R00/-5C"(%W<$0%$QT2EP@F<@%7%PD1BQ4+%V&C
M-#<$$=$!<-+1<AIU7N^U%DA'>L!7'GX:JAL%$WH#D3Y4K#GD;@&T0GHJ#_OF
M>BU+>N[1 =\AIU73<8"E/]^Q$  P?-R8$A5D'R31!48TIN2FG$16![I@ 5X
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M*'UF*BEM2[E4 SA0TY$";P8**SXPA0,:NZNRTH"4+![0!6_@+-"B#&+8 R6
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M*0<T2$#VR<&%% :ID?',4_7A5X&6UB)*U4<X[0*A?SPUIDPQJETVXX?-'E4
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M1YP.<FCT2":"PXHO%?:(X  E28\)!S:\R+$E1*@5&SZ\VM"@2H4#CT+,RK0
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M&45(",<!PEI#< SJ2$\U88?AC,>N;5Q(1%K;8!PY78;V"976U!30F,#[Z=E
M-$Y.Q<0"[<,#21)Q&1>8+"*83 L/70F)L)SE$5^5'!?F$?\?B0C7)79BTA%?
MM("BY2$?)U(>)QI)!- !%86 !#@ '7B7,K"  [B "(3 %B"!1T3!!$P1$J 0
M!^Y=H0@!#! C,08C?W6 $YB "7P!,S*CW:%1?9&=J.B V<4=#MA7#:@*%^&
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M-5/N3I@ !;2=-KO=VK5=+VSC-9?*$L2!SCP"CPXN#-2 !FC #%2CWCY! LQ
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M!JA*LS/3S3E3*K?T+$-HZZZW*>8CHI)WEE=2E@NHASDM@;IDR.<C(1#>!+A
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MK?+"*:100P&&.:/*/39EXW3F(%93@.P*0(4B8N+3*["14_!*1L"F<N8),CK
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M&N]-7V B88 ,]O1V,W(%# HA?4$ ]Q1X,W(YQC4Y_VC7<<J5><V%$&0 "5S
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M)(N\)XG<R)7\Q90\:!GZ=XQT,FNG$)/',\V5!'\\I1Z:,J>N"[I@FR: !;;
M ;; !5A@HDJ@"AQ! EYB*O&C;_]652W15:?/ \^: #NTXP(F0I]>  ::X'[K
M7-"E ZBG@P6>87J[H0<VH:(X:J.D@,P@. NZ8#%%,"9\00T,, %$(<9>@'U_
M0 ,T (!A<@74H ;8J0:NH,1*W0C^O 9TP#U*_=1A(-57_?%0_0I.0/)N'0:B
M8;#WPO%FW=?W8==GO09^7?)^P-A5O5Q%<X1%<#743;1.)25TAA7)T2)R( >,
MQ(X6ER70^",D.WS4B"X<7(K<9%HR)O&$*%;>T]ZJJTNF!E8:-.G 2L%3XC9/
M]Y$6]U($%(.TQ"&H<[!N:8\M-H2$^.N0[1M[KDXFL85J*2)221%YXNNJBX@O
ME(!2"./_N@23K[:0( QS2\M8F-87E9OC[P[B_^=SC0Y+\O8Q2,8+7XMD6&[8
MV,6U,$XW4^6)8,7-US6SLL@] V5#%^BYSEF2HB4[$WI O<BS8'.OTLWP?E,G
M0&N6Z,LA> 2^0MO8B.5EX;;CWG/ LT@C\*Z8-Y0\>W'E0Z6.6*5AULNV/PE'
MDA84-<D\=/Y]Y.J.J5U(2E1JY60C8#/KBZ3H $_9T+-HU#/@2T[B56E)%2GE
MD(@D@FT-X=A!(I=<#_L3GURDL++9Z=Q$G.?'Z7PR+[3986(#2N"B[2&J74 $
M/$V!/2 J8<+\)@ +6 !Y!QWWGV,)_OP'FJ )OCH!8/7-/I+/_W/?^(VCT*6#
M 1VP"]#\#2[0 Z1 ";)O$TH@!A+SOH@Q.=Q\(%\=B()]5U> UF%U( %M+S3
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M!LA3.I?X)SDYV4SD$B,DQ20'8!/*"%160S+D-$4X$/E<<M02,J5 [24]"@X
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M@@FP#U^@ T?)0#50</J7@G'B*R3 !250 HM0 &925BPX)BMI 1X0 R6P 1$
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M, %'>  %,NA1%%P@!RG$(A9;  -#)& /(84AHT_$;6YUNZ45P, (/KC %RA
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M<C/!$OQ %/]$$J;0P,_J0 Y4G:6QFQNDP=OJ+]X[HQ8YDH4@)3H@ 17:!!8
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M3TEDR3Z=.Q#EKV&=P? TUN\$QTWT/GS[/!>!S%4XPDV8 %:0 WY@ 1__<8%
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M&E@/B44Y(OJAD.M-'O]0BR\8N0[>5S'9@6Y0H2@H 4OQD1!@!1+@ARRR@!(
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M:=+%Z=9IV[A"34 M\#5MT)A7E])U8+5 U)MH6_:(F3%BV*!46]8$_%)P0\&
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M!YLHX0$*3GGP1@,>9&$BJZVZ^BJLL<K*:I/.%53KK+GJNBNOO?HJ:P=D"%M
M+W'LT]ROR<J*PPP)U'!"JT<\D4 "7[0Z[0S/*KLMM[Z2T,T$_QZ$T(,=$DC
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M5!-L<(A_\!0R<6#&" A4@4G_9&!29S246>U:##5.Y,2&)C&:<6A'0N0.)CD
MV6Q@XIU80A5$]M'(5)0=2F7,@15-*37-$B"".LH")3#" Q2$)JR""/@!)= "
M&."!+J1!/FJ")Q!#N5[F(BP!*=Q"N>)!,Q3"'< K+=2C)R##&Y2 NFX!'N#!
M93Y #L0K&*P!'F1"(2P"8L@"*3!""#B 1"9")M#"*HPF*5AL7X[F!I""6)J"
M+AB"!91F3BR!3)8 3=3!*MA!QS("&_B$RMK!M>:K*5""(;!!#B"") 3G&D
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M@AG4@2?L@">H ^P3+6IC CK8@A>L0'?S@SQH@BZP?N/OIM,,H/%]NUUPH&<
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MTVY!]@HPK0-^N/IM/@<5+ C" E8\SSV8VN.'()ZV(Y$K[Q#)XP99\GA#C#3
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M$6 @@0,TL8I7;J<.JUAE&D@@!BA5@0Q2T\(63)&)+6#B"//*0PD6D@A!= H
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MZ+CQP"=!/,G!90M2Q[/UP 0>HF,;H]-&R>:'.RAA$7M:8A(')>AR-)*C>'H
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M>OXKO_COR%XC F2@#[8 "5C@*3@C!#S *"; $5B !00B"CR ,F0@,ES,+<C
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MA%IQ9=931S;I &ACVH4< ,!=]6==5-%%@VE4H4G<85F!_R98!*9)=55IAT5
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MQ5Z$F%F=XEU_F$GKR3$G]#)**257!4X,Q%>SDR9CX735H4#6<2>JT1TOAA%
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MU@[H(YYF%X\&$JLX&BW5B"UA&"%:*<XK.:_!?MX[>VV6%RLPQ$MP!5+1!"=
MVO+P _] VJ*]#Z1]K#CPVE>P K)-VDL'-AQAH25)H)1Q O^+Q]G%6"2H43:H
M@6OQ]$D1#0 H1 (6L E_L#!RL F1C 5;,$54U!U@$ I5@ 4[X(Z7#-[A32U+
MH <S< (K8 0O>T8XP,K;(B_4<@+LC0I&\ 3S_01/T A/\ -Q4-\U\ /W?=_V
M#>#S;=^H\-]/H)@]*,OC<@39&3 A4 (RH Q$"P94P!!O$ +*P (H4$AS*[:4
M!,V<!4DAGK50"^)B2^(HOK6*!%^$TC,.1E"49A5Z%\(:B4V%YQ_P-].U,Q6
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M4 >-CS4V7(!RXYG5TK$CGPV(C"WP@#=P@2Z@@[KCC$"0 &60 "6PB#=8!!;
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M WFER'QY*HS$>19NX,44(+J*)SI,6@;92,0W&85,/^1*".V7P6B)A&= #.$
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M0*$+=%@N1[NP 3H0XJT<W4#!"=&%'O2 HPYGN,$W (']N+7@$(! !!(N@_U
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MK $8K$$?D$!<[2()@($+Q  +=,$IR@ 8H  8R, >],%^R$,M[@ 8_V2!#.S
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M:/N\SX=;7@.5[5A''*@;[/0.;OC #*@V;N<&&>R.M@V]=/1!5H< $A0 $HA
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M^J,*'L %[J  ),R+'. (^D "MJ -/6 _5&4'IFE%), 18C#_03P "R8@/AR
M#$0H12> "D)!PPC8E@H "78 5?C#5 IA"_J@!+H@"JRE"QJT&T3@R"8 0KIA
M$3)EPJ[%RJ+T:EQ++LU1/&1'.WI"+54*,,\O(<YR(3.*JX3*7/*T,F+R(_)%
M,* 6X+K2,/2'?,"G*Z,+,#9+WB[$+!;&;7)"OD"#='"8+89#8W3C?/0-X,02
M*( C88@+GYKJMM)QH6ZJA6D1'I5"-7I!#8S >@N  F @"7K!CCDF(6S@![!S
M7X=5N=HU),I5"(0 D!>5CFV@%S0@"?;AS$Y@!0JY "(Y.X6@%VR !W#544^
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M0!Y8V<Q"XO\"?$"\9EF\8%H#3OD+0M6D[=F0M3H)0E6\;%J\NMJJ:_8N:,.
M%BPQ!++S%FKC,.KH(H(N-.JD+D,8"0?@JA4ON$9LNP<7Y:4@X<<PFFMK)<M+
M/^2D='$A@+8UDD]_N/9"(JZ>;+"L])JGB*(LVACS9,6?SG$[;C@DC$,P'N\[
M% RF[,LEV*LLU+4'2B *HL 2)DP*0L 24"!'O: $I$ $ %0""#@&#&(+)* 0
M>KM!6&%96HQ1E$E1'("6B$D_ZL)\'>%_2^#3GL&+XDF&E*$$M&6$<(P8P. D
M%-$ZDH4%JD"4!E 9'/37.$T.["!V0\ !M2GKNA>_\[LZ>V$:<,#_"O5;(OBL
M"9^@6J4$"[<7P-OL"#(3BQP@#97@,3.%166@!QPTV":@!!I3 K[( 6A@!^S
M0$*@#Y" !43 5111N9LH"[B)!89E#4J #F2 Q8?@63:X4P!D!V( #.;P0*@
M#'J (6Z)4Z) 6EB!-2U #CR16LI0.4W( V+@8W31@2QH>=8E@&YX.=Y%NQP&
MMM[VW3XFGY:T2Q$,]\KB7:SU+?=-:$QB73S&Y@K5N2+"K)!CY$@+MY"CN8I6
MXQ#F,'A&3(DF;ZR#*<G -_"I8*@F:NI1C*^3 O:U %Q9 S0 !V  !V"V );
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M_$=[".(L^3PB^.%PFG$JR2HX&F*RE4OSF%+G:(XYLAAHZI8CK$?G%H(N!+(
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MK@<9#GJ$"?$&A9P2,@H<Z5$E83<6_,"X)2@!">E-FUQX\.#(PR8E+AP4* "
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M@Q#\'''@CN&I]P*0:NH@!'8O)-F$#WKXZ8,/5[S0A!%5WDE!DWX&8QU)9%
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M5?%"F84#/Z 4-? $22$47R!Z1Y%JK/:)I.8#G)B(6*$5."$C.S!"'F '!>
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M2( "(D!KE)0%![<O'1$#67".X8,"2" ")*0$E@$&?9 %,H $W5 &(2!*$5!
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M&B$/(3.*HI8 :9P11_0$Q][KS*X2>/P&L2 !A""E%N "5!"MDQH"W4 %7>
M+B!P;71EEM&,YZ8,2!".&U 8>-@7DD2,+$P<A !\ )!_/ (),N ")! *,A"A
M'O!F0] %GI2-#,%D[YALXL8]OE$"64 :+F '<J3M7*3MU(R"VF=\,Y9Y=AN_
MX)ITXD$#FH 'ID )AG *J] '2, $E+ %BT ?2T **O_O"Y= "R+@!=E@",2
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MZ8 0!)&/;-""/V@3_ZBAA3? @S7  SQH!@+[&5IX  ?@!D-@A%78@1X($>,
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M#,S#_,O%7$NYY$O!K$N\9(#$'$N[+$O&1(-Z^B6%XH]?DCM?*@ P:!AE8(5
MV)8H^"Q^$(%-D*Z0 H,28!8PD)?FZP9'\ !6P /_?MB3"6@ >Z""'J"" GB#
M'@"# IC!-[ $,% 6ZT("),BI MB1-,@LW#0J"2@ &4""?OF60*""'1"$-:"#
MBQJI!H#!-X""\6,8XF(]%K" -_"J+L""*9F $B! 5X$!N-+/_=Q/$\C(^P30
MO^H ,R((]]L_EN24+[ K_9P!^[,_N,*_ +45 [25/WF#;@C.+# 6%MB$?MF$
M-Z""$H"""QP"+G@J.J #552"/7&$;J 7"3A.&@@!*?D1$N '%(B +.@!< (
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M..#/\-7/&O@"!.U>3*'04<D7*E &#QA., @!.P@!)-@$$:"".F&]*-#?*)B
M&""!-U""'M@ 0:&"0*!?CS*.:K&'$)"!+(B '2"!+""K]N"'7J%/.K!;$B $
MVEP#)Q0K#T _ .@!.:""&I'"[/K?'2@!%%""*,B1$% "%" N.B$N*2"N[.*'
MK4Q9N\,R%*DFH!W3@'JGKO28;,@$6SC&]EJQA06<1? %3%P$+U Z,E P0S@%
M%DN.R,$",R 04NP#5'2#)K%5_YH!@SU !UKX RYFCLB9G/X019<1!CM0Q0T
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MU!"0 0YW#KEA.@(<<0$71A(:CBX7OM W(($A* 0E -P=B%__%X"^(7"M/6D
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M' >=1[Z1(..C#"540'M8-)E?'Q==0DB1L^G-FSMT-BD.H2RTB)(%MG/?3J;
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MZ $) $ #%V A-+!Y@P.$N <R6(0$_"B!!"3PA@9T! !D&,4;H#B!;N1&0A)
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M!+C>!(#_QC+QPQILP>61@.RI!  H02%D@00043=0 3]\$0M80@F8G0RD44U
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MA!6K#AR!O Y+MCZ9@-& @SU!Y#S0FP"LO#Z!OB BH^  #R!0H K1QQA!.]@
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MF_3K#P#K-_,RMZ#%T'#*JO=+OKZ-'GTI,N^J0AT$I[1:1*M6N)S .JK!KG;
M"3#ZM]*-)/6<%8FJ'O3R>RPZ#= [L)I L\Q6 9Q ?EB1/1]-QB=!GG9+5^.-
ML:;Y4,2\>"066O)#F(E"'AY*E!48Q#\ZIZ /M/A*E.= QU!YQ _A4(3QAD1\
M5V_ZU+Q Q[S %["YWAKE0;0#,MQJ=W1/QS1/@TC;C1+;=_@)H$*:*K?.$72U
MG(<(#!8/3T;Y3>H.0PE6W.L/UD9YDS.QWE9T)T>0^\RH2<ETHN:5^V0;^012
MPZ[\D.M(F_>54"PNX.K_S]GJGN(B:AT;4 XP0K2Q!_F\3[!]=>/FQ -HM@=L
MPB:P.!C0 %O*'CR= 1BP@!&M'/6FQ@;PPX@W@#TT;F'<@7^\@2D]U^ZF 6*
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MJBQB<L ##QC_2 HY6$&A"T(0^@N S&@@) 864E=&@AC><" $"5  (((L8H@
M"0DF_["'J#=**($$.JZ20H)%9$#!$26H&((*#]Y01B\7P@"@!"6*]Z $BL@O
MWWR&0$U _00V.]_]]^&/7W[S?6EBAO75KX$'T^9W2 =_DO"$&?BC!AEKR!4&
M\@3^+>0)ZOL"0Y(PD 08I'\5?(A$^B<"H#3@#3WH@P<DX $9;*(;;\B*',(
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M8VR2B1^RX-'>( J4(! V81-43N&HH(U<P *F0M] J(98H0=H !,* 05X8HP
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M."VCZ1:8&9^BM.+&/(R6AGN<\C2<.Y9\DUYIEVSSB*T<.C9C-*XD1SN 4I.
MPQIA836 3[8+5O@AO;;K3?J+--C+E9@BQ65#-.0$LNKT3O&'S\?<1C9$/C2
MS/4O0F8E#K[ %@?:-\8\5N(8,[9K2#I#9QSB/D0&C,F@8,(%82?O(+X@0Q96
MELG !IY@8=44*CYE2))-E!%6J&<&9#.%^9"8A/%</J4#C=/D/BZKQ49E\$#7
M_[Z@ _]D&0!,G0?J%(_E(4-IO<?G6-7]CP<XF).6_9RW3#EVMBD 0!9"4$XC
M*PX":JY<1S&XYNR4=3K>PVR.+L36KF_>4SQFH^G4A@0,866^1A-J87Q<XQL3
M$:,!PP28P!N^51Y>P!,603#&>1U9@PG4M2\R0Q.\(:-;HPXLP M&*342*0=
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MP&"1,*%;%P %^-$ 0*-#1AID.'HL_T Q),B1&4=2)%.Q@,H"/5;RTZ@1948
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M]I)6P#7" P"TZ?!"$XV<0(8-%=+D1!/Y 4"&:-WUML]HL.567 ?R0*9!#<&
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M$$M%>DP-HO#!)*\I!!O8P @XL$%^3N $"L&' @M*PJ30 ALCR-,(-9@!B5X
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M JT5-6(M,F0!!4-@@1U"$$"\R4 )$XB"@_]V!!)(P!XHX$<)9!"&+,BA!"Q
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MNK8#64,"D&!A8G,]!31 #; V$[!L*<9J;\ M%U9K?4 ' [$%=, /=R,'5E,
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M>U4EV%RVV&XVR@F@MIX3MJY#/' .V9)-$R< V88?^'V/V:K3]5%@TU10 )O
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MML*"S20#(SJB !-,^ >^#N[B1RS8<COBB LWC,RA\BXDJ;8..SR"),F FBE
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M"2ZQ:F$-:L /VDV&1G9X$RSAHJ@W^(D*!)$+ /D_J2&.GUB:@NB,%_@!(=
M'&B")@BB5.L%5-@G&+ !*3,O#=  &X !/8 !'] ##?"!'^C 09M "D@"]RHO
M#8"!)_# )U"#)L !(3@"5<.!)7I!-8"!'R#!)A!!#'P$*2.#?:  )+P<"O@"
M"I"@!O0!#0C"&ML)>;@ 'P O&$!!"LC"#AS!(#Q!']3 \E)!#=NR"WC!&+2!
M'VP"'U H)W@$5(">$NS!)@!#$10""FB"#H2S*F1"W&%"5ZLT-O_4@!_P 1E3
M"GF@ !P@'3U,,C3KP!?4 S8D01_<PSS\@@!+(CR<0Q^X@!]0@Q_0@1LT 3AD
M0DN$@2;0 STP@BO,PSTL@!.@ .A)GR5L0C)8@AI40T/D+@JB@%9L1"%XQ!>$
M 1HTP2S4 5+4 #WX >FY  A9M3E<Q!\\01W P4?  4PD0A_(PR90 SVH@0[\
M F"<CEJ$(B1D(M6IP1R+P@L B_R!0E?LP!> 1![\PF-4-1O0 S5P1A.P 0@I
M1AJD@$\\P2N8,#B4Q2ST@1CS 34HP4F,02$0@CBBB-^PHOK#-C%*MIJ@&Y,[
MG:5I(89P(KA(#W>3*+<Q$+VAMN[ &___P"+Y6XM%6@XZRB'3@)O9,HG.X",Y
M.DENRXW<4!K8P(X^8HNG@<GE.8A-<CZ[T8@U2B'E0X/O2P_^TQK,0HD=@#VT
MH@,'V(%5Z@896!D:2*FE$JH)Z 9UL8H=V <N(8&1<@$J4 $2* 08B8 ^ !@)
MV+DL8 49Z(.[%*<L( &FV $Z8(&5,1@6Z"46N!,'((24<@0DD(-N" &5<H08
M*($T*($W" &(BP%^0()58@$L"(%4D0!E."NGX[J\NQ5]BIX+6)#4?$W8U I?
MH(!'2  =X"=^X@&)8CM&FQ5^<*BX8PJ[0[L:Z,W8U)6]TY6P  .*>X,)Z '/
M7(00>(,>.(*Z_Z0#)!B\P:,#LSH^95@E.1B"@0$ AYD7&=!+.:"#2.F#/7$
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M>G'910$J."GI90%6&9BKZ+Q5_[C< LB"T+2 H1J3-Y  >?GL/\ E,! 8V/:
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M4.T,< ";W$RWO5GAWG-K@(.!R ,&U*U!$V*Y@@L$-@Y?**!Z DS=P@I!J_*
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M6G9$T.R& 6744HS/7)*&!*7<9/!'_63-=8!EZK05!5@F!5@/9A;>#_B !N!
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M*0[<G_\U6VK*H 6BZ?(]@6Q>@0HW6]O%@0X(L [*:1, <-MA5X^Z*7H'0X(
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MW#KU\!C>S@U(169-L 4J>IU>WBW>G@6'Q!S@]E90#85 F+-IFP[;'MF.S(0
MI5"--&Z)_)Q)',%4[ !'LP 5 )RWO4$)I/L;6 !5AL(0% (8D,$0[$!&SE,4
MA( 9R),CN$#_#]" 0O? #I!+N$B "(C+'0# KHD;4;H D^P /VBK*]X3%:&
M"(@,R?3 S0S,%D1!%22,%U0D"L0 %'$T&*# .0H\*R"!P5H )B6L5,^J9+ J
M.+.JS?-\K#HU8=F*K01>#-[2%SP!K@S7+;D*#N ?>P$?SS?DKW1%2S; ,'FR
M#$1!R[^!2E*MJ4'2G5E 0$D:*Y!**!1 J,F "%B !6 !Q 3,IY0:NY(,G+@
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MXP< 0(<7>AJUTX-CWQ&(O9H(T? D"0 339Y\(0C1EX:&-'I%:]0#P)$.-#I
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MFA8_]KO+\--/-?( 3 T__Z"C*;::VFJO -/20V\^B.;C23_H6IL/P>\JC)#
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MR ,/>(,'-N&(;HC !6^00"'X@00Y',$!PL03"93 RBT4H@0N8(4<L&"M*3G
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MC .1+M"A.')X0U&-)0)H"^JB6P##)L P"FAQ<A,R@)8#@HD%%+!@J"X%DQS
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M<L\$T8)5GF__LJPHR"L.OH "C  '_B\)].8T>F$:.##Z&O\A@'KA 57"_0I
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M CP'>V*H0G^ "=%K>_8A#(\"%6" )(9'*'_ =4#10L2K+BB "2Z =)J@=32
M2)M  &E R(S@"72@"6J4 O#/>K3T"7S@//&O(QQ1#Y[ +-IA!>SS!_J""'_
M!KX >_Y'")H =  P/UW'!]#S/R\'%"7C$8JO?G 0XS2T1W&B>JZG!G2 26O
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M7QS!,W?@?^6@YKH "OBA[AQ!E@+F#KC+ 92 J5A@$SX*)AP >L/%JT;! 6B
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M,;30BQ!)E)!&,;9X!$4+W=C!$2XR]-M&&G40$T<.];C08BV^N".-$2U9)(\
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M'BK@ 3)405N  COT!C+4#1+!$SW %W)0%Z$$3%BP!9O0#50@ <GF &_ !8?
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MB L*\(>IED .,"&!!.PPDNYM@00W2)X<E&")(;R!#B19'@I<X $E>&!F/P6
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M>E&]W.",VL@8=EHH-3NSRYC_HDG#I#_RF ^RJ$QTH%\J%W1")QH2BPAP@ )
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M$Q6"X8.,%U#1)FG1&C "'/B')6B")%@" +6^\."5+/&.U#R!#A!1 R3!^M.
M"!5!%Y$2(W4YYFM ;"F !ST")[6!%2DG$\5-X?P"#2@^J\#2%6W1%FV$N%0+
MP\$U+ .Q_%L-&6NAOT1,\G@8B1'_1#-+,-/XEQIBPX4)LT:DEG\J','X1 G#
MM'YRH,(!1!_#1-N0#+M4Q?^*H4CMIWT1&%;MKVJ:-88BL77R)8X"@'%#@2B
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M%B9A(4 0_+4!/>@X-[R Y= #XG7A*_E0[-"!ZH.0(VF.7FD"XKV0_25>4RD
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M !*PA!# MQC0G17J 7Q[YXZ0:QH@+A18H:3"@A)@!3I@ 4)HBYC:&^0A"9U
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M-J/1)@HU$.7780F,R"M]I,7HPR@,L4Y6ZHD&HY$)&!1PR%JZ\H<-#3H<'^E
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M8J661#G<@;RS%..3?-B/>$@I8576]CR<VJY' >S (LA(9I9 "%1!"!0 "HC
MEKS7)N#0!,1 !S"8"J  EVA9%4A!B2@!/_P4#51+#]R!DS27#$#!$3Q7E#2
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M:E;_W*G5IAO5'2*47P!/9/.WS6('L&L3B'E2I,0/3(I!O !'O"I1V(2BWZE
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M IFA9F__)M58@(Q#A&L?\[TL-^%%NH8/DBZY$&O+IVR[OM# KS1=F$$C!BU
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M5---.>W4TT]!#5541>DHX086Y" #BBKH< &,&-QT! 4W-RG! 3H<Z$$&?GI
M8@L69)#" SU=0$%%+"00@14)F%5F B1Z. (%5UU@P8$F>Z"#"A=88:$ $B1
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M.M[%2$*79CH$8>;69>)49DQ:>M1#%A'9>-*G2X5%( ( F)8#6.#%35!X$U5
M@01*0(8^L,+#9_@##7(K!W(M0K-4$%1R93"H';37 F#  L",6Z<SE,"X.Y #
M"PHA!^E*H L1=\ 6UJ 0$JS"1XLPHPO^L D'("M:$MA"#^3 BA"4RDYW @,7
M'+!)0?6@&R;J1G8E&EZM;YWK7?>ZU\>+13 TH$3&E4$,^A %.JR!"E+P) OT
M%,LN@"'&5/" $J* 1Q10 05D[((#^)$%&62!$.\KP)("@:)NM-<%>!?7"D.P
MB1\AN)4W?&,CU]"# U/<!7:(I 5(JZ0"Q& 'L?]<@Y#&-8%-R@$, !9B9[3W
M%8_1QT*+P273<$FA\L#996!C\K(]XNV%> 1$W@'S,7VIG?3@)J\\B7/QAS=\
M>$MY=^5)&;33BN1>NDRH<YG+[9WJ2X.6E-]V#E]&T-D4&A!5F-Y,S?-.9NAC
MN\[(UZD:TO+F?I0@K67/:_0_+:WX:L?_;FUFLH^A%&4WQL(@TL/=_NKY/*;?
MZ*K3L"^L'.>EW&QY"LK5RL9M/)!SNJ.J#$-J:.K0,BU"#(T 2P*9TN-OEN?4
MI,:E,&2NQ&?]5J,Z! -".LIS4&HM\F/[MLD'IPKYQD.I(.T[Q&>= G#'_$I"
M2A#.BHSX=@PH&FT(MT?_TTI-G8)L9G*BF8:)>E)B<YR0=;1L06K/^<C&*$2$
M2I8D!%:+"JB 65JO2[Z%"KH [CS  MX@!% @"Z0 !;;@#79#L@AAD!2H )9+
M2/YH2  Q!+A #PV%!4X.16K$ <B $&0 #.2@7OC!X;9@"*(DDOZ @=X@M3:I
M)%K/MH;%3Z# 1.:'!#K #"9@ NQA K+KZW Q%W5Q%WF14\*N4P(!71J !(X
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M#6H28FB6K-:R+2:2;/T^8\XDDC^R$-T,$#Z 241RS?_\@R40)&P(Z@N#;7U
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M#OK Q%A@Y%@@#6JB#PH!!3QI71HO\;ZD&W*+%72,P."H<%F "N1@%,(T@PH
M"I3 321@OO(0!8; Q/+83D(@Y)3 %I=+4 AA3,0$Z^ZVEFWYEG%94V(B!AJ@
MEU& 'Y# #L*D&R+  7;@#5A!5JB ! H ";I3&91A7=PE"J@@ MJS"SR4!$I
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M2H!#^04)C$(&)@"XT!M#OT0"=J +MH $R$4"0J%>@$M*4;8A9M$>+$!N<[G
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M%]4#.%5MW+8D,6"6,XQ2 ]O5/9$:WK)\L H[-#4!4: Y#K )'OP7)# U6.(
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M$0A880',+*X)((0=2)?_(0R!PI(#.M@!M",(82D!^?&DA.F&;PN2^D$!18J
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MB@$9L  L.+ )<(%%> ,I:$R/,E6&VDLD#1MINX@E0 0P8#<7U29YD!9^^-O
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M:(Y#K/J+RZDP9T/GA*S1> 32$L_J#O"%2]@"==B+<X1=G. )VF"F=!)G\-%
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M@6'_P1WXERTF ^U*$A<(+1ZR@VU1!BIP&",L@/Z"9.0.>($?^#^,@0/;GP@
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MBJ0>"GS=9G)F9WKF9X)FG81=GY!=T?4 "U!(B-B("U (:U)!#W!5ZE$!,KD
M'83!A+ 4.Z&*@90=F@Q!":! !,B I0P&/^Q!.85& 2A!1P&?+?4 ANP=2X5
M#QSA#N1*A:!2%Z  $A#"#E#!E73#<#)+V:D2%H1 ( 23"^#_#/!MS2)AAQBY
M2V5(VR:MVW.TU1N$ AEH AR@02F<0?3=AF*]EE^Y56 -UBK@ ??U@2DD@BF
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M;JP:+<=KK/^1(OELT0"EN<D'T);520P$'5@(I$0!L\Q2TX*!XDE "% !%3@
M"40M$K""/CB3![ ""0 ?":C42H$!PQ5 'Y0 Q0P'&( M2D3 %JAM 6R+ PQ!
M#$!ES7U<2]8(BD1!ZO%#%B!! 81*1?&#W(D N-Q!2DF!J"S"**!%V>4*"X3F
MY%)NY5KNY?;):.I)633*2AV+5*$ :E9(DVR"!6#!BQ8 "GS(HO1!'SC <[K
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MDGPQH6?&%7Y' !PY4J"7FADX]I%)2#!D@7T%3I@H0.'C%1,3'UGDEY FRI0
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MGW[Y-F#S0I\"T+>!6I(@F\.XK@92X[X12MP+L>" ATCF'G)40ZL3#/T7!S_
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M#/4B(]4#O((J)7EW0T BH+*0:>=4=T<%HT %5)!-\ (&0Y %,E  )+ !C <
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M"%$&$ONP$9M!%(\A<^[1?T2Q>[E)$&I3$/1+OZ63("%(BQL!NS1@0ZAPOC1
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M/ ,#%P B._L#V[D,.=B"T6@ %FB.33B>!P@R#W $&3B"+ "#0A@"%F"!'G
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M$._<HQO)FP'-3N="G?J;(^O3KK/HSN<*"]T#"W9=NG8UG/KL#WFE5Y> O&G
M@7_H3@AYO&=9)7O5+F<)E.YTKLUT%+]CNC.I@6#P-[#8&9'9AW<5)8(MBPZ
MOBM %0" /%SA@;>C@<V:!E2X6*;[.N#,C_'8F49!A7_H#E;IN7K]DKGCN?9
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M;W.;;JNV G3C^;/&[,PD5ZJC#*$V"83D4 HW_.,_L+B<:B0<[E+DO'EDN3%
M<_4+P-',F;&94YX!M&&5&3AEFWF"+W!.EWS:9]/;:^D\%-FI65FH.[%8QYM7
ML/ %6=[:[A+<CXTW;O$5/6@2QDJ"#!'.&= !Y/^ZO6-)/I#5@$9I95_1 3(X
M+S*834'1G-1Y@=#<9GFXYE9VY23P.G2^31WP-P2<KQ@)VT:P/7;\NJ=-KPO8
MNJ;$$([Y%5 )F;CU9;_8RMO\@65.@'7+#_5P.FMA*]K[5\@+RV'['#+ O;BU
MZ$#)K?0X@C-!OGT8C^-#9U_! 6-6KVU++V]-KFP\+@WQW?&;0$,JQA^YSO(4
M)#D.D.3*8V$=UL>9O\Y]8U&NU5%^1L!\1PJQ(TX2:D2RH^+U9/AS)/J0+_2Z
MY&,$)?D24$0BWC7>&S,^I/= '&DT#OYR >9@0BR@# 5"X#C2L*Q07RQX ,0H
M 1*BBA/J@23.,Q;=A$__W(0MD"(:H ,)D ,4<  DD#%^0%46 +020* HX((G
ME Y0;8Y%9(72Z$-+FF$ P 2@P(Z#$.P-E0 +V (DZ)T0H% [& N,M>#59NW6
M=FT'<BX-\D(R'((7PT3F&:'8L% 4\%$2$#(ZZ((HX D@S FI<-2#> /6Z$)
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MA4;C^2% WQ$6 3N U)D8^IF0@Y<0'@GXBM<6^[$G^[)_"TDM^BZCL1"P"A>
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M WZ00 8LL "YHOD&"5@B!$?H ;JYG04ZD#2:5.#'&OB1A7"*  D[H -."0&
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M"_3 $?Q2" 2D(PP!BP+ L[$ _\KPX[W80P.(@-OMR@0\7;/Q";I(0"",)"'
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M#R#!&T2!S+B "$B!M$6!2Y4 2:6+2"J##(!!",A "@, (8 !/TWEI;"D3[%
MOV2!:<,*J%B '6!N"2#;UZF)7X< I]@#E\H!9S^KCD!E2*'4!$N ;@M*K$BE
M"X!!N/P!I[! 7QIF&;\B@496BB:NL,UB'CG-)07;V+2(:P$-OG(L%8.(?5+2
M8F$Q*0V>&6^MB8AH>">B8_9:&"N2_]IJ(H5THM'^ZXRD= ?T E(P((-[Q%#4
M %7T@A"PT'*ALT+<Q"8'10\*A448 5,XX%/L(04T.$HX^$M,N/DMUQ'<Q&^1
M 2Z'AA,$A0X$!6J<UP6(>(.[A8XK!>@$145PA%5HQB^?,B^#!H4!.4S8^%"
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M@2>D4 CZ@RH G/"(B.QU)KV@;GWG:P+IGJ"[WS6*>%M;@X+X52 <L8L30EN
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MX(>: #"!9'5C$9LSY[OA'6]YSYO>]684.B65G!V(R .L( 2L132F;H0 !8O
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M.@Z88&J9"T>26Z>0.'K!KYI@RBY@8B=(#<*+P[Q2R0"6#& ,8$M"#5Y7G(W
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M!R3,L;'=!TR[*^3V_+#=!DIC(0Y7](1@RA( *Y3B* IB@)[B GK7);[3('P
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MINQ/B$W='KP!BD*$!1DMC;IX,S3$&Q<AEK[1.@2,!RHN6+!PL<,D&#HL>CA
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MH($SLLF5SM$-C6J BD=PT09G3( H#OFG>TI1DDD@ QG\&8<B"?(+/BAH)IT
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M>F=\I?,?C &2.MWLG",4()1])"J<%ET??,XI10#P!:V@!.@?-$'9/_"!H<E
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MX #P5P(/ '=R,5RQ\P90X #]QUM1H 2;-5S_]D-XFR #-_  <B !S#4V(?$
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M71LN:8I"@/157AU"MNO U!H+3_*D'4@]*2 O%9"@2G($('LO3NJ# BB!+9@
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M!J"+!J"?!!F"@44")0"#0N"'*G"+-R@$%(B!#KCF+4 "+K)/&=B"UDO:U)
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M?.FEWQ!/[Y$&KN]^][_/?>C??O;IET?Y^6'Y?;B>$Y3>[)%3)9&$XYT  )S
MZ[D> .B?[DT?]*G?YG5  20? #[,ZA4:*!48&9R _<U? J[ ^?]]'O=1H#R0
MH F,'AD40/?) ^2UWQ?XGY58E#)!G_TI7@.BH/AYX WNH!.<WPELGN*1P?;!
M4W^M":)8U.CPTWPI&%J$':,ESH61#I0(7XFYCA[95_#A!)\LV2:E'8WU3>E
M5#&]5$=]CJ.Q#J5%F5JTU%DXRN(H!9?)8911Q&Z @24@ 1>$@ BLR,.AP X
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M%<R6[<@ (=! .Q0I2!C=XQQ!!$Q1!79!D18=C_1 #$RRL-(%$@BK#$1 &Z$
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MF7&0LD>9Q Q9>N2B*MN('H2!ZXM^L9M$:, /&7B@/AZ8@!P>U(,WT&<(BY"
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M/(/_(,K040T2&$W $)L-&!U54C&5KS3I#'_ 4P\25/UL5)402D]F)U32W?2
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MZ [L1 1VP 5N2P8(00;*ZW5(8+?0Q#[,$P .),%"0 YHRWO:JP3 8!1:;Q,
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M)PG=>-# &ST@T0T55+@00I)1!((C"DB$L(D+;\A0  D3A"KA%B0XD,4?_R&
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M3-F8_Z?;KNC@R-'O9N<\3'OE4J "3+0 ])]?D:3'(3E-B8W2E>;JR5':5M_
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MY#52WBB:ZQ074L:B^(J?F]E[*8:>VF4X[A)/8+A9%S*9$J I'K"H?>  1?H
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M#DCM-!KIK,FW%%6TQR42$N.B=N"?*OF;C2MIF6WZTR.L!0 H".]+R(0%3;D
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M "M&IC&-+8(%81"!YUQW,@DT9P+]>8,2)B>!-8#! 1-X0^.H$(4W[  E__8
M ]"4T 622 <%=Y 8"1R QZ\@X0@HF$ #^N,"0O##*V] 071&8A02S"0W]IA
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M%7D@NU#60,1 "-P %[B =WD .M7<!$C!!,A! 2#!?V0C(11"=X#!'72%'(1
M 5"! Q#"(+J'GZ23?0R=<(8'X/$# *0,#;3##G"C [!"&'3!$%@>'7"!*!8"
M=QU!TTF ?$5!X[C 3I2 !)R!!-CC(?Z2A8 %A^U&^0TC>[:G>[[G9!2C9ES$
M+1D%><0 )5G 2'@.$JP2*?T2"LB2!&"!%$0!<,1 %H0!(K+ -@(!)UE>"<2
MOW1!=NQ$ 71!,/D$SV4!W!1*!$3 WI2 WX#!8%"!Z/C>>/5 602D!UA>0'I'
M%SR%3["HD0%-N^VD7:*D8BY:37G_'Q>*WV&]SZT)EOE@3[)1FZ]HCU4&8%=Y
ME;7ME@(=9O3-'7)A9?PI)?Q\3T^N%O"8FTQ.:0\=:<;5T!E>5A<JBE!%*?T(
M3_K0"?4)"YRB2*:18);*"_/5GZ.)T B6H(^^7Y^VD(XR%F#U:*^I9/L)YJJ(
M8?3,T/:4T!0EQ&)*5J4 3_G-$;)%H4\^Z1<ED<+1GU)US[84#Q2!JJ!HYJB5
M&Q52*JA@WU[2E/\4"_909*0U5A7IV[MMY)=4FT2FY$3F( Q>X?.%6D%@1Q9<
MF1ZAP!" @6[NP!L,P1N85P',8NPD8SR1@!3$ %<0!>?<XGQD@0-L0 0<P8L(
M!PD @0OL_\"YCD0L&:<#M)Z;<>B;]<$.1"M7G&-7+%AW)!XNV4;8L0*<>=@M
MNH (O(8?[8#JH<0ZJ1A\+BS#-BPPRN=F4$'1A4<$9 '@:%0W6 (8%,![64"
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M_KQ(8W*IA!BA!_:.BL35I3RDXDJE&G(;QWGM^$V$'=& ;;! -[C V.W S$B
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M"70!(9"!YQ"^2S@V"H!U#T1=R !3SLG-)G2!*AG)#FP!R/Y!X=V&/79#XLC
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MCY L',A"40_$<T#V+.Q84PXY0BC/DC<D<(^?+OB!1 DD8D !#$( ((3[/U'
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M\+U]EI(+EWJW!&EXO771!HW)D3,$"WD;1Z@O%DYM)J\Y5)$"2 @B2<A+IP/
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M5F$'%NP,0F%:L*L93L$4SA -MD##)LL5_\Z !.L/NLAB"=)A!QE!!Q,A"\3
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MJ@=8X.AV@$GN@!5*0*Q"@ ZH0 YV8!/DQ@'*P*,<($@<( UZ0 [X@1#LA!7
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M.N!0X94BED!58](3WJ !I8#:)C8;:W  4PL=M@ 3_^CK*Y; EL5 $N)L6;4
M&8*9(3!U"#$UUIYP7P\&#I !&8A!F#L@FEEY$=87 !*7&!:!#"[AFK.9(#"U
MW=@BXMX #S*!5K\"#L3Y)9:@'4I 'A(1$R)C";H  C#580UE69N9F(63!C[P
MS(RM'2@$ "*N$-8@$][@PRZAE4]1G*%U&%UY$]E+8FC" \\YH0G! T>V(+"+
MFE^9%!QA%R2! T7:84NZ#1AP9+]%((X9>AFZ'="I*/0U9DFZG%O! Q-2E-XE
M)B+N:/,Q(47B&ML@DGSRCE#B$R7M"): ">X =,/-(\A9$G)!#+HP72,B58E!
M_QBP&6C!"+^Z"XEA%!KP)_]UK*;9S!"0(1/8 ,'@UB@&MR8%@@G,8)^C.2T@
M57@[\*^9FJT!8ZKWH ZT "Q-4B 1HV'P.9O%0.5>&5-YMJY1&9@K.Q-: ;,9
M FY=JQ# ,&&WX@C@5J<O@1Y70 RRF10\=EC!-BHS 7E3,Q,F\RNX<!YH0+4Q
M 0X.00NSP1D<-Y:\-BW)(ANPUWC9DMK6(B]6$+<C(K4O,'P9H[B3FR*:E[B9
MFRU?H@.HFC.7U[:/.R*X@19V^RD90KI#8@FPES,GDRB""9>.MZ$.(GS?TG?/
MAEVJ*")>SOU0<XGP@@P00H34;Y()(DB8*?GL1_KL@$@D  L(V&TVN@ Z8#_/
M8*O_=*-+'$$9N #WK*.?J X]).0&OO-ME* /'ID&=L!TP+0$:&#NY, 1]",*
MW"0\[N=/)$ 9L, ZV(8%QF4@!D3ZN,0"_$,9'($.NBFM"H _^*-0-#2(G?S)
MH3S*/V2(280?DHIM(F (E&$(-@$%N*  P.!&Y, %^(0%&L<%"N&OE& "4@]"
M+* ;[L %Y$<"^.,-&H#G\ -/0B"A0D!KQ,\^^F#N="0"%*4X (5TN&>B=",$
MC,YM\J>MUN<-W*8$EM-TQ$H.L@ \-F%-)%S"MULT_N4NB.EJFL54E,8OBJ*P
MV 4 :4&ANH )J)35U0' &1I364 > E .2N5/S[8#!^X,_Z#M 8*D*CSY0+YB
M:RV@"KB!&!X@!RA!#$^15 MPX02"&R0AEU=BV9M];5D5EO&@$F R M/@!IGU
M#OC!(1 [ET-"W'>@$CP@NIA5#@:N49,"ET40M"E!%Z$U#2;IU$<RXF 2MEG1
MP_)B6$^A$/:@4 ! 'FD!"2" "4B "9R$#(R;$0J!X(T5$"]>SE)B)!6LM2>V
M#]R "?" 4V] '@/V+O05"2+^U9W$)U;0XC$A!TR;%MY@!_!@#<#P*\-+%T)@
M)Q,5RW;96*%6'>31&=[@X2.>$"A%%%EQ!]Y)_8J:9]M+$BR@&FKM#=P@XDF
MXW-(JDG!"<_]$HP1YW6^ K-Q&O^Q8.LA'@(X/KW[FB,DA:'[3U$U(E5OF196
M(>6D6@QN(0]N@0L84 M8L@WXX<)NP10D813DV=(PXEBK ;%;H?^,OJ8EP[Y*
MX0R@7I06PK7TCS<!=]9/(AL\P0-R &(=_R#8+!/^@!0801MX\XQN)LC$D1@D
M.^(LH5+O6E=P/T.W]@W@(/>Q5N4*P"TK02&I!75#PKX@<N!,OP'[?74[4L%"
M]UET#;/SD19"0<$L(0>@/[R"MROXS!4V%W)7EP;6<@H@X-5G[Y&/1?G1UB1#
M(?TAP VZP T@(,#J6S$BKOHS(BP!XA 8,S0Z&-2$3=&:A;L2&;)UA,824I9:
MU#&TZ$C_!TW-;'D!T$$6G#EM:,C"QHX$$Y4D'!BD 0!F00"^ZLS11B:FP265
MMKAIEG(EDQ(=9';0"=.@QH(:.RQU6A2JU*9+=6K4"*   *I%018T^A1J@0+\
M2(2X@Z(*B@*Q)(0(Y8)%CTU*2H3X4X)0H3<EE'D(\290"2IT0EAB]<8#%@\>
M7$B( : $*Q<NP) I8*? $1EOJ+"*T4'&'S 6&'O8,L'2A <>Y(3P8&="% <A
M),CH44C"'=@EZ+@H@4("%ADE7,3P[6('&1F6NC$N 2 Z2.G4JUN_CCV[]NW<
MNWO_#CZ\^/'DRYL_CS[]]T%5SH.Q]R;*(GY@D(2X'U>$'!0N_R8H<8Z%"V\X
M0H4#_/"S V,L#/'& V](T0UERDSPA@1@E-!##"3(L<-M)=#WQF0%].! #"C(
MD 4A/92@Q!L3= /&)H%UT\T;RG01P@0>=*%5#TA(T,V$'J" !!(NR""'""Y0
MH<P; I( @ -:>=55E4G-9*552E5955=,O:133%H6!-56!G6P BF1E))/*>^<
MHLX*<&RQ" T:R4G+(FD6<H=.:,)1B!S2D5E',XSP->B9<LZ!##%:&(+&(7?(
M0THAH<AS"3&C@'0)+:W( ^@=30%0AQ9L.'"5+X"&XDNFHQRAZA9WU"&)!:!N
MH4ZLZAQ5$*T65'$43:&6^D8U<ZHC"_\E?&W903:9L)$#',2H4ZH%T=)9YE&J
MIK&K&,2T$E$'$Z%12BFGC/(1 +*0@@8##!PRBJIKEG)/N8=D!, 2<)!K[B@.
M1#=NN>=^M&VWDH#;ZIKUEL*('2YENLB6G,Y;[IOJ7!751(:X>0HF&EVR9IL5
MG](&K)?<TJVI&HD129OUOKFI+V)@0V^YYK8!\+X"B_#1405,)$$H8&5#R1]5
M7$(SFPSG8B=4!4V$ZQ$TU4&QS8R4-+/- K>"5+YSAM(4F?SHNX705A%=2"):
M()&(!%7(D@@6E^!:T]IMOQTW.I)@,J>@6FF5K 0MB'$P$SU9I O.6TFW!#KD
M,G *N$W)>8C_.M')N86@285$R1D0()(Y5C/5A TCI<SA@8%:0B4U &3(4@FY
M\$;K2"C1U9')/!'EO$5['>!N"REE:X2[[@;YX4G)T9U) T*G:.'H'%?3@'M)
MSGX3$4):,PRN0=(95/T1$]E2!:TER9*)1\UF4M*5S3;SC1=. <!1_"?97"\C
MN61[TO/$(&.(JWGA?@MCV#Q"DC2K*6\F,)%9,\K%"#8 ZW[X<Q/V?.$'5S!M
M">F3'P47=C6-4-!JV(O.YJ0F,V%83BM%T=<A=H$-D>6#$>QHFM.\\I0P,= K
M//S*ZG3XDOG=,"I8T<J7ED(&*1UA#4P* 0N<^!LC.0(P'GC#)B10_P@4'(@?
M2IC !'PS) ^PA@HH>(T21-0#&:" #A=:40'>\(9"9($,/>C!#F)0@AV02 82
MH% 47+");M0F!%@(@1P\(($W:"8T$I  %1(S 18XP@4B*(%K7'"?";B %24X
M AF4T0TO0B=8ZBFE*4^)RE2J<I6L;.4JV5,>J8$A%HQY0P_2\  +V"$QFP@!
M(;) !R-Y$0P-Z 8+2@ &%C@ #$-BP1NZL8DO]L<#5-A$#_@AM:+0H "%00$8
M9*#,+'1A$V"0P(G($IV<\(,%(IA0" 83A1Q5$@QOZ$(5D  &%<B(!'X)@07N
M((-0E)&04IA CE"P#P=$0"8@J<J7P.(E7O])Q2A.DVB7*'JEAG;%B#'Q!2EH
M$88NB)008X,#+=21$QIX%%=D,UM!8F4['TJ$%/=J':] HBI#T$(7NC!%&*I
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MI6V.90<R<H$'_L"%=UXH,(YH#&#HX( T8*B1+"#!7V3D@$U@P1$BV-24-%(
M!SB3!1<B 3]&80;[O($$1&G=5AS0!1<HH8IR<$L;' &&'KP!"?QPP"%V0()
MI(XQ*'@#%%! &SM$09-O ,P. ""#"32@F%#ZGO\K?P[TH M]Z$0O>GE@61XR
MN(!&%.I!%N2@A"<Z,03*0((R7:,,+I21!(Z10!<,I/!NH$ *(9 1&$( !@?T
M  548 $2WE#("DF!"C#J 13**2"WU,@#=W"[#/B1<7J"81%.C% )U(X@"7B
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M?ZARYQ=H+JT 6TB^D!U@7'V #B\..9O@$H6N-8P0 M6 #@E4,4:X47#^)FW
M#S3@6KEJI;0@_P69DE@ZT5^?**:5E@F"##+E(C*E8"FBBNHD#&0S[*#W$-(M
M!BLH)@4<F8WU%0HLNJ?@<M3"1<207BXA^A5%<:Q=[B8#S**P$NLAO0F"_H7^
M1PEN@RD:UL</0#^>X#;'2GY'8,4/).NC&&+[Y16-<PK:4!VB:G_W< JGHA,N
M9#ED8.R4/HHV%83\4@IO5F++HR_MS@29X $S-AV-,R_USM4S%'RM*C]"YB9!
MXSJ%(NO!UQ1^4 F*$^+FH[/%8U.<)@&[T&B!OBX_%K"O1S6IH_$BUA%N(.P
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M,E;(QILJ6LL-@!6Z*(&B^#KB*D'X1DH0N))B:@I")6'2$4G@6$J)GXQF.Z*
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MX (4L&!@(7C#&TJP@Q9FK 34"D$6D&"!;DBL34A@11JZP(\WH& +EC!8",!
MAX;YJ ]#("$+2K )%#S !=5Z0P&.X  )3, >3DQ?LOSX1T &4I"#)&0A#4FL
M917+!9?R0 CF) (+H""+C7Q#")"P,@=D83@TD,$;+)&%$'@@$-T8@@- Y0 S
MED!53809/_C1 WW%( 9OD%,62C $%A3 8%38@1(RU@.@["!-+BB!'%B! BA
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MM ;T'23,(,+J&]-Y$**B$J!PJKOX-MU8IS1#&GZ;N.(Q$(L[0/E;*;]BR9"
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MC"ES)LV:-F_BS*ES)\^>,P=5T7D$A;(0W=[TZ",AR@0/K%Q,D$-%3@@E$R:
MP:(DQ)LW#5D4V-25Q:82 &BPD!"#"HJN*+JQ0$(B1%LE*L#(0;+I3C<4(:B\
MB8'D3=L==H:X<-$# +\N+ #'DG$C"A"K(99&<?'&Z!T7_W>,8KF()006&4<<
M="EPMB0-DD<ZT   N\/KUK%;OX8M._;LUZMIZ\8-''AL,L*#RS9I>[?NX,Y;
M)]\M6[?JV;QOLSZK?+9)DMA]"]?._'?WU>9C5S\)W'?)Z<3-MP=0_79T[<+I
M)T<./?;YU;YEYW8$@/&MYYUZK95D'4H%\O=:;KRMQA]V_ U76W;=(0???@2&
MUQQO#OJ77X$"BA<@;>5)1V!]Q UWW70.NN:A=C+N!P!XK/468VW^>8<CC_0U
M]Z"-]KVG&QDF;EBA<R9&:!Y*_)D$(XHD-;EB?^VYUMU]TFUW$I ;#FAEC\UA
M*)Z6XR%(8G9D3MCCD,.91R*"O/^1B6:=,F:8H(NZ 4#&<'PJ-^!QT=$ 9H,Q
MN@C=>+11Z)R&)^8'74D6ODCE<="I!B5VYR'J(VX'\EADHDINFN2.2QI8'9(_
M1E  #6!L$8('L@8RP0W=B!6%(TIL,FLW2DCD00D%N#"K'"BH=H0,&[UAAPM*
MD# !'2Z4X,$='N!%A0-;R,&"!RQT(TA4F^WP1@$AL$"7@$>PP((R$[QQPT-4
M;-&-K$I$@8('"_7030FC.?*&)1-<YD!'CG13E,%8^M2PPP]#'+'$$U-<L<4Y
MN="-!_OR \8;@;PQ2@AR@+'(&UF$D%@((2#!E0OI=K6("U)0!$86),2%!,HR
MT(7"$&#_M.NS'(FQX,(.Z0*- @HR[(""S4@4#48,2KA 0A8_!Y*8"\H\HP0*
MZ4H 6"!@A.)"#"%0Y+1?W7A,0@%D%*#FAD(*9R*J7Q:HI*/AU9UE<GVS>!89
MXE%(]X WKEK>=?%MN!R?!59YHWSYR:EGAC;&F&.4D_>HZ(!_;B=DG0\F&&6.
MF$ZN'N82"LHBE 9BR>!L\>7G)7?8 6IEFL&];OMSI2>WX^*TXX@@I-EYGOM[
MWSFWO(>D%M_CJ4AZJB.J+0:.^^TX4EJCH=Q;_R5*N2T8HY=G#?IFJ""J"2-P
M,W:GYNRX__=IA.]/N'I]BX<Z*>RF6X]2@?)<?SJDJ3!A#D;"_V,<FFQG(@'N
MB4LSDI%Z3D6GS=T/4"2)'H0$Q2-0;<E[,U*4I:13*A9!L'KKHU'VG/<C\"'N
M>J_A1P'XL08L@*$;0RM!"!I"A6[$  Q4 !D5E- N>"GC,8FA&@ED$!>@C6P'
M6?A:":C @J_)X61!_)H'ON8S%32-"B1@10E0((*T+.UH?=&:,F;%@B$HX2EO
M2 P_E)!%%KP!CS+XB&9(T %^-*4!#EG0Q0IIR$,B,I&*7*3%2@*&IDS $H0H
MEJR:,BL7R*$$Z;)#'N70-!=L(ET3Z 9!BH:1P,0M"TP3@0-VT(,8R& 18/A#
M"&2 @AB0@ Y?BU;1)E(")"@-EE3(0O\!>-:6"8!K8_ :PA!$((*3R< %8-@$
M%630+0M<!@N6T(P%LN"  JB&4SPBW^[R9D'9K6I439J=W)ZGI%!Y#G#T0U2*
MAK0[$H4.?Y!*48>Z]"$23N].ZL00>A*XI@8*"'R_@=+A'L<_\%1P=A']T ;_
M@[_MS&E&('I/F/+G(OAMR4@7*D_VX*>ZC+XO?N9CJ/'&1SM.L7"$_/0@JC3:
MJ0?2\WL6_)R%1B1#YS'O. M\3WH8=L""JH=*.CI);C+708*Z[D184J#>U$32
M&*8T3$VES]PH-ZDFZ31!%Z5G32-%)<5M,()G>BKX%B<_"['4A.^4E(L2^C\$
MV9,\ETM12LW_>;>2J"933%501@TEP<PM<('B_*FH:!K2X5TG CTH0 PD("N"
M>, .+'! 9UB&!4WN0)J+8,%5+/$1DGUD94?@QPX(T0,D]( *Q+HB$K:  CK$
M )9TH((F/>  )?3 !04HA"V1\$L9 , !>?3 !!P0@H%MK%V)*<C/'F"R'AS+
M$AHAR"8D  8P'*$'$VB ![J!7/4Q,KWJ72][V^M>H.PD8X)T06,V@8+$/  ,
M+OA+'E%P%Z?%X" R*,$F1$!-RV)S,V_H0P^^.> KDF '6=S!(K@B SJL 06$
MP&-BDD:"'J@R"SV@(<J8$H4H< 5;69.#'&10@"GJ5P931$(1HP &_Q$0#06;
M(,$WXU:\1P5TGHEJX-X,A+H]D4^E7&V1";ED.>VH:F\DG,ZC!JM0/?$51'_+
M7*">TV0M511Y6YX3[=)GM[[UCCLR=9R0*.=/YK@OKB**\V]4I.0U.4XE= 5K
M\&S7. EBSJ;A65WGHB.@03O)=D2BWJAZ>BJB_HBGVTNGWMJ$4Z$B%G84K>KV
MSC,X+0<ZJ8B^#0T$*-92U:?)03JKZIZ<))<RSX7[(U*1-$C2F5ZJ2^U)J#J7
M0^CV&5FNKTN32NUVJNT<%$.*G?)W4KV<<GJU4$H]$VS:O%@DT^;3!I*K7W%'
M)SE%&D]!%>=C46CD'P?'0C14#2',J)D*^_\EB[:LXGU90(82J* $#Y!"7"R[
MF6Y8P )@H($#CK")+I  EDB0 6'2TH<2=.%H!0#,)F*\ QDX0#%92(T#^O"&
M*%BV&Z.9@,JL:1J@]6$3=+CB'-] A4U(4PK19 $8DMN ;G2C :%(M7M[[O.?
M SWH/PE*3B;NB ;HPPZOS:9E1V,'&0RA!*!<L%G&N(6*>V 4FG5 ":K  @NX
M8!%T8#BR'.  :RHA!BB8B@/X00)[E: '/8#C$*#&@A)\LP1O0,+*VQ*%$AB$
M*D;QRAL* 8;)[L"*TXR!U.F0PS_$XB.6<"4X^<&I(*]3?$?&49'I/)_E^1FP
M</ZIA) 3V,S#Z5#_;6+=CWUMF]\E**&_^<]"B612KB9U1^%$\N? ?&SC04E*
MH]=GG4+->;Q]E'&Y'G=*[FF@(_7F0*[['(24=$[:SV]1! W3XV87NWT^%M?F
MF0^18NT;\K-SU7M:OUS77#UCZT?T=X-I8G,GP4+UR:*+>BK^]_8D)E,01CF/
MA>#3EHU)X@!0^E%/B9@.F]54>[Q.]G4:A<S:I:0>@,@4LEU/C7@*1N$:H+P>
ME=T/W4 * 8Z4X^Q)Z3Q;]0P/[3F?HYP> 6[?\X1;HV5:8[D0FG$.<4A6 ?1!
M-FU!5[B '91 )D'-%F1!"0S%%D@ %W0#,ND0 &02"UA"'FG2%K  /QP$_\Z
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M#Q>D('(3)%R0X0@H;-SD#0]@!&.''F)8PX$C6'BC&P]<P'(1+*)PP &$LI!
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M0#91_1"(013B$(E81",><8BD^E0,NO&&%?6@#[EZ0PA0< =;H4 $4W2?!%B
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M)@@!?RC0#KB "BS! ZA "B3@#FA 3%KH#^#2$5A@" :"!:+_B! (HK#Z@!^
MSP'@Y09VY0TJ+3*;!:Y62PX>@(I*BP5FXPAZ($P$JR_?H %@" 72:TY*X"8:
M(+?>P#?L,?MJTS9O$S=ST[<DPI((*0J@2 +L0 Y(  DXR X<L!M8H4MV0 +
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M"?XQ#4;!*U:@1:O9#(:C-0;5 Y:N([(A#\# U;;YG/O9%_P #]: $L09#_9
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M9*/_"QO57$*+"!AEDPD6#OB"R!P6.,"JM0,]^48.]\+8@;Q_$ )'I3W2TLI
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M$6&B)30 9W;@!716:!=C)4'5 I?P6P6A,6!R7S7""&=P!S2@+FS !)5@)??
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M=!$BLF) **23*#$2&"$B"(%2&L4)PH=>!\$-#"&!D5!3HY10D^)709D1_QV
M#L*W"*@2*E124P?A"^B0H+XP@:% 4B<%$H/""+IP>GD%(AU!!EP25*7(5I="
M54CU>B$1HX%5+#CU#CM2$/Q55*BGCL)W!S:'H6C@5Z-C$+*(#4<U$%V55P/!
M*9'@,&2 )H&E#C0")+3')XP@ C(8#A90BBT*(R2UDPGQH$B5?U9:)Z7@5S1R
M5&5S:RZB,S9G0$5#6?I%+7.P"GM "$]B 2V #I*@#B0U6G5D$-"R"UUR!G*0
M+78 *&> "4P  1O0!810A\.%IU.PITR0";TU7)NQ+Z,P7$OVJ+%& DL'/*[U
M7*SB8=)U+=4%)LGR,>'"74$"0)[P!PUV61  %?^4*J([&#&K6  *00Q@0 K$
M<A YJ V<(CDC-:RM( :98 =X8 CAHA+RT&"YYCH%D:LO8RZ,N&1?XVD$0:A@
M4S3:4&BDX &8> K&U063>JHK$3;6XRT=$6R%P&=;0$)%E@NH*%FM@'^T8 ?X
M10-VV#BVU3AS\*B$H&AL(R]?TRQO8%D8Y8LL!@#2V &NE:^QYS@',35'\C%_
M@ Y;8%-A@BW-4#DT\#$MEC\0\$&CL*M0\7_.>&3>96@/1&.JDXPF8$),:EEL
MUBL0 +,0D /\.%+,LBRCM;(B*P-P< HHX*Z2!@$IRV(TUK2CX*Y0L0'JN%P=
M$#8LMFF=9D!)NS/-N"K_)L1<WZ5JFW%K@C,S8P85DE8OQS.7 Z$)B< 0K="T
MQ7)2=8 -@] _+;9IPM"M(L(HIQ U-/!DSZ,)?IM0.HE2GJ<26J(1*"427+-#
M9$H#*Q)$&E&>47">)< /QN$5#M ';U!('B"9I!L"=T<"?5D<0- #:20!V5D
M+K %%WH$,<!-8& /51<#C'052- 9-<0@$D "0] '2# !-_ 8)5 (A$!YT*$"
M0[!(G[L4SN$ F51+#\=&8<$"0BH#]@ 6;[!'I7F^Z)N^ZKN^KW&:KZ&:'G!'
M * "?K%UK-L%!8 "'C $6? &@6!WK"L!CH "=N (4\</=  %2) %>2$'Y<F6
M_SU0$WJG&7V <EF <0#P35V G/RP!]0) %W0 T-@('10 IL !HO@ L_T2U0G
M1_6;E&_ '5@@ U3P!F; #UW G:SP!\54 B>E>3*2)-$V5Z-GDW184=.VD>\
M-1+1#$5Z!^7'))FE>XV"I2)U!$^6H-0E$DO2)+^6*'&U>V+"$?(2"<32@T)X
M*CO9CYF !F;"?EG"?FY25@RE$B7E5SQ**']0 ANU#GVP!I" !X+(")@ ?^J
M$?$(4B0K)AW0:$)8 M]U>L3"4&Z%)S=P)FBZ,RY"+ 7@?4#".T^(6UH*(WX
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MDNULF&O$F#MM1YPJUHTB/JFB!<%/,:=)T)%$<P$9,H "A:!X6 !NJVD>$N
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MD>DA 150T ,4R $)+' )3[K @B[(!RQ'Z$'_%EQBAYG(,P1@.(\#R* 2!_2
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M1J("IU"HF^('_ABZ$;&'GWL#9= .8PVC<(6G!V$/5#,166LZ."2!&+@H)?"
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M I,! P\H1%R%7ISH!BKXPIZS2)B$)YP  QPA!!0 @SM@PQU @1+8@C<@!CH
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M!Q@LL D74.$QR@ .%<"@@A!@P06;>$,)NM"%";P!3EL@00$<\ 8E4*$$)(@
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M"]$]PA)(L5CU/BXHY2K <R,RWO)V;E0T..],N&BOKRX$8[":BD-CMI6JY X
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M-(,$A#J0," D(8?8YQUB<H<HF!$60B D%VQ'&2H@ :)20P<9.(#&'@A!#]:
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MTM$[KD@'Q$ W%(FVH< ##(J6Q) $1 $+< &6V20*[* #F"<*L (6D(>1_SC
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M%N18Q@X*"B@!$,J K%%$?LA &CB "W"OCD2HH(1  2Q3"12 ')P&;UC"'\C
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M 4#M D %]\MA 8T7CT-Y5[B/>TZ0G1=<Y0/00%\_@.S ^P9O@3HX51T80@A
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MD(!_<LH=]K0##!'H *YZ8"AY]"&;:^@"%=HE QEXP ,-F, B"\ *#Z!(!%1
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MAA)TK#>$0$($3B*#'?2 L6 @A L6P8)N8"L$)>C!#D207[)V0ZQO*/\$"G9
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M( O<B03ZPZQ<H I<P 'X3(0 @ 3 H"4*8 >RH%SBB1]>1PE48!/"HP'L 04
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M<^Z +KQ&AFYRS,Y@%$PGDPBA1."&&/J $@#'*7RC+#CGTJ;B:5KM><1R<K"
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M.G#:F@_G.;0#IH2%/KJ!IN3  70%9E:D6)1 79% &9 *!600J%!"&*&J#P
M"=*+!+BZ TJ 727  K!E6X]@#8X@!(X "=Q+ IZJP3ZN#R1 #H:% 9=U!VY
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M(F1"Z#,C$B"B:^!8Q<E@1VT& -A.(^0!$;P/+3["R76&%(2!D_7CE&Y]#]P
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M%#/2Q ,+((L'G@A_6RJ3 AO2 4RM1"4H.I&/.O0S#V7J0A8<5H\R9+P",*0
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M'3P4N$#9>Z$!(\0!F##AND!3TXL:?),P,N%Z(][2B[#O_Z,J<1A[SO^><X:
MX20>,#B!0N#4;E A!!(P8Q50H)OAS(:4JZ2"23B.!0\H80T]0$)'VXV"'H#A
MW3U80P3V  96>" *+J#"<!Y2 .VX1PDH"-#G/="%+J#@#1((04PI0H4=!-4W
M"?G-&U@@ Q%T8P+ >4-(HX!RK>Y(BQPBT1.CC6TJ#IFZ/,80<RF4)B28[J[:
M/W.'HCCD\P.QV]GPA'G.W'T1G2Q3<ET)F#7T?731?]$4DB+WRTQEVM8C>8%?
M';!KL45ML&57^-4S;Q9CM;-MQJ-^GH%EHT9^\I,&H7 _?8 "? 57$N)GQN,+
MB* +7*!K3.9:VG8E?29_%G1!._]F@"+B9Q'7+!2H:8RV?[RU6 P4@S<V1%@&
M'GG%(P1V8QLS5UR49:]U04@8@V2&7S&1@&#&0-/A:J^E58O6;:\5?QCB1"1&
M9'85(K,6@SRF0J\51'3%;5VC!:+CA1,8$VK8-V.F$DK$$QW"3<CC7D]#"P7S
M@N+VA$!H/,W3@BR!A)76+!E2(IE2:.?58O^'.8 F85Y61%BT8.C!;?VG0EX$
MB)FBA0M(11,"-,T%$Q-" WA(9(P6$Z\V;<:CB);!(S?&6OQ5.V8F5R^X?OOG
M?]T61!,61?T7;1-R?D2HBRTV:)KU,_4W1-:G;=EG/!.B7[@85RF"1%.8;;Z8
M?;*&BEK_50 HT'B+8!*+)U;^UAS*<!$3@ (0,@1(X$8A$ I4(!]((%U@T%$=
MI2,AX !(('H%L /($6]M=!%($ ,%P 1'H".#P@)P- '#X0"Z)P$20 4Q\ 9O
M$ A(L -'X  HX @=!4JC- 0!YWP3459OH 0IT0,<]08=!G@IR1*RD  Z\ +1
M$ POH'9*YQF/, -"H'7X9)/JA!I\L4PTZ1(V^78 ]@@U,)0S491" )2$&!11
MIP:BL ]+V4TU, ,311!VQW8$L031(!F2<90M\0A/\ 5!T90Z9P0UH ,F0 $V
M4 -KETQ==QJ/, U>!T]0J9)W25&PM'Q1X !E%' A0 +QP2#'_Q<#<L!R805*
M.U (8.  <M!&46!2;X"/KE=4'A (<F!3PB<A00:1#P( 6< *)$ "#W($:U "
M+L "^B%YN+<&K$!69D13_- %A; *61 <W8 %(2 #M>=&^G%5F\![;72.!8!4
M*"-M'Z*")A*"OR9LOB9M\,=]"[8$F1 )BL "I-5G'H*%Y!>*FR@BTXD&IS *
MPM9<"VB#+!@B)J(A2H1JI/5G0N@CW68A$:8BS]:<)&9FSJ5D(\)]6^A<%*9_
M\3>,YCE$V]9])\(V#Z!D\G!A^;F</L,AXJ4.2\1DSSF,F4)@-&BASXF=9K:)
M^S5L$#J+HM@L3N2''#J'T?F<"$AA2/_8+'0F?PST@GPU1,]4(;/FG!G2;:?X
M:MB'A4G4@]N7A3MZ9F=H8KV85U\8.CQ6@R#R$GSE-Y+0!G!&GV6F88\8H&!T
M"9' "&U0(L'V;(ED/"/Z;  H;9ZQ@J386C4ZIFN*9]3U3):QGM]W6=#F&=BV
MC%A89GQE1%:$@UL(BSYSH;HHHW?X?^595\1H;5>ZBE*T7UAX0>2'I(>:%\SH
MI^RIB/4YIWIUJ5C&?3G*0-@9HQC*@LI(7735(:A*6@\:;B%: +K5 3&P"790
M#V\@!QDI4N81 U05&]W "BZP Y(T2.MHF!)P;SMP$K2D!'(@ CUPDEJE'?J!
M8'T@$#&0:!W_0 4]0 4<9PGC(1]D0 *6X'N+$ )EP +;(IF!&6^%YY@R\!N;
MD!".Z0AB!4K@II$>\&1X^7?PE!18UP%Z( HY"1Y%V01/X'-[0;!&<+".E+ +
MRV0$:[ ]V; 26P,%Z[#A-1A=*1GVY!H=  -4>05PUA>,\4P=4'9EAQC(])8:
MFP"4<70U(5 >&P=6F1;1<)-QMTP4$%%2J:\P<5$8U0$[0!SQU@,Q( )88 %.
MQ7Q24'BYT50>H Q<H )R$ -ID 4$DA#C(0'G"@#RZ*U94 ) 94B*!@ D<! =
MT@5OT 6[V ,ET -4*P=4P' 2$ $6*1[M)A]*0 +>L 4R8%(LAP6>_Q4"L.$"
M8-5XRB !W5![#@!N?;B %YIKV1A%*3)LU A%*Z ).T!*%GHEV">CQT-_F*NY
MM8AM%B2@T?F> $A]5-2HT7:GH.N'QOE>-FA7;QJ=/SB?DC6H(9IABHB&DL($
M8" #)@-B?(:H=E4[2[ '/< C!$&#!GI]]>>\QU:B0UJD^D=@UCMD?1BHER5H
MMJBAIQB$UE8[@IA1_L>H0.AE+@B -]<2Z;F+6!2]VQF]V A%:CHW\PNBDDIM
M7%1^H4I=&] .PH(A=_6$K$6!2\ $4&!FV#M$HRI_'> ':_ ?-)BI"/R_R89J
M@\BZ8R:?^SM_O#BHWYN?TVNI8[IF/@JBSO_H@OJGPA+XN2^<BUY&H1Z6?8[X
M7@^\P1((C8!6N5928:PH;BQA?44\(IS:18!6BD?\IZ[*BB\(1?X;5X(FBA@Z
MJ,>HPG2:1$"<JNAWAEHE W\I A511I:@#%002@&W"51; H)0"&F;$(GK 5AP
M'ORP XXP'M?A #J2!1$R13L@ L8C W^044?0!5E5>RI@'1/0#2-1$);W5'%T
M!$I0" Y@4EP0"V]0$&_P !(@ B3048L0!87'<A9I"8C)/3V+<[[0!#.@!G:A
M!S-P=T09!V3P GJP3[1, U^ RS3+L'' #[><RT/W"'%0 +=L&K1,!KS<"#R@
M%\5LR[CLS#TQ#4;_H ?7W 33, -Z\ ,\V9-\T76:5)1?R60>.\Q* 0-- %$_
MH =-(!J.$99)$)4RJ0,G< (YB;/#A ,GD'?)K,JY]+,8%0.C0%7_ 9$T)5,A
M( 7  1Q40 BG^7J$D 7GR +.006! %4[0 (]4!+E<57V00BUYU,7LM$9U0%9
MT 45DGLNT 6A( -T$ +>:E-T4'#Q=M&_<%1FNQQP5'@E4-' $07.P<C\U@V
M*7U"](&]V*>G"")69%FLBI[E66CUQ[_\Z8RA^!8]@VJZ9E@Y"JD^@Z1;E)Q)
MU&DOK)Q0I&J!>*CPQU\J=J%&ZJ>\B*',J*(V'%=GUFE%B%^QNR$2HFHL_RJF
MX99%3*3$L974.YIES;,Q%BI9CDO8%"IH?[U](:R(8"V[95UH))J)L6C2=';
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M#62^%V8^LVE> ZC@=^!!Y_NPY44I42^QE5< 76K0"%F92T\':$?G"YHA%WJ
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M5GW'/+7IHW*.5$CX/(B(B(S?(;=8P!PU258>DH^B5JC 70'J0:["XOCRD\@
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M" $K$G<\$BQ%,4HH01;> (:VEJ  *& *&&*PK4 0!0QAR,(?5I$%&11@#V]
M0A@D0 72(4$&=\!GXJS"@A[(@ I4Z,$.$O,&+$B !"0H 158\9<[\*,'(?"
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MIL[&X3297(.H/Q,)0Z<D5AB94ZPBA]=0ZNOE>5YU&DWQ@PXB("T6L  9CDE
M#J)U!, D8!@2_.$G'L#"&VC0AX4>@0ZQ P-3J+"(.VQE+&!  0H*\09"!!8,
MYP;#*F*P,20X8 @H"$04MC#6=+$ "3N(IR40$Q3(2D "U()M";0Y%3LHK!L/
M4($<R-"%G_@$S8R2*DZQ]E*8OC2F26!(!UYP 3)T@ (^;8C'02YRDG?\!4*X
MT<A3RI(75$3D<Z.)QV5. 9J#).8]P_G+*[ZWOETT 8VXJ4+L%H=_O+P#O3 ;
MVG@ EY]'7>I8_P)# WX"3R2\H0P)3:<'+! Y,$3/ JL+01?XR12K3T )/2B
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MJA9P20R("H$=(8$'D()0D(,P>(M*X8=-X((=< !^F!@/:( )V!@YV 3*";O
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M/I"";%$L%'  %U ,#V"!.WB,$C@"V"*EN.@!?KC*STBM9NH!O33'H^@V)8B
MXV,!<2D+>7$$=9P>I0@!_]2"J 80@4U(V1@(-=BB4_2)C4 TE30\C140 Q%@
MNP[0!#RHISK(@EU(!"U  C.@,D\H!!E0#5E !UTH!+C:CB4805UX@SO0%'D8
M04EX ZLX$^20!3Q@/Q$0)QJ0!40HW,.5ASJ J].PW#N0!R98 T@@!5U0K"NK
M!$8HA%%P@ ZP7/:S W$"W1W  T_H PA0W#?HIP[P!2: J[G5VS=8 SQ@ =/=
M@]1=7#.8CB4@W#0XL_O0A$187;T5&%EAKT/H U(@!COH%KJMIRZ1A37( A/<
MPDJ8@RT8A6J @^U4W=\UP<35@NDM >'S#ARS PXT73S  TIX@U @ ^O5@L7=
MG/\..%U(Z%S)90W0I01B^*L<T 128%\[( 38$P/[[8,H%-[_#>!0<*0EHP7O
M]:X.X5PM6(7<!=XEN-SMG#A-6(,]Z-Q58 $'^"TTV ),4*_NV XF0 0M( 8E
M0-\ME&$:+D':\ ,:-@4M> /U\@[_!6 D".'$9;\I-I'!E815  ,\R((<8((=
M0!G3I00M'H4<\ -20 -B"(,JJ.+5[=L58((/?H-N<6/%LHTL7H4^L%&=D(T5
M0(0DU%LD:-P6C@'9I8'$W5GN0&-#H 4P0 =)8 ,-7H51,$'0M>)ND8X7T@0/
M]8("R(\1=K+'93\Z/I75B%XM!H-=V%D_J%MYT(0\2.'_2J6R"G9D2,"#-0A@
M0@;B"(Y= L9E73832_R-I\&3, *?(*D3/^$]U,._]G :3VJ/(QU Y?@.56,1
M30O!1'N3^EBA_)E$8:&1%&);4]8A/4TB-3O#MKVP3$,/HG'0-54^0)EF2%0C
M21SF=W:U$S$1WWMG'NW2^H&E JK '5 &:[(#?VN 31"!>%.&K%#'"0" ?_&
MS*L4>2D$.[ #"7"[RCH"$4B<S%@$0BB!/CB^F1U2N5(!R) #@%*,R+#&U<&>
M0BB$$G :A&ZVS3D#B+('6 S+5#34*""*$-@",)C*Q+ Z=O0HCITZ69B!BX6]
M&=B'#F@"(= H61"%IUZ"J.X _WU5B*O.ZJUN AU8B*\FF[!^6++1FWH-:XI5
MB!?@2:B6:JK>5XST&X!4JI^321P8J170 [4FZVC  0HP AUX@2> :X7P!2.H
M :-2R6FX@HZRF:;2@VE(R1_0@P2X KQ>:IS0"<-!G(21V;L#F(_QG F(@A*@
M WH# WT@K!X  W&9@,TA@2[8@3NP@+#CBTW8 :>-@G%! 3#H@LZ)'"HP2T*P
MG! (!'*;)PO #(HI@#[( C"@@KRR@WF3@RZ@;2K0U,7H M^.@D P: = @=..
M@N5Y Z;PGM"P5#U!%1[EM>#HM Y8@DR8/=JH UJP WD@!4-@!/9#@T.X@]BS
M[QIEA/\TH(0Y^ ,S6 %2H(55,(5,8(1%",XT:,)3:,KL$!']FX,TT(4$KP(L
M,_#UG;TEH 3MTP[\MH,-,$!#* 1= '!UP#(T<.0JD(5,F(-"0/ SD 'VBH12
M*(5UT((6M_"FY"[MP[)32(-*0(-P8(,<@ /W<_$Y. 5U$-P;S_$YF+W\S(0D
M7W)&>(/?3!1?((5(>%U/,(1#4 <;_P/\[8!+( 8#X\%,>+]6R(%+0(-WV )*
M0'-,V%P$SW%#./$2<@WPDP+UZO$?5X0[0')3V/,"JX9+P(93. 5*>+]%6#)#
M. ,(=U$\F/-3^(,[\(,_WW/MXRX?+X4 1P[VFKTK=.(OX_+_#L=S"?LM'-_S
M *<!,<"&,O/P"]>_]Z/>^@"S4WAP)VP%&K@$5]AU0SB%-B@ SC3P%X\PS^Z2
M%4"'4Z=R]JKU0/\NSCR%'"]S"6@!'&N% G@P8F#B.7@#)ECR4T""/2"%UR7U
M2[^$:Y_P"@;T0RA!6O_V)SR=UJCV,B<&1\<$)FBO$"Z *VR#[C2.;*AT1N %
M/,"&4H _9)B#-D!D.)@#8LB#92]!6]MR+%A!6F;V D2#0E@%+E^$\1QU/-^"
M4' S+#MW+9B#D"_X]UN%1+CV-GAV8F>$-K@QG1^.]"@-X4--0 K-(W(D27.3
M<Z:.%RJE,&G#TQRBY>@1]F -.$L1_S4SH/D(/@!,-#=L9E93VQ3RDQCA-/4X
MI*VWC2-%(0TZS:Y_HE/KD^9HHMB:M41I+ABZ3=KX);7=,63!(K<OVL$ F'M2
M!M]^ SEXC$ (!*L#@P)0 @GHGA);@Q+0EH5R 71B@1T0#=]6&!?( K:8+"1H
MITKU)L];K;GT":W8A,B7@1#P)AE  CD( 1*0@2[H BJXK )@@6O\1L@@*\[P
MO&*S ,7?D0FPAP9@*P'E[*A; 2.(JA5H@C@(N918".@/AIJ9_NKG:B&@5P"
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M 0EZL80'L+ )%BR"!3O@!_H\H(QN4&4G&MP@!P6RA!\(X2!+,,)#$E #CW1
M#\$0(0D?TI'2P&"%!AEA"45Q @#X(H82*<@2'/(0&^(PAB+T80* F,/_8.S0
M6"TL(@^"&(P,CNX+3OC"%TS@! I\804Z[.!.5O"(&CRD!CJ HD%RR! U,*0E
M+T'(%;_P"!@(X0LG2.)'5O"$&>P#3C6XP@GXQL4_XJ1C7+0-&*+  A1(81]]
M:%X(7.#(GZ# *%U!B@10T(5 )(4%:]B!45P !@N$@ 6!N ,27+"#'1""']E+
M'US>TAEE3* ;#7A# _ R@2B0H  Q  ,A7$ ",,3 !5&P  HJ@X(=R, .6/
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MJ3@+#62A"3:803TA-Q%,L9R&/# +_K57L]#4%NR3%CB+0LE*$%K5<LF*<'B
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MD $%V( &F.4%G$"^P5L'4(!9GN7&'80OD*5;HB5-L&59GN4-I<18NJ4&U*7
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M:, 9E6Q)!_#(C*C&A^A5%A!"&](5:_C*=PB$"1@6&K"33ME!C9+76'7!!D
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M7/;O!",$ ,3 LG5%!/2F!"!!(!R2#,0 *W2!2!H%'>Q%IZ%  :P!"X2DZHI
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M.$4L20 )3,8=P/"J;1H5Q$ EQ0 =D$!01O^ _Q0 "0@"%8B==+H/"I! 9'1
M7>22INV $E"!'*@:$MQ %(B #.S $<A %(3 6SA"%W0#861D)=$!$E1/%+S%
M&R!!#$3)^%B \Q0$]U+P1]!I$S3!#^C!AF_X9P9<3(0<#*W0"JB06HHXU0B1
MB2,1#X&<BI>X"H7XBY,X&9BX$- 1G=)X!P@1&>B!$)"1CH\XCR,1BQN<+)3$
M#+B0!!.O+-3 1< 1&<" *#"Y!T7#\8J" =>$%H'FA7LYS:D;"1S%+)7 #H2"
MX%K ^'1!<X]/;+Y!2+[!VGG%&[  !27&[B9W%A?>$.S 1ZZY T0 =]IEBM5%
M":R!<Z) ']Q! :S_6OT4QD^8I%T(4S=(05(TQ;%EP:^Y $2^0;!]A0O$P-I$
M"G]:+37NC=B =N@@-I8 U#XU0SAHWQG$\W9@F"+(P;"H7H[,@0@P02;,2 $@
MR1^HE%B]2B:\7I28":B8!TDI G<!5*R2@B<6 !RTNAB\NHLZ,@TP%1O -4#=
MP3Y8RQ^8P9*@R(2,]!+81U8@B028 98\&*B$"!Y<.^;%$S>(R9D80KC@*4\I
M>RCX"B-\1YE8QQQ4JW2PE<2>H:U3BI"9UE3)0ZUPM UFBU&-.R(80L 7;5K1
MJ4SSL7TL@CP,(,KD0*U&:A/F""T<,J.P4Z'$2AT8 CLUUQQ8@(K<=.?X_PIQ
MX VFU!/(?*QI,8+ F!8[=2NQE,N7" 1)F0>2[!5[#*LT1^J_O]:7E!.&7,RZ
MFT'+A ,6!(I&UPHO GM)W8$)@ HX#Z!@J93K.:N)'(@#M QU*/TB4.H==&N^
MOQ@R!\D*,$$S/-C<@S.2M+$_H8&F/*"-7T(DG,(H+$FS1->[&/Z)O5DY^950
MB8$N'$VW5('??[QI2<#6AXU6D]F' /RP?SRHF"*C'$(8B $EO,,9/*Q:SP&W
M^Q=\:$PF',(:1.")K<EBT8 FD$(X2, NPA4<*$$H(..?P3:!=LUC.R/:. Z!
M/LCAV*WSP_9N+[;C$"UCP]GA".U@\Z/0+IG*<O]C CY.S'H.D/B1G2%VY,2C
MV?0LC@W^UX9CVK(->8_3XLT.DB$_/N).:Q<VF0$VXP'$D0(=:   0) ,C81D
M^"T4"*  1()'$G8HH/ (01H=!':8Z)%&2#(9'Q:XF,6!G$T>/+PI,&2+!U9R
M7'A 43.$BS<L))0X0N)/"!:;J/"D<J2'"Q([>K @=,1$#S( IAJT:I5,@0@%
M-H I(>,-"@?\2#@*)$.HA! HCCAP%,)1%&43WCB0L,F!"T<26!S9(6'"HDVA
M+( Q2,6#HP8RKG8X>!5R9,F3*5>F+"O!E<BR9E0%T"L./P"/-$.6)<ISMC@G
M/I>^>CKUZL\XCIB6;5#_->M>KJV>9HU;]F[/!F7=!E!<]Q715Y=$JR'DRX5'
M-1HMMWR=\@KG%)HT@1'MRN_(OBYHT& #AIH95X9C=_\>?GS*@ZK(-^@8 (H0
M]B;8HZ/$@PDLH.*-(7J(HB4J4'AC$Q:H< &%0*+( L$L>I!AD[#LR(G *"*0
M80>E_N&GBX@*. *%'JPZHHL8(CB"A@T*()&$&&)P  4E.'S#A1# 0$&.'I"0
MX"8?Y0##!0>5T"] %DH((00+NIE@ A9FC(@@C2#:TD0N*0H)H8U.1(BDC3;J
M0!92T"B%D31H:24'4@J1@R Q:!'!CTJV".6(%=!9DTTI'.A DV8B*>4="4(I
M_R";9DK)AY$S[LBHRPY6N 30+>[@9PETYBBEE%,>\ )-4@YMDQ@IXBQD4AK$
M0,8.![+)! U%5T $C5.EJ&()4K:0 R)-,LD'5$F/6 (.5LD0HQD&3B&&%C:J
M27;2#NJ0A(U!E[C$$&(9:<,! /S,E1%H[:BB(AJ6H&0.9 X]181P 9"'VVX<
MJ.TBB]"D]0P2X$A#'3(ZR,83<"_MEDT+JLC23(W$D"16 'R!8XN %:JCF7O8
M7$4+"2" 0Y=% *#A6C:J\(/6>QBIF Q-=+&#U!68?2?A*B8^1!VJS/3E$EJD
M:%A=1(21P@N,0R7&D+KD859C1A3NX!))%LE(6'MEH?\DDD,6W=):1_,Y)8U,
MSH @:FT$=OF-*I8VA$UDD$D[(8-6@(,8+@RB069'V8REOI8SB:1<2?ZH0@PM
M%J'A:F(9.&04=4T]19V9$<5";3AH,9LB>>I ^!W*"U@Z8T9H06:"^DR4!Q%#
M:%F3$9.SZEJ"^@B"K%<TP#:<.%(\6-AH2!6]K^$Z,NG&"P R(K02QC'V-O;[
M-*D$<&*T<"24.K1HH]='0VTCHTXC>9:6-D;N($\&5"Y$ST7$,$3\//>L**.&
M&[N;(XLD$C/^V1LSLTLPNXR('UDZR(GPEY  \@,C]NO2_H#&,(*82']CLHI"
M@$:# B0D@5;YWP09EJXLX>?_?_$S4P/-9#PN;8F$!3%1NC3(I0!N!$9>LD@,
M#1*1+RD0(B*LR)AJDR5*060D'#$1 GV(G_&ED$PFRI\*(2*F^Y7D(1ZLWU;X
M 08)O$$)=)B '$K@B ET PP9&@()HH "%%A &3QY QV:(H*=A, .1,$"&/A!
M!1*@H NUB8!!^'$$))@01C4"8!<LTHZE0($%(7A#3EPP@0RQP"L]L,0$=*(@
M%40A!B200!BQX(&>]&"348C"!&QBO  U@$'V4>4J3;.>R'2@!L%@S1*:T @R
MT%('XXDE:U:@!_8L00\Z:(\O=BDN7Y+!"<&,S J,($M+-8$]R=2!=>3V!"&P
MQ@G0_[RE'H+1'F9>$P#)C&8PVX.98)BP TT0Q3]8>9T.+*$&%X!! A+0B'V\
M)YU78&<[^=G/]]!GE8YQP92Z@0)^T*$;+%$&"D@@!R1X@ 7\V,$;9* 3E@3H
M2"Z0@0-Z, 068.$F'@A$@TJ !!<H00:U,4@7D$""38 A C0X B%"D(40(($0
M5XD!"Y#  A2P8 AOB((<1.!3.13  8DD:BR8.@%+Z,<10 A%""!*AT6(( 2D
M=(%/3!(_+CGD1%EIX@/O]Y&(-&P@ BD(#4S0!2\<0:7 \\A!*'(0A5AJ UVX
MU\@.$@&] FT)72"$:,XZDH$,9 5+\ E':F."#1 B7 5IK/]>>UB0^\QU2P"(
M0 X4(K$-F"%? K/L?=K:@SXZI@-DD,<&%FLMB!7OB!_L[ H>*YH/K@ "\H)A
M80_2 ;_>JRH=$,,MIN:1)1[$! XH2&IA")E;ZM6!#1S)=!N3):T,]CZU(:P1
MK;+:K2"$*B.;"FWU*IFUFM"N3JR*+UBKTEEUHS[([8**(@+(JQ1$M3V0:=P,
M0H;'RLL@M1$K!SL@CR7T0,#C"V^ [T/:\A[DL>ZE!!9@2Q+5/G8@%J2!/!"<
MD;R&BR("%NV9VAJN/AI/*R\R'D<2.)4";T"Y0:2!L-I *AAR=UY[79%<.V "
M0L37*B"!S _[ZV 5V=4$=)#7U6+_YY$LT=8G=JWA'B^[D1,L@1#UQ2P 1#.5
M#9Z5(_1;+@S%^N43!AEH.VSB=#=R%0B*T+KWH^YHZQ?=,#E$@%*.;0/SM\ S
MRW6W8=)?#A<B$D/;>2!<1B$%HXOGM>*'S+N5"#\VZ,0:,BS$91YA_=HLUQ +
MFM)<$I-E\[=$'_;/L(0NDV%!LI"Q @T #CA1%P+4#1=L0@XD8(E!E3 !!V3U
MHE&X08%*L(\2_-0#7%#&(H%$ATUNH;X9R8($Y(""38B$!"$@P1N08,0"[$ .
MBP2#2AQ1%Z&$H 0 .#9$+<"2-R1&!MW8 @E*,(&>5%LO++E#"1SS@! DE 7X
M42F._2F?_PY\ >$)_\()R+#P5R[!"/1,P!-NF0 <M,<@$)=X(TZP@LQ@'  :
MIR?'/7YQR8A\XAW_^,,C3L\GG, )*X\,RCF^!)DSIP9/2,)!LC$-CA><,F0@
MPPL<;AFA,YP,LE!#'/X!<J _O9T 565&=M"?**RQHN]62C<0<T5",*@ 5(U"
M5I4QT*O;<:=RH$*#%*D$.=#A/^V(7P%B4 @/A( 5(H"0%4-P!@GDT2J9=-(;
M")^DF_Q4!D+" A:*^N^[3\".40!#KULB%!0D- ICW(<#LGQ$ );P1$#TZIA(
M3V@+<OG&^5)I?>T:W1Q^T".%QH^^&A9 LLZ(89EM?6&_+&!&0__Z@=/]_.P$
MQNFYDO5,HXZ(+/0D!\<18VJ]K:!&!,;7WCJ9?DK$X <7>#56A&+/@N8?"KD;
MDK)NFH(-7%$'']A!%7+7VTL$LY/;3,$@T[XBLV-]K^IV!)Z%[]6$3(-&PLVV
M1+10*_F,*","2/<JPC/BK(76S_QZ*^0L)V<NY4TJJR(:(G^X)KJZA!\0*/W
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MSW+/1 Q1K6#M,081+=/,SPI+TDYD!1]B"+W*3.XP_1PHKM*0TVC@$=@&#=#
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M+1I_[0W^U 'NM!O E04*UA)8H1# @ KNA@I"8!-<X(%1P!'J[5 %P@.Z,2R
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M!!R !(+JAAN@);:H"V0@\=!"&;D@#4@@4?L7&Y-D$Q=! N[@[L24!;J1"K:
M%?((#,!@%Y7 #KH %OVU)AJ 2K2.#D(!"AR@&<& +EA"D:* !3K;$4#*()0
ME?_6XBJ&^(W36)LF R+I"5?WJ8EG+B(3 %=_8[EII[F?.XC/2;J1&YPDI@ER
ME7:B ;NA6P^XFSF\V[FSNP-@0+RM8@74P!\FD@<>81J2 (T+#IZ8;A[)H!<T
M #KV:3)68%;UH#L W%9_@(J'V\ I8P<$-I$<("_L+0O>E0J^: C68A\J2@)L
MY-U"(!88I+/?S1%D@!]D8!'VF 5ZX$3(-$I8N9%T&0LZ&PL4R05$X(O^30)
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M6N+7>D3KPK0 6" *9F)!/& N_]+H 4C)$;:@CXY- JB #J @UHS\R+M1!"1
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MF0M*,)4"., !9"@!,%DPA 9( 0E$"H&/E.0C#TS $DN* AWH4 ('6.D-[0(
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M6K73$@/$V21=P (BT",_$@A4$ 5*4&$DX *!<'I>*P%@,)]=$ I3) 4AH"'
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MY];#@'&WK8E+Z6987;YL)4>WX<\#I]2AP&36>G9)$>E +*7E!N8Q5MD!"D(
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MI3F",PG() #@DP<@@1H3@;J9@&[_F*-6LH0=6):%@!HP6)[62[89]#11. $
MZ(4X0)A>\*6.F8$;S,$=[,%1^T$<U,'7X,%$ X 7L$$C;!<>5+0F#$(D',+7
MD 4I;(0;G(LD9)85B(8:^()""QE1FT%\XB5>J@%ZH<$U9$,_8X&3"*4>Z+)5
MD0,YD &7J!N]614ZZ $'("HYT)L[: @7P()NT+@_.(,[R#9"\$,N,*H0L(-N
MV(1.2I4HR#(7< 0JX).Z$:D2N*@2T(@%5)LW"(1-&(*=408ED(&E" $J( J.
MB((ZD8-0\*JFV02\(*X'TY+;61,>X1"8XZ#LD(G.VS"XR#D%8CH*>;JTB([J
M2$8>61S>_Z$NK".=Q[&KPP&ZJD"?Z#O&MZ P-*FLS8*<N:,@\J&]!.LA$(N,
M\FD.Y-&ATRB-!;L1\*JM]<)&W[N27.0ZS-L^Z\B,:;2N(U&/TR+&YZBN_4J/
M"H([[?@@W@B>*U(<'%HL+R&3+]$B_ZD0VC"@Q,J@SSJ^M#NM$>$?C:2\SSH.
M)FJ1":DZP2@BL8.Y!6''WGB+Q3JM ",^&-$M*\HB^]$[^@ /VOF2-0&2R6F+
M !D>Z/A'UR ,793'!I,M!0L[YV".7\PP%%*0YF*3UAJNY<HZGM-&R=NMB*2A
MRV"29XP*#[L1P7JB-@G&H_N*"& *%-@"C9N 8Y&#3< 4%M!#1?\I 0< @S>0
M U;8!!FP%3P1% ]@!59P #II%3"0@RTH*UL)@3NX 1<@B9O(LJ%8/T?8L1XH
M@)RJ@BWX%"RP  FP "K &DS\RS> @D79 J((!$%Q 1&8I1)8)3Q! A@\ BHS
MFT)!KC8LF0[0 ))Y@7&)%F*Z@B]8@4.K%EDP@B1@IA_ @1-8SB38!S)X 35
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M(*$BL_ @Y&,=M#(D0D!1A B!*%""G9&"B^*S5]PI%F@'*JB"PX0S.FH:&2B
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M% @$;3- W"VIF"@ 7#$3(;H?*^I%J%2Y#D9+#:*^+3F>,<[%,(HN^OE'%\E
M!M/)'+G@FAN[J%X0M&,>7T7*V= ^]"TNW:$PYH)4?D1CP3N0W]/J8JV1:_^E
M8I4LEPMNU-HC((;$+]T!L"<.W]B(D>HQ;$_UC@SF#0!S/<A);.$H%_H%8KQC
MIN!((AE1._3]81T!$1EN2#3M.^L[7W,5C_9U1NLZH*;+5L"5#I)LWZ;(8K+0
MQ^0)UY6#,.@2']?;1\]#C>M:5\4ZXP(9#9UD#BM*J^\9OFP\H=&VWPQ4.3&9
M7I2TQY*4NJ=36._AR=9>QH3D'+#6;-HN[LO);*)LK>4VHC4.C%8-DZ5FX1T^
MG @@! #( KT!@U&X"0\8@HI>%7:[921 @B/K!O:+Q*-5E"-+7;+1FZ(P*65P
M3#X91#RY*)JJ"$F!L[(:EE>2 SL0 4 TN$!@@2G_HQ-!\0E/08%N$!9,H5R)
M'@@D8 H *!NH$8'R4<)_E@5_2 )=$H4"@ %MAI85"!=QL8$D\-N[I8!>T !Q
MN8 B-]L@3_(+\&=F 1<DUP -6/*M=7(K9_(N//(JU_)\_N>3P<Y'L.:'004P
M#W,_"^B4^4R;>% ER!1?P<N<R@DL:"J9]<!L4Y0=N$6+R (C:ZHH6+)5\96F
M$IN+4NG)S"B+6@2$*&554:HW" J8Q:I5R@(2&"0/M#+/C &FJBFQ680:NQ,Z
M<%I"9#A+B %<Z0&3A!_[@ X5[BL'X56VP*TJ*NSJ!2X5OM_8(E=!Q:NUF#J7
M[-+;6 WFV_6)I![0.%]<_Y=&^DU?M5R<^B6@DS/&X[ZL#@&MRN&2P_C@9R1+
M_PIM(BK'O2)MM38N$2D@<J7'*(+)Y"MWN1#*U#O(7D\/_8)A/GZ.>JDBQ1@M
MVIB^*S[(K9L1+76BOD8A9JJ@JX/L7)QLLBN=QR,-?4^+69>[Q"ML!>/M@O0M
M"K%BUCL?9U6=\+9LTG .,C:.R4'&DD_&VF.2FN0M-@FPU(DM5@<<?1V?V9Z^
M+F(N]$[C?9PZ[ "-W_,*O1KVJ=B2(-(..=YJ.#7&^P'LQ&XY;#03PE)7B8S'
M8^0=[<-ZRID/HRDCTW0!.T !#7642[D4/IM$$1#9-R"!0YF:1: 32'8$N?1
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MG,T #O  G%5,$\P J46+/%  #'03.-U:!4[APX ,+/%:-S1 HG0!'1 $0'D
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M!W'<#I<84,WY!V-(EL$M01?P@R^(@210(-.=$%P]R^^@GK-4I%5D0R9L9&=
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MG ) #&1AHM !$B1$2$B!%,S,'1;$#GQ9KA1@M[',)G3!$/S)!*P,&%2BE_5
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MC#TEK,(=//__O!LP"7$\0) BE@:%@P)'.M!(V&&)&%VZWICIX(>4H5-@[@
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M@0::T 0AI(E3)HA2IE;PV$"MX N:<H)D 779/TG)!"?8+)%:$EK"!JH#A]5
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M@2.YZ8":JX$.*X/*TWZV-"9,G8D14T?(LV2)<$C]@%R_ 0+$VR'D)-$'+W3
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M(X_FC';C,TS W(@-T<@$."AHY-2IG,[@#A0N!+P@&PO.?=@@!YSHDDP'(KR
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M4T:+!7S$ NR@![H@$-Y+6[2%P.Y@J"8 "RR@7ER@&Z* !$Y0 LZ+"M %"T2
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M#:  !0O!OG)*&;*5!B6 #NA@/J(@I["@J=Z 663C5/RJ7VVV4ZHP&(+#%YI
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MP!V<XH(&=*,;'IC )DKH"!00" E@R& $[M:#/C2Q#SV(#1C>8)@NT* '(9"
M)5P@@O\0V,,%48B",KK! C"8, NZX0<2-/G)+G9# GTPC%-".48EI+( Q<0?
ML^)'*?RYYFWL:8W_<O._\JUG8>%1A0A*5!T&,$(*QR$#=S35FB5D@A',48UY
MT.,@7Z C$N.Y0\HH6HI\E.(>I7C'V>H0'O%HE#]W*%EX-#I2^=SM-4< VAN8
M9B,'O4I7#N#;'\RP </9H6#AR]6E,G$(.<@#I.&P0,'$@(P_$&)"9UA#)HBA
MRV1MBT?J" XQ_A4<6F#"-7! !B:HJCQ$#=40A<"IX;"#&W=1XA0BR(%40\&W
MLA)I#G]@0NT6,53KO"$'I&C5$7Y# ];8E! Y[9,7LA&AKG7_[*\EB]0>$)$F
M !Q!%IY8EAB:8:0-P($6S'G4EBY["B208!>40,,?'"6&3$C #)BB12X(L=E%
M].82D=C"*/YD*5J1%0*%94,+5*:FD*Q5'8[+1#C^X 60GH$$.1 #,3#Q.0G(
M0+,8:VYD 9 -3WA@0RP]E)HT48EW_*&FDI : #1!B3_ 3+5W0&\XMEM/U]0J
M2<VMF&25-Z):-0A AAB12A2"WFX(CQ2GV"IXC\LS]N+6#CHU%)H\)PF+U4$+
MK0" +\3@C%RX1@RNR,6$I8:@17BK1_R5E?PJA9T4I6G"K7@54#$A!O@\*V:L
M@94$3,56!\ J'#N+G)$< )XS>*ZT_UMH@<G:D)MD[?>R=0+0'%)L.!%[+7+R
MX6\L'("I[;*/?;7*179/L0,27.+)#B"2OVH3&RK?01:D",<6$KP%3/PM')8H
MP>?F<9,+1T)V!2 #/WCC+G04AQ#H1<.;JW,(.;<99RFR6C6RD>&[R0,1.,L&
M9M61 _NP V:&F(=NSML,-I "#5C8 PF8T 5E?AFOE\69'SHAGS]%XA"AN%]O
M7MVJ$E=A>+L&7L%DT>'W'&(43L[%9#-QBE$4 *0X<YZ&"\ -AI: <W8#4!HF
MI9("U6\V1X G>\@PM8349GP#+ #^S(W/P+8F9.UK][E;PRS6=+O<GLV?/M&-
M9G/O@ 7*>/\ "9@"0E224I-'D8 '2M !?O3 X-TH@1A1X $+:-(>,JBE!U()
MA30H(8-WX\<^"E$(.^R 'WE"0F(D8.X2;,'@.72,,DZXF$TX$Y71<H C,KF8
M!K@ "Q)0B@>L$D(62$ ]9-!D-[" @G-1$I => %"FGZ"I4M]ZG6$"4UD(HI_
M4-U=,;GZ%2*Y];!OW9)H9 T+HC"!"82@!TH0X<]#\  4], !+MB,!"0P ;+$
MN0"A8.9AAI!#.40A@RHH00E->'$4R(&'$XC!&XAY!"3(H  .0(+CE5# 38P"
M!:Q(>Q+'\@8JY) %)7R##.30 [9+0 FT[&)92 "%*KA@@ECP@!+_)D""M]U$
MV^+[36K.%QMRM[M]]H8G;RQ=4=8H+Q*JD"T-MM,=UV0CO&RH0OP>R@YH7:@2
M:$C/0\4#?N)8P &M"REQ"B$#QH(4_(QXUO;P]QI99 (-%0H6>Q"+)Q-< @T4
MO4[!5.(:R/$AU? Y&W4*JX ,9^,QRL$?LI4L&<4(#1(<VY(R6R '!5"!LA4<
MM_!5:< TH%)(]J%1_K<EKG$ND8,&]Q"!=U  ^L> C+!38-,,''6 (F(JB-(M
M >@<?*-1IX G"Z,+4O!^)8(_*1()ZR )A2!E@X)"2O."?X VZ/8:RW92 B4%
M0,$1]I%1IS @E^,?]9$)AC <C( G3B@>_V189JSB(]T&4@R0#Z>@"UKP+$2"
M!JUR";>@#M<S@\2!)_5Q"TF3+,OR>^;6AOG "&F0A&9 )O^"-V!2!2O -\1!
M"PF8';_G'-S1*A23-+*0![)2?N^@@LP1,J3B"?7B+:4@4*N@"SC#3PQP#SXH
M/)40">_0@!>F!0J3,.<B+A$C"6P0-A>C#> &4AKU#F$B;I2"*>)Q#XE& ]Q0
M7O=7"0)5""X#,\_8 7Y0"3L#7K3(",1 "5=E)6B0-0 RAL2@"Y;0 OTB,T)S
M4HQ0)]&"*13U#K)S!'\%)7F%BHPP#\>Q-073/M?3B_&8-402"1SE3U[ ++\!
M4K0(AV^V;)$0"?_=N(I&QC@340"69CMI=2XI,H);L%:+$ '[%Y&G0 EO)@_G
M8364 P#\<#G%TPPCB 50("U1PR%297[$&#R)XX:,< @;XCC-P)#G""VG\QL/
M:(AA4@##,V#!XPO)T@9+TH[C!XT,(!ZTMC",LSWFD8)\Z 7N0@J,\"_A,X7H
MTS&Y<6[Z\VGO8Y:X(6]> WRA0Y3?<SOM(1N#6"#VN)8!Q!MEZ6VN44 %T <G
MY &;\ 9#X (%( >C()AWYP)WUP5RT0,$QP*;@ (DX $0MQ>:1'!#! 4M9($2
M  9W<P:4YP 6N 5@4  E  :+L .M- $-$ A<9 %_  :$67%_\ 8.$ K__" #
MK31%:?< :>$ PSD6AZ<$CK!"1_ &GI=T"H$:8K<3@N1'9+ "1A ')W 3(+$"
M/@!'%/$%7Y"=&[&=7[ 1WPEV"^$#Y$D13O %YUD1Z5F>X%D2X[D1[!F>%+$"
M!U&?\@D2O@ #3? # *H'37 %][ET_MD$33"@/R $6H<29/ %)A"A>@2=%;H3
M9!=',1 %'F /2-$.'K09FT!Z)Q1-+C 50W #:U :77 4D]D-=F !W=!!FU!-
MRC!*-S<!GQ0"72 #+- %0[ #Z!<;:[ )8" #:[!!0]! 5- -]N ((4 %@: $
M'G09$[! V!0"CH $/= %848"+-"C5.!!B*$,_XM@&!XT!')P-PY ?/0S;[PQ
M;UO6&^D6/W/:&C>A&ODS$>UB@B'S&NT2IT>P>V<920F7$.WB3G;T>Q-A AOP
M0O$46 #0J%W0 V]JI[H!1&RZ)98X/PGA"Q! "%W#/J'#6*^Q!!LP=_]5&QVP
M AL0 >!S+B;0!810CZSA1]$2+;V!J_]U+N<V/GYDJQM ""7R/O+F"QO0#H20
M)T38JB]$$?(0 800GIA:@H]R+JVJK*&C$*Y!/ZVQ#SW0JWTJ60NQ!,X*&WJR
M)O@CJ8YJH!PAK*:QJ;M1'VFR!+0Z$9^&K<>A&_?*4AU@ MFZ$?)P')+59ZD1
MK96XDN*V$5-C@O[Z%_\<PJL*\4=;TJJ_E!#W^3WF%C+R$CHF4$ 4\6D1V['2
MNA(F(!@7FQH;@#;/J:T;^VEBF1![&K- !+#=]FT!V*K%Q![U*$A+$!<)86-8
M>"ZZ :C@M@00D)V(*D@$PAK8BAH-^[+^"K"/(@^SRJ\LI1#_JJ^!=1OH:F[K
MMB65VJM=$ &\DI<!2 ;":K.LL24JNQ$<XAKZL8]S"FCG4DC.*IY6^S9K0@;0
M6H\$BS\W(;B22JGLT1N(&K/CJKCL%BU56P*2];+EVFWM<C_F9I'ERJ9\NJUL
M&2V"VFWU6HFJ<1.R>@,*6X^UP3KO*F\%F[!BR1KV<V_HLQ[B]I9K,HBR&T__
M,^MN<5INLJMNZ7:6Z"9 GC6GJ0&N0R0"J&2BXW1Q;R ",B #&[0&=I$%9_ &
M7> 45^I!,A=!5$!*!O< $^ (/?"E/> ".[ %PUD 8# $?5 ">^$ HS0$LZ1)
M(1 (5! "2.! 4V0'LU0"W> (=M !8-$%!\0"I/< :-% 7'!,6#$$900 KXD8
MH\"R%IH3OJ '5S<35U 22^ /"5"@"M$+T1 '#DH1'@S"X3G")7R>*!S""=$+
MT_ $B;01+JS"T3##+1P3+PP *[Q'-3P-,X #-QP'/VS!)\$00I!(9$##BO0(
M&IQU1RS%DJ02'9 %W2!&4M #2$!*V'0'4S1PFF0'_UPJ 5E <ACT!YK1#21
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MRB9PNAX664^ [<N6>_*]!\O]3$_&3.IJ&4DE(M=R+=F'3=9N*=0=,X2SNQ[
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M$KTM2+_N;% YS#H3;2Z[TO2O,QH &\Q 'I/,\T[P<HMT4 H7[0P]ME!UJP<
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MP70LV$(6^/$&BQ#$!27H!AA"0).;C/,&U^H&%3PB@PX@ 0P2@-T6Y  ]$I3
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MAE5J>>*HL$2:(1W)T.45M8&=#,@QR\?4!DX-<-9L*.N(+XR=FJ@+NL$*@H0
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MLC)9_EI+#2.<2Z)=3( HT.$(@((%"P! *%!APB,T.M"@8? @Q X0'RJL2!!
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MPE63O.0LI3D.BTPRG>N\RU$1,@8;=D2J)%">;MQ!!E+PP [^@X7Q^'G!]6I
MJEB!(S;6:Q%@"!$*2( $$CB #DI8$3O96<5ZL;,!')ZB(][0!1B&RP4W?*($
M7,"%-_\@00EOD$&M/$ "*/1A/#C2UA"Z\09EA*+ B Y80M92NH6(9:K;55]1
M&N=!A($F)U$+F?'(,IB5,D4Z2&M99^L&N-,61'[5:2D-L+VQ')RO:>95C>/L
M>SGV+N4CF W)V3@W,^$)-8$0(<AO,IA6LJA[VZ\CZN!\]A2M<<1GP!&;1V;'
MV:9)).*1 9US-E*SA'@K-EEYF,(34L#$@24[!<\:VJY*\*E:!"X3B<URBK8P
MPHG\,CFQJU1PJ[*?'+Q(D!$D]'B^P+L0%G5&&=UB?\[ ^2*6K'#-BVH+-[:7
M[6VNARGVPNTV5HF;5.B#FPU9W;+ HNVUYV(!:W:00A&%_93_+BV3+L;6XEV+
M82?I /?:Z=@64HH?K:9 $WI((W,8 V:;NZEIV[X76_7A!)8H<W> ND.HTFQC
MV_% RUO9/%<1S[1=)QG4*K99N@\"'@]]BV4W!Z5G=^!<!H,13'UJM!-OB._
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M=,@,Z5A.?&U,P/_Y36VM1/8\U=F SBRV#<(\:9?NFU58Q/0$'.0Q14Z$#4S
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M%V1!"<A*7:_U-*F3@;$ (=S*BZW!.(%! :"A69< $J  'HI:M8"!7 ^4JLD
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M5G1OPK[B<S&_ N;C4<(.2#P"01KK<T^> 24DHT6B7)Q/R/IR?+#*#.M[L48
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M+%1JT(0D-&ZPD9UL8BW;V,<6=K.*Y=Q6/FO8:%#V!WPA+61-BUK5'N6P3[B
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MPD@DH#47L"($0]'>!!K0A54&\[B /2SNAM*+)WSA!6H(QNB64 .V \#M)J"
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M]L @!A9A9QY >2: !'"C"W1N-+(##*C@S8^ >F@B"H8F@X? O,RD"WP\+I%
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M#P#]>2528]^EEU>&XQ$VHDT<J571>EP]]=U0)K4W7H,=;32E51^1(8,=(:
M1B!O#/0&':-XT T+#TP0A0P[L- %&#MX($$40U!!A0P \-/G!!.$P (-(130
M1PDT5I2%/6]X@ 468#@0%$4N%/ &"26 @:C_I3U4! 88)83@IPL[Q'!$(#<@
M(<$FFW3C@:(HO(%"% ^Y,($+*) @X1NV8K%#<L@FJ^RRS#8[VA(U)"$6#,$
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M;00A9)L,7QCWLE8 @RL(=-?PCK>\=WV$'333J07PYALV84T/6#,+#K F&+C
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M!QF/9$5[42$>!$B6U!]Q!Q@2,EUB_X)@NK,@54>5<=0?0!9D?B>6("B3&R)
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M5$6N?6SRH,+"A=GN<]#Y+O^_@G<Y=BXLD6%#$Z'AXLQX$+7(U?(<F.B!LBT
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M5T."(<@",, F(;V!<U&6BG"Q\'N#]>N#F-T$?F$0,$"!$Z2BA_* 40A08^J
M1YB!']"#&=  /4B !&@$&5237A@3/:@!'^!;O]7!P)T!-6B"!-C;OGT"P,6(
M7KA;/9@&PX5<R46(1ZB!)R!<S$V R/T3ROV!'[C<Q@U=S9W;U67=4!E05!F"
M_RAH "V,@ 8)!#FX WC:I@A$HVVR* F0D=^\D2Q@#'X@@46H3$/B/NY  @LI
M4)@= A(8 JY5 OAS 2X@ 2XX0C!XAO"3 !GH@!?M 3D LBR FII5$$L @QY
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M:U+0-U@#)^.'V.RU0% &"UP0$NT"0MML$M45$JRR!-R!/I#:',5:)" !]IV
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M>'=PEW=Z/_>N#G< &/=R/_?$I?;_@5]=NAX5N2"!=9D !-V!;B !(_,C"9@
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MYB8WS+Q)"V3P,@@9D'43KT3*<P39"<42DC*=Y"TD2$M*P?!UKU#9TF.M8HI
MAK(SFOUK4TMY9NVNQA1*<6MQ_&K85+J%G);Q<V#A4A8LB;(GFC5J5LH:F+WZ
MF3&#CLND,35H4@"Z4>2@;6@X_4ERH$FNF!(-9",MRKMF6K"=T.1LQA$95]+E
M2F[9Z9]."QA20\J/_T39:4ZT?%K-E-54;F7EHFBCV"LQ)Y1_'5,BV03J[,P*
M*[#,TR#5RHE5WODX>OYLKP7)P4E>(KE\O8E<61L)GL;9,V7.4Z7Q>DDTK\)8
M;1+M*A$%E4$QAZ=GR:TB*TW6M J:-&<*-);/JBC"^&$5&E S81#]U^IZV;F\
MOM*SN-(8(3:Q V5,( I?+$$7>E ",W:#"@Z(@2-$$ ,D],!-6<A"'/.X"0>X
MP %K($%P"?&3(P!RD'&I3)$2^ 84G*8E_KMD%U" !#F 009@* $*VKB&$MAQ
M"); 7Q:ZT0TLN( ?72#$#JKX!A=H<1,L((H2&C 9%LPLB@YF#AF^\ 4C,O^G
M Q*F\'(B;((3($C#'#X0&5ZPX0Y?^,$F/C&*4]P@@<E@$R6XP2(*H*$'LH +
M+'C#%F1PAPF@8'T[<H'\4, *&?2 !'10 A+H0-XWI!$)7> '(?YB$(SP@P77
M&Z3P>"P'3^&K!W+X21:8C(0LG&@-6-B$''IP0!D V0,[(,T;E($",/2@#X4(
M 0OD$!@LG"DE?NJF5;!BN[5&5:Z=\Q,_+?HG@TR+;9,SF#8A8DR/Q2HI4LO;
M/I;5SD 9<R3G9 E#'"*/EX2.5@TA"$S,VN5SNC1L<3.OI-\Y%89$8 ,L 99-
M:/4MWG6.FO)$5-?N]C."(A90E3J"R>1$,4S?#FG__004M 0V*)#]:6.TZYK!
MC)D3XXR.<^]$-CQY2LR*CDR: \%<: <5-(=U*ZF^&^DZ::;NXN!,U2$1:3 '
M=3)H*25@PHK3RV9++9Y=U*3G<AVR-4:SA0K34B =&4P%'NA \RQA]4+8<1#]
M%9]V.VB5-O:_/!52LXH$.42+E+QHY5"3*<PH3K*TGN#Y[<[U52:Y3I:BQ,45
M//5 ;L24V:.["9/"'B10<8*FRF72D(X(A"#+]I5J7X4C$Y@W:35K"4>\-5MO
M>8LD4)^;2O"$.L3V0-2@+GM)3,56;UF:L0+A2%&8LFVGS%U6X$KFK$;&-+P>
MC&H&!?FX4-X4A4![[G^^_Z@#.-*'#<F!#G.40!J@8#P68"$*/7" $N""@C<4
MH 0L($%F2D#G0I0@P*?!HYJ!6K\A:&B0CIC AEQ<K8$(-PL_ 4,:'$ %S[O%
M!3VX$6@<P"%'D.!#$P"#"U# #[6L=XYFS Q&WL"%X>Y Q2I^P8<I8 ,-)"&&
M0,S^]L>3'.P3Y0OAQW!QR ^ %YR?8%_81_G#[WWCJ)_]W)^_]?.O?_U':(.;
M (./B-(=N$ 9O4$WA, 06%(7U=$F[-X.3$ 9A0 *0 $)\$46?%X=@0$AD  *
M[  =D00)F$ 7<$1"\ ,_7!X*@DI!A" $D  AQ, DC<(.1$ ,M%<,Q, 0L$"7
M%/^ ]Q0)*_"7>Z$ "FS"%P67"W#2AH3 *@F4NQ#*1'34N75$MPC$59!5WN2$
M3NV+4>"2Z["-4:B42J0+PG25W%$312@32274,#V$.H4*5T!5-?412N@3U#W+
M6]65W&F3"2 +J4%.&,Z3T60-I;C5I473. '478T3+#D$9VDAR^E=K,Q*H%%5
M62F+O7 +.?W48GE%5>S,E#%4%:*A3EG:L/U$T2 %+U5*+TF%1>%;5CE,@TV4
MP9#4<C1,%;X4O0W,X5E$+'9,LEV<Q<6BPX@,Q;FA4@B,+V+APYS<?%3453TC
MT/0+35 55A%5V4P4LQ0%2.V,U7S%*ZE31Z'B23'*#Y'_X[/5B2]1U4)A"\Z\
M"RW%SFL]CLJL5,=8UJ$Y(]+XBL9,64>MW"U!2C?M5%Z]5>,TDTAMUT&DQ&39
MG-1 A$G@2=JE7M'A(1=.UC"5RD.DW;]DBRL*A-]<X65M5S;M8U7D$E!\53L5
MQ% LE57H5-SD%;B<RS<BA."!&VO5A!G6UD8:$U'0@2DY0A0<H)&50!3800<.
M ?X@02C% AB, C^L0??(T1T((9-EP2,- 0F001L!0"(!U9N02@DX@!]QQ1Z0
MP1Z00 2$B!SM #^4DNB11E\\F0S8@0=LB0= B02&A@2P0!?< !@H 62$@!(>
M&  $ A4$ AC<@7$HS/Y)40D%_\,*-$$"_$ 31,,3_(/)/69D3F9E-@)F'D<'
M:*9DJD%E7B:%A28.;>83E.9G<IMH)H :_(!E_L-ION9J6B;\-:9N[N:#]=^$
M;-'Z;(&6A  8<4%<9$$)*$%<))D,.  =X%D5S(4R;,+(E$ ,E%X7L( $X)E8
MK@$8/!D-H*5'[  A" P![0&@- E.9$$?R( VW5@8>%[R$9E$&(\<<" )_%\)
M"%<!@$%<L$ !;!Z:D< #C)=*"%2R^8RXQ,KAU8X*[@FRK5;NV,[&",K+2-8P
M(56RD%PT/4Y6%%VS( O5T98\"=0BP<0\I5T$>(O:;4K3(9:MG9M(1  AF,"E
MA [5D?]$(DE3U"V%1\+-Z= D0Q9$2C2.NA@5NX!+XJ6$X"'-GT7%1UP*DQX3
M1@5*5\",0MB$,AVIE<8<,24*2P$53O!:T^7:W:S367TB-S*CGS2+E<YB0ND,
M3&7C,:FBQ07,UBW-0K&;F+I+Q,2IOZQ5I=C+1"V66?')1$$51:4I4E4<LA'-
MF&(.QQ2-30Q>GBA,MYFBUTQ*<TC*Z #51JH6Y3#F/BF$%VJ+MI3DH*R,NMR*
M*^4<.DXDM-%)UE1JM;D*3^B-TR&<S. JUE'.157+M#W63ABI3-E.5<0*+FE+
MU& *3%A.IEE+J>5CK:'H+&D=9%53<,T30VS$L_"B6*630/3_0#J](=G G[]X
MA$U$E(\6C(/&B4S1E0J2H,S0#J\55%R!E,\P:["8SD>4SPX0&!J)B0J4 "NP
M0C?X'@DX@!PH@0HXP -408<DA'"1%Q440!H!$ V0$AAD6@=T 0#LPT> 0=,4
M0!K(P!%<W@Y0Q0Z0K'!M0B'0F1"*@',2!0M8PA!:+%L2@EZ\A6GP0PALP?1M
M@@M(@!T<A!G90S=HT)SRYH/(P@QP6"^,$%'X0A-< 84MP0SPP(#DIB_H =:F
MT-9V;=5>;=:.[=1ZK=ER1PWP !FHD-I>@?=IK=O";=F&K=/FK=Y"B(1,B O$
M!9#X)(=X  J$@"48V=]VR!N,&1(D_U\W[&4(.((=. #U2* +)* ,B  2?!X_
ME !0)=(1"$06O%Q">"<=_$07I$9=8*R:;*[GC9<+C%D/$((22 #K>< =^48,
M?-$0/,8=')<$'.&1X*Y>$!->L2)+" 1M)>BXX$EM@93O#%-MB03*D6*@6*GR
MNFN6VHUJQ01//F]*O M$'*)9781 H(1HV:.[8EV.<$2I6%-+B& ?[2'6P01+
M*"*M6([:J:1,2878984*<DY1J" -. 23,E7&<%1 R@,NX0HF;ES!30[C.(N7
M\E6Y$(4*TE6?*(7G*(VEI(3-B.E4X,T7.B$'6QWK*,>S71,_W8JT@69.]!V<
M]NE(H=1"#?_BQOT+2]U+T2S5Q71%PR3'Z+CK*_5+1#%FEK9.HBE;Q>6B,_%2
M+NH;RS5MZ<36,'[A@80$PAD.%5<,E"9:+'&%%&-Q$,OC"4^DZR#-QL#2P%T$
M15SO'\H,D2:KR$!B4##,+3&I]DX9NS5+'^T$()]566D6E!H.VJ3$-ZD=A%+=
M^[+$'(;.J*T$Z!#I!FQ %]@:IY0<K$ %^J**-CZA0DKO5DQ:)Q)RG7@.5QC%
MAVIHU&P*5Q!$WZF:+GED[H34XKS6E3)J5>R 8A#G!/1 %VR"F,@ *[@ "6P!
M"VR"&97 _'P)$MC!$'B@'(1"[%K2[!9'><K) <E)0AP!&.S G)#_0+6HV1U(
M$!A]28Y% 0OT@7]MP1MP$6XX@ >,F8D<80C0A1WLI1F9T6\4 /QP"!CL+0?)
M@BA(;1S\4"]<@0=%+74<='$D-!*_0$$W-$)? 1(3M$%7]$5/="\X-%$DM =Q
M=!Q\&'4HM$"?-$HOAV\Z2 >@0%P8X.^Y0!1 ( J0 )F\ 17(P1H@05^$4F2$
M0"@$#Y3TP(D((0NX@ O," I<IY,1!4MT01>! 1+(" D@ 19LWAN4&E'L0??,
MD1""P2;0 90TB0.DT9ALPDP+YGA102'DYQN P7V2@'^&4GPY'2U:S$:*S:MJ
M7?;*U:H&Y()"7+XHDQ*#5#=EQ<V!T[KD_]QI:9-'A<LP41/E'%/>^ KJO$FM
M1"3-[42I]5&BI(2O+!U4\)4E1O:LK'$:1V@UM<JJ=HQ4T9ROX(PQ,:%=H?#>
M$1LMK6J]/"G(K;'I*)JQ/56#84O<@)O7N(VB7,JZF-3,Z.*[$$Q"(&-6C2%"
M701,Q0L3-^%U&VH?QRG/ #+*J=8O914T0N]=]TLOV@M!W4U3Z3!HZJD.JTLL
M6LTS\EUR&-U&0J\2(P4Y8E6?$LURATI6V*1%0513\*\K/HTV]K:6CO A2N'/
M4*K9B,H&?RL<IND1=UT[#8K-S=ZTK40Z\8EQZYLLO=J_A$Q=-?)D(4KHE,KX
MLNA+[&&H%18>BO_<Z/@97P%WB;_D%,:=3^3-X>V;;8L+D0?:;1?=VY3+!-^3
M3>Z+UN$V5JSNEY %A]AT7W11%5"!$FB/9,#%/6N(#+@GC%PE((%!,N,1*Q1'
M!!S!,2/?@*T!"SP&"IP!&&SLF+Z7F<L@D,T%&(@U2VR"!'1## CO9*C(&T2>
M/KS!#AP7%44&%8@ "6C,!%B (;D :*9TAX'M%T2F?)S "ZA!$IC<U6[Z#R3!
M"7@ZJ)N<'N  J9LZJH<Z:&HZIY] B('Z::XZ#\QZK8O?K?P JY-!$YCZKN,?
MIA>[TZ[T@M0+"\QT-U!G'WB ?W:#_]R8A@@ARB)!""P""B U;^7S&[#_1!_8
MM!+$0.,MUR;<P"J +%=.SR9T40B "0O(0#<@02!T@57Z$3]PM?%$28TI00AT
M@1+( !DD9Q5U ^L1YR91 1WT00Q(01EU27.] 7_Q& 5316CQ+RO&5J14(B;:
M4^(X-D),"RVI(D&4[!YOF]'XU45,&F,MA4*&3,CHHSPQW4GBH5#(A/[..",Z
MQ$XPL*I )!#K&C5%J5',)$0XW:Q$J4Z]TF;)E"?BBE7I8:G2G$INC>Q(G3U*
M(BO>A,#<I$MI/=$K$UTMC"ZFZMM,!&HSA;"UU;WQW<?W;U68CC/=BD7%6Q2;
M)-)XMTJ!S7QPMR?3&RK2EFM)U,30J0,;>!FK_Z'AAXW%<>JZ.3G#Y#<5]TQ2
MA6$O"E0,*PQ/>DU7X/5C4[< _V%3/"+>N/>M-(TF7^F<Q%8K#EHT[E+*4P54
M()0*ILXH2EW<14#YKI//<04;TM(C>ML\B5P5?C&R<.%J]R%)%$ .R E'))ZG
M(18AV$K2W&%/D1-0:4I-#@3/CTI-1 S+2-K:*P5J&=/ .;63LE66>OUK$?'F
MQPLXBE7 (1M$(-3J?!,O ]D$T $=\+)@L@! ['!0H) R&2*DN%#F2(H'%_R@
MI"D1HY <.G)V*&'18PL &@"Z;''@0H(+%W(DE$!A"46('F!(>.P IH0<,/S
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M/\WZ\<(X)?W(SRTC1'/"L\;LL,,M>RP+ !C3]#10!3\=54X&8>RTQ4XC;7#
M#L>:4$),$:S25!)C?=!2$C\:U<,1N9KP13\YO/%&L\22\-$8;Q6+U+-PO%'
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MC$"@E%>)V*7(- FSGHY,V"EYU3,"=>"0 ^$1&1<)R&:NB$<#J9:!PC5(!YC
ME$]KI92$9+"R=*!):_Q1#]X(TI!):0-F!-H^R$+)8:FH_TDT:E*S+G9%A=7H
M44#)TH[PZ:,R<M$$#@B5'A\DRID)2JC[9&1!DV7)':G(767*I:-,-JY;S>IN
M2'  %;K@@MI80@(.V)![VN>"1=S!-EM8#BMVP)_\%0(,2&!-"+H DBU@I1MW
MV 397- -+Q3% 5@@3A18@(0M9,$_,A!=#+H!AC7(P $,%6'89+")1<3/!5'H
M =T X "W*D,$2*!!#*J  @DLIRPAL =HJJ J[,V6+2N@@ ULH $-7. $M:5
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MG'$&5'\"!*A=CLE'.:#C0W\M:X4"ZDI+_*231;0EA3HM1T3K9Y-QK; NHRA
M.!.7?S@FY@UY2-_U?E*!NA ED1W)S+4T\U)QRB([>4JA-0XHD+J<H7T0LT$E
MXJ*_W56P-+490"Y#9RT7)N5U22I CTR6F!04T''C&\4%6(/86' $!["X*&\
M0Q]$=80C@'@V@2B*"]Y0DQZHB 0]@((<>H "$I A!(XHB0="_^" DNR5!99X
MPR;*:H$WN.!J9^C!$<#0G1<[  I T8T+)N""PG7=!3+8E']0\(<'8,&P$@AM
M5CQ@!QEPI<'=\,!6MKM=640C 4WX@>75D  <S-HLDY_!#R[_@\QO/BV]B$8-
M0(_Y!%RAN6;IA1$2D/HFP!X'_TB++&"?>M%KWO9H>?T,]!#ZT?<^\L4W_O'1
MTEW-#*$!W?@*<KPC@=]\K1MO8.L;"$$&J.R@"U18CA14LXDHN( 5A>!O ;@3
M@\2I* L3]NL;P :V$(!!K"PP26!)T)D)D( &A^M#%K+@-61@#5CA;ZA@%%R
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M '8@ /FA_423@-X ">@@!A9,!/9+-01,"6(@"B9@[<*@24A@#=)F!PKA#:3
M:HIB KJA)I @?9 @#60 *B2 "C:A-*!.(.@@L,+#-;R(BQJ$VJZE36[LDW2F
MQHJH8>XE&A]*C]:,C]I1C'!M(O4LD8HF8=3-BA9)9,QSRX"BRPRN8D+&6B*
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M)@IATK/.)LQ.;$XBE=_@H#?A#L0&!8Z@*DG@*I;= H3"E>D !<SKTQO:CAW
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M.[ %CK #_' '.=,-=<,"5" "+! *G>,!!8 Q7- W0S,!BR !4O  $M -PO8
M0T,#BH51=^ T+M #)8!Q2.  <M #&+<%=/!P'I7_%!17 G< ,;@S.#(@!]UP
M TD% #AG$W1@'2-V<+$HB[,($4O0!#PP%K2HBRF1<##!#T?A 4J -3+0#4J@
M#*B%,X$05$@@ TA@%)T3BF]@ 3*@<6L!!HZ 5#U@&$*G6,?H 7?3#9VS<0Z%
M%5A <A(P"G:@#!-P,4.#.*S@ DJ@.#JA6&Z5!:L0 SN B*%0 H$@ 1B# BA
M%#]A!Q6%!5+P<N03/C7T+7^T'^?RA%ODA,,U3JAB96I2 &M@"+1@"GO@!FO@
M=EW (ZJG7>M7(P\X&N_2?PX&:,:D'80W&@[":"0('Q%(?ZW1(FL2(?>12OO
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M5@[ !24P!#)P&W: !7<Z5@YP&*$ %3+@;1)0!3)PP')0;X50"+M;-R6% EN
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M)MA3:0KF3CIR'TF6SJLBT+K1(V!T=ETH&UFP"5S  E#P,CPQ 4K@ I>]"@X
M!C&P"$,0V&_ "ID3W8<1 @7 U+*#4&! !\]+ UXZUX4@!WZQ5_.&!,N+ E/3
M _+F (AX&'TC P^0!H4  %"P!17M 3L ;"9#!;IN!EO@ EM !7;@ (MP!",,
M-ZR@U:RP5,^[LFWM[_\.\ %O$2@@ G*  IM0 +IV%9T3,< &!ERPJ$-E D=
M!Q?\&!(0%"23N700 E(P,EF@!&! /@Z@%E0P,JA[J3$ !HX=6#7W&#&P%F(6
M=6\Q"EG0#06#B2SM%WD#&2[0'S&P!M'^_SFIA58X9Q5<X3":0F7,LT7EL9Y@
MR6.J]#\5E%O(10-=H 7(P 1=AD7)0084-BFW%U\&V,(M,ET+XIOOC&?H"?9N
M]LZ"ED"#LG]&9"]!9F75B8 L1$@QW,X-[:MX9B9HCIY_CTEJG";*<GDUYFK(
MF77SDF9GJ<<X#B#"21R<%O59IY2GEI]9<F&SLJWI8F9#%+UY0JI)%N#+LI=6
M=&3&1V!,%!+LQ'^SPB,>RZ]HE+-*TIKS%WWXEQOA@B(-FV.N9O=\DB9.A$32
MJB7FN;1/5)<&*($0$J#-\>.5CQP8M"7-7%W]WN;AXS]XC"F(+W@L9E_H,H&
MC!QTCF>$5K7P _^6AE(LLH'?*G2TZ+$\MXR>'%0_:/] :.^?8(X>8@80- H
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M(SUB,B2)@"2HAR)3NDBEA5C[22&5-+KIR9/$([-(AMR4":.3!OHI(2][8A*
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MPP4P2!B"A *02)(RR[9XPY+UF/) CCLV*8&\ MY@ 04ZJD A!$? V,(%&>0
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M)KD4%,L8*]$:P22*&YFFF^&5.F(4M"&#Y].%+J PEAG#G& T+ZFC,'(:0DE
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M+>B&>P2--PB%;A@"QA&!IRN,<:4#5H "?N"?<LTZ*/]@@3]8/!28@"Z0@"X
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M3-H<(3]W,F-Z>N8B3Y6'A(K:4)A8LQO__')-%KPA;0;)GM2$M?\ .]B"!20
MM>MAQ2U4.,HHP! ",'#A)]V GD!D\!(P6&]WU^L!&!P@&1: 81,HR!H+4$""
M/O0 !3L80A3T)H>X($$&2O L$F3ROA"\P0,E2%OTM+*)MFQA$V 8 @KHH#87
MR*$;.0F$!&K+M@*X0 :Z=8#MFNO<YT+W)$NHP1=P^077=>!?B(HN=YV+NXU\
M9 <3D(('\G:$$LS6!5B0P!NP,!?TWN$-2'@#"@1' L--H %O\*L+D&(Y0A0
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M_9"'!B8X^@;/L_.P[G'I'BD9R72T&XCU"<B(3*MV-I4>8RG$0FSE>JIYQ!T
MU,Q#R-&/=DJ]QO[09EYR99ES<$SLYV#'.46BM"+I6C+/C!D H:"#%-Z@!()(
M0"[\X%TA7. (%O"##EQHRP2Z 1,1U,0>#WA#%H[0!0#43P8[*$ A=/]+!V5(
MP&I=.,(.(B\4!WCV#1TH00Q*D)8.D*  %G )%D)P/ \X0GHEEH%E=R"!S#I@
MMGW80N5[;P'!\8,$1^B!!T1 7AG@LKO:WS[W42>+.+@. +XP0A(.T@L<<+K[
MZC_)=S6B)3 TP/(AH"QL+8?938P/)SBA2RBZ4(*QD< FN #:T(0(+$+EA$ )
M]$ ,= $_$ (AD "%(8$ T0\=T,$$TIX B<UN>06"@$T6A);E3, F[ !<0(T+
M!():4$$$TD$,8 \84(%=I,_U#$\(P!8*K%$;24E375#7<4BUI9V765!Y8)$2
M65%0D<:-^$AHK$)N-$QMC(RJ<<92E0<D'-K_*E11W&5,Q_2@ T'50P52#QR+
ME@0*$4$"+1C"'AS;I=F5!%E)S43 /G1!'FP1 "0"+32(38F9+B0"FG7!IS3)
M'B31UID1#L61CVA=;22$+?D(59%0P]@)6$U)T'P&>\P19WP$-(''C/A)S2!+
M::A1ITQ,-/%:*I6:#\F5E.!:QZ0?$6T37'&&'A$3*D94LOR:FY0)L5A:.!'2
MSXR2,/')N@VA'?4'93!1]HT;&RUB69W1+/T((6E5KE'3EJ#;5)7A$Z[BF7A)
M-9$25H4(KMT)<K!1Q8U5F1C$-0E3GW2)6ZD1!Q$3  P4.1%1-E2"!X3"$I#"
M'+S!&B1")AS"JZP _QS8$SX-E"'\@3\AI&7X"ADB%"740R@TBA %R#0)6Y'P
MPT0-0VV8  SXP,V=XT;JP#[XBP8D0<GM [R0)!-X7,E%2Q.09"^( @PT @]H
M  YH0#OTPC!@E 8( 0^XQ@;LW'"0Q@LT01*$1V8L <M]% TL05"N1AN"%2SF
MXH9(R*E153ER79;02'DL2UN!V26^(C$2HL>T&LL\H51%B6< V;),4,VL22?Y
M!G?(%1T9VUOQPTR\A0=L A7\1 E0@1R\ 1W0A!P0@E]&F#*X0 G,!0H,Q>$8
ME@-T00S( #]H36?5!&-.%@G0EP/L0"#L@ ?$0&K]33MXAF06P/&\ 4Z  ?_\
MS$T"_008T $)E$ ?9(%@@L$;D,"+44%\N4 W=$,  0#G^.8;],#Z&>=Q(J=$
MK, 3Z, )D$$OU$ -"$$O1(-').=U6D3[;<1?2,\F%  *A,4=P%:+O<$?K$4/
MW$$/A D=O($EA WE= ,*1!X)0,%JRL5X-F /0&;MN>#<Z WON$ /K $*N* +
M9($#](!Z#H8-)D8(!)0<%( <P-9A;(($.()W H #T($#-"@2(,X;@"ACVLUD
M*IJ>=,C??0<-C R/D,R6B5UMZ.>\Z()QG*)_;%W<#0<R)(*=P>@JF= :X$&&
M98;6,0@>F$([>%D&M8C&4,QW[(,# %EOB!FF>=G_F8C''AA"@^@=UXF'I!5+
MEJ@:&529@B###DPI;72!+B"#+E015R:"+FQ ++E=7$H2?ZA1S"BCR_1HRZQ)
MRO!8JJ&;G081HNQ,KF4&)4K,B0(96BEB,=;E6W73%"Z3N[$=N;F5JTVAF]25
ML?G2*^E)D%C10NQ'=WR'!KU)FURCH%@)$=7)$"82AAS*,V7J08!3IB03IIB)
M*(W5'DW*6'F=(XGJB=1)DVQ2WFG<,67JMK$HS1RB6T59K36$EL01G8B3J)1:
MP'F  V1#,RA</B@<(XR*/%Q"08E(!X3*/#!D)IVKC6:#P'E!%S8JC?@:/T2
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M.61 H8 2'"!A$Q*Z><,#.0J0HX<C>N@#_XP2^"'!D1TVP<(#$5CPP(42'/%
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MXJ,-=-%E#P#(*X )8E99"Z$-_LXACU6L@XB,/0Q9Q82E"EA#%TCV*L !/.9
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MQ1<ZY8MM>D,(7# !*F1KD4@0V)U"X $JE, ._R&(00RNE(4"L$L"(>B!"L#
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MZ0\TBA^,Y A*H"))0 208!&B+@8*@ 5(8*2B0%ID@ Y*JD82BEU>:0C$9=3
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M@R(E'U_RAST:>I[]:I1-'#GO/H Z4#NQ::BWN,67G=HC*=\B* K^I:"K\DF
MCH7)-$TJ362!IBK1."(TDN92SMN,/K7"Q#G)8!,JH (5P/^@/"H$HG,A$(E#
MUF"Q-\C!!8$HP<X6\880Q" &NB'!&AQP! =4#@M2F-WPD- #"?"T(3U P1TV
MP8H21"%U7=!A 930!=30P0XNL(#E,A*"$-PA!)8@J@0*T8,24"$$H=@$&*+
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M"3VU ,E)X "NW*4'86A71I @ W[0H;FAO<EJRF1CG<Q1VY;2MQDM)!(2J"?
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M%-471T$AQ/*COD:G_\X#36N$CFA:4-[VIH_RCC_!*Y<$%-,(C3\A$N2" C(
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M _K'R8*Y,F=;!2Z0<Q+3 /\Z 1QCLMB<S8.UPDO3 ;(0#36@!S4P QH[ SA
MLMJ<SI<E=)L0",OCMJH< B4 !3%0<C:U S&P#TC ==V !'E)>V! $#*P!G1P
M.#&0!;E3727 (JEA./>RF$@'!NR2-R30 \?T.C<U!#M0-RZ0!:=# A%0 M6Z
MD*K7#9Z#!6 P!)I#!0T@ ?1: L$ED780738QBI[HQYU*%$V<J[*B(*EK JJ"
MA=Q2*$.R%FFP 3BT'/[7ACQ*!FF !ZOA%:O@&K6QN$GZ& I6'(>+!R*!G@Q&
M8__F09XNF0AX0 QC<477-!^VT9U:DL@^L0?T,P?$8!D": CGPXJ0(D:D8H<4
M]3UR6B"8.!ALAD],*"U]C1_RZV;2UF(80D(]D1JZ.B=Y86;2=DGIPRLWH:""
MHBS7-&LO FYS9K?/2!F'*J=!D46Z>!>EIB>NJZD"=I_+B[[H.*IT$FFD:&%H
ML /R4$^OXBG&-M2'U!SH<9WC*+D@=)ZK! 'A*;F3VH9I0 -*@@RA,B ?I1_G
MD0,\QA./*QX-DAF(U&=T(HS3"''H.*NHJ$&L?:&EM,*-W2/=[1='8FYHEJIR
M]&?EV"N.F$E^-"T"URU(O$ (==@W0F0U/8Z3/:BF[8G_A+(FAKV>R)0M1US#
MWL)-P98891,^N"9PSE:XYKT?I,H4B#(IZP3:H6A'.?H62,)CRKLF_OEP0*S(
MG\H3/; /!]*%6 8LG5TJS^(3J^%-M!I-\&034,$RE+$&8S4!&[D#[A("6\L"
M#E NQA,%DQP+LP<&#D ".Q!5?0#3;BL%H9P&6>, :^!SV[6M2O!\'I Y.U 0
MJ?%R!SVSH[ #0^#1?CF3;Q %CM WJ0.:CH ",5!S/M-:6>  I3D!/N<"$A$%
M+A %.>64ZOSHD-X>3O %7V "DQYW'KL"-9 $'?((@+<"32 $61GICSZ63Y,Y
M>ND"/9 X?:4,(<!4-. "L4"O_X6PT7>.$?KB B0)'W2@4Y7CE[C7!;!U786Q
M!SG@!7TP75T''Q71!4JP!MD5*AW0#CTP!)$#RG(E![SE=85!!=T@ WCN 0\0
M,RCP!G_@-]U "*,%E[B. @:!C!W0V7HDBT0X$=P[C]521,A@"@V\3^"$@P4
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M#\0ZU9QP68O/DL=1Y$!.LT/^EA"#W#=DX$^>.G219!46:F9B#0>(DT>,49C
M(Q0#E\ #A0WP,"4/4TSI X\]$GGZ:3!DT*1JJ&7059-$M%A%!.HV@$0&?N31
MA)*<Q2[ !**-+@#I+)B@VA0IP2"$[J9-<:'%/2/T X\[#B)#DZO_]W' A#I$
MT/OI[@X-L7&HLZ#!C[JI!J,*!C7)0XLTP@@0Z1(*\-ISH)#>VVK)30$C%%FH
M7L7I(?BC.P\I\P###*_WWN&R_X([=,0[78;6SS,11%/ %D/DTT+^(*WTP(,B
MM1#QD*]?U%%$@VLUQ#L-Y/C!WQ_<08(WN@E!A$*.@F@V"5"0(1 6Y% &B5 $
MRJ( &91 @@3=H"#!&Y1P Q4XH 2/0<G#^ &&6ST,#"1XS!'V,+'KR$$.9P@!
M"JJP$3J !PQDD(,C+($"\WT%#"Q@P6D"88D0T P)CMA$-_(C@9ST0 +ID0!8
M*+-#'O;0AS^43 =LH($A:J ),PC&8_*R_X(GZ  Q*VC"%4ZPA";H0(E Q&(6
M=VB9R;@@/QYX0P]VX (4N" $6)# #L0X@3=T)PM9H$T4-A&"48C%"_SH 0E0
MH,?7N$ &>22!"[)0 D($:3K-(<%%T@* /72!. Y80P0VX( ([" &Y.E!#,"0
M'3*RH LE& X84!""$#R$"EU@ 1TZ,@$EF&T'8*3")AYP0FB=A0;"X]2"?C4I
MX;TJEP,JP,]T80I(&2M16]I5%[30,.>M0A==0!$DD+$'&9FB"UW(4($V8 I[
M'4Q51P 2/U1D"$-0DPP]D(0I !6!A27B.A XV!YT04U6[6-# @+1I)J3ECR]
MB4.+TN6;,,(K"O\EZC]J\8^J.!6B;3&T/R;XF9^V]2%=#A12H_+3L%!%O.V-
MB#@B0R:K=.(?30& .#F(E*&J0ZGKL0I, ^5/G$)*'%P>Z)O%PZBU4(06MQSG
M+&4"4Z*N%SV,]1-1.ATHISY*H*2NY:=H29[TH&6H SF 2+H F*Y"]!^)<?4X
M=>J"*=:P@3480A=YBD BUG $>72N"W5B0AXF>(0D$>(Q25H#OOK0!0J%%0\1
M,,4<5I&2;L4$2<18$O,<8 HTG-50U\(31BFZTPFY):%VTN7?!.0]G89H41D;
MTYE<^M.0E31D<LK,ZV@!!CQ0@A:+, $<:(&$'5 "&6QPP#[$<(M0#$O_%I3X
M SH888OK,($2;V#")1*ABSFD 7=BH,7M6&<&,3@##)!H[6MID(U,%&(-B4#&
M&VA0!TG(01ZR_<-W,R&!*FQ N+88G1](80OH2A=O=>"1*2AA" F$8A]QZL *
M+A&.+82"09<8+B$<\-LIB"&_>>!O**3JBSI8-Z^D,$0KZB ,4R2B#XF@20$N
M(5CULI=TGE '=PNQ@T1DPA81$(-^YU ($._"&5*B6A\(4>&HM78.;2A '5PA
M7=<P8<A-,T2!79J9-&VL46 2GK$X&M)4(0NG(MH5FIC'Y.,(KT+&,J:!>MFQ
ME.K)IBUS'@"RX()-@($K$T@D"CP0@A@X8!,D_Y !%D*P"/4@84'\H(,>Y;"#
M$H"!"CTH@1XOV0.S[,$!29E@<R8$!@> 4QX?[$(/9! &0M0Y%#L( 0GD,)08
MT*$+1^B!H96@#*[T#2BT>0,2AI.?$+!9!"'( @ <T)4&O*$$)-5BL(4];&*S
M99%MZ8 >&M' O"Q!#8%YP@E6, T<(*;8U\8V6[@H&10HXRDDX <*[#&0-[A@
M$8$L06]<H 06("$"<KYA"QW@9OC=P()]V(%VQM.#+$2@"S13"U4=( /4H- ,
M_2E3<[I  O^U0 Y:(4$66OB5UR#A:H4V(Q8<,006>-$1._"-"UQ  A9(P30>
M4,;.KG,2B<)*>P2*U?^3VX1FX>4L70H5K:+8B2Y7,?:9*&H:7Z,$";!!<TW%
MBQ5Q>I#7E/"G'=:T%5O\A(<\\%7I_ EGA!85*I4YE:D6TE6B$C6JJ'HH5',B
M'++0I+V!O>E++FUR:2GFV58U"D];^F^CU+59R5IOIP3:5%H.53&VD+1DK.J!
M"?[L2Q0Y2$&32M:F,,+LG@*58I2:Z,3 I- ]02SN$8NYF*@',9.Q!7S_Z=#%
MCL55-#%V%3"YXAI,\5]#N64/IM@#/B.0AWZE@9Y8?QI&E(E5)IVU0'M8!1,P
MDH@T],>6(0(O-,F0@RZLP,D3:XN8I$ZD5:2LR1'KD$(Q,B%"'9LM;!??UP__
M;R<]W72SQ[*6HT*J=UU]R%&# @"%):$.M:P $1+8!4E8A$BAL%M0!WE(!V^X
M@>/XK3= AU*@!2"3!5+X!B_PCVSPA% X"S%00--; 3%@A<L @"68KQP0 T>H
M@@Z F2TP@SI ,?):A(.@ 4W8OR6 @T@XA58H ":8KUVXA1M8%#*P&6>H@EM)
MFWG( 9*:05(H!$H8P"6X!#3XL06CA"G8A7JH C(@ UFHA'GHE2"3!,WA!QL$
MP%OP';1 &TEH YV@P0%D D]8A#K8@A+H %\0@P(3$$WP!#D(&/+20"T$ )L)
MPT>S07:(@#JH!PT4D0X(FD0\B]^:!WFXIC 9O&8Q_YX[>;++>[F,LA"A(HY3
M4118$2HX>;+TTYY)J3M&<3(N69"#,!A^R(+5\  LV 06( $J*  J> .0NT5^
M4(UR4X82Z($WT"0Z@(+Y804EX(="."4'@"82,(LRJ0X:2#058($[D $Z<)0C
M(*DN( 02\)D2R((T^)FJ8 $'8 $9"($=," R4@9+8(42F E'D(!8=( ,&@G5
M<(1R0P*,\("K: #*PY5L(\B"-$BWZ  *N "%O(!',((XV ?(<((OL+: .<B+
MS*)MBXSXZ(8&F( 2 #44&(5-4(:(Z(,(*($8H(*$F \48*-;DX$8: DJ((D3
M.B$D*#6&TXA;L0X9 #4/$/^-KA"(KI@ )'"!$E"I DBT+)"!+@"#+!"E+$ A
M%T A%! *&1"!U<B"CHB"-Z "&=@']V CJG2!D*RE\7&R9#F.18&63L$G"^F4
M#S&%G^.5//$3XJ"Z#6@5," G76@'+M$"4\ Z+2@2)J@0G.L3]OM$LEL2XUF6
M#A">5< #%!DSNZQ+58FI8WN,S"255RF44=&H-B&5VGL^6(&IST1%2$$F8]&H
M7?FHG]+$EO&0N 0F24D4-.D!O92_A7*>8,HHY$B+PAJ5*RJ6N""\\W.^8T.1
M07FL2$$F!(&3;>F33SP6.Y&J@ (3JE++.)D38[LLK1*0E=J8@4D3J^(1ZM&Z
M0(S_ -+$O^HP@3S J@I9 UUP@PX8S@_9![LID#K1RP4Q@5LYD"[8 '!BFM\Y
MD[!" S2PIH4JJ"L2ON4@$_HPA#0P 9GZCZ62*33;O.@\MH23'O"+E#?1J;=D
M*!*M3NG1J(B$.P,=0T1P!+! BR-8@O\+A3(Y DBLAD<P0[4@05M ARTPA2VX
M@QP@!2\\CFS@K?_0T3_DCQQ84OXX0@>H@TSX QEX$Q. !$_(@CLT,+0T >C*
M@RU0AQY%Q%!XSCI@!3,5PDNP! /#"+31!4R  P^H@J#A,%I0!_FRA3K@K9I!
M!$NH@I59 4CHTP[P TJP!29P!C.=E$O8@D ]#C<I'#C,_P97^(,[N!4$V4(4
M"QA-6-3AJ)0RI0&W0=02\$-D,H%L"$.UD(=+. 0\<(4V@)"UI*QS8JD0<3S,
MA)0]H2E:?9:8TI,1B9",D2P.&96+<LY8N27[:Q7J'+]D+3-DDCB2\(@H\ "?
M$:,0\$BS00()4(\0J"20I$H6" &G%*/?$#7RT+PLT,6A),JN,!]<^S6UT+1+
M,C4)(($88('VH,G7V($NB($JB )6B,<>P(^MB  '*)\WB (46 21:R.5\ "/
M[ 89P,@?DH=>\ $-X%@AB,BX((,7$((C6($O,(&*C(L.>(0$$ *!A(N0'5FV
M6 $*2)"^\($D0+87^(*/G0R_"/\,P$ B'^H%'G#0BS5:@BP3,.C(!I #,F !
MV0 C%$"!4/B)'J"#,WJ#-^""'@B!GWB)8$HTD6L)&1B%$H"D'K"63%.S-PC*
M@9@ CWS;"7A;N*4"!P"0ZP" F$0E&;"#US@A8?P9VM *-:("5GB*0*C7$K#&
M;I" /X@"$9"#8(()/%&4F:,8X3F5+='<,8F0$:F4^:0GMNQ5_M@#23@1%"DK
M//BP<'(#+<@]_B !/(" J\-$F(,6O_L5RFR1-TDXE,J#$R$#2BH>S6VR0TE,
M2:N57=E0EM&8MU03JIJ3BYF\ZL3,=1FS7@+%F:H.V PF>>BEF0/%'L#<MJ04
MR<(RF,O_K.D9WU1$/$L$ ,1)E;\)Q<Y31;@#._K=U?E-/5E1$[;DNVW1'K:#
M7O.[%E81EI9Z5M%B*\::O6']D(/JJ0C8@R61(%T @U#I LG,"+O)O<X=GV1Q
MJK. *N/1,AG1!1+H @C#@YF# #QP V-1(GG8 R;P#SJ1!Q5)@Y3Q&#0+E:\C
M#JY[O_M#MC&A$\!+D['['JU[RQ/U$[^!EBTI%!*D4S^90#K]G1ZM!C%(1 $Y
MU#? @RW  U)X S>@A'GP@LW9P[,1@TA@  :X!T:P!!-DXW<9KD -FF9X!T;X
M@U"P&4]  3BPA#/> #'8@34P+T38@CT@!2PPKC?8A4B(A'LH_X5WL 1"T.*+
M ( /5+*7000/R($ZP%,G<%02( 4/(&/ZPL)1$3 \Y(\5J(,Y+@5&F((J>.52
MH&-+@ ! UARD68,UH!D]Y((@:X98WF-KZ0!9& =U$)!:MF4X;H%:?I=2Z"_%
M@65*#H5LP$(.^4!AJ-$ZZ6%HR5]+3,R8NT^MBRJD8\O8Y"4>KESXXP^_41[9
MA!@TV0>QBY ->8U9],I-J (4^ P6N(IN^$@;^@D7L YG=(FCC $Y$",QVDQP
M.X*:^(-_?%N!GMBKZ(K\V$6,."",8 'H  ,Y0(*%N-I'NQ494 A6 (XW\(:N
MV 18!(I%& ()>(H0V(0[P(@HB *!AO^"H]VA7JB!&FB":)B!)M"#!,"! D'(
M1YB!1B"#)0@,H4Z"XYR31Q!J(YAJN>B 7DB 1OC8IXZ&)ZAGMUB"&D!JGNV%
M:(!(JD;(%?@!'J!JM*" N5Y(#:B!)"C:NN@ BBS:#FB"8'!9GQ;L8$N+BAB-
MOCD/TQ"UCBN$/G  5OBB;OB#3%L("8B!+-@")2B$W4 "*B"!JV$!GM (!\F"
MD\,"@/3(!F@ #["'U?;(<;. 0M(TF!@DF_3L&T "?T8"&>A6$: 9K8A;UB !
M5G $%Y #.K #-MJ*=U;+[O$09-J2N.24EB,.#,D#O<P3H(FHU$41>6@'0\@#
M"9XGC,C+F!K_D;ATWEYMD1&E5>[)LB+."+EZ* =9UB8#D2=>3NJ1.F.)[B_$
M3$M<*A!Q%K78S.O9JO;.K>O@D,HL%9%JBW>V;^H!O8L*$:'R'@/VGO^N7R8+
M0F05J@C( 6^&.^+E$L<+)H_"J%[)+.Q-Q<,<D,QPN1?_LK]KCL(R+!?_4.3(
M[C"Q$$E)DQ[  \$B$ &) #Q8 X0"84;2A1,I\CG(!$=JFRE!!C3( R88<AU'
M/0A^B^J SE=AI[.J$WEP - #K_YT"VMY"_/,87<6\"=3D^FEU?>3N^[43A[G
M\0MW\=[TS//]OC?QK42@4^'HCP@H9<WACT.=!RGMTQNMPA\-A9OA_X4R/N-]
MX%-U* !73N4'"43RP@0R[J\UD=&88<$L'04VS<*;009#: -Y0.10T(1,8 -$
MW2T1K! ^%<%5K@)(>?53F$M#F(<(<%17SX0W0%0FZ%,R\+\">Q-7=H9%< -2
M. ,^MG4SZ0!1!E32L2U?IP$F2.91 8 OU84".XLWY+\"0%(-/(M((:]1>/9#
M:-H@XZV 8Q!96-0"T>0[:)EOHDWO&45!A[M?=4U6X;*KBQCH)A"\&_,+;];B
M$59@PO-7@9!7DB$'>+@HH H'8*&NF/A'8]PN0((MZ%9">A\9& )1,AL4'ATP
M* 2@5.W4GEC6EMMNL(>GD  1( Y"X G0@/^"+>!M0>B!06.!,S )U;#%(Z "
MIP"C+5#8U4BE$EB*-V#&(^ '%[!6#[!2\QMLO"AKG#T+&! " ' "/0B&MY"%
M&N"!Q'@"$Z  -1A[N%#9.#B"%U #'-B'O : LC_[L[@ !(*!*^B+&O"!)G@"
MPI@3&+ BO7Z$P;=[A"K\9=.+)8@&P'@"(;"V#O#ZQ<_ZS-<V$82,(U#:?V0%
M?D.!39 XAJ6"DB $%.@&D9,CF(@!MJ4">9 .*M"-H_@)K8!*F"@ ,#"?!A#H
MU7X*]0#NF?_'6) A#W !_GB@'8B-]B !%9B)?W6._!CIO"W)]&BER]X$78P"
MD1L"$0"WT](I3['_2U3<O&+ME.\%DW0P!.-81111$191E#W@$2!Y$4C@#V*8
M3+9D%?XWULX%"'D%!A8X4H ,#3(%>I@X:+  #8@"U^1A\I#@0'X(,RKL<# A
MOP+\(G:@ >!D 0 ?"1I4J%*EPI B9RJ,B/ ( )PJ-1;DF'"@O!XU"SC8YS#B
M0*-'-AY,2<:!O)-'/(:LBO&JRZ89,<I<2L/C5JT#$7J\.-.CRHO\P(KLF/)@
M2*1</2:LVW0D4:,.148,J? O1C)+"W@L"5/GR9,=O(ZE$1$F09L#D8[<N/9M
M 4B&TIA8FKA #H@(ZW90:0H9'F2ZUJPRI?#('E-[WH8LG+)TXI(;3296_ZR5
M7X0\<W3M43BVP!IDQ1-/)0@V0DJ4IM#@F5PP:]N[<!O_=8Q0L/&O.'%+-3QY
M* "\.\N2X3ES8 ^C(0W*+2#OTA8Y Y=<HK5J2RC@U:%+*_*((8E^!?A!"1N)
M;%&%/(C,@<P\7M @#R2>R$&&/'7<$HI,]HE13Q4%R$*)!%7(0LHW7H!6AR>8
MP'C'@7(D1,:*;6R GQSW36@+)"3R8U $9-0AI(FDV.+ 0@9* L8:>%"R!0F7
M'!**">A,.,4NSE01THI+OF3D+54 X <IEK1P)(@U&>B,.NWQLP0IN12@B2>C
MP,'.$5]ED\DB -"0C2=<\--A/3=@U*&7!=#)3O\)\J3C94@JF> AB(Z2PHX#
M3))&4'L+;749> ?)(Y-&!G5%4 \$R>>62E>UQ.1WA!5T(4N"70532+1B%E*K
M(3X$  F;Q(#"!%&$ (8*,<0 1@,N@!$%":V"(<$$* BZ1P@[D  %"BR L<D;
M7?214@]O>.!!"!:LVX ]'E!1 @H>--# !!YTDZP$?Y#0WAHE[, ""IO(0((,
M$SPKSQ$...)!'^FQ$ 45+B3K !@$=_-&%)NXP((+*'0@@P3K3E""8KVIO#++
M+;O\,LPPRR(*/XG-7',O5]3<VPNB_)/8$C/LTX$>P9"A<@=DF/!('">0L8(&
M">BPS]$\^WR2+T8D 4#_!SE7#?0,270 PQ/[*.:URE!KL#;;&M0@RA<[)^:+
M#1K4#8,>"<1A=LQ(G_""#7D_\84O17_=-^*)*[XXXXVK/(B9CI^$0A0-O!%(
M 4I(\(8E+J@@AP@>O-'#$00OX@(K;T00PQLEN\!/%R200$>X!+\!!AB$%$!'
M%!Y,0 4*@>QK,A4L0 '&NNMV@X(+4>0;0TA*[(!$""S0,00)*I#  B$E*+%N
M%+%OO D+FZA0 .MOF,_"&R&H*\,11PRI6Z^8&20?35=!]%Y/[A&E"RT@P;^0
MK&(.>&C502* C%5L "A:,$4$]H&'+NQ/)A%H54S>PA2BS$0E'0@15T3CJ@*8
M_P*"L6(55XR#JLAL)R:YH<]BC!.JF;1$*PBIU/Z^\QG2V&4AT"%,2*#CF*8H
MA$D$40D-0J04E7WE*JT:3!)[4I05#@0R S'B3ZP2PJUT1R9D0"!!0D1%X^3%
MAB \3TB"LA=;?80^CED+8_:W&/*<Y"MG7.,,KX-#C=2%C+9JR1X,08P(,.<E
M9XS #\G0!5T8 A)368,69I,T,F105XMACA_[B)%+UO$[1S !& R!# &JI MI
M,(5BNB";/2)'%S]\BRD8@0=!#:6*/:&!03YHRXA(1E9BP<A75I:2GQP'B-;Y
M"3$GXY>Q:$0CFJ $%JIP*2VTX9E3*,&=*.&( #$A$__SB)08M- *_(0B28RH
MT$%@)(=/LHF99"IG >J0B38X0 RT$$$)3'"@.S !01L@A2+N !4Q$&,>)D $
M@/BQ(D:\P4-F(L@&,*6I+2RB !%< AR6E!!-S%,, "H $TC!"%NPB0P;0 0M
M%B$8Q4@TGMYL*4$P>@@6B,@0;> 'GM1A3Q$<P1=U@)-!<GH033BCG,TD@R8^
M%-1FS&,?2061;T84B@YL  XIQ9#NP#*8BP@%(E11ID@BB!$/^D6, S&+%T.R
M#P> Q6PA-,X^6G7"?;@G+@-IB!=!59>UR&0'$E"")5 @!Y!)@!41X(<(-C&$
M0+"K 'THV1LV=# YR"!<<K#_P[+6(!0Y/"Q?,K! Z[ P 4>X@ 3\*)G)E.&"
M':C+ ^LL )74!P9ZT8$%L>M!%E@ANC<< 04EXP+(NG"$:V&!!2I@ 6DML04'
M "!=(9C &YA;&L1(KKK6!8 3:B"$$V!7#U<@PPOTH(.5K< (P>#N"F 0!S(0
M+0F' \ 2$B#?^=+W"M0%0'EUX+1>Z$T(O8C&UE2VA!JXUQ?J3<()EF"XM-6-
M;75[Q-K<*^ :T#<!!+ZN$QY1@Q^H00COO2Z(0RSBOD&NNC0(7@BBT(<>[*!@
M*'#?!$*PB"R (0+L\UT#)$ ( ,0@7TB00\WXD04EH X%,9"!#/@A@S?DRP,[
MH (8_UP@AQ+4M@<!HP,=0E&"'H A!)2;0 ,\X(("$*(++& !$E  9>$"P $[
MR)<2VL$/,(!Y74KH @H*-BTEA,#+FT!"#/8GJ"'Z\82VY$M[R.C'E;@G EHP
M!!Z@L]8U&,(0L^&) O/00/FD9C9$?(M>PO,>MN@%56A!84SJ4X \F! CI09+
M9:[S$U''*BVYJ<TM/_V:[!23CV=%2&[LXA'C@+$##H!.!A^"O\;H3R1TW E@
M.%),9B;%B#4<%68*@#^/A+HO/0PCJ'C2Q>PPQ" /2<A2&)-,4*D*+( IB6'N
M^QG(S!J'T\YC&'FYDO2P!P!=T,(@<U*2#:RA"S(,"23QX/]%,.BB"US+ 1[6
M4)(A>C"8)Y'A8\2R%#C"&S'P;N(>#&Z01&CA+1'0A20$HFBKZ.H($5B%I55V
MF4_3186 J0RI^+*=FJT$+2[#"4E,0AM7.\ $)-&YOHW4C%+<@Q$68!)'T=!T
M+ 1(1&B(Q#M.(84=":E#F?@&4CP$9 -%(A+W* 4#3B&"(U7!*$M J3I,  <T
ME*(4IZAH3G%$"K.7@A$B\,(*R,E>CGYC%Y%@0#[0[G<Q')X!I3A$11%8!RUH
MPS@;F!(B+!&*?>2@#LTH?-GK#GG$I#-1[;D/+4S1>,4O@A]HDKK=70#U0MTG
M$G57A3J:HHEQQ"F>MD=\W]M04OO_(.(4.CU\XIO>BCJ$WNZ+Z$$=YO" C( %
M,GK1RK#9V(/#[D0LRQ356&HXGT5;IU1]*0FXK>.>EVQQ*]7/2 RR@((^N$!=
MQ9,!&/A1+VPU( J"0IX'S)9*<!D27 MMT0$ > ^^>( 2D( +N$ )E,!@%4#^
M=0$=3)GW4$$,;$$W^$X%7@_SL,\.(*"Q(0&V4('!_0&[K L8.$#(+ (5=$.[
MN, =D,L.--<$=.#H< T/CI@/]LT2J,%\-4*")8#.L,P2&,%\B8+9$$TPW%?2
MR /3[,,)K  E'002"F$"A$TOJ &!?5C0!%C71(-\-<+/6%<'?($:FL 7T)6(
MD8&&'>$/_\XA'898B34.;IS9(H0  I9 "#C"&\R+ RS"!"B,"R9+F+E #^!2
M#\@!"<C!#L0 <_$#/Y0 36'3$2!!\@C6)M"+##B+'#@ "72! Y1 #,Q.)&)9
M"/B.!+  /S#)P52! ]1,#_0!"G"!'-"! ^#$$0A/%+0."Y2 '4B %+! #XR"
M^WB ,1H$6WD0JH&?+HG05B"0?*3%;QA'+)7"<!@"&C#0>SC:*D '&!7 *E1'
M_V $ HG;SEU%]D71LN50N.F"*90:?(#;"?D1?=05J'B58K0$NC5%#86'KO@%
M4M1$=R3&5R %DS2$J\V$9(RCKI"11HPC__1&B/0%1ER$H77?<?]\E1:!D*K8
MT&!\403YC[GM(T'XRF#L#TJFI%(,A"[A$B<AC3.R8RY!A!C51*J@T0=UAZXD
M4V+D   Q@;!M0!<(Q'NDACG&Q!*L@BY A$GP1FD F\JP!$3L@U%V@5'^$%O8
MBF&DC%,DQ@:8 AX8!QX0QTRPW#H>Q 8PDG#-46+P7$CBI KU1 A)QO?A4#2.
M570($Q)MQU5$45-D7T%T@ ET03I.A0EL@ ,0$R5U !-4RU%D$<]EQ#^\QTJA
M1!(E#0=1HG&LP ;0 26*!#_(1Q"1#F\@)"Y-!26E!4ZT!P <S<:E4*)I&VE2
MDK4=1$G<5V @D0IIQ-&LE+D]S0;TP&C_RDEN;  A(-.0R(]?R&9.Y,8'#>!!
M?!@;I<1@4,U%:A$'&444?612[*,_UJ4)"$5+V%5=UN-9A46LR(110 >N$9-5
M>.<7T404/40'E$#);$P).( (6((CH( #($$.=B +3)<$LH <A( ,G,0KRD$/
MS$X"-EDWY*+QC& 6Q$ /.,!L-.(.4!D8R( E6@ 6>( $W&"K0."&JH0#M.*9
ME4#-R(^ZJ,L6]( *?,\#L$ 5=)D'L (=E !.#($<J( *Z,2SU2&2QJ83F !W
M]4T'+,$%?,&'M8P3\$W?D$&53BG22&EO=$"5AI@L;)@&?$&3^J#3)"F:IBF)
M18[CT  8=*")__: $KR!E)4 D^7+$,B ]#B/L8!!#P# DB6C(VQ!%A %$CB"
M!)! 'VR ;V$!%HA +K[!&80 ":  $KS!#B@!&+!6&@1C"$@ "I3 #81 -T@
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MN@S6P[*6MH4@:HVL^[Q&NK;=AHF;E1\6;80ZTM6M?L'!-'*]"K3]A%!(7H&
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MD!WVH$VON+U<80LJ@1&T 4M!\(RGU$[1 0V^F G$!&<,T0N]( OQE :P% T
M&0V^ 2$X%0O$(!+8^,C((T[?\(4+XI"%F SD@6<B$ V$N  $U0-V]!)/,!+>
M01A"@1O>P8PCT M'\! HX0UE\!(0PPMUT1[..!5/P1"@U7A'\3!X.1+FL ';
M"QML&9=)E&E@%_B,]VUJB"/>SF> 9K?.2_-J!G8G3^\@XF2XK1 6$MV6Y U"
M(9).%@R480)\4@8(P04*X9.DY/\CWZ +^,&B' %?0,9J"^ -2  ,-B"@N80*
MVI90E* ="F -CB $CD!E/8U0:)8ND, 2!%..)& +W@ ;H8#4J&!3IH614(KB
MHJ#<L. -5*H')(!Q/> D@_:E8=I89,56:/H*"#"F<3JG[Z@*XH4?M(U=UD0)
MHD &8@ ,LJX;I$ $/" &Q,D%6*MAUO+E,F)0NB0$WNDCLJ!"!BIFHX!+"H4*
M\@, NJ  LEIOR2 +U$D"1"5F38[E[N#Z+.H<74 BVYFCUH1-2DYA4& 1S@BS
M<(HRI?-\3$0:*T=R5<A^*.>L/H(?(D"JZ*,VIJ.I^L>(R(ZP'*!WVN]I3,)J
M<D1;N<K__+"H-B-#(ZRB]_SO0WK"EN3G9\S*A1^(3S4/=%/D/G+CLGP)6S7$
M[JCFIHIJII[CTF2;:^:#1&0*N/5NMJ_OJY*J*((.=4I;*G+ [F2(>$;CBNYW
M]G#&+4QD.N4#0_'@)"*, /? %(2H 06GB=H!&2@0&<[E@HRCIR:D/"/M<2[K
M]>+#=BAP#BRT<^K"N)@#/D-K]D:%<?8 &4R![6!/=]4#;[Y+L>WJILF#)EXK
M=4#CA9LH\-B4%"S0K9C@2'&Q %C4 WB0$9#!$%9!BC/! @/Y%)!A#A@@V)34
M"3AU Q6Y#2)"1]L0,22@!7;4"''P$-1A PX1,52A%724 =! _P4=<1)U]!38
M@%/ME!0UXQTL\,PTHQ1*4-&$* L!E0,K>3.P_!34X<PD,4U?-0=0<+86@29\
MX1).(9+U(XB]Y@AB%0FQ@E$/84=IX0XY0152O%7[L,2?]0[<?!XRM0KDX1,5
M 4<385D+H /WT,:O",1C5!%2O-'7U"44>1ZR 0TLH0H2,/#RSD"H"'-#XFYF
MZHENLWX@C=,L^"JXJP/(;5IDP!+,R5P01=;42 9"( VR("9@20+<K=QRA^((
MI6:E*L^@8 -B0@8<P>*ZQ 48I[1<H -2AI'VJ*5C0F0=@!6X1)2$XAM_,JF9
MI)6HI%RGA%#&R XRHE]*8,SJ+:?E??_>:V():H"F;045BH7>^9TEA0+KI,4G
MLX1M!V4(Q(D$W@#;"D4"0(T?0@ )>J +NNX!W@ )IDPAMD7K'""KYU9>!MS<
M&L#B'J8FOO(-LH 0PD09&D"MD2T&RMD%NB$&R%IE^4$&C(Y+Q&D3P,!OP6@1
M%%=E*X)/?0^@+A,AJFAS[RYU%; NN$:S%?"H=(BS%4]^R.KI$3QFE%LJNN#S
M9*:O]D.T\T).[*(IBEXW<Z@]ZB+V9&B"6<_N?D9IY"%HY.;13EMR10(JFF+2
MG%,XVD(F6.:;O4)(F,.#L,MIF(HNELCV/&]KQJ>):.9D\BJK>LIF^ <EX^2Q
MM,NK^@_QIYG_LGF/?_GB>Y*"$ (F0<;[?S%W[?S#)3"X,TS EU9H0::[+()W
M<O_"ELRB?BQB'VA4N+Y;B*[3A./BNS4W(<S3!$R!%OZ7]L+F/\(#NM*7?1QO
M?%J*5,0#?HA[<BZ"9>J\#61"'J+8 JL&$8H8S=&@$'#4$(BA$@Z!!- A XD!
M">1 1^? C$=Q#LK "SKP#6\<!O^ ! "BBT!YZ-"<TF5HRYT"#)>(H81FRR@X
M:!2MP4,*S3<'FIK-09((VZ$[Z$J=HA1IBSI^2PI*V$."21=^#,G0W(".4:X"
M! TBW,*%C(E+&H_(JS,GEI<.2W9E/*2.C#RBN0 4X$>FP!(XC-I8_RVPC\82
M4EVM'D7C"-VI0LU.H6%7Z=2B2Y%*,4+V1H:?2FB0F&J[:"JC>071S+'EA:$F
M;):J%,A*DZ<8-/.(&D9\)*N?3HR0H&O+A6:'JP5H%.C!\+'JK*6O9HU04S5I
M,IFOH@;K(#49TZ9I9NV1=?0^TEA)IT8-P(&\ F DN)"Q"0L+%&]N4!GBPH,$
M1R&.5&%%I4"6-P\>N'CC(@8  $>H-.@V! ") E0<E-@ @,QZ?F_L3;!GP1'K
MK5= * YL08@,/9300 ,2\&,5(6!,$(@+(J!'0Q@>>,$/"XXX8DDW+)PA!WI<
M3! ""RQHUP, /;RA3 @A. ! !P/>B&...O_NR&.//OX(9)!"#DEDD4,*B*21
M2B[)9)-.,CE(%4QV<)X';[S1 PHBN-"-%")($8(+*(1@AP46A/D&&"R\H40/
M/;#033<A!+(("RT>$4)_(:! " U@R)"% T?00* +_GDP 0H%#$@&"5V L0,=
M,KC0@ >.R !A#Y-2H40WSSGP(@IR@#%G%&]8@(28(H0@194N/,!" 1T0ZAM#
M1S!$DU61Z?:8:;'MQMIMK7W5VJ*D.3 <0Z,54%MLJ2E+TZU9T4 &LL89RVQI
MR>YZ:[;#V<20K\_NFEMIP'9+4[JJ#4@HM%9E-2U6IG7+&F^QT40M#0*N=\2L
MM,EJKFD=W#I:#SG_T&!"N<2>]NNXJ=EKJXT$+EIC9.H^MNNN-(QFVK^LI?;M
MK03?FF\!R *7;U96644MQO*4RS%#5MVZ\+.9T1#9K+,"0"B[_0JX:+Z[6L7Q
MP.&"BVNOX*HL*S_4]INS;VL8@H> $G>@7VI'F& *'C*O5E.W!>QA2"EH>$V#
MK[72MB^_)0=GW*R1S4LQ>P! *&O:1^R!C-E])/UQ5EU(8@@)_,3L:P>0F (;
M>TP@DTB[3T^K6LDM;^QTP+R&.W2V'P>,>=T#[HMDKPP).]4<%CBP0AV&G)'1
M1C0P058;+9WR1R4FL5')(21<,I@#OLDCQAQO..!$\?-X88):;9@\E$8=_[,$
M_#Q3H7'(&I3(Q1(IIX11_<9(S4,#-W65@OX<[!3_30Y$;1'*4(QL9'+&#:$S
MQSP]R/]- 70=$HK6'48YW'@+*52Q" "8  ZG>-X*+G&*>?##8JF3W6(L00BB
MV$)X6QF,& S!#D[8A0W>4P<W&(&8C97O?*7(!PH+@ Y#?&,)ND-AN63ABD-4
MH5:I*> W9$$)NVRP-";8!0M+\0Y;B$PV#!G.S$C3 1Z>9A]/3%EI>(@:>-&K
M)CA[ELF.%JZF?>PK_"#!JB00@D64(4Q["L0;/ 4&#ZA( F H0 DVT0TE*(,*
M*EH4/\!0*3[2H0 AZ $8>L"/?97  A[PSQO,P/^S]9"!3TH@00DF98\W2* *
M BJ!"DH4@FYL8B$E*(0<Z/ &-J82"2AP 1Y=X (L8&$38$ !#1S@'RQXH 0W
MDMB3?@G,8 ISF#\B0R]L((0OZ(>8S&RF,Y<4)285@$L>\$ ALU#-.[A  A*P
M@SU<( <'4 $+8ZJF&:XB@S1P4P(H@),CD(":$"#* Y9 @0/ $($L1& ^=J2"
M!V2I2P^@H$4]H $)>J $%,C@#1-HP 0\( .3(<$#+AA"%!YZ!C"4RPX>B,*$
MV%D".,FIHW*09PCDD)PN $Q:KE%-<9)UK7]9K&,10$YJB@,O+\)&7K(A7A],
MD8<^9$%8JA%95LJ5E0W_X$$.JV'"&A9R+,C<E"$FB !-4%.<I,'T6;N1Q1HB
MVJPE($(+:0!#"9;P5>,L 1(1_=7L2/&&A4BE#J:H*U #%2Y?UHAF5QD-7QE2
MK@U$8 -LS0UK<F._P#E$%\1  B$8P@1$% (/B=#"&TA (QP5*RP,LQ7E=)6:
MW/@*6!U+VZP* !N M49=NP&9UN#F4B;NBEEZQ5&[LNK%FT51JE_)*:Y:^[&6
MQ:U8HW':;G*P"EVTR&C%HDUK\9"&/6Q@#W@@@3PNEI6IF<1K;J7-C8P3.)P)
M;+@V659I:JO;L96-:KCJV*WP8 A3],"\6KQ*!/9 &AKDP!3(B(!MOT(P<V6K
M_[?@O96\6(.TSYK.BTFCF21KI-E_,:0.;7E#(IK!""DP <.%2$0FT""!4&SE
M%&Q 1SY.@0E*T&(1^/M&"QS0VCI@XQ0@:8LVI((_\FDE)Z>H:U!)4)"- )$1
M;RA(]DP1$2 /Y@B^4)X?2I@VUVV!$O-S@!^H/(\-7,(D0 VJ#(93&YS,H0T.
M6 )1OD$#69!E'CE8S"G>@ <,8Z(8D5 $&$AA"&&$0BI$:<.@X":+9J#A#XFH
MA$X*X =!3Q8B "P&&G)1DN]Q0BYB*,4W$J,5LMPX IK((4G0,(C610*%)7A,
MIS%8!UUX!3C$.[2,;9AJ.TS:SX@622A2[97.<G6U?O\T#6<W-QM>I9994CW<
MO7!C@IL1VS@&3E9NL%F=34C 4]8L]03>L D+2&!#1W  "[90B/^H2#M@N%4<
M_S,!,/ #"?SH0Q<P50 ZA(";_=%.%FP4@2.(H "%( $)'($HASJ@ W38 D0?
M8*DW; $)W7: !.S!*DM(@ 4AM40JT1B*;H 4 "78MG9X6=MGBGSD)!^F+(PP
M@P2H_ E4++G+7S[,:#+)!==6!I:0(($L;.)*++ Y%>R@*6W^$PL2D,$12A #
M%W3*H@!GQ0YZX$__3& 3=.B##)X.!D*L09-HW,0FY"D!)$2@"Q&(00G X (2
M1*&1#P64)EGA@2&$  M[DH'_H,#P!KA[8!$AZ,(HJ G+-T0A%-2)08MZ9JS+
M9:M8UL*8YP2,M*1E%5_J(FK3NK@$3TAB%:N(2PA*;2L!\RHS3$A'K+J5#5J(
MH%P,/MH*/$$%T'MQJU<A6J[J<(O5IT86F3@#'O"0B3= (@TN<$#+EI".0&&E
M6RL@15D)09/7;SX/INC##@RKM8'Q:S<<8TUDAF,"4BB!"7@P?+BVFBRY,<0/
MGB!&'_! B2T$!@Y:Z(,N)&&*55R?1^)26;\$EBO&DEI$TQJ^4C-:8RRC$3,'
M6!H&=EX;0R_\(CK?%47/,AJ-=S>GA3@(IBZXE14DXWWF H+YTB\2PS=XT %1
ME -X_[ &"0@!:9 /Z!.#]V (>0 ).4,:9%,*AM"" 4@S/4,@[R*"%?@U+5.!
M:1,P" :$-0*!7: +=L%=D=<%^,6!B\<T5T@"R& *$Y@9/.,O7=1;).-X"Y8T
MO8)3BS<PG],:D2<P;9,K$P, @88^)#9P3, 7=O$'"W$]N5 \$F"'OI,3&[0<
MU'(6Z,,(%@ <MS,/N4$0YQ.#WP,\&]$Z;8$)<% 7!K$(3:817D &'V0+G09
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M""V2'R2@48N !!["EQY0;CSSNHAR485P!#T@!_QPDSO-D=21F-*Q3:Y$TW2
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M_,!^JY &U8$TQ758T9PYOS55QA9ZO"$NP)KF*0LPPMHRH-5>Y&P3C2I59 Z
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MLNR,+_0<+&Q>G=WR:V%AR!:#R+>Q R@2 J1R)8$0FV]@MA_Y!HL@MVM !SL
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M % JJ"BA 4;Y(:00$M9T1% ))*AS#1:4D6,(#UB080@[/) @!#E"P*(;/!T
M@PP'' %V@A(@NS139IMU]EEHHY5V6FJKM?9:;!WKX!'_(Q)(X(DDL%U! W++
M)3<:4<+-=EUVVW7WW6<5!18,!Y"HE0M@=V5!SC=(4")075D +XM-I'C# T=0
MZ*&$$M(J(0H\)1#!!1>D\& 4$I@[ C+& -A!!E:0>* ;%]YPP0(/HMC'@0CH
M*$&&$ )]8Y,H(A#, 252G@!5%-Z(8A,5H@A4A%!Z1F&^^D)[Z*'+!ORJ/KS
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MH03/:  5N$('.O0 G'-"@J>RL)82.$("W= H/^S@B#S)H57_W6!!%:@@ 3
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M%BLB"TE(@0FWH-=N<P .012D .S;_RXMI+ $Y3I@<@^ 7 [JL 62' A^87#
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M-UQ<)"6*DK\H$.[1*>)P#TMABQ7H @,A _=AB-UP !;:@!ZHCS;3+@%1HLN
M#U?J@<VAC_B@$33:!]@SH_E8@0@@A,UQ"+[(B^PP,=@+H\US##FT$?' CMY8
M@0TH 2Z)@!XXBP[@4?TP(RJ5CLN( (9PC/?@!TMYTB/0H=FHQ:]P4@=(D@B
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M@(.=QG8^(7A*L(6T>&-D_;=BS \T(D,&9>HN#XK4$ MR@V(&YS>H63,<;_E
M'?GB,]4^L(00$(%]LH!Z\ !>*0 +QLY/*0 4F!.4V@I^4(*2X0+TV@0ZR+H;
M>.N#48;_'3!,\6X8!]@#&5T3AEE+$C 6BNL&?@ #.N""H]\7R,X"L@ #2Y@
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M(QY(($$6KKWA ;1O;"('"K9ZL D))11"0A0LA)"%$C>$  82NQ$R00,3'.$
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M]3+CF-"I!'-S:53_7:CG.:=LI(3U+&%5GAB!4'F$,@4X: %VX $1R*%M'FC
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MD(<(I ?[" OJB),%)+S_0:>\I>P;9-"SU)9KL&Z+ C_Z@ 0[(,$%1 L!"^R
M A?T ;)KX$?;6,$*=Z4V:UK#VD1'NP,Z\$->)#!7#][@ HTJ81-VV(02^E"
MFKH #$, 0V+=Q;4=3):P*4>N<@'0 X]VHP>&M"O=ZV[WNU<,K4F8:R^,D( $
M-&)D>!\\W?&*,C(0SAX2<$0$E. "+G#!!=&20- <0*Z_/?5E'E#&&V*@A"'8
M2P1#> -OR4Z(&$@ "3TX0@^Z4 (P6.L-L4!J:?^&M6H=EP1T($%2LO"&/[ @
M[&X+00P6<5D6H T)W>C7%E! AQC4J@P@/6FT0C $%;# \<))2D9T=Y7*[5/"
M_QXQE&4L1Y;A:4Y_D1%+Q .U0H6R9)\??\P^H >3@"($<@9<"_7,LN (_U-_
M>81+ (H2S<[Z31<!&A  98]-=)^0!052J(_K1 7QB(0\+(X\+<1Z,6#N%(3Z
MQ%\(AH2!.86D*,1(5-AT<,6@%80\*0IRL(0 Q<5W-4["G9^?B<1YK=]8*,1P
M6%% -8Q"79 N1,#F1$ ,'0:2(5%=H$D?E (M[(%+#$?SA,1E*-03S9.$G1A!
M/49Y6<X(&400E8(6&,H_K0$Q1, &X%"9@0$ 2<] ) (,%10/*DR%&1 "&@?O
M*-3JK :@E%_LL$05L45#:()Z' 0G\0F%M$&KT4<'=/] '6A!&""")9!)*YT"
M.UP",6!"( W)':1#A:"%JGD20M0;F5!3&PQ$!S"!>824/#!!)K1"BDC '10
M&VG!/#Q")^4 0SB!*)%')3""+;1  :22.I"% ^3 !JR; PB$%[7"D 1<JP5C
M+54)(M")<QB$)C@#F6R;*[1!#O3"J#'@P!T"+2I;&[C((M2!,(B '3W:,!6
M+$@"%S '$VRC'3%!,\R2!#A 4F0#O"'B0&A",\R# _A!.\176:B7]?R37$0
M^*G&XX@8]PE0#*(.=3F&I!!0650@6?0 _"E1B@'/_)W%SUW?26&!(Z! /YZ4
M(X2 10'7! 1"Y[U!V[S!(K#_@"6  =LD%1B<0=  P!$>P=6!S=_<E#U,5 ,\
M2TW2P:P4  FPPAO0 1@X @M@ 16P0 ET PN@P!LT5@@$@B5X !UHB[4$P@T4
M@ LX@@1L =_( ;)0 0 X@%0]BPQ\V%T27E[JY5ZB3 =\P5QAA!,('E\2)LL8
MWL8<019T0[7X%1(\2P@\0 G( >EU =>$@ 7(@0N0P.B5S1MT 3\<EF61P .,
M7K-XI@.PC0S$DT*\G@?\S&AAE"5(P [DE=L5 !@LUQTTW\K%U@1PY6<Y7B#
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M(BQ!>G2)Z#@:-JS)DYR""(@!(2F$,F[!I=9!)BR"2Z2(!U1!JSE)*9Q"*^3
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MY1>8P!>8+=J>[0DTH,1\P=[1!!G\Y=C2[5W5IL: 00AL JGT0/!1U@18@A(
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M#V#$%W T6YGZIH]T26<,&>S 8L9,"3B4M1!N5M*,"TPEU[@ 1<'4ZHY+#\B
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M.CU@P00:5I+4>0PX.Q@(7[A /*^)>Q-]Z$$7H! "1P1" G;_"(0,/E8Y$7A
M#A)X QV,FH4[( $)+KM-;F[C !+(H!N;.)D=&O:&/X"!"@[H 0 :DAH)_&$3
M3^/95GL .I.DI%1\E?G,:4Z37LQ@!D;X@1Z:$(T$B&(?/^F 'MRJMYDKT"=&
MK/E._+H5%(0 ;!Z( ,\R7E..34"YA>5'";8NAQXT+A"L\  K++'<$N#V+"%P
MP1"H4 (RD, PC4.!'6+1M1#,1ADJV!A"/(8Y&1SA=47#W!WN[H N^-MYEV.!
M'$2R=7ZH6R(GZ0860K"(36C4!;\T"OA@>$SBR"M*?0JV%-_7'1^1C]@.<J6#
M)>1#&[6XG?$+\ PEQ&CJ OO!*SR4_XN9J)Y?R3)2B3ZT-+\+)U]YJH:^E(>E
MF44_5%L'52I6SCUWS<T!^>A("E2@[5]]Q@<Q]SUYRJ&%#5A*]RT(6T4\0B%Q
MDDW\G"@Z!U*GMCL9["5O:CP;T,4JR+.!->R!D["K.;I@#_9@F++C"!8%&0BI
M07Q(]!P0/7(D HR, :P,RVC!$-:@"[3@'71A'Q8%S/;@C?SOC;H $A@IC*BM
MQMSLOJ)L%00I0R#A_["D5G2M '8 &?;@2CQ,4AZ)AYA#?\3'5M@G2)+/^6;D
M,7(BF^PG_H($ 7WI !]MUJPKU<"GD*1#^]YI@[J%F23$BK0#6^S'0KQ#^L %
MBNA'_J0C O_XX_9@34=.[] 0"<_><)>>C=:8R/MVA S2!7W."89V18;VQT%&
M)#R.C0T?P\*(C%L"YIPV!<:P99D0,(E8$$!2J N_#T ZH ?,8P<D  DVP1&,
MIB4J0@Y(X @>SP%$*Q0^Q@XR(F/BB.!*@ 4D0 0"X0YLI@,ZT0,6P0,(;R)*
MP /,P!ZZ)F1*( 0>P 6V( 24 PP:!@4<00)BP"U^!7.4R@)<("3D@ 5N  I2
MXNQ,HFA YNY<P!%<!P#X(60:X W29NG:T1W)RJYF8*[FZ@>"3N@>H09@X G4
M2N:6P ?^AB96X M "";\T>AD@@R^H%EJKNFPXI3.PGD<("_>0 G_""X$H.YH
ML, MNB +P$ &8@MD)F "HN 7B"<*J( 0^$$&6,"V2" &>J430T"CHL WGD>H
M0H!R/.L!L  +J$ RLJ  <(8O-D$& $0&X.(BL1%DP@(%+$ZW)'(R1&<DJ> .
MSH+=A(,X(FR!=@R&-(G6PDPYG"LL/44,/P6>5FE3Y,0^8&^@8DA7'#&&7FE/
MJO">.$Q': W:GN5+&.B[>@]1^!)!@@]6:E!<W*L[(I&]ZH4\F&_7DA":%E(F
M/H,Y>F"85BR4#"U!OK .P6=(Y$7#% PZQ'))C(-)'!,F3HT@5VQ),)/!(D3!
M9.5(U@/&!/$)N9)6.D7_\N!^F* +_ E#__Y25B[E'M) 4\;/OG)%3]9D#@SA
MR0H #^YAD$S % 1I CLP L! R*S( :S(C1IE+H<EV-(HU4PA'ZIHDERS0L;,
M]\@ #Y"!"5SL?&S$A?Z)E7:HOP*S3O)3Q&JEADQI2<B0)E9,-:NK.S3M0";-
M,N<%-"<M1N2(TL#D/UG$/$K3)A#J3XZP+>\E-GO@?[ZP@MPPNV3%0,)E!4=4
M/P>S2C)MO^Z#G?RG]AHL5-PK@YX%O<[#5V)%1GRDS^Z3?N3$7\ EP$),7")$
M,X<DNP2Q /B%#!1C EXJ=3I.990@-+( "1S -T"F)<! "KK!!90@+K;NZ;H&
M#,Q#9XA'L.[  __ X'*X@"6PRF580MPD("5^IVI:0SJR@'A4AR)80N&*<C!(
M@!^48#)*H@&XQAA!A@K J@LFP!Y<0FW>$5(C]6U.X M,P("RXA$:X0260 \:
M@0>.B*Q\H0EF0 A. $3(X 74  <.L@,ZH EJP&^6@@QD057M<>D:,BOZP"*P
M0 (BX"]\@[06000VH00VX0VZ@'D<80=VX \D@ NX8 @.522/A@Y(8!-^!RA+
M( P@DN BYBRZH2H-0W4>8#&:![?X@0X4ZPZR('*:QWDV80A( V3H(*KZH 3
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M,B8@(R[B?D-A"R0 #(X <W8@4*.@"NXW:FAQ,B3N'!V')5Y"4G>8A[%B"6P
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M'&$"-J$!PH(%2J '_J +HB,$)$ 9'"%-[P(,[& C_V:1\%A@D26 @$T"#"0
M0%A@!X[  ;@ ZSP@LUDBJ5#@!I" ZY3 ?[,@(R9 &0KX#6Z@"EA &53X\23
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M\44T8*G:1N;B'*NU,#W$P0M,D ::/DP 0)L(P290< 06["!@EG!5".IUHQY
MX0VNDH$+7,""<=E+#DCT@#W>0 @1.* $*"B$'-*0!>T4H@2]2D,HMM"''I0@
M!CZ4XALL 08H BP$*.B&A,95JP+0H1!:0F*^1@1&$H1 "B'X410:!( C_!%
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M>I>T"00L*U,(5H(Z5*<]\*G^:XUNJD.]M+6&@)V!G-R$AACQ!6<O_U/=SU]
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M[)40.3 _)\,7K>%=^@4Q&S17Y - +1-]W!$VCH<WR!=>_6-3DG,U^K5;"U9
M#M$<YA-\Q?@8J)<T>+$R.9<9@Z-=T4%@V3$^LN<;'L<772,0U(@WS;$1) 5
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M'L/Q4S;3 TOY<S#!$*A'?"Y5EKOG-1#1$^D1+:P@ ]T@!1FV83O #__W!H$
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M 6\@(BHZ 730)04 (,ZD9HK4G>"9MFK[2$LP#77VM@D@"O'I)BN@!CK@:&0
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M#R ')>!K!*A#44!BP]D@+' (Q!2'DBL"-# *2$ "EN!D*BI'$V /CA (A-@
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M$A$0=29@P$&'$%V0")AE$Y!@"(:P!N3Q55./,36UCHA77]F*DZ MWX"##&A
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M-L$"Z,C& EC  @H<Q!&*44Q!&$K8@ER&(&D1:(P>FA2[5O0B8-7)3Q0+TK.
MU:"+Q:M6[!I2B/JDI##Q,4(1V$>Y^,&AFJE)C]K_6J.%5C5("^'H4/YR4H8X
M-*\%U1%8'(+1E0;9((+Y\5_2&I 7U4BB+R5I8] 2%2C_%*$#I:EDSZK9D5ID
M)37Y24JM6E.\5J6R1R92EDJ"HX],@8PNB-$$$2!3N2*P!SSHPA1WC$ :2J$+
M:"525 =B42OQ-*LWV8I5.DNCM 1),5.24AY]R <QNM!*%D4 $JLP! /F8(IB
M=2@1U.0)(=*@BT!.ZY&'0I.^H*1**=4R8,]Z&(MRZ<94UO)6*@*7B42%(CBZ
ML4QE!-,>"U C.;D(1SMR$R2/U$]=A;( F#I41T<D(GELL6&Y+)=#(Z6P7&(S
M8&*T4$<-M: >D,58?H03_UDB5M%,+=2@%*+3P[845#IIJTFY&M"0VKB/%LFI
ME1HZ40^T>4=^7%6B%H(I#>BT@]]X@!5R6(0,'I#"$H)A"VLX C^,]@89. (%
M#Y A"BR!A&Y8 C8E<%P)'+ ).?S!-(YC7!5<^(#RE* @6' !$CW  CF4@ :.
M<T!9)T"WVCA0AI&=0 D(M(6V 4B#4Y1#$CV@#$>\H0\#40(!)S"2X_7/MIB3
MA2@. X#<TJ475]@M25X@BOTM80;[Z,#HE-<!,I@@=B<@PPHTD  =W"XEPPV?
M+YIBDM\JS[A)\!Q6.M?=E$AW,(*9AB@TDQ)?P  G>M!#$X00W+J<I0:<,XD&
M@O\1W28D[[9^60(.T*<2)PC!NP)V7H'[\M_,_2]S[GG#(C;Q!D+P8Q%WF.(F
MC&,0"6#89V  L0..X  :;"(4)9""([K1@*B19XD# 0,+7/N&$%!A E%@042<
MXP$/G.<X4 S!"F6 A!@<1\150"!(H@8;991@$24(!4=D( ()4&$(<HA!"*+P
M&RFX8!$B" 4510L WW7U1-N2*BO/[*T(J0Q*4F44ADQ)245VR))D]&:_'" /
MLI0+5J#4D"@SU*:,96Q'F%(8*"5&+S(]U9K3TEF;X_4@8#VR3?:2M%/W1.B"
M+8S2&0)F*B==(9>Y#*MN*I%2*VE+1"[(6HM$=:U4UNC_;MK(6F@<$\HVM*YP
MF0@/R&A'-?_XZU*4 @V2,$47*J0C4Y1""\I.]8R@Q2@&[?J.T.K7DHQJHQZM
M\MH-$I:SL\0GF$6@#VA @RELO8]B$F@#NJ FK;NE239'4D2Z+M2U@<F3,[:H
MF@MEZ*Q2+;")2MJA,657H$Z-HH>NDD#E.M>B] U*2/54EPXR%IO:7$M_NRF@
MAO+C&KEI(6QFVTPSVRB?VD5O2*9<6K>B$)\1-=!)9FQC*8JY''N9[1@1^I8Y
M:A6AUQC0<@'  2@H( HB$@5'6* !@$4!$J@@@C  X @]<( +'$""K$D-)/)!
MP99*<(:"C.<-F["$"[A &SG8_^$,%I"#ALNNC,AF5@:+Z(.JZ%##C\"F&V\P
MH#(H:Z#=;($%)J:A![;08Q?<0>N;<"Q)8'B#"8R"P9?WC!,JTQ?15>\%>M"!
M2E9@A&#T17UQ($-R!XP2HDS/]5?0"DI&SQ@R1"4.0@@+?EE_7S*T-PY)@(MR
MRQL8#>#%!H$QS$K(<!<A1.9RLHC#@@&0C>@#@+R8;TF I8^2YB[7>M@7GX,Q
MUP$6*%D"/4"!!&#C0M:(  R;"($=MN."0-@AQ];I!@I". ']A^0-,2X!U8@"
M*\.Q&.L&ZX@:#?.P%5(A,%@$*F !*=B.VJ ","B<-WB&$"*-"9@ ^'L#5GB.
MZHB"'?]XOS>PC23JH+^+F@"A- ,)F(99(PTI)X*JLSQQF8+Z)A%I*H:". M)
MLTV"P3+BJI#RN)0;*3@*E$\3DR\YE'^:-P6!N#3J)2.Q*3RQN$P)J1YHJ37;
M*#(X-9L!-25QF67: #J:-#G!*@[!F)83*DA;D(ZJ-T51D5:2DU^2*(HYHR(4
M)$(Q0R?!02*4)8JQ*7.YDG59 UU8@Z^*D2[ @S7H A,X JU8I0Y8 W1+1($*
M)28D&9%;%%+R1%J#-5EJE'SSD#U AG2+J"^)@#4X15W8@T*4$S)H!UW @U6!
ME32"N'RQMS2A& < %#^I,ZI*EX@9-6D#J#8"*T>)ES;$*!7_"11,;"2,0A@V
MDZ. \9*0TA"LTJ9)XL9I^\%]P)018;AI,2@F>220T9=_2J1PM+D\V9@OS!B>
M*KAMH1"7J<8(2*H!.9 FW".A I2&BB07&2E4BA.#41$8H1 XP9%)H8$LV *Z
ML8 0$ 'C,(YNB (EJ UE  ,Y&((F.CL>ZP86L(0)R!J$Z $D8 &@D3&\Z2#3
MF #!XR$1<#^2W 0+L)I0H#&Z00$E> X6(,FL24E[: "L>8,SD $<VH$_V 0[
M&(+)DH(D0@$/""&IH8(8Z( C>(-84(9N@)S: K^O9#TUD)Y&@ OJH2^26 (C
MD!Y1H(KD"H;8.QXRD(?8V8<36(&V_^")R1#+!)B!).@%-> ]Q.C+\8J&HFB$
M_1$?QY">&1@+T5B!)V",LVB"*X"+_CI+OS@)T?"%)H@?Z>L VKD"Q!P?']@^
M][$NL/0+\;L<?G@/D'"$+D !$8@.Y)@P9<""40@R_GB#(5"Z&PJ!EZPAXY@B
M%J"#(;BQ%:(AMI% .4""Y.#-@^ _.^C *-B$D#0.QJ&QO]L$C"2!XXB.0 BA
M%9H/&5B:$H*-(7@ &;LB+5.[16"!)TL)A',2>'RY 4D2JE(YC$JSH0O#"LF5
M@81!,L'/0A,U%4&7;/NF'128?9"Y46HE;7*X-O(W5\M!J.(IC".!3LH3( &E
M-<P5J6J0-?^@!4-XQ20T%P4E YR9$(VSPTAS1R)DLTWL)8E;I25Q%T\#QB,P
M@:1RF2U!*(.\HUXK0ILIDC$B U)1MW9B F53%#79PUOI F*8)C_215:*M''I
MD&PI2&G9QTZ$N'0,4F?D%4-8@UMQ "98!30P!#QPEB ]$AI@Q40TQR:=-OZT
M*$7;17+)D3TA$#AL0ESS.&[ZDE:20U1Q.3)(Q9-:1E1"&'W!F8!DF$++I6J,
M0VF,. H%&$5MF FMSS]TI3AL$"WM*0*1AWRDDI"KM9!S%F%[4583J$RJQH<Q
M0H%IHY2Y$F8\$!]5%S3I(WT)M(91DR3I !G8! G#FX*(K(LP3LG_.3PZ8 $2
M^ T9*HWTY,@;H(-"L(--\( 2,(\@BR#LF  YH (/2#\6^!N?G+ 2B +$6020
M" ,L*(@W* $JD(.X4P8>DZ%8" $ZP"$9L(1Q;3LYP Y+  ,+R+$AX *Y(8D6
M\X =L!S4A-BJ< (3*,VG6((+<+ZZ<(+Y@0DRV-CO0XD.R-C.V=C;&KT$T( O
MH  8F '@$HVXD)XGL,MIP(&*U9PFT(!HV*_.Z(7'X!PG: *:K=@5X$S_*@E9
MJ!W1C%C,.XDAR!I[Z(8>4(*L\1L 2<D5^DVVH3'I% $9. XZ>(#88(&)G*(H
M8!S&P0+ "S((>C_'T3"W#8$%,@X6V@XJ_V@ %Y@ $0B$THB(XY A$^S.$[*.
M-\"(UF@B%Y""Z) -)= :^8B!+:K#2;FE5,+/CLLU-^%05SHJB(N 2Q.I1"(H
M0BK'0H2D<9Q/C.$FLK D5W. 3D*Y?-M#?SM'3]02(PF1+MV''#BI57BV2KN6
M0I,H4ZM!5I&'53 V/'B2.L(IF_N2<=NUE^NED>NGEJ-=1LI/4GS!1"DG#1FC
M%F'(C4,D@K348S&D3ZQ!'R&5-."D-=@#C8J0#=B ,8F /"@%28  :/PF@HLD
M+(4U_Q0Y@$L5?TDT"LF7"%B%=,*4(MD#0Y@F$N"C$.F"2W00/# $94NHD.L4
M_=67'CBD"0TG\_^%%!B-I2>)Q0S!D1OT1)WS)E7Z$=$-2(X1R/^<3T7!)%$K
M&3\2.M#]M$P3$[#B."<!*.OMJD8JJ>>5MC.*  [IW.DU4=IU$Q4UT$F5%D?*
MBDBR1Y>;1%99J"LD(UF1I/JTW)S!P0DY$'?ITD&BF#Z0&A7" @DLB*@$@X7X
MH+C=33J@@A/Z&S#@ HD<@B"3+"=2AB3"&J-A@4"8 !)0AD5@A1+",2F@@M*H
M,;PM@0A3@C>  @")L?0+@2RP&A8H 248USA>!$<P3A$( :_%B!I2,<-+$MT,
MUZ6%Y5B6Y?Z1A00(!KHP$#5@2\QQ@B^0/I#EC.6[@-WIC*50@ZO@6)__H "?
M]5B6I4Q@GF7Q(8$H:("/D-KS$"T+@R(>XB$E2%P).\I08,U#)H$>F.3KZ#$6
MZ@9E&(+] #QXC4 ),-L 48'WDXTIZ@8I,"P+*+()8 &FI!M'P((MR((>Z"&,
MH ,'(*#C&()%" %LUK\'[((1P[ H6"(2$59;HU32I1%JN5R#*Y$_DY)'/1(C
MM4-FI$<W(;0C.!D6;CFD6KA1RB1AN[:'TQ-Y\Q: ,TA^, 4T2 -,$3IQ(<(=
M5),V5)">[I42#<-M6B5!(2BFGI*F\C>6]C9(B2A/FJ-"!+D+[A,HA)9LP3EK
M@S1(&\03V0=3Z-T-69@S:Q)3P">2PP-&6%-J__2F7]0V6ZLF;^)"903=@HN0
M!6:$)%61'&B'0T0W9, #)N6)+D@$#8F 8<JX2@O3(GR8:;QKG1&5DM;HCWXD
M*<[!E^N7"ZY/-A*UGXO0:DH1.'*D*P$17=V3>>%$HRZT 36T:_0V(IRW>L/1
MD>-@>:DU K$2V"Z0; 3#!LF!+[DU6-1A?[RX5/7M5&7K%];=E>K$A_H09I22
MF.Y!$=N!N/,"!YB;/OB[298#"9"P]^17T1(:*) !?BAO&9(<*K"$]/O($/@#
M<^7(_9#O&!@"KH-6&/+)R%H<#.N&$@A)'I,<)/*"H_R#+2 !!ZA7'E(Z"?!:
M!P :$G@#HQNL"4,!DO\("7O((KB$RV@F\1*?9>@A2Y(PG12_K5Y8+_Y9OEX0
MC M(9I6 "K6<@9TU"_A1@VGX@1HW<=7TC /9P&X8@@)H6\$J@"3Z/SF(,1:Z
M@QPC'#K@!S H!!(H 2CH@C= (-B( 0^R2',-!!62@/<$,@N032YP@9HT6.2@
M@C\P9=OP ,?K($>8@#?X@U$@A!Y2 B7H@1[@UR$X/)^L#<"*@BPC!/ ^O#?(
M@D;J4M(-%U$!$G'$[?YT--N-N-(M1&8DT!2AT2[TI#V\F):6EMZ^&>=E;FG[
MTDL*D1Z,%40!;D#" S5M7S^:=,PU4&=4)3 P!$L$E%+-]/RMI#1"R/"]55#_
MNFKJQ;46.2,R <)._#=-QUR*84+074.3<A4_S%\!CI!?*R86]I$U2$1(R ,2
M,!)2R8>?IK47_-$5I4;JU14?T2D? 9=8 <(S,X%F0P8F<'>!(9 N@(1TJ'4T
M*I<-V*=TV=6#.BJ[GAC6!F% '78]J5, G=&",UTPJ4*!U&E.GQF&,?60>IAK
MIU,L%DB9\<0<;L8<QI!QBVXET45>-5^0SZ4[J9)*,I86Z:EP0A./R<=;J1$D
MW'9U/-0?F5TYXM 9G?DPF35L6Z./1U739G8?B8'H .^Y^2 /H -ED(&#*$[*
M4IH"0((W@/ 2(('-^HW-@BSU6X0ML(,W4($H* $-_W.$%>KOMR\_K9\P%UAD
MYE@<C^ "L_( )2AS!Z L";CR"" <'BI61U@$%"B!WU2!"3@"P=(P"8B!(Z !
M%U"&CV"!S#3QSP?]I?V)Z'F"G!C,(??EY6H"'<\<QZB!)VB"'V@"L9P*EOB\
MRKB,S #9&^?+T@O]SP@-\8F!C_ -.JCDQGT#^2OD!WB#Y%"&,:>Q__-:3XZL
M #&.'*.;)J(A) JRV: "%( _#3,-4P8\%[".GU&ATCC $"";OHT.J7$!$@B$
M$W*!L)>-@C4-^D.!)(J";D@;QP4(?@4<' %0@ :9@PD+"&18X"'$B!(;%B C
MT.+#ACT@4CSB,"&-?1LETO]P6+&B X4F,SY,F#*AP Y[UJS!LV85G@@G*9(I
M^7#DQ8H-3:1L^7.D YT0/9YDZ3.HQ)8(&V),R%2DO!V&&*4;N6^H X'[6)JD
M&+'#20?[0IJ:HRO-&K(#OT84>#&"J35*'ZJ%V9(IQH/[BC*L*I=EX(HT@C:$
MNE!HTZ4G'Q_D1SFHQYX)%S8<VS(HQL63.1I]O!F2%CQ&(5K$J]J4+A,]$B4J
M70!/*4-["F1F/;FW[X\F>SIL'!PJ0LAE([/NHJN4%L_!%U(._+@=LG04H4)=
M'=%@]<Z1J4(4_3FB8>HF2XI.S#FJ0>_G2S=^[ #C/I /,VM$#-ER1&,)=)]9
MW0W_9Y18$9D H'AF10718!N1P51ERBVW&6D87B;17CH!")%./BE'1@\YS,>4
M6.+-1]E*4JVWTVIC^13!AR=U8-Q )JCTWV@X^H:A71"!MQ]?!70 AB-O> "&
M!RY$H<(;+C@2B <H*/-&"'U,@$()RLA1@A*L4"&''2ZP$(@($L3@@1)@A+")
M$BQ$(4,(B[C0  G*N#"!G$AL$H(+;X@0 J >E- -"B%$T8,+*+@@!PH3O+&)
M#&_$T$.4$H0PJ02;8/$G"W"&T,T;FCJ2!0  C*ID&*FZ^BJLL<HZ*ZVUVGHK
MKKGJNBNOO>+:02_1))# $TF0T>L2PA(KQ FI=@"#$,?Z_YKJ$C4DP0^LS^H@
MK:N^/)( #OFE2L8C-02#;;9+Z%&#$/M08,03/' [+;VQ#E+%M!UT   *#4PP
M03<]#+$)%XL,8<$F;TCA00PN[,FF"T/((0<)2@;:@,.4;L(""A* @<*2489@
M1PAR4&%'E"YXC"B3+'3C0LDN2-&-"&]0X<&D-LM@YB(BE&'!!,K\&X(,)L-)
MZB9@)"S%!"'XB8((H3I04@_ZPHC>9)8%*5 / BIFVGP0$ODABR8-AB!$(Y'V
M4T8;U+2*+LB@@08RNMBM"QYIK-*%410^-A):VQ6@=E#[Z%C /AZ^-QJ&'P'H
M%T1HN0AB#W@8@HPI?$^T>0'Q2?_D=4-'D"%/ 1&L,@=LJ^C8^#ZD>Q931A'H
M,D=<#[5>UW(0.D"Z@W9QUKA\9C?U84,E-;@08-QQCGN-][48'%F:%5?2>\ZE
M$3L>?3S6AR[[D&#*'F28LLI:$>UA2"FJ/Y7[2<GQDQS8/_8H'/V^!6X:@[?=
M8\@:U/-&OX]L)R(\(&,WC>O.100B.@LQ)B*$V<Q3#HB> AEO)8][B/_(LYP$
MGH<B^Z#0:BBBE*( +S+2(<]B*+.1\C'P<\8CSH.  KFQJ$5X9WM(!(@B/]\
M2'+_4TQ&UM<X@R1.+(3Q"-?&LCB#]& OJTF(071RMB 5!W&1V4B-6&09$1&&
M(3)<R83_!A<5GK"$(CW0X=8.9#O2*) ,*3F"##:VB2ZQ0 (N:-*;E/0F+I&
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M*1 #&LR!%N0!C7 6&2Q$_5T(:PC87Q@%87C&A#U/TO%%#M#%>R!014X&;)
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MXG@6=0A$!-BE6#@1: GE\&A513#%1D3 A['86\JPBT$(-0?R.DOS,3^10&P
MY-&R\\V%PYHL.5-=(%^0R)X$77BF61R)!'>#"E!!&X;*Q[% #S#*%NCM*)5
M(?Q!#Y# $3B # 0H@ZJ;/0"2NCF"!+B2_<I! :Q4O154"<A!+]'!'92 _([O
M%$I4DH2"!!0"(>AA'6Z!(U !G4B "&P!*Y1 #RR"I$&A Z#  X"!!<R9(Y1
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M--;)XT[ )F0!!2.NDCA"*3D4"3@A%=24I#VP/RG))B!!E494E=2;Q(> /81
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M8.0)C_'.X:\>5"4^@"QDN[GHX0",![(>_/.O&S# 6.N--Z(8P@47Y-A!@D+
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MP@F40P8R_$\([P' "GZ0G-4X(1@"%$W\'C&-1NP#-1VP07@LZ+[:S*<^*&C
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M$(6AY "]>+&',K 0@DW8:'CG>](1,'2'$DS(!5 42%),>R 6R( .H>!'G@#
MC^4"B$'.)0L5+O1AKJ#  E((10E )P<'W$=Y_HG_\8*R4!":7 FEYEJ:5"4I
MR9%5;0/1RHE6MUF +A@B#UV0!ZX4MS9SIFR0!=G#&A*Q"D.LX:.T0 ,8]O%6
MG)ZS!U>[";KDZ@!62:0'.3"6S02K+F2L 5.7TH46VB$/,!'SDG,RUCY6,6H\
M:$%@:&CFE/9 BTM:&F"2@FE/*DW,55SMJ_SH0!?RD BY6;,C'EF:LHZ@)T%&
MY AI@[.;S00MI%9K63SKXTP#I;)LBRIB*?M:J)7%N)'A))D%2<<I(#&NE6P
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M8$ ''/>"IC,!!@S^.@@\U& :?B"M$U=V;0,W6409HL 1(B +2M-W0:<KH/!
MAJ!J:@^]Q'>*2 0%E($V3^P(90 )!?,P2#-31UH)LB &NL %8B#-^"$+9* M
MA 1!=/HR<,0_/JN)\H,KP  *HJP%>Z $ F$"H.(_[)<H[ "UA@5<] 2!<39'
MP<V=!G8E'H7-VO^M&-G)!-Q T7 1#P@A@>^N"_8@$P<&#-0N)-9@#H@A5;9T
M(--!%TQ!%Z&*(#8@$V\-K@+&69.E2_].[#Z-3;3@%'L (4UA%9@I2SJ%O7N
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M8E,5%BA8=?/@09D'"8MH%-J21<:;(2RVAYB A84C#Q,6\7. 1,91,%M<3/
MQI$+%&]*2) A 0M@;$*='%O(@9T]8$C@P!$[L "9?^Q)X8(];S@B@0MTO"$#
M&6](L,,0ZV$1@@<-O#%!"0ZP8 $6?9 !P!O9O7''$0#<:..-.N[(8X\^_@AD
MD$(.26211AZ)9))*%MF!'CCPX$030IQ Q@MZ) 'CD@"LX"0/)]Q(AA.]J($E
MC[X\D@ .^^A(QB,U!+,FCQTLH4<-0NSS@A%/\)"E_Y9^\CA(%5H>088+SS1@
M3Q0]Q!##(F]$\<9^+FPBPR;Q\1-"AF"P(@$)0VQ20J;8X1<*"2RPL$,6#O2
M@@O=O-'%)DI$D>&C+-C130A2A #&&W*4Z $*A#@ 8!9W9-'##H%$P9X'5*#
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ME)1D!]J4@ 3,(),)>%.?M-2F:7!2DV_B1X]6T(@R\<@)0OAD!SKPB&DT(DX
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M<^Z&+ )?!8W8J'=7$_!V VKIX&.",SFCK74.I4C#:0O 6QX2$' +I(EH2PC
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MC* +*4=B!X%R">B8J7$^<C. SC$O+_,7A+ !+ ,OA7$_)^05(E5C+W: MF%
MX2<8J0& ,;$:K^=^QD><D46<QTF:MT%CAD,3&K%7O2.>1;<X^IHO"]A8_[.Y
MKSVF=D^Q&H.C/! ;=2PV,;I@&'JA>B2D<25$$[@W%!'0!X9P#\Z%#&MP0<91
MJ\B'$G 9<HTW$J8@4YM%L;V#0>[R&R; 72['%QO56F\G6."Y=U&70;'YFG.5
M+\JW&Y9%/?0C6319E#J3<1E774_A<(23&/O2&(D%,9VE85FS@#+1&"CY.QV%
MM"PQMH5)G*&A/W:A?LDE.8:Y#SG M6X'5F2[$M;7&[;!8WO70>VCMJ^!=G)S
M$N!S-2G[%'8[$VEYLPS'M,]7N,C'MW;8$3M0!?<1 B6 GO,D 040*3/X*=?1
MJ1ZP'@A' @%"BY\Z11+@+7_P963@1"4P 5TX ?\NX C0@1\>0"Q@<",%\$Y3
M- 0N( >.:@FC\!^^N 58,'!4E"MR<+LN< @RL$C%UJ@QL!XSA 0W4FS8(0-R
MLJ7?"[[A"P O( JTM".]< 6," "^H 'MZ[[M6P-QD 3JZR>P5 -J$ U#"B0=
M0 %-2@9+  ,S< 6O9J.]MB0=$ /=<!U#%"K7,5'I=!_=4&Y[-(M(9D,*_ 9]
MT"HLP 5@L @D6$B50@)(0 (YP@][P IOP&@HT(L[P J$M 4IHR-9D*>A$ )(
M0(MWT*%VIBI@$ 58( )RH SW\08J'"Y(0*IO$ )X*B,3, 0D$$XZ0GR((W>"
MLQ/PJG?&H1HPQCO_\W#_%_<1>< (6B##[M=>DLM<0X4&.$$"(8>Q!5007; '
M.?!*9N$97@&<0R%!'4&WP2H3)C ;9)&N&T ($=!T=Y4#M2EX/#&UQUE2?W=@
M)864)#:<DCL^VY=@Z)5BMK&75IQ_)44X=NG)9;&:0^M>MQ>8-;9CL!$8PSJY
M*=G*H)EVRM&U?A<^Y%@ZPY,2A, $YUJ5Y?B:[+<2@^,&DN!<)9LT T$($QE@
M'Z%ZW%4*^2!ZN+,#886UBZ69N>D13JD2>X"Q2$%XV"R>GMR=CA$8YPQD37$5
MK#P^MAH8KAEW^<H63"FX;(=\&8>TD)PX'913CT&.<Y7)SUD5?P<4 G2.B^42
M_]45'-LG%LVQT)J)@"1&CJ)A%^?: X5<%9+!01T)QK$1&>6SQT(1&J!,FD.Y
M$?.W?#SAFO\$N%,AF7"10K/'%?>S%QE50N2X$SAM70,;-YH) *%B(1)0 O\I
M 5B !/S@*P50"-541>5QICM  N""3M0A3X^&;0RB(_RP X7 "H=& L#8!PZX
M!3W()H\FU$HL 5) H1@J@C10;"12 J/[PV:] [/8:& 0@C(BU"X@%G_F"&$0
MAG HOH--V+OF"WIP!5^P:F$R)CL* &1@ ^\;V9&M 4[J(U5"V1IP 4FZOTRJ
M2<$ I#=BOVI0 _H+O@:<)$?0 77=+&K:+&!P3J$PG_]/Y (J>DU1,&[!HDXD
MT -=T"K6E$XH !V)ZBU$UP'G4@ D$ $H$%TW@D\QL 8DD!3H,J>Q(@,B,""4
MV"I@D 5=D-<=:D;V<6:,%@,HT*E<$"JX$L$ILRIKR1DOB:_<\[")45T;=#%Y
MFR\CO1SE P&-HW,]9D"&^2YXL0?$<#M)DV'X\A1/<1FSX[6KW!401)/N8L@]
MDV*]N8Y591=_"QHC-+#3O<DAWJY &S&*,3AO\4#RLG"OUW1KAWPV;2^-ZW4F
M]%D!"QD@E'%L1R@,1[8";K6XH1.N&CBOUT*&2>*+%3?UFLT:EYRT%P%YX#B[
MD7%^%\J%6<[C+!2$D ZVXUS_T>SE^K@*NF (#%"RC3?-I7!R!"E8EEETYLAV
M>L</@$RXET,,7G/?0<M:,X[-9Y>U01M!U>.5*P05?"E@'?688I>P@Y,5Z?*<
M$ .4:^$6"!VQ\K5]>BG@@/M?"$L_.AF3T:="!P09G2/@$4 (YQ<:?D$9.Y4#
MF'%^$*ZK_0,8+K02A]X59=>N!MM\;[&<8$'D>DE2BQ,7@;FO&77C%C?,@5OE
M7>.Q[M5W^,*8B&/'H;D3*%#49^0K.#A/P_:!@> (LQAL+&#4=  %)+ #5! %
M"?RH5  &-Q %1$BY4K@#A:9P,.( 80!$7Y84 + B)4#N^R0@-M@J=L9$*%+;
M;TKM_[Y"0U%=1B5 !QDB1TJ@<$<@ <9D@X5M\1<OAI@T2IT$VH^$AFJXAFJ0
M)N:[(W2"2_^ AK;6V4;PV01\HZBM)-VBPX0VBVR=: X0UJ0; WD*G_Y4;J&@
MB_P !>$B+=0142QP@4B@P83 7'=Q(W*@%UPCA00I%GO ,GC 'WO$*D7, E^4
M(816 *XB XL@!70 G\Y&C=1^'T.PB=:T"190NW9X(R&MZ<IQ-8G1&EU9-B?.
MR:-<%,9^8!LQLH47&.''&LTI/@  $G- QLSW8@ZWER8NXI[<E=3'T+;AMI$A
M-I?!,KC)/^YWKGH\8"KV6 E#^MN<8@/]5Y6A&WO+<?*M8?\>P;#/[LD<_I4%
M[7X@NQ/QK'953.R+!<EFX=!?67W93.S/B10V#?QX!3X1H NF->6[^1)<''69
M[$(YS0\1L ?0W.6W(\T'[EQSL HHTV+7[#Y%.3EQ9X[B&9"K0 M,\,[M2,ZX
M3\_=V9.-*9FP<>CAY^BR?QOF"!!D"@PLP*_ D8($$PHLT,$@P@(T%/90:'#@
M0X("'100:/%@1((6]RW,.)"&1X$4!ZJ\*) &0XK\4BKL2% E#0<C$\HDF-,F
MQY<_%:Z,,#)"CPB$(G L@)0BTBX?$W:86&"IQ*$6C\!L.-#A19,#C^AL:I(J
M1XL>@3(L&W*@3Y!,!VK<MQ$L29/_%MDRE4A&(M:\-(?.E6IPGT&9& WND*!L
MB(P)+!Q(F."!E1P7*$K(8'&#A;(;;RS(X$>'RY82(62XD/!&#C\2?7;$Z $@
M*H " +(<X8V[1 0  .3M(5-BAXLT).A 8>V!RQL1CAX7<!#"PQ I+AR0>$V"
MB@H7E5GU*"$A!&8L;Y $#^1!F0L9'8('ES_?_GW\^?7OY]_?_W\  Q1P0 (+
M)+ #$Q(TX00#\5NBAB3(N(\,&'20T+X5'DD AWV"(X.,1VH(AA_\.EA"CQIT
MV.<%(Y[@X<(&8[QOD"IDW*$;%P)YHP06<@RA-=6@H +''391(@H20GBCFPE"
M"($..;IP_\&%'G-\@P04P "#!3KHR(($G_AQH(LL=M"2"C!<(*$$BVB(0(8U
M9:#"!3"X^"4*%NI$(004[NC!A2@FF* ;#ZC8X8W,7%"2A!YDL$Z)$#*C [?<
MP&+++Y?D\@BB@MA"B!_ .LVATU#1BFLEA?:)P!1)UI!'K0+(JHD@LA(:2L(U
MYD &$KN:8LD@O[*B-8=>*V6*#%A1M=77?7*(X%FR-D+* 1.HL^I9E<@"UMJ!
M:L4T5)% "M:CD0 K]MC!RN*IH+,0(N/3BNY"*=V@MBJ),)K^TK2O;G>B"M1T
MW6)((H#QI8DG=SV"U=V^&&9JWG4QC6@O?O8P1)<(!,(-CU666O_7U$X/RC0M
MAM;=%EG<(B!AC34X7F651%C>HZB@]@J6H8YP)@@BD_]U<X^A5IT##TX5-EAG
M?"\E3%^0< /5):0%(TFKP0SJB]^P%KXWYV4-^A==>[O=".N$$)*(4[%&SC35
M@(NF6-BO>&(IJU"+_96ANE15:B1ICWJ+(!.0*LH!FJ52ME:G;W[+A%Y1:E@@
MA(B-E>Z)L8J);;#6I2@H@!$;2!Z%[!JYYIW<6A;RJ*GF22]CP<(*@(V.D-,%
M"SSP  SRJ'@C!C V>8,*$NQYP[H0[-A.CD!<D",$$7YDX3@PY*!#AAA(H)2?
M'KI P4PS7=A!AA[:[(($Y5P80H3H#Z7_0S4L^I3! 1?>\&!01S+SH$H)D'"@
M!!(<\<!)$6RB"\%1PB9DX($LR$B!"V1@ QWX0 @": 4:2,)]G/ %&-GG!7%@
MT'TZT(LK=&@^'5C!#R*$'R<(H8,C?,0T&B%" '3 !BDB400'1",#U2=)W9!?
M!)!@"0E8 #[/"4$7E)"%0$Q #EO:1&4>X('W+8(%3EH$&!;QAB$HX3(.V,'T
M'   &G2@!$APA 0D8#LTRL\#6P!#"8X @+'TX'NPF< 0WM [S'2#!2@@!#^0
M,*4)2( %B+)._+#TAS>P8!,NL)T$=O#%W.#F*W<YB4(>UR]+$099IQH*;H(5
M%+300"<& < J_W01%6!MRRZ5Q)I$ZB*437*D"\3(!\8(X[=WB45DA$$(M:BC
MDTU6,B&$.\Q /&:5:N5@'SU@"5)4M13J"&X#.8E %Z[B$;OMC""B;$M92L45
MP%!$(._RBT54HI:2;7-6\;(5I5X"+TNIY9U>,4CX.,(S;;+%+FC+R$,V>4[3
M,21N[,372U)IJKW<19U2P4JITL:47*UB;@F%R$N89LE/6LTD+H'5P+I"J6V&
M!7*6U&A$+$*IM8&4(WO PZL8@H<YK&*A#A,71"IJ-7^:-"XUB25%2S<YLWUR
M8G.I)U%=]Y&]7(Z5NM1I2 LJK))4$J4&4PA$,I4S@]B%'T6E9["$4O_/N5FR
M5F599ZS"JA;"$:('9.B"4I1)D*)@BR@.>*O?E%6 P&$EEI,DG++&R51.B3("
MJ^2EQK8Y$KJ,K9U5N]?D;$4&<8)$GEX9S,!&&E*C\:4KPES6PU#%F/^Y9A-8
M"$$!7$"')85&#BCP@#U0@(4>P(\%YF&!%&9;G3?$=A/?B^$12O,&"?C/?PVP
M1&4\((%"+"*2D)V,#(ZPB2WTZ $HD ,63@L&!_P)!5&87PG^P(+*Q$ "#J""
M!*A0@DU80'YG $-PWF"/$'1#!C:D;WWM>U_\[F<%3>!!?AZTH7_,IQ?1B,,^
M,@@ 7_P !SSH(!F<T LUG- ^]0G0$DR8GQ3_'CB_$41!-YCD 4+\D04L> "A
M)-"-\,F 4)$QCOSBAP(EQ."U(F#DG#)3@A@4 @FUR5X)['#&-S1@?AZ07V4J
MTXW6*,=/ "#!&]*@R-Y-0 DHV(0=S/>&0UE &;;+ AU80*@H=,$!+"@$D%A
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M2X$5@/((K-@!0R"&J] T*3PYTXFXLMB'C8.K9B$$I: UM9(KAE"INFBU.HN
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M<TTG"0$E0"_5VP0I"($8<  4D!\JJ TP0(+SR)('4!0JX",Z4$S;<0$ND(%
M*"/-) $H8 P@HX(1LP[S8A39<!(4F"(9V 0J4((=Z $24 (BHX,"V!,J6 0=
M60T+<!)"4;_W( WJ4%$QW2AL.XN_V#=PR0B&X8>(^PNC"ZH"6(-,@ 3.4:AV
M1,8654[P)-N]< !=, 2@<:QFNPC/6:?+8:QIT49: T^*Z,6["I@P$1O'BI7!
MDL$\&_\*5LL)T;&521H,N. L1%M#;E$HSCV+9?Q;2_)<80N,RLH:QEI$?.G-
M6[&(R]TWUB%2@OL*3_K >[E<Q)@EO6V(,'Q1& P8CBJG2A%"2]D#72".V%W#
M3;JLH&C>FHC4>7N)+B!12"C'4AQ%#'47[5TZWD7%=$HTG0HJ=QN*?T&:C>!"
MB&!1/6S.-JDX/!0XDTLH*EW>%TPW=I$+7*05R0T)D*J;LBBV9,D;)M3?P&4)
MRL47;2D >:!<(WP+)W1&L@@KLP**C=-<S.G'B2&EOX%3/ -%CAI'_8Q'4#08
M#8T7J*%44]D<^(TWHT(=9>N1$+" ,ZI:H04#/7H )R&! FC_31Q!"/4XKST9
MV2E9 V:*@?F9 &4H 3E0(\H0P )0H_FADMG23/!) Q5(),3<V"AP 218 P"@
M@PF(A3? B2'Y5/4J@"B( B<Y,B$"@P3BAXA%,A;PH(:M8SM&UP<)!@GY(",@
MOD;H5UGHXR=H@A]H C4 L/WH@!!1@QK8RCONCX<MD Z 6=N)@!_IAD 86A-3
M$W[H AZRG3>( #GHUAV#HQU @C?PG1!8!#G( J4-%,CT'?+IDM+LY/#9'SD8
M3$19DM7L@2S@#!=H'Q&P R6H#:ZSG6Z(@AY@K81LDFCU'=M!@458I/ B" #(
M&8DXEW1"0X%QF$UA+(%*0WY8!5.X_PK"*%^FH+6^^K9E^\=H)#F\V( T0 8F
M*-.P*-Q3U)=M^49+JZ9G:4_-4@EW:HI(0ZRI(8KYQ-PE%);L@C7">35*6JBA
MR)90>[B/$+31'3I-VJ6/X)2*WI;]Q(M?*@FNK<.$N)POY=":X#5SH[.U@8CF
MC#.G"5L.O5^,[@J,[AQ\3)LV7!I,Z0))0(:][0L', 53B)I^,B@4%IB+;L-$
M$,2L:5X/C<3,^C5W1":K&H@NT *]Q;2%BQK[+;FAJ-&IHC:3WJB37CI#F\/.
MNA<SE J[T#=A2RB-*AJ;3N?+XFC '8Q_Q&FFRDZ67D-O@[E0>PJ61D* VN9J
MZE+*(>BY"?^C;L(*^;2F+DU/E3"X8*&49Q0)Q7HHI^K.P;@>KUK#_'2+==O0
MDB@8A^.JJ8Z+3PFG!VWMD%:6@KE/&MB!+2@#%W@ %G#-7N4'%K"$A$SF(U@$
M4VTOW("41"(R%N 1V!$\>S 4'%/B6B8!@X ":.V!'/M5^4D/!T""&^ "'>$"
M% @$5I@O/W($>[@=?DC((W:!(Y"#'<!,%E@$*B@]"1@%W, "(UN$1_YO (>^
M#CB!#.H )R#8$<*]8, /,F@"'2#+$>J%/IZ!8(#PX%@"AF5P'HBDI(SD 7DC
M2K8 0C@_N_QD06H/0HA8R)2? 8H?TG* ,%+)-%$]5B"!'8B \+#_!WN0@!B0
M'OC8*@X_@I.(UMGH :8]8K6* 5:('SY!@CZ( -Z0@2A@!0]0,S"@<L.+#%2^
M@_@1GD"8KFY  6OA#:^"+%WJP&#9WI%6Q#(WB5<:;:?"C3Q8A4.L% L^++_!
MC>\TE62Q"A4.&7GH W(+G;#HM*1!.JPP0EI#-9!AP^4\PJ'"IEHY)Z6>'*=X
MMW3YZE2<"2-D03S$;'-:B$9E""'DS9Y[Z<8=Q:7A![31Q7W,:P5%0])QP2K-
M=!#N\ZN23L,)"U.D"0@@!JBFT_#]X%"QJ+I.U$./@%4H!8SAW!5N1'!;ED+\
M1(.PF*ZN42.5BE LV^&]B[.@PW5R]H*#_SI"RZ5]#'6NE6H+GM0/S%2R:I.$
M"I6:"QM;J714H7>IT,5T/@J<2U1+O!>#!D&G>"M(+.B"6.!"HQ5([W,6SIZ<
M4 HX[5ZXG6"8.-^>.U#(1?B<>C=0(J8\C%R^14:AVO6MB=TA9"JY4"G$B "'
M4)J_0 $I>( 'J)TEV2-6\((0,"Y!08C6E  1^ @P>(,U< %6*(&-!8,"D,Q
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MP1%9H*A,"&_(   9):P10B [K.' BBRZP((,5" 10Q9@H+!##WTX0,(.49:
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MZ@ Q>]F!%20K =*49@V2D*I'K> )/(B4$X0@,4@QLP9JF)4P<VG.2S4*1XM
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M0B].I:U+K:":*V@"K51UA6\"8 EQN&8'C(!, /3BTY&*_U43I#D-'&PS4DO
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MB*5E90S-$7?S$ '=B*G&6#@'$#VF;K25.?Z'492 !\S;)CCB ["('=A!"#B
M"*C,&]@LRTC %J2,=N+9@<@ (9);D95 (?2 #Q8 &$ANHQ#"%HSI<\C!#I3
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MF@"BDZM@BBF.@0JA-1(:L")&A@[0( LN"(\2N\'6&$BAA8'(4 Q8<(8='(&
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MTQ&4@ 1HX*[2KA!,R!%::#P A!^0P ,"81.4X2E0IP/D  I0P!%"(!".X@V
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M9,@46,K4:8(927JIJ9&$K<\E< ]VZ!4-ZK^B@ '(FF9$SP\]3:;-^/$CB57
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M6<"GBN[J !-KK&)(*<26@H8DNJQBRAIX[(#'&HFLLHHN:)22C[5SK(('"?)
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M!Q;D=P(O9" )WE9$$J! &8M8$!(<<#N2@($&W7"!'"+L@6[ ;H(> ,-!HM"
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ML YI6&M4L.X %?CEK#2\R4LD: WLA^: D@N)HRYIN GH$WU28JTR_  V$'+
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M'=B'(W!=,""#1.D".(L!!T! )+!/,.@-,D.@$+"#;J "*O" '6"03+K-,^D
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MB9;2O(^Z"Y"$#9%HPJOZI:*:R'(!.<ASB5\R*KAB%L,[9Y+\F*.RN8X[2:S
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M\9K%^(MVH9>[8R99RJ9@^3NRTS>7 :=Q[BM"4 \!<0$P"%#_%V"%Y(M3*I
M*<BC$K* +7"CYY8#"= 5.QB"'J #.A@"//.1+@" $KC1]B)-&D !<-Z".$."
M#:&! <U9# M"%Q"5UG:C.+%@2Y  &A]..=B"$/H?F1D% ,\C17(C,L "+I.
M%[+O]G?_]X=_$Z'.%NF +' !%P@$*L ]%"C,;J"7+ "(-P)9[-CA  P6%\K>
MN&!!Y8V=$%VZQ)#! @R*(6!<@"'10TD7,@ *Q""!1$*(-RC>7,3R$ D)0OP
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MG-0R@QE-:5Y3FWORI2^W^4QM9A.;WR2FI@C836DR*9QRJF;$H!G/=(;F$G-
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M";! 2MS$^ER7XTD (0# 0=0.&+@6 8:1"\2 $FP!"3B-9^U CW3%2KC )KB
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M"IG O-YL<CXMJ)A5R4XMD=HG09H*50'LEFCLE[C)@TZ& _ #"5061P@">(5
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M^;G 'PC$:WEK;'B% (:ZK!9R2IB>"V"!5/C/UZPV"U2?6+3=%O1!![:ELD:
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MK0#&HT-8X$A((OJ$<BB)LBBW!TRNI$B&X!DF8%,V0 D Q04.12'X:7_DH\W
M8,A48!%*P [*!PGNX @LAQ5*8 >4; +_E($\Z  )4( 00(T$V&\4-D2"\">#
M2N!0]J$$W$,&J" 0:.U1+")/NL !D,"OMB!_AJ#+&!(NWP )_L!4*L0!5 AP
M6,'X$K(#E.F9<G"9 *.(Z VQL$5Q5@,<+^QL/DLWL(U9;O"(;B-KQ)$V^&$4
M@Z[IA.[@=$GBNFZ/-*Z6?DGBD!#AH+ 7XT@/V0L8UP@*,XX3P:@8/6X*(P[@
MB/%@0BD"<D".J"A? FD4&^9@>D#HL+-A8DZ+YO!@VO [C9,3;5&2Y% >OB5?
M;NZ0L',2(2 ' +&YOM,Z;;'KKM.-\K,0(X &\L4-(0 [:VD._5,.-_$\2]&-
M>H ]WQ#F[.U;_Y;@8.0! B# .^5H9>0!D\@SZCSIDI"0OMSH0I\SZ+"(1&W)
M%YWSW[@PW_((.3E4-T$1EF@)1K,(LX[HP>:"-'>P1SM3FKJQ.-3&'&V0-9U(
M[^BQB6BC*D2S \"@I]2'!6X@S?@&!92@! JA!]Y@![B !#;! ;; =]+ 0EAA
M"Y"@H^!$]>HG 4-AQ59H"-Y !?9C$_R#/JB 'SZG!^0 "4( "JS2 RQ  HSM
M#.8)3,' J^B*!4;! 92@"TC@#KYJ439!\CIJ$41@$[8@) !  -_ #HSR4T$U
M5$652J8/2[( ?.PA"OYAA3;A3ZA@ I0 3MY !!:A!_9@TP! !EA! O^8:@*D
M0*@*(!20#0P"X3S\@Q4BX/ <0$-*( :&0 E Q04(@050H(-0( 9B8 <0T@$V
M32)0( I(X$.037CJAG[JQX6<JE5*H >R8';L9$.:TOT681.ZH%5.@@;,[H=\
MB!Q5,S,KK#..J3<NHRE"X^P(=AYI,$D[,UD<P!IC% R_D GA"QK/Z!F]#AFO
MT>IPCCB%T46MD3:KT3B=\]Y<Z4-WJT5/JQ,I=(T:41)+#F$0QFVZ8$ GR0P)
M]#I;=@/V80TWR8KPL&%64&8;ID(5*6>%)I@.9EG;4SI;+@(:5CGW4Q'#)1:!
M=E_6< /<YEN0T9)F43SE, >H\& *8!"5MA'_]:@/A09G#T8:"U$0@^D-"ZX5
MQW 7BY,V>U!$@]!CL2L7:;1C"PDYK_%B)7;E=E,(9].6.M9O-T"R: -'V\UK
MB,-J-D,<&3<U>6B)E*5?GX5@E\DUZ.XFND,&Y  %9(#T#O";J&!4'" &:$!Q
MAL 1!'5P&(<.CD!T'4!7U(D@TX %6L(DP  *1F4+UC4$:$ $&D0].I)T3T+2
MZ$=_'( +@FQ\.J +M@!2 ,02)& 4"*T Z, !'N ./,"@[L 17.AO[N#8CJ #
MK+<!6&54W?=]X=<H2[5*E#(*-,41Z  ,NN%1HJ"N"N5#2$ 9M&H'W*@$LJ F
M44 9C"T$4"!UX8]__S0M!I"-#KI@A<# _J[5!4I !OJ@?[)U/[(R6]V(6QTP
M1O2W/=9@/\*@R*BU)F4@?W<@(OAT%*2 JNI*"AYHKQR #,1D:VCBVLC162JL
M-(T4!+6E6)#ILE!LW4",,CK7.:!X!KOB)F3S.:O("ML(./GK<*'S8?/680O7
M8;U.C$FNBYO0;O6MC% TC6ES1<EXB@B!/ONH #+Q.CW)/S> $(+)!-B3$_ES
MD?[0BO3X.XOPBN@3F/:%CK%('@ Q;AF)$>.3/7%6-G4ID($Q#R>Q/3?Q;><P
MZ\[PEO"P"TSQ#,>6$Q'N;1>QCQCYD1T@D/.8$+=N PJ /LVV/$M1;KEHC?_?
M6)1F-);Q5@_="YCOB DO--] MD1#-I1LE#BYN#>O3A-58^YTB'$_;%B8XS6-
M@C2/*8I\P\.D^&!K<.R@*7)[:"[ZA"F8Z@W\XR$^Q(+B8RVS@(++D@I*0,?.
M+ 34:A/ZB47^@1!BX--(@! P000"13V&H)YLI5JKBG$"A00PC01HP'L0T@[Z
MP (F@ 64@,8\8 BHH!M*:@<(@4+V*A1"Q ZT:A&"IR \(@20H$?*) JP  7B
M=Z9INJ;];'ZGA-  P"S'0P(VK4(N^/,D)P0JY)U"H!!@I M4Z $TL"/TN2#X
MHP/VY")$I0=V0 4,94,2 JZR(!0>#PQ*8 A4 *S_>X %-.0_G5:?-$4*1, "
ML."E@T\.FA4,WH#+*F01/ @D/4*NB:B51V(GP/$U>4BRCAAS/1>RDL68SB9M
M>BC"/E/L/A W1(.)6R)PHS#E_/:6,'9PA[ ( ]=B^>L7B7 *J?$7"UEPQ7!N
M0PEOE[ENP]!$/XXZ5\9#B6X[&4D-G;9EY["*?A;FT"N4P;.5OTN/$ZP]/SD0
M[;A#TXLZN:@1'Y054626T]:2)M%L-8X-G3N8]H&T;Q0\?=OCSE"WS19G>T!E
MW:@26[:5KLX7L9"-#%>TMWCCW)A&5QN,7SNUC5E!H= 9Y:AC.1:V%Q?#3JP<
MN;$<,_-Q35/ QW%AB^6)_V50[-P"FXE%<EN#*KI#).0@U#(OJ":@3C(-/R('
MAE2H\'IGG0HE\^ZD .8#!3S2!<C@#.:G*PNB $B #)R*#K# !0I 2)0@5V.@
M;A@0V/37 _[@ =Y "MAC1(3O5\!@!\X #+A@>5@D3&', KR <H;D"'*%UK+
MIKW\R\'<>G"Z2KQTA40@/9)<&4)D5%" ?52%@2]8"E;(!9 ,?#S:A=R*Q64@
M6\6C"X; V*@U4%! G]5*!@J/!92!!$;EV*2R#Z@*";(@"[J/I7T'_L*G&VJ8
M6H^\R$@W!(9@5%*W+SG\(V9")+8&'/5.Q(:XFK%%FG8(20,V!(/TL:MY&S>3
MP/^!J(J+F8PD%D8/-Y@_#K9C>=?5&Y \>Y9L=#B+$S>O6#@W"47?F-B/78S;
M&V?_16@(86>U$V:U:(B&Z%N$VY4E*>8<"0UC66B.W;1V.U\(@8^-&SS5"YBZ
MX)!EVY(I)@(F5)(DV1(SM WUO0ODX0[#FXPCH!;7G4(3K+K2TP'<UN )U-P'
MIA"]VY4)D=X-7FM!MIG9^.2R6(NTF-^$'3CM6PRAW9?[2Y<U.Y$X#HRQ:XQ&
M(XBW*3= T''%;K)+DRB4"&!K8]4)_,-H/6#YPH?^%7,@B'\ 1U'WPU24@ 6H
M /+"5:S^4@;VID90( L8! 5*@ H<0%H+K_M$[7_[H ?_1H&<^,,.(D(.J""A
MV:<L2\VONN%O',5%1*#POBIUST<"0L$%2'IV1(38H.?RSDQ :BHHP[SP#?_P
MK:=(1N$-8D%O"&%#X"=0,,\C$L@F8Z?(3J>%'D6NAX"!2P  CJ!.ZN>BP^ -
MLO(^'$!&9D>?+6A#"(<D\R=RLE(.E, %P$"'C^ (T!XBPOH-\,?2ZB>H?&<1
M9$!5?%^H'@IR".%V0D+ Y2VR]94T#ER*?]XSY2+G7_V)]JX>IUA?:9XG!-LL
M&K:21M9OA5&T/QO XON5,C:,%32,"O?7%6D+W3C9R9]O5<LY[7_:5ZD7CYN*
M  )"EPT#-QB,L*$=$T(1(@PL__@P(9.'$0UV84)0(2&+!#MZ]/C0H<$-#3NV
M&ZD0X@8('1L2BH@P9<>!$V=ZC"!P)L(N R,PK$B3)TF.([LXG%BS"TN'$'E&
M+ @2I,:01ETZ96GSZ8:D6RERA(AQYD6M#Y-BO&@SJM"L6UE&Y,K$+<BX!,]R
M?>N6:\>D8]4:A!L49(0"A L;YE<8,6'%AA<G)E. ,6/(D1,;AHR8L>7*A"DK
MUJR9L^/0C2U3KISYL.K2BC&+1KWY,^O2HE,7.%(@PI$82%AT*V"!A0<76URX
MX"+!41078"PYVO2GVR8'<E!TD],#P!$9(23(D% B!JL=(4J@*$#%@0L)<L X
M^,-"PO\;*"%(R&'1/0N8$E104 EQ1W;\L$#%&R70(84$%CCPAB,>W.%!-Q.8
M5\($ZU'1#0L62,&""P  4, ;$W2#Q2@=?(ABBBJNR&*++KX(8XPRSDACC3;>
MB&...N[(8X\^_CCC$0"@$$(#W1A(A0<A3(#%<&_(\0 +;W@@00@H%/)&""&\
MP8(2BQ2 0@-O;**$##0<,0J7*+CPQA8HO)&%!"@H@4(44<C@ AU(H,#%<LS)
M&0(50RA!Q0Y#,$=(!S1D0:0''@Q!1Q1OOJ',&UENDN4$,;B IQ+=>#!E%!*0
M@)@# &2V3VJ([:,::86YAABLM*U&*VR@%>#::*V^-NMIE[G_*ENNC=FV66>O
MUL:9L,#"9I@)7UDT$ 1WS<25M$*AU5=?9AED;5%UL95M5-NJ1-:W8Y5+5DWJ
MD@LNN&'UY6Y=3V$DT$378FO124()Y!2[X1+UU+G4D@O625G-JQ6W2)U[D<']
MMJLM"?;:15!93E5LKE==Z%OQ6=="^ZVY"V<4,D\CS\2QO&E%.^W'^ 9<,D=Z
M2?MLM]F^2[%6+5.KLE\=V>R1S?;Z11;+Z7JD*K.O><:99+,6BZO3I,DVK&/&
M6@WUU%:302S651>;M-?%^JHUKUUS;9EB?6#A0H02L$F''9LTH,3;*#BB1 AV
MO$&'!S(4$(4'49" A .X22E'F^(E_]Y%("1X(!P5<9=0B!PR0&X!&%O<(8$(
M.TC #Q)T@.'"$?P<L<,F430P 1UR2$"%!&SC_<80Q5DB@SXWO!'X!!XHMT4)
M'TKPZ1L[ ' BD,HOSWSSSC\/??32]SA(%3J>B(+O$SC2Q0XNH!!#%C)PE\4;
M:Q+^!AA]H !&^S*PT,<:,;#0I1)]6$K"&U2 04472/31FQAX#X [2)\22! "
M)'A/"9N206^4,(0=4"$"_4$"*Y" A#2@( MKR$(?=B"#&*@/#)O8'YQ8, 0D
M? \,).@""W8 0SJ J =DH,&Q<+48RIQ&5L+RU6IL([5:X7"(6)M,#F_8FJ:9
MQFR5T2%M;/_C1&)1#31.I(VL8G4LVP E+$31"\!&XJTP5B0M72EC0;C8Q3-Z
M1"\UV<I'@&*1-O[E+U")RAI5<I8YTH1G9&27'M\X$C:J))"$Y.(@VX@4,'Y$
MD=J:BQH=YBVT?'&,=:1C(/=HQV=)<HQY5&,:GU5&1%)2D>WP QZ/UI8Z[E%=
MC'0C(65F23/><99\A(HHVU5&.^9Q99:\I2'=6$DPPH6.84'C&:%2$<@XL8HX
M7-;5/N.:TX3&AU@D(F9\:+5;53.(2.QFVEYSJ]ELS6E';&;5A 4UPX#H-B38
M 0J&X$(21"$^8$ !"5AA/B6P  PJ[,$.#@@)$@S!$2&X7R$^MP;_%R"!!%O8
M 2M*$,$=V$$);"J@#,9#PMIQZDD/74,(CB !*:WB#7V0$QW"IP0P=(^?+HB!
M"<.3!5:P  5]Z ()X"=" 4U >RB8GD]_"M2@"G6H1+U1]7;4 1?X+DL]*,"'
MR/ A&_+C0P[@1P^J6M42:-541X#JAWI@U1[T8!]5)8.IKGK5 I2@  YP !F@
MP ^XWH8?_& 56*' ULR8U0%DO>H-G(JB4HEUK54M0%H#Z]6I3G6=-   9$"T
MS*TUIH>J428.+8O9RVIVL\D:8F:O9LVHW1!MOK(L9SM33<R2)K-5).T3.?O9
MT!)F'XHL"AKGZ$K<QK&VQ7RE*X,IQMN&_[&VB\2M<'D+2>(J\K9H/*YR7=E;
M,'KRN;Z=X[MRBQ9CZG:.!M.C<W,+3.B"=[G$92YYATM=80JSN^4];WK=BY'C
M?I>WX[4M>T.&W^*Z][W5;2]_Y<O?5CX77[ZM)%C\"\;+O*HUD\%B;)FYPZNA
M3;/21&UIN/99UAY+PQ.&L+%8F]K-1E:91F3FAF%+X6:2V#6.51&N4 0%!T3
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M=ZTI#X7YA7<)F6A)G+6GEL6)G,FIG,O)G,U)B'9VA\P'"880 <:'/#E@"H:
M!J50"LB ![,) -$I#UK G=NI"[]I?+<) !& !FBP_P>H1P/(@ Q:0)_$H 6Z
M8(=[@ RE@ :,8 BF$(GAJ07SJ07V:9_TN09FZ9P+RJ -ZJ /"J$1*J$I&55:
MP BN:8>Z< __N0;$P)UX$'4%L)]:@ =KL)]H4)WJ69.K4 J& *(K(@\MVI_M
MJ9UZB3Q'P 3MJ0MK8 J,X)XKTI[;R9_;Z:/$$)[#.:%)JJ1+RJ1-ZJ1/"J6@
M&)Z0@ :&@*%)YP8MN@8?(@]XT)W@.:6EH 4HD@.&P AC>F;)N '<:0COF700
M@ 9KL 'RD ,Y(&-)=P2Z@ :K<&9,(*8K=P1K(*AKX 9[L :[8 IH *(*&J6-
MJB+'Z:B1*JF32JF5RGZTF/\(JZ"G_ID#>J<+_BF)(EH*D+!RNE *(&IFB="B
M5;=RJV (>KJE_;<':'"EX6@(AK !7[>?3'"3WS>@*VFIP?HBD"JLQ6JLQXJL
MR;HCDEBF[3D)_8F>I5< 6F (L5JA_YDB-$"MM=H%+5J= =H!$="F:?"C*T<#
MB8 &(YBMX1D!I8"?:>H&D  !X]@!:S ''ZFLE$JL^<JO_>JO_^JH:.8&@HH'
MR$"=B$<,<:HB>LJG:6JJ7:!Y3# 'I0"Q,$EK?6 ( *"G(+J2B7I_*+('IXHC
M[(D, &NL^VJR*:NR*\NRRDD&>NH D4<#IK *O,J:NN"B*@*>O+8&I3 'KX<\
MYZK_J'F*!FZP(B):LNN4C+R&KA6+KZPF#\A0KBTKJ2A+M5>+M5FKM:?(#SC[
MK8@G@<B3L$;[?Z;ZKBJ2 RU*:ZLPM4<* &B@"R1@"/=P#UH0 9*8/.0J#QO
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,W=--W6[=V1\2$  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745697584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jul. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DocumentAndEntityInformationAbstract', window );"><strong>Document and Entity Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Celldex Therapeutics, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000744218<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,341,785<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2017<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DocumentAndEntityInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_DocumentAndEntityInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>If the value is true, then the document is an amendment to previously-filed/accepted document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12b<br> -Subsection 1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746141152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents</a></td>
<td class="nump">$ 66,162<span></span>
</td>
<td class="nump">$ 42,461<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Marketable Securities</a></td>
<td class="nump">87,822<span></span>
</td>
<td class="nump">147,315<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsAndOtherReceivablesNetCurrent', window );">Accounts and Other Receivables</a></td>
<td class="nump">1,359<span></span>
</td>
<td class="nump">1,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and Other Current Assets</a></td>
<td class="nump">4,709<span></span>
</td>
<td class="nump">4,009<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total Current Assets</a></td>
<td class="nump">160,052<span></span>
</td>
<td class="nump">195,569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and Equipment, Net</a></td>
<td class="nump">12,069<span></span>
</td>
<td class="nump">13,192<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">81,039<span></span>
</td>
<td class="nump">81,487<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other Assets</a></td>
<td class="nump">1,935<span></span>
</td>
<td class="nump">2,134<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">90,976<span></span>
</td>
<td class="nump">90,976<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total Assets</a></td>
<td class="nump">346,071<span></span>
</td>
<td class="nump">383,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts Payable</a></td>
<td class="nump">1,975<span></span>
</td>
<td class="nump">1,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued Expenses</a></td>
<td class="nump">21,275<span></span>
</td>
<td class="nump">28,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Current Portion of Long-Term Liabilities</a></td>
<td class="nump">5,538<span></span>
</td>
<td class="nump">4,826<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total Current Liabilities</a></td>
<td class="nump">28,788<span></span>
</td>
<td class="nump">35,223<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other Long-Term Liabilities</a></td>
<td class="nump">85,826<span></span>
</td>
<td class="nump">82,704<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total Liabilities</a></td>
<td class="nump">114,614<span></span>
</td>
<td class="nump">117,927<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingent Liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Convertible Preferred Stock, $.01 Par Value; 3,000,000 Shares Authorized; No Shares Issued and Outstanding at June 30, 2017 and December 31, 2016</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common Stock, $.001 Par Value; 297,000,000 Shares Authorized; 127,411,975 and 120,516,654 Shares Issued and Outstanding at June 30, 2017 and December 31, 2016, respectively</a></td>
<td class="nump">127<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional Paid-In Capital</a></td>
<td class="nump">1,011,066<span></span>
</td>
<td class="nump">982,255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated Other Comprehensive Income</a></td>
<td class="nump">2,577<span></span>
</td>
<td class="nump">2,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated Deficit</a></td>
<td class="num">(782,313)<span></span>
</td>
<td class="num">(719,486)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Stockholders' Equity</a></td>
<td class="nump">231,457<span></span>
</td>
<td class="nump">265,431<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total Liabilities and Stockholders' Equity</a></td>
<td class="nump">$ 346,071<span></span>
</td>
<td class="nump">$ 383,358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsAndOtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, receivable from customers, clients, or other third-parties, and receivables classified as other due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsAndOtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6801-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt securities classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65884222&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66010992&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=25496072&amp;loc=d3e14326-108349<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6734445488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Convertible Preferred Stock, Par Value (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Convertible Preferred Stock, Shares Authorized</a></td>
<td class="nump">3,000,000<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Convertible Preferred Stock, Shares Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Convertible Preferred Stock, Shares Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common Stock, Par Value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="nump">297,000,000<span></span>
</td>
<td class="nump">297,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common Stock, Shares Issued</a></td>
<td class="nump">127,411,975<span></span>
</td>
<td class="nump">120,516,654<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common Stock, Shares Outstanding</a></td>
<td class="nump">127,411,975<span></span>
</td>
<td class="nump">120,516,654<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746344448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>REVENUE:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements', window );">Product Development and Licensing Agreements</a></td>
<td class="nump">$ 694<span></span>
</td>
<td class="nump">$ 604<span></span>
</td>
<td class="nump">$ 1,250<span></span>
</td>
<td class="nump">$ 1,057<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromContractsAndGrants', window );">Contracts and Grants</a></td>
<td class="nump">3,135<span></span>
</td>
<td class="nump">785<span></span>
</td>
<td class="nump">4,113<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total Revenue</a></td>
<td class="nump">3,829<span></span>
</td>
<td class="nump">1,389<span></span>
</td>
<td class="nump">5,363<span></span>
</td>
<td class="nump">2,692<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>OPERATING EXPENSE:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and Development</a></td>
<td class="nump">24,999<span></span>
</td>
<td class="nump">25,711<span></span>
</td>
<td class="nump">50,792<span></span>
</td>
<td class="nump">53,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and Administrative</a></td>
<td class="nump">6,534<span></span>
</td>
<td class="nump">7,790<span></span>
</td>
<td class="nump">13,763<span></span>
</td>
<td class="nump">17,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Loss on Fair Value Remeasurement of Contingent Consideration</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Acquired Intangible Assets</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">254<span></span>
</td>
<td class="nump">448<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total Operating Expense</a></td>
<td class="nump">32,757<span></span>
</td>
<td class="nump">33,755<span></span>
</td>
<td class="nump">69,403<span></span>
</td>
<td class="nump">70,762<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating Loss</a></td>
<td class="num">(28,928)<span></span>
</td>
<td class="num">(32,366)<span></span>
</td>
<td class="num">(64,040)<span></span>
</td>
<td class="num">(68,070)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestAndOtherIncome', window );">Investment and Other Income, Net</a></td>
<td class="nump">362<span></span>
</td>
<td class="nump">414<span></span>
</td>
<td class="nump">1,213<span></span>
</td>
<td class="nump">1,445<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
<td class="num">$ (28,566)<span></span>
</td>
<td class="num">$ (31,952)<span></span>
</td>
<td class="num">$ (62,827)<span></span>
</td>
<td class="num">$ (66,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and Diluted Net Loss Per Common Share (in dollars per share)</a></td>
<td class="num">$ (0.23)<span></span>
</td>
<td class="num">$ (0.32)<span></span>
</td>
<td class="num">$ (0.51)<span></span>
</td>
<td class="num">$ (0.67)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Shares Used in Calculating Basic and Diluted Net Loss per Share (in shares)</a></td>
<td class="nump">125,202<span></span>
</td>
<td class="nump">98,817<span></span>
</td>
<td class="nump">123,932<span></span>
</td>
<td class="nump">98,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>COMPREHENSIVE LOSS:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
<td class="num">$ (28,566)<span></span>
</td>
<td class="num">$ (31,952)<span></span>
</td>
<td class="num">$ (62,827)<span></span>
</td>
<td class="num">$ (66,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract', window );"><strong>Other Comprehensive Income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized Gain on Marketable Securities</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">416<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive Loss</a></td>
<td class="num">$ (28,551)<span></span>
</td>
<td class="num">$ (31,916)<span></span>
</td>
<td class="num">$ (62,791)<span></span>
</td>
<td class="num">$ (66,209)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromContractsAndGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents revenue earned during the period arising from products sold or services provided under the terms of a contract. Also include revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_RevenueFromContractsAndGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents revenue from product development and licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_RevenueFromProductDevelopmentAndLicensingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Other Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831270<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Comprehensive Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831223<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Net Income<br> -URI http://asc.fasb.org/extlink&amp;oid=51831255<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestAndOtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestAndOtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6742965856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
<td class="num">$ (62,827)<span></span>
</td>
<td class="num">$ (66,625)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Loss to Net Cash Used in Operating Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and Amortization</a></td>
<td class="nump">2,367<span></span>
</td>
<td class="nump">1,434<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of Intangible Assets</a></td>
<td class="nump">448<span></span>
</td>
<td class="nump">507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments', window );">Amortization and Premium of Marketable Securities, Net</a></td>
<td class="num">(161)<span></span>
</td>
<td class="nump">612<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on Sale or Disposal of Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Loss on Fair Value Remeasurement of Contingent Consideration</a></td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-Based Compensation Expense</a></td>
<td class="nump">6,989<span></span>
</td>
<td class="nump">7,913<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfDebtDiscountPremium', window );">Non-Cash Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,638<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in Operating Assets and Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables', window );">Accounts and Other Receivables</a></td>
<td class="nump">425<span></span>
</td>
<td class="num">(146)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and Other Current Assets</a></td>
<td class="num">(511)<span></span>
</td>
<td class="num">(3,124)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other Assets</a></td>
<td class="nump">199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts Payable and Accrued Expenses</a></td>
<td class="num">(6,812)<span></span>
</td>
<td class="num">(10,212)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other Liabilities</a></td>
<td class="num">(566)<span></span>
</td>
<td class="num">(803)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net Cash Used in Operating Activities</a></td>
<td class="num">(56,049)<span></span>
</td>
<td class="num">(68,732)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Investing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Sales and Maturities of Marketable Securities</a></td>
<td class="nump">151,470<span></span>
</td>
<td class="nump">149,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchases of Marketable Securities</a></td>
<td class="num">(91,969)<span></span>
</td>
<td class="num">(120,053)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Investment in Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Acquisition of Property and Equipment</a></td>
<td class="num">(1,316)<span></span>
</td>
<td class="num">(1,307)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net Cash Provided by Investing Activities</a></td>
<td class="nump">58,185<span></span>
</td>
<td class="nump">26,206<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract', window );"><strong>Cash Flows from Financing Activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net Proceeds from Stock Issuances</a></td>
<td class="nump">21,489<span></span>
</td>
<td class="nump">2,551<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockPlans', window );">Proceeds from Issuance of Stock from Employee Benefit Plans</a></td>
<td class="nump">76<span></span>
</td>
<td class="nump">349<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net Cash Provided by Financing Activities</a></td>
<td class="nump">21,565<span></span>
</td>
<td class="nump">2,900<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease', window );">Net Increase (Decrease) in Cash and Cash Equivalents</a></td>
<td class="nump">23,701<span></span>
</td>
<td class="num">(39,626)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at Beginning of Period</a></td>
<td class="nump">42,461<span></span>
</td>
<td class="nump">72,108<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and Cash Equivalents at End of Period</a></td>
<td class="nump">66,162<span></span>
</td>
<td class="nump">32,482<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Non-cash Investing Activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Acquisition of Property and Equipment included in Accounts Payable and Accrued Expenses</a></td>
<td class="nump">87<span></span>
</td>
<td class="nump">$ 108<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Non-cash Supplemental Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance', window );">Shares issued to former Kolltan executive for settlement of severance</a></td>
<td class="nump">$ 263<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of shares issued to certain executive for settlement in lieu of cash payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_SharesIssuedToFormerKolltanExecutiveForSettlementOfSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of the periodic adjustments of the differences between securities' face values and purchase prices that are charged against earnings. This is called accretion if the security was purchased at a discount and amortization if it was purchased at premium. As a noncash item, this element is an adjustment to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=64930785&amp;loc=d3e28541-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4332-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4313-108586<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6367179&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3044-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49171198&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amount due from customers for the credit sale of goods and services; includes accounts receivable and other types of receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsAndOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3574-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow for purchase of trading, available-for-sale securities and held-to-maturity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66010992&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66010992&amp;loc=d3e26853-111562<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a),(b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3179-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Investing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6516133<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the stock plan during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6738586096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Basis of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccounting', window );">Basis of Presentation</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(1)&nbsp; Basis of Presentation</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The accompanying unaudited condensed consolidated financial statements have been prepared by Celldex Therapeutics,&nbsp;Inc. (the &#x201C;Company&#x201D; or &#x201C;Celldex&#x201D;) in accordance with accounting principles generally accepted in the United States of America (&#x201C;U.S. GAAP&#x201D;) and reflect the operations of the Company and its wholly-owned subsidiaries. In June&nbsp;2017, the Company liquidated its wholly-owned subsidiary, Celldex Therapeutics Europe&nbsp;GmbH. All intercompany balances and transactions have been eliminated in consolidation.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">These interim financial statements do not include all the information and footnotes required by U.S. GAAP for annual financial statements and should be read in conjunction with the audited financial statements for the year ended December&nbsp;31, 2016, which are included in the Company&#x2019;s Annual Report on Form&nbsp;10-K filed with the Securities and Exchange Commission on March&nbsp;14, 2017. In the opinion of management, the interim financial statements reflect all normal recurring adjustments necessary to fairly state the Company&#x2019;s financial position and results of operations for the interim periods presented. The year-end condensed balance sheet data presented for comparative purposes was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The results of operations for the interim periods are not necessarily indicative of the results of operations to be expected for any future interim period or the fiscal year ending December&nbsp;31, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">At June&nbsp;30, 2017, the Company had cash, cash equivalents and marketable securities of $154.0 million. The Company has had recurring losses and incurred a loss of $62.8 million for the six months ended June&nbsp;30, 2017. Net cash used in operations for the six months ended June&nbsp;30, 2017 was $56.0&nbsp;million. The Company believes that the cash, cash equivalents and marketable securities at August&nbsp;8, 2017 will be sufficient to meet estimated working capital requirements and fund planned operations for at least the next twelve months from the date of issuance of these financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">During the next twelve months and beyond, the Company will take further steps to raise additional capital to meet its liquidity needs. These capital raising activities may include, but may not be limited to, one or more of the following: the licensing of drug candidates with existing or new collaborative partners, possible business combinations, issuance of debt, or the issuance of common stock or other securities via private placements or public offerings. While the Company may seek capital through a number of means, there can be no assurance that additional financing will be available on acceptable terms, if at all, and the Company&#x2019;s negotiating position in capital-raising efforts may worsen as existing resources are used. There is also no assurance that the Company will be able to enter into further collaborative relationships. Additional equity financings may be dilutive to the Company&#x2019;s stockholders; debt financing, if available, may involve significant cash payment obligations and covenants that restrict the Company&#x2019;s ability to operate as a business; and licensing or strategic collaborations may result in royalties or other terms which reduce the Company&#x2019;s economic potential from products under development. The Company&#x2019;s ability to continue funding its planned operations into and beyond twelve months from the issuance date is also dependent on the timing and manner of payment of future contingent milestones from the Kolltan acquisition, in the event that the Company achieves the drug candidate milestones related to those payments. The Company, at its option, may decide to pay those milestone payments in cash, shares of its common stock or a combination thereof. If the Company is unable to raise the funds necessary to meet its liquidity needs, it may have to delay or discontinue the development of one or more programs, discontinue or delay ongoing or anticipated clinical trials, license out programs earlier than expected, raise funds at a significant discount or on other unfavorable terms, if at all, or sell all or a part of the Company.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccounting">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccounting</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6893699232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Significant Accounting Policies</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(2)&nbsp; Significant Accounting Policies</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:35pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The significant accounting policies used in preparation of these condensed consolidated financial statements for the three and six months ended June&nbsp;30, 2017 are consistent with those discussed in Note 2 to the financial statements in our Annual Report on Form&nbsp;10-K for the year ended December&nbsp;31, 2016, except for the adoption of new accounting standards during the first six months of 2017 as discussed below.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Newly-Adopted Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;1, 2017, the Company adopted a new U.S.&nbsp;GAAP accounting standard which involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company elected to continue to estimate forfeitures expected to occur to determine stock-based compensation expense. Upon adoption, the Company&#x2019;s gross deferred tax assets and corresponding valuation allowance each increased by $17.7 million related to tax deductions from the exercise of stock options that previously would have been credited to additional paid-in-capital when realized.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;1, 2017, the Company adopted a new U.S.&nbsp;GAAP accounting standard which simplifies how an entity is required to test goodwill for impairment. A goodwill impairment will be measured by the amount by which a reporting unit&#x2019;s carrying value exceeds its fair value, with the amount of impairment not to exceed the carrying amount of goodwill.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Recent Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s financial position or results of operations upon adoption.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In May&nbsp;2014, the FASB issued a new U.S GAAP accounting standard that updates guidance and disclosure requirements for recognizing revenue. The new revenue recognition standard provides a five-step model for recognizing revenue from contracts with customers. The core principle is that a company should recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard will be effective for the Company on January&nbsp;1, 2018 and can be applied using one of two methods: retrospectively to each prior period presented or a modified retrospective application by recognizing a cumulative-effect adjustment as a component of equity as of the date of adoption. The Company expects to adopt the new revenue standard using the modified retrospective application method. As of June&nbsp;30, 2017, the Company is still evaluating the impact the adoption of this standard will have on the Company&#x2019;s financial statements and disclosure. During the second half of 2017, the Company plans to finalize its review of all applicable contracts that will be affected by the adoption of this standard.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In February&nbsp;2016, the FASB issued a new U.S. GAAP accounting standard which requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for the Company on January&nbsp;1, 2019. The Company is currently evaluating the potential impact that this standard may have on the Company&#x2019;s financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In August&nbsp;2016, the FASB issued new U.S. GAAP guidance which clarifies the classification of certain cash receipts and payments in the statement of cash flows. This standard is effective for the company on January&nbsp;1, 2018. The adoption of this new guidance is not expected to have a material impact on the Company&#x2019;s financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18861-107790<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18726-107790<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18743-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68058157&amp;loc=d3e18854-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6738610272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(3)&nbsp; Fair Value Measurements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following tables set forth the Company&#x2019;s financial assets and liabilities subject to fair value measurements:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">As&nbsp;of<br />June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;1</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;2</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;3</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Money market funds and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,622
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,622
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,822
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,822
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132,444
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132,444
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Kolltan acquisition contingent consideration</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">As&nbsp;of<br />December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;1</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;2</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;3</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Money market funds and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,445
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,445
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,315
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,315
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>167,760
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>167,760
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Kolltan acquisition contingent consideration</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company&#x2019;s financial assets consist mainly of cash and cash equivalents and marketable securities and are classified as Level 2 within the valuation hierarchy. The Company values its marketable securities utilizing independent pricing services which normally derive security prices from recently reported trades for identical or similar securities, making adjustments based on significant observable transactions. At each balance sheet date, observable market inputs may include trade information, broker or dealer quotes, bids, offers or a combination of these data sources. The Company did not have any transfers of assets or liabilities between the fair value measurement classifications during the six months ended June&nbsp;30, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Contingent consideration liabilities related to acquisitions are classified as Level&nbsp;3 within the valuation hierarchy and are valued based on various estimates, including probability of success, discount rates and amount of time until the conditions of the milestone payments are met. In connection with the Kolltan acquisition, the Company may be required to pay future consideration of up to $172.5 million that is contingent upon the achievement of specified development, regulatory approvals or sales-based milestone events. The Company determines the fair value of these obligations on the acquisition date using various estimates that are not observable in the market and represent a Level&nbsp;3 measurement within the fair value hierarchy. During the three and six months ended June&nbsp;30, 2017, the Company recorded a $1.0 million and $4.4 million loss on fair value remeasurement of contingent consideration, respectively, primarily due to changes in discount rates and the passage of time. The following table reflects the activity for the Company&#x2019;s contingent consideration liabilities measured at fair value using Level 3 inputs for the six months ended June&nbsp;30, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
			<tr>
				<td valign="bottom" style="width:77.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Other&nbsp;Long-Term<br />Liabilities:<br />Contingent<br />Consideration</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Fair value adjustments included in operating expenses</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:19.04%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,400
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:17.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14172-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=6957238&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13537-108611<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13504-108611<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=73719730&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6623419200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Marketable Securities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(4)&nbsp; Marketable Securities</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following tables summarize our marketable securities, classified as available-for-sale:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Amortized<br />Cost</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Gross<br />Unrealized<br />Gains</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Gross<br />Unrealized<br />Losses</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Fair&nbsp;Value</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:51.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,253
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,254
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,253
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,254
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,588
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,568
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,588
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,568
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,841
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,822
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>52,754
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(12
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>52,747
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>296
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>304
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,050
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(12
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,051
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,320
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(56
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,264
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,320
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(56
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,264
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,370
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(68
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,315
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The marketable securities held by the Company were high investment grade and there were no marketable securities that the Company considered to be other-than-temporarily impaired as of June&nbsp;30, 2017. Marketable securities include $0.4 million and $0.6 million in accrued interest at June&nbsp;30, 2017 and December&nbsp;31, 2016, respectively.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -Glossary Debt Security<br> -URI http://asc.fasb.org/extlink&amp;oid=6509901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6379141&amp;loc=d3e15032-111544<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27232-111563<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -Glossary Equity Security<br> -URI http://asc.fasb.org/extlink&amp;oid=6511694<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62557-112803<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27161-111563<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27357-111563<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27405-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619273008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets and Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(5)&nbsp; Intangible Assets and Goodwill</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Intangible assets, net of accumulated amortization, and goodwill are as follows:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Estimated<br />Life</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Cost</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Accumulated<br />Amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Net</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Cost</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Accumulated<br />Amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Net</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="19" valign="bottom" style="width:77.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Intangible Assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">IPR&amp;D</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Indefinite</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Amgen Amendment</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">16 years</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,500
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,951
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,549
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,500
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,503
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,997
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total Intangible Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,990
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,951
				</td>
				<td valign="bottom" style="width:02.00%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,039
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,990
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,503
				</td>
				<td valign="bottom" style="width:02.00%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,487
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Goodwill</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Indefinite</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The IPR&amp;D intangible asset recorded in connection with the CuraGen acquisition of $11.8&nbsp;million relates to the development of glembatumumab vedotin. At the date of acquisition and at June&nbsp;30, 2017, glembatumumab vedotin had not yet reached technological feasibility nor did it have any alternative future use. Glembatumumab vedotin is in a randomized, Phase&nbsp;2b study for the treatment of triple negative breast cancer and a Phase&nbsp;2 study for the treatment of metastatic melanoma.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company performed an impairment test of the glembatumumab vedotin IPR&amp;D and goodwill assets as of July&nbsp;1, 2016 and concluded that goodwill was not impaired.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In connection with the Kolltan Acquisition, effective November&nbsp;29, 2016, the Company recorded IPR&amp;D intangible assets primarily related to the development of the CDX-0158, CDX-3379 and TAM programs with a fair value of $40.0&nbsp;million, $3.5&nbsp;million and $18.0&nbsp;million, respectively. At the date of acquisition and at June&nbsp;30, 2017, the CDX-1058, CDX-3379 and TAM programs had not yet reached technological feasibility nor did they have any alternative future use. CDX-0158 is a humanized monoclonal antibody currently in a Phase&nbsp;1 dose escalation study in refractory gastrointestinal stromal tumors and CDX-3379 is a human monoclonal antibody which recently completed a Phase&nbsp;1b study in patients with solid tumors. The TAM program is a multi-faceted broad antibody discovery effort to generate antibodies that modulate the TAM family of RTKs, comprised of Tyro3, AXL and MerTK, which are expressed on tumor-infiltrating macrophages, dendritic cells and some tumors.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6624698880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">Other Long-Term Liabilities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;punctuation-wrap:hanging;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(6)&nbsp;Other Long-Term Liabilities</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Other long-term liabilities include the following:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred Rent</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>398
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Net Deferred Tax Liabilities related to IPR&amp;D</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,054
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,054
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred Income from Sale of Tax Benefits</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,940
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,436
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Accrued Lease Restructuring</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,150
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,154
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Long-Term Severance</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>181
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>539
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Contingent Milestones</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred Revenue</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,729
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,749
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>91,364
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,530
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Less Current Portion</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,538
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4,826
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Long-Term Portion</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>85,826
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>82,704
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In November&nbsp;2015, December&nbsp;2014, January&nbsp;2014 and January&nbsp;2013, the Company received approval from the New Jersey Economic Development Authority and agreed to sell New Jersey tax benefits of $9.8 million, $1.9&nbsp;million, $1.1&nbsp;million and $0.8&nbsp;million to an independent third party for $9.2 million, $1.8&nbsp;million, $1.0&nbsp;million and $0.8&nbsp;million, respectively. Under the agreement, the Company must maintain a base of operations in New Jersey for five years or the tax benefits must be paid back on a pro-rata basis based on the number of years completed. The Company recorded $0.5 million and $0.6 million to other income related to the sale of these tax benefits during the six months ended June&nbsp;30, 2017 and 2016, respectively.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In December&nbsp;2016, the Company decided not to occupy the 11,500 square feet of expansion space (&#x201C;Needham Expansion&#x201D;) at its Needham, Massachusetts facility. The Company agreed to lease the Needham Expansion in August&nbsp;2015 and the term of the lease expires in July&nbsp;2020. The Company is actively trying to sublease the lease obligation. In March&nbsp;2017, the Company terminated its lease in Branford, CT and consolidated its Connecticut operations in its New Haven, CT facility. The Company recorded restructuring expense of $0.2 million to general and administrative expense related to the Branford, CT lease termination. The activity related to accrued lease restructuring for the six months ended June&nbsp;30, 2017 is presented below (in thousands):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
			<tr>
				<td valign="bottom" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Accrued&nbsp;Lease<br />Restructuring</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,154
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expense</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>267
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Payments</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(271
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,150
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6623949360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(7)&nbsp;Stockholders&#x2019; Equity</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In May&nbsp;2016, the Company entered into an agreement with Cantor Fitzgerald&nbsp;&amp;&nbsp;Co. (&#x201C;Cantor&#x201D;) to allow the Company to issue and sell shares of its common stock having an aggregate offering price of up to $60.0&nbsp;million from time to time through Cantor, acting as agent. During the six months ended June&nbsp;30, 2017, Company issued 6,731,066 shares of its common stock under this controlled equity offering sales agreement with Cantor resulting in net proceeds to the Company of $21.5 million, after deducting commission and offering expenses. At June&nbsp;30, 2017, the Company had $23.1 million remaining in aggregate gross offering price available under the agreement.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74567-122707<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21484-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21488-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187143-122770<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21506-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23285-112656<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21475-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Preferred Stock<br> -URI http://asc.fasb.org/extlink&amp;oid=6521494<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 16: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21564-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6616580336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(8)&nbsp; Stock-Based Compensation</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">A summary of stock option activity for the six months ended June&nbsp;30, 2017 is as follows:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Weighted<br />Average<br />Exercise<br />Price<br />Per&nbsp;Share</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Weighted<br />Average<br />Remaining<br />Contractual<br />Term&nbsp;(In&nbsp;Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Outstanding at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,218,710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11.14
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.5
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,283,100
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.34
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Canceled</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(413,100
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10.66
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Outstanding at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,088,710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9.49
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.5
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Vested and Expected to Vest at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,931,869
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9.54
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.5
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Exercisable at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,085,429
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10.93
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.7
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Shares Available for Grant under the 2008 Plan</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,292,650
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The weighted average grant-date fair value of stock options granted during the six month period ended June&nbsp;30, 2017 was $1.57. Stock-based compensation expense for the three and six months ended June&nbsp;30, 2017 and 2016 was recorded as follows:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,871
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,008
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,764
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,824
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,579
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,965
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,225
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,089
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,450
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,973
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,989
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,913
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The fair value of employee and director stock options granted during the three and six month periods ended June&nbsp;30, 2017 and 2016 were valued using the Black-Scholes option-pricing model with the following assumptions:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expected stock price volatility</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76%
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>77%
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">76 &#x2013; 77%</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">70 &#x2013; 77%</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expected option term</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Risk-free interest rate</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">2.0 &#x2013; 2.1%</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.5%
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">2.0 &#x2013; 2.3%</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">1.5 &#x2013; 1.6%</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expected dividend yield</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 40<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65895303&amp;loc=d3e17540-113929<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68057994&amp;loc=d3e25284-112666<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5444-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6622360544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(9)&nbsp;Accumulated Other Comprehensive Income</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:34.5pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The changes in accumulated other comprehensive income, which is reported as a component of stockholders&#x2019; equity, for the six months ended June&nbsp;30, 2017 are summarized below:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Unrealized&nbsp;Gain<br />(Loss)&nbsp;on<br />Marketable<br />Securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Foreign<br />Currency&nbsp;Items</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(55
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,596
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,541
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Other comprehensive gain</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,596
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,577
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:34.55pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">No amounts were reclassified out of accumulated other comprehensive income during the six months ended June&nbsp;30, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e689-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e640-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e716-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e709-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e637-108580<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=d3e681-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Reclassification Adjustments<br> -URI http://asc.fasb.org/extlink&amp;oid=6522872<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632941936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_SignificantRevenueArrangementsDisclosureAbstract', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_SignificantRevenueArrangementsDisclosureTextBlock', window );">Revenue</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(10)&nbsp; Revenue</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Bristol-Myers Squibb Company (BMS)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In 2014, the Company entered into a clinical trial collaboration with BMS to evaluate the safety, tolerability and preliminary efficacy of varlilumab and Opdivo</font><font style="display:inline;font-size:6.5pt;">&#xAE;</font><font style="display:inline;">, BMS&#x2019;s PD-1 immune checkpoint inhibitor, in a Phase 1/2 study. Under the terms of this clinical trial collaboration, BMS made a one-time payment to the Company of $5.0 million and BMS and the Company amended the terms of the Company&#x2019;s existing license agreement with Medarex, which was acquired by BMS, related to the Company&#x2019;s CD27 program whereby certain future milestone payments were waived and future royalty rates were reduced that may have been due from the Company to Medarex. In return, BMS was granted a time-limited right of first negotiation if the Company wishes to out-license varlilumab. The companies also agreed to work exclusively with each other to explore anti-PD-1 antagonist antibody and anti-CD27 agonist antibody combination regimens. The clinical trial collaboration provides that the companies share development costs and that the Company will be responsible for conducting the ongoing Phase 1/2 study.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has determined that its performance obligations under the BMS agreement, which primarily include performing research and development, supplying varlilumab and participating in the joint development committee, should be accounted for as a single unit of accounting and estimated that its performance period under the BMS agreement would be 5 years. Accordingly, the $5.0 million up-front payment was initially recorded as deferred revenue and is being recognized as revenue on a straight-line basis over the estimated 5-year performance period using the Contingency Adjusted Performance Model (&#x201C;CAPM&#x201D;). The BMS agreement also provides for BMS to reimburse the Company for 50% of the external costs incurred by the Company in connection with the clinical trial. The BMS payments are recognized as revenue under the CAPM. The Company recorded $0.7 million and $1.2 million in revenue related to the BMS agreement during the three and six months ended June&nbsp;30, 2017, respectively, and $0.6&nbsp;million and $1.0 million during the three and six months ended June&nbsp;30, 2016, respectively.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Rockefeller University (Rockefeller)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In 2013, the Company entered into an agreement, as amended, with Rockefeller pursuant to which the Company performs research and development services for Rockefeller. The Company bills Rockefeller quarterly for actual time and direct costs incurred and records those amounts to revenue in the quarter the services are performed. The Company recorded $0.3 million and $1.1 million in revenue related to the Rockefeller agreement during the three and six months ended June&nbsp;30, 2017, respectively, and $0.4&nbsp;million and $0.8 million during the three and six months ended June&nbsp;30, 2016, respectively.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">International AIDS Vaccine Initiative (IAVI)</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In 2017, the Company entered into an agreement with IAVI pursuant to which the Company will perform research and development services for IAVI outlined under subsequently negotiated task orders. Revenue is recognized as services are performed under the negotiated task orders. The Company recorded $2.3 million in revenue related to the IAVI agreement during the three and six months ended June&nbsp;30, 2017.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_SignificantRevenueArrangementsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_SignificantRevenueArrangementsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_SignificantRevenueArrangementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element may be used to capture the complete disclosure pertaining to an entity's significant revenue contracts and arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_SignificantRevenueArrangementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6623896352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Kolltan Acquisition<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Kolltan Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Kolltan Acquisition</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(11) Kolltan Acquisition</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In connection with the Kolltan Acquisition, effective November&nbsp;29, 2016, the Company issued 18,257,996 shares of common stock of the Company in exchange for all of the share and debt interests in Kolltan. The Company also agreed to issue an aggregate of 437,901 shares of its common stock, less tax withholdings, to certain former officers of Kolltan. During the six months ended June&nbsp;30, 2017, the Company issued 75,637 shares of its common stock and at June&nbsp;30, 2017, the Company&#x2019;s remaining obligation is to issue 150,185 shares of its common stock, less tax withholdings, related to this severance obligation. In addition, in the event that certain specified preclinical and clinical development milestones related to Kolltan&#x2019;s development programs and/or Celldex&#x2019;s development programs and certain commercial milestones related to Kolltan&#x2019;s drug candidates are achieved, Celldex will be required to pay Kolltan&#x2019;s stockholders milestone payments of up to $172.5&nbsp;million, which milestone payments may be made, at Celldex&#x2019;s sole election, in cash, in shares of Celldex&#x2019;s common stock or a combination of both, subject to provisions of the Merger Agreement.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company acquired Kolltan to gain access to Kolltan&#x2019;s programs including: (i)&nbsp;CDX-0158 (formerly KTN0158) which is currently in a Phase&nbsp;1 dose escalation study in patients with refractory gastrointestinal stromal tumors (GIST); (ii)&nbsp;CDX-3379 (formerly KTN3379) which recently completed a Phase&nbsp;1b study with combination cohorts where meaningful responses and stable disease were observed in cetuximab (Erbitux</font><font style="display:inline;font-size:6.5pt;">&#xAE;</font><font style="display:inline;">) refractory patients in patients with head and neck squamous cell carcinoma and in BRAF-mutant non-small cell lung cancer (NSCLC); and (iii)&nbsp;a multi-faceted TAM program, a broad antibody discovery effort underway to generate antibodies that modulate the TAM family of RTKs, comprised of Tyro3, AXL and MerTK, which are expressed on tumor-infiltrating macrophages, dendritic cells and some tumors.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The transaction was accounted for as a business combination with Celldex treated as the accounting acquirer. All of the assets acquired and liabilities assumed in the transaction are recognized at their acquisition-date fair values, while transaction costs associated with the transaction are expensed as incurred.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Purchase Price</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The purchase price for Kolltan was based on the acquisition-date fair value of the consideration transferred, which was calculated based on the closing price of the Company&#x2019;s common stock of $4.02 per share on November&nbsp;29, 2016. The acquisition-date fair value of the consideration transferred consisted of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;">
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Fair value of common stock issued for upfront payment</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.60%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,397
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Fair value of contingent consideration</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Kolltan transaction expenses paid in cash by the Company</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,768
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total consideration transferred</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,365
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The contingent consideration relates to the achievement of certain regulatory and sales milestones as described in the agreement. The estimated fair value of contingent consideration of $48.6 million and $44.2&nbsp;million at June&nbsp;30, 2017 and December&nbsp;31, 2016, respectively, is recorded as a noncurrent liability. The Company determined the fair value of these obligations to pay additional milestone payments using various estimates, including probabilities of success, discount rates and amount of time until the conditions of the milestone payments are met. This fair value measurement is based on significant inputs not observable in the market, representing a Level&nbsp;3 measurement within the fair value hierarchy. The resulting probability-weighted cash flows were discounted using a cost of debt rate ranging from 10-11% for the milestones. The range of estimated milestone payments is from zero, if no milestones are achieved, to $172.5&nbsp;million if all milestones are met.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Changes in the fair value of the contingent consideration are recognized in operating earnings. Changes in fair values reflect new information about the probability and timing of meeting the conditions of the milestone payments or changes in discount rates. In the absence of new information, changes in fair value will only reflect the interest component of contingent consideration related to the passage of time as development work progresses towards the achievement of the milestones.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Allocations of Assets and Liabilities</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has allocated the consideration transferred for Kolltan to net tangible assets, intangible assets, and goodwill. The difference between the aggregate consideration transferred and the fair value of assets acquired and liabilities assumed was allocated to goodwill. This goodwill relates to the potential synergies from the Kolltan Acquisition and deferred tax liabilities related to acquired IPR&amp;D intangible assets. None of the goodwill is expected to be deductible for income tax purposes. The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;">
			<tr>
				<td valign="bottom" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Cash&nbsp;and&nbsp;cash&nbsp;equivalents</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.60%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;8,160</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Other current and long-term assets</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>799
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,072
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">In-process research and development (IPR&amp;D)</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>61,690
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Goodwill</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>82,011
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred tax liabilities, net</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(23,393
				</td>
				<td valign="bottom" style="width:01.26%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Other assumed liabilities</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,974
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,365
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The purchase price allocation has been prepared on a preliminary basis and is subject to change as additional information becomes available concerning the fair value and tax basis of the acquired assets and liabilities. Any adjustments to the purchase price allocation will be made as soon as practicable but no later than one year from the acquisition date.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Pro Forma Financial Information</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">If the operations of the Company and Kolltan were combined as of January&nbsp;1, 2016, the unaudited pro forma net loss for the three and six months ended June&nbsp;30, 2016 would have been $39.5 million and $84.8 million, respectively, or $(0.34) and $(0.73) per share, respectively. The unaudited pro forma combined results are not necessarily indicative of the actual results that would have occurred had the acquisition been consummated at that date or of the future operations of the combined entities.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1497-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1490-128463<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 6: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 7: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 8: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1524-128463<br><br>Reference 9: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7000-128479<br><br>Reference 10: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4922-128472<br><br>Reference 11: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4934-128472<br><br>Reference 12: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4926-128472<br><br>Reference 13: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=SL65897772-128472<br><br>Reference 14: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1383-128463<br><br>Reference 15: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6996-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6637082400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(12)&nbsp; Income Taxes</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Massachusetts, New Jersey and Connecticut are the three states in which the Company primarily operates or has operated and has income tax nexus. The Company&#x2019;s wholly-owned subsidiary Celldex Australia Pty Ltd operates in Brisbane, Australia. The Company is not currently under examination by any jurisdictions for any tax year.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The Company has evaluated the positive and negative evidence bearing upon the realizability of its net deferred tax assets, which are comprised principally of net operating loss carryforwards, capitalized R&amp;D expenditures and R&amp;D tax credit carryforwards. The Company has determined that it is more likely than not that it will not recognize the benefits of federal and state deferred tax assets and, as a result, a full valuation allowance was maintained at June&nbsp;30, 2017 and December&nbsp;31, 2016 against the Company&#x2019;s net deferred tax assets.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=26873400&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32718-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32639-109319<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6619497344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-weight:bold;">(13)&nbsp; Net Loss Per Share</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">Basic net loss per common share is based upon the weighted-average number of common shares outstanding during the period, excluding restricted stock that has been issued but is not yet vested. Diluted net loss per common share is based upon the weighted-average number of common shares outstanding during the period plus additional weighted-average potentially dilutive common shares outstanding during the period when the effect is dilutive. The potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive are as follows:</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Stock options</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,088,710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,260,073
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Restricted stock</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>96,668
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,000
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,185,378
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,320,073
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1252-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=65016374&amp;loc=d3e4984-109258<br><br>Reference 5: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 225<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=63488584&amp;loc=d3e20235-122688<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6738553264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Significant Accounting Policies</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock', window );">Newly-Adopted Accounting Pronouncements</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Newly-Adopted Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;1, 2017, the Company adopted a new U.S.&nbsp;GAAP accounting standard which involves several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities and classification on the statement of cash flows. The Company elected to continue to estimate forfeitures expected to occur to determine stock-based compensation expense. Upon adoption, the Company&#x2019;s gross deferred tax assets and corresponding valuation allowance each increased by $17.7 million related to tax deductions from the exercise of stock options that previously would have been credited to additional paid-in-capital when realized.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">On January&nbsp;1, 2017, the Company adopted a new U.S.&nbsp;GAAP accounting standard which simplifies how an entity is required to test goodwill for impairment. A goodwill impairment will be measured by the amount by which a reporting unit&#x2019;s carrying value exceeds its fair value, with the amount of impairment not to exceed the carrying amount of goodwill.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;font-style:italic;">Recent Accounting Pronouncements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that are adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s financial position or results of operations upon adoption.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In May&nbsp;2014, the FASB issued a new U.S GAAP accounting standard that updates guidance and disclosure requirements for recognizing revenue. The new revenue recognition standard provides a five-step model for recognizing revenue from contracts with customers. The core principle is that a company should recognize revenue when it transfers goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods and services. The new standard will be effective for the Company on January&nbsp;1, 2018 and can be applied using one of two methods: retrospectively to each prior period presented or a modified retrospective application by recognizing a cumulative-effect adjustment as a component of equity as of the date of adoption. The Company expects to adopt the new revenue standard using the modified retrospective application method. As of June&nbsp;30, 2017, the Company is still evaluating the impact the adoption of this standard will have on the Company&#x2019;s financial statements and disclosure. During the second half of 2017, the Company plans to finalize its review of all applicable contracts that will be affected by the adoption of this standard.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In February&nbsp;2016, the FASB issued a new U.S. GAAP accounting standard which requires that all lessees recognize the assets and liabilities that arise from leases on the balance sheet and disclose qualitative and quantitative information about its leasing arrangements. The new standard will be effective for the Company on January&nbsp;1, 2019. The Company is currently evaluating the potential impact that this standard may have on the Company&#x2019;s financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">In August&nbsp;2016, the FASB issued new U.S. GAAP guidance which clarifies the classification of certain cash receipts and payments in the statement of cash flows. This standard is effective for the company on January&nbsp;1, 2018. The adoption of this new guidance is not expected to have a material impact on the Company&#x2019;s financial statements.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to newly-adopted accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_NewlyAdoptedAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6632941936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Measurements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of financial assets and liabilities subject to fair value measurements</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;"><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">As&nbsp;of<br />June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;1</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;2</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;3</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Money market funds and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,622
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,622
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,822
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,822
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132,444
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>132,444
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Kolltan acquisition contingent consideration</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -11.2pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">As&nbsp;of<br />December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;1</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;2</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Level&nbsp;3</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Money market funds and cash equivalents</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,445
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,445
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,315
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,315
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>167,760
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>167,760
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Liabilities:</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Kolltan acquisition contingent consideration</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock', window );">Schedule of the activity for the Company's contingent consideration liabilities measured at fair value using Level 3 inputs</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
			<tr>
				<td valign="bottom" style="width:77.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Other&nbsp;Long-Term<br />Liabilities:<br />Contingent<br />Consideration</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Fair value adjustments included in operating expenses</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:19.04%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,400
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:19.04%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:17.74%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:77.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.92%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:17.74%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of contingent payment arrangements including the terms that will result in payment and the accounting treatment that will be followed if such contingencies occur, including the potential impact on earnings per share if contingencies are to be settled in common stock of the entity. The description also may include the period over which amounts are expected to be paid, and changes in the amount since the previous reporting period. This also includes contingent options and commitments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6604026720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Marketable Securities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Marketable Securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock', window );">Summary of marketable securities, classified as available-for-sale</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;"><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Amortized<br />Cost</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Gross<br />Unrealized<br />Gains</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Gross<br />Unrealized<br />Losses</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Fair&nbsp;Value</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:51.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,253
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,254
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,253
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>18,254
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,588
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,568
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,588
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(22
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>69,568
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,841
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(28
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,822
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;font-weight:bold;">December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>52,754
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(12
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>52,747
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>296
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>304
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total U.S. government and municipal obligations</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,050
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(12
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>53,051
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing in one year or less</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,320
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(56
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,264
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 40.4pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Maturing after one year through three years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:11.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 30.3pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total corporate debt securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,320
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(56
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>94,264
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total marketable securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,370
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(68
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:09.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,315
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:45.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6893606576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Intangible Assets and Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock', window );">Schedule of intangible assets, net of accumulated amortization, and goodwill</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;"><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:32.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Estimated<br />Life</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Cost</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Accumulated<br />Amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Net</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Cost</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Accumulated<br />Amortization</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Net</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="19" valign="bottom" style="width:77.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Intangible Assets:</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">IPR&amp;D</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Indefinite</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,490
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Amgen Amendment</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">16 years</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,500
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,951
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,549
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>14,500
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,503
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,997
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:10.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:09.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total Intangible Assets</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,990
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,951
				</td>
				<td valign="bottom" style="width:02.00%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,039
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,990
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(6,503
				</td>
				<td valign="bottom" style="width:02.00%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>81,487
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Goodwill</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Indefinite</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:07.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>90,976
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:19.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:09.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:08.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:07.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6622883424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureAbstract', window );"><strong>Other Long-Term Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock', window );">Schedule of other long-term liabilities</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">June&nbsp;30,&nbsp;2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">December&nbsp;31,&nbsp;2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred Rent</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>398
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Net Deferred Tax Liabilities related to IPR&amp;D</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,054
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>28,054
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred Income from Sale of Tax Benefits</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,940
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,436
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Accrued Lease Restructuring</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,150
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,154
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Long-Term Severance</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>181
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>539
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Contingent Milestones</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>48,600
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred Revenue</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,729
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,749
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 20.2pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>91,364
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>87,530
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Less Current Portion</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(5,538
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(4,826
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Long-Term Portion</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>85,826
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>82,704
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock', window );">Schedule of activity related to accrued lease restructuring</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The activity related to accrued lease restructuring for the six months ended June&nbsp;30, 2017 is presented below (in thousands):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 86.00%;margin-left:36pt;">
			<tr>
				<td valign="bottom" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Accrued&nbsp;Lease<br />Restructuring</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,154
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expense</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>267
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Payments</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(271
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:13.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.30%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,150
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:82.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.30%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.54%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.16%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other long-term liabilities, not separately disclosed on the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_ScheduleOfOtherLongTermLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6738660224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Stock-Based Compensation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of stock option activity</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;"><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Shares</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Weighted<br />Average<br />Exercise<br />Price<br />Per&nbsp;Share</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Weighted<br />Average<br />Remaining<br />Contractual<br />Term&nbsp;(In&nbsp;Years)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Outstanding at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,218,710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11.14
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.5
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Granted</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,283,100
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2.34
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Exercised</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Canceled</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(413,100
				</td>
				<td valign="bottom" style="width:02.50%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10.66
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Outstanding at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,088,710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9.49
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.5
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Vested and Expected to Vest at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,931,869
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9.54
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6.5
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Options Exercisable at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,085,429
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10.93
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4.7
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Shares Available for Grant under the 2008 Plan</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,292,650
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of stock-based compensation expense</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="5" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="11" valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Research and development</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,871
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,008
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,764
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,824
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">General and administrative</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,579
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,965
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,225
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>4,089
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total stock-based compensation expense</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,450
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,973
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,989
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,913
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of assumptions used for the fair value of employee and director stock options granted</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Three&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expected stock price volatility</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>76%
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>77%
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">76 &#x2013; 77%</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">70 &#x2013; 77%</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expected option term</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">6.0 years</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Risk-free interest rate</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">2.0 &#x2013; 2.1%</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1.5%
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">2.0 &#x2013; 2.3%</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">1.5 &#x2013; 1.6%</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Expected dividend yield</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">None</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for share options (or share units) that were outstanding at the beginning and end of the year, vested and expected to vest, exercisable or convertible at the end of the year, and the number of share options or share units that were granted, exercised or converted, forfeited, and expired during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6616815408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract', window );"><strong>Accumulated Other Comprehensive Income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Summary of changes in accumulated other comprehensive income</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;"><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Unrealized&nbsp;Gain<br />(Loss)&nbsp;on<br />Marketable<br />Securities</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Foreign<br />Currency&nbsp;Items</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Total</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="8" valign="bottom" style="width:41.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">(In&nbsp;thousands)</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at December&nbsp;31, 2016</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(55
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,596
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,541
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Other comprehensive gain</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&#x2014;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>36
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Balance at June&nbsp;30, 2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(19
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,596
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,577
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:55.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.88%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.12%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:10.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6873876960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Kolltan Acquisition (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Kolltan Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock', window );">Schedule of acquisition-date fair value of the consideration transferred</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The acquisition-date fair value of the consideration transferred consisted of the following (in thousands):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;">
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Fair value of common stock issued for upfront payment</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.60%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>73,397
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Fair value of contingent consideration</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>44,200
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Kolltan transaction expenses paid in cash by the Company</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,768
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total consideration transferred</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,365
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Summary of fair values of the assets acquired and liabilities assumed at the acquisition date</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">The following table summarizes the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands):</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 80.00%;margin-left:54pt;">
			<tr>
				<td valign="bottom" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Cash&nbsp;and&nbsp;cash&nbsp;equivalents</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.60%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;8,160</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Other current and long-term assets</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>799
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Property and equipment, net</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,072
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">In-process research and development (IPR&amp;D)</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>61,690
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Goodwill</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>82,011
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Deferred tax liabilities, net</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(23,393
				</td>
				<td valign="bottom" style="width:01.26%;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Other assumed liabilities</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,974
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">)</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td colspan="2" valign="bottom" style="width:15.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Total</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.40%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">$</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>121,365
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:80.62%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:03.12%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.40%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:13.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.26%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table  does not include leveraged buyouts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1486-128463<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6734523040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2017</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net Loss Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
<td class="text"><div> <div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;"><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display:inline;;font-size: 10pt;font-family:Times New Roman,Times,serif;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font></font>
		</p>
		<div style="width:100%;"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;width: 100.00%;margin-left:0pt;">
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td colspan="3" valign="bottom" style="width:26.50%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">Six&nbsp;months&nbsp;ended&nbsp;June&nbsp;30,</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="bottom" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-size:8pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2017</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 8pt;">
						<font style="display:inline;font-weight:bold;font-size:8pt;">2016</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:center;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;text-align:right;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Stock options</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,088,710
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,260,073
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">Restricted stock</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>96,668
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>60,000
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt 0pt 0pt 10.1pt;line-height:106.67%;text-indent: -10.1pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						<font style="display:inline;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>12,185,378
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
				<td valign="bottom" style="width:12.00%;background-color: #CCEEFF;;font-family:Times New Roman,Times,serif;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>10,320,073
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 10pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:70.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:02.50%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:12.00%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2pt double #000000 ;border-right:1pt none #D9D9D9 ;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
				<td valign="bottom" style="width:01.00%;background-color: #CCEEFF;padding:0pt;">
					<p style="margin:0pt;line-height:106.67%;font-family:Times New Roman,Times,serif;font-size: 1pt;">
						<font style="display:inline;font-size:1pt;">&nbsp;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 10pt;">
			<font style="display:inline;">&nbsp;</font>
		</p><div /></div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6734552928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation - (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Basis of Presentation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAndCash', window );">Cash, cash equivalents and marketable securities</a></td>
<td class="nump">$ 154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 154,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net Loss</a></td>
<td class="num">$ (28,566)<span></span>
</td>
<td class="num">$ (31,952)<span></span>
</td>
<td class="num">(62,827)<span></span>
</td>
<td class="num">$ (66,625)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 56,049<span></span>
</td>
<td class="nump">$ 68,732<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAndCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of investments and unrestricted cash as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6879938&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAndCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3521-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=64863997&amp;loc=d3e1377-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6878343216">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Accounting Policies - (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jan. 01, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cldx_AccountingStandardsUpdateMember', window );">Accounting Standards Update | Adjustments for New Accounting Principle, Early Adoption</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>Newly-Adopted Accounting Pronouncements</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_GrossDeferredTaxAssetsAndCorrespondingValuation', window );">Increase in deferred tax and valuation allowance</a></td>
<td class="nump">$ 17.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_GrossDeferredTaxAssetsAndCorrespondingValuation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross deferred tax assets and valuation allowance related to tax deductions from the exercise of stock options that would have been credited to additional paid-in-capital when realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_GrossDeferredTaxAssetsAndCorrespondingValuation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cldx_AccountingStandardsUpdateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=cldx_AccountingStandardsUpdateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementEarlyAdoptionAxis=us-gaap_AdjustmentsForNewAccountingPrincipleEarlyAdoptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6749846608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 29, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Roll-forward of acquisition-related contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustments included in operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels', window );">Assets transferred between the fair value measurement classifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels', window );">Liabilities transferred between the fair value measurement classifications</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember', window );">Kolltan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Roll-forward of acquisition-related contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessAcquisitionMileStonePayments', window );">Maximum amount of future consideration payable</a></td>
<td class="nump">$ 172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements | Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,622<span></span>
</td>
<td class="nump">$ 20,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,822<span></span>
</td>
<td class="nump">147,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,444<span></span>
</td>
<td class="nump">167,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Kolltan acquisition contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Roll-forward of acquisition-related contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,622<span></span>
</td>
<td class="nump">20,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecurities', window );">Marketable securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,822<span></span>
</td>
<td class="nump">147,315<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,444<span></span>
</td>
<td class="nump">167,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Kolltan acquisition contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities at fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Roll-forward of acquisition-related contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements | Fair value | Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Roll-forward of acquisition-related contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustments included in operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value Measurements | Fair value | Level 3 | Other Long-Term Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Kolltan acquisition contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="nump">$ 48,600<span></span>
</td>
<td class="nump">$ 44,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Roll-forward of acquisition-related contingent consideration</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Balance at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Fair value adjustments included in operating expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Balance at end of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 48,600<span></span>
</td>
<td class="nump">$ 48,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessAcquisitionMileStonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of milestone payments to Kolltan Stockholders pending certain commercial and product milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessAcquisitionMileStonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transfer of assets measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_FairValueAssetsAmountTransfersBetweenMeasurementLevels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of transfer of liabilities measured on a recurring basis between Level 1, Level 2 and Level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_FairValueLiabilitiesAmountTransfersBetweenMeasurementLevels</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt and equity securities categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65884222&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27232-111563<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66010992&amp;loc=d3e26610-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash<br> -URI http://asc.fasb.org/extlink&amp;oid=6506951<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Cash Equivalents<br> -URI http://asc.fasb.org/extlink&amp;oid=6507016<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementBasisAxis=us-gaap_EstimateOfFairValueFairValueDisclosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6745958288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Marketable Securities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">$ 87,841<span></span>
</td>
<td class="nump">$ 147,370<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract', window );"><strong>Gross Unrealized Gains</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">9<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(68)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">87,822<span></span>
</td>
<td class="nump">147,315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired', window );">Marketable securities considered to be other-than-temporarily impaired</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestReceivable', window );">Accrued interest included in marketable securities</a></td>
<td class="nump">400<span></span>
</td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cldx_USGovernmentAndMunicipalObligationsMember', window );">U.S. government and municipal obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Maturing in one year or less</a></td>
<td class="nump">18,253<span></span>
</td>
<td class="nump">52,754<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost', window );">Maturing after one year through three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">18,253<span></span>
</td>
<td class="nump">53,050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract', window );"><strong>Gross Unrealized Gains</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain', window );">Maturing in one year or less</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain', window );">Maturing after one year through three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">7<span></span>
</td>
<td class="nump">13<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses', window );">Maturing in one year or less</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(6)<span></span>
</td>
<td class="num">(12)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Maturing in one year or less</a></td>
<td class="nump">18,254<span></span>
</td>
<td class="nump">52,747<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue', window );">Maturing after one year through three years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">18,254<span></span>
</td>
<td class="nump">53,051<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt securities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract', window );"><strong>Amortized Cost</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost', window );">Maturing in one year or less</a></td>
<td class="nump">69,588<span></span>
</td>
<td class="nump">94,320<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized cost</a></td>
<td class="nump">69,588<span></span>
</td>
<td class="nump">94,320<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract', window );"><strong>Gross Unrealized Gains</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain', window );">Maturing in one year or less</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract', window );"><strong>Gross Unrealized Losses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses', window );">Maturing in one year or less</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract', window );"><strong>Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Maturing in one year or less</a></td>
<td class="nump">69,568<span></span>
</td>
<td class="nump">94,264<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Fair Value</a></td>
<td class="nump">$ 69,568<span></span>
</td>
<td class="nump">$ 94,264<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the amount of investment in debt and equity securities considered to be other-than-temporarily impaired, categorized neither as held-to-maturity nor trading.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesConsideredToBeOtherThanTemporarilyImpaired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of available-for-sale debt securities at cost, net of adjustments, maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of available-for-sale debt securities at fair value maturing in the second fiscal year through the third fiscal year following the latest fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature after one year and through three years from the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsGrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the gross unrealized gains on securities, at a point in time, for those securities which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the gross unrealized losses on securities, at a point in time, which are expected to mature within one year of the balance sheet date, and which are categorized neither as held-to-maturity nor as trading securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearGrossUnrealizedLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AvailableForSaleSecuritiesGrossUnrealizedLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the cost of debt securities, which are categorized neither as held-to-maturity nor trading, net of adjustments including accretion, amortization, collection of cash, previous other-than-temporary impairments recognized in earnings (less any cumulative-effect adjustments recognized, as defined), and fair value hedge accounting adjustments, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized gain in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of unrealized loss in accumulated other comprehensive income (AOCI) on investments in debt and equity securities classified as available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAmortizedCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after adjustments of available-for-sale debt securities at cost, maturing in the next fiscal year following the latest fiscal year. Adjustments include, but are not limited to, accretion, amortization, collection of cash, previous other-than-temporary impairments (OTTI) recognized in earnings less cumulative-effect adjustments, and fair value hedge accounting adjustments. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of available-for-sale debt securities maturing in the next fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27198-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6957658&amp;loc=d3e62586-112803<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=73527792&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments in debt securities classified as available-for-sale, expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 25<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=65884222&amp;loc=d3e22054-111558<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=66010992&amp;loc=d3e26626-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesGrossUnrealizedGainAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of interest earned but not received. Also called accrued interest or accrued interest receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cldx_USGovernmentAndMunicipalObligationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=cldx_USGovernmentAndMunicipalObligationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MajorTypesOfDebtAndEquitySecuritiesAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6748493456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Nov. 29, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Intangible Assets and Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 90,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-lived intangible asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Total Intangible Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Cost of total intangible assets</a></td>
<td class="nump">87,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible Assets, Net</a></td>
<td class="nump">81,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81,487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense for intangible assets</a></td>
<td class="nump">224<span></span>
</td>
<td class="nump">$ 254<span></span>
</td>
<td class="nump">$ 448<span></span>
</td>
<td class="nump">$ 507<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember', window );">Kolltan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Intangible Assets and Goodwill</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 82,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cldx_AmgenAmendmentMember', window );">Amgen Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-lived intangible asset</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Cost</a></td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(6,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,951)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,503)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net</a></td>
<td class="nump">7,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,997<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">73,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 73,490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D | CuraGen</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Indefinite-lived intangible assets</a></td>
<td class="nump">$ 11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D | Kolltan | CDX-0158</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure', window );">Fair value of Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D | Kolltan | CDX-3379</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure', window );">Fair value of Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">IPR&amp;D | Kolltan | TAM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived intangible assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure', window );">Fair value of Intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_FiniteLivedAndIndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19190-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cldx_AmgenAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=cldx_AmgenAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cldx_CuraGenCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cldx_CuraGenCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=cldx_CDX1058Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=cldx_CDX1058Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=cldx_CDX3379Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=cldx_CDX3379Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductOrServiceAxis=cldx_TMProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductOrServiceAxis=cldx_TMProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6748438128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Long-Term Liabilities (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="4">1 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2015 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2014 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jan. 31, 2013 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2016 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2016 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRentCredit', window );">Deferred Rent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 710<span></span>
</td>
<td class="nump">$ 398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net Deferred Tax Liabilities related to IPR&amp;D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,054<span></span>
</td>
<td class="nump">28,054<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_DeferredIncomeFromSaleOfTaxBenefits', window );">Deferred Income from Sale of Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,940<span></span>
</td>
<td class="nump">9,436<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued Lease Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_LongTermSeveranceLiability', window );">Long-Term Severance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">181<span></span>
</td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent Milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,600<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,729<span></span>
</td>
<td class="nump">3,749<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilities', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">91,364<span></span>
</td>
<td class="nump">87,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Less Current Portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,538)<span></span>
</td>
<td class="num">(4,826)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Long-Term Portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85,826<span></span>
</td>
<td class="nump">82,704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ValueOfTaxBenefitsAgreedToBeSold', window );">Amount at which New Jersey tax benefit agreed to be sold</a></td>
<td class="nump">$ 9,800<span></span>
</td>
<td class="nump">$ 1,900<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ValueAtWhichTaxBenefitsSold', window );">Amount of sale of New Jersey tax benefit</a></td>
<td class="nump">$ 9,200<span></span>
</td>
<td class="nump">$ 1,800<span></span>
</td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained', window );">Period for which base of operations must be maintained</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfOtherAssets', window );">Other income related to sale of tax benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAbstract', window );"><strong>Accrued Lease Restructuring</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=cldx_NeedhamExpansionMember', window );">Needham Expansion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Accrued Lease Restructuring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,150<span></span>
</td>
<td class="nump">$ 1,154<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AreaOfLand', window );">Expansion space (in square feet) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserveAbstract', window );"><strong>Accrued Lease Restructuring</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Beginning Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRestructuring', window );">Payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(271)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringReserve', window );">Ending Balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative | Branford, CT lease termination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCosts', window );">Restructuring expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_DeferredIncomeFromSaleOfTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the deferred income from the sale of tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_DeferredIncomeFromSaleOfTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_LongTermSeveranceLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long term severance liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_LongTermSeveranceLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_PeriodForWhichBaseOfOperationsMustBeMaintained">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents period for which base of operations must be maintained in New Jersey.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_PeriodForWhichBaseOfOperationsMustBeMaintained</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ValueAtWhichTaxBenefitsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value at which tax benefit sold by the entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_ValueAtWhichTaxBenefitsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ValueOfTaxBenefitsAgreedToBeSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the value of tax benefits agreed to be sold by the entity during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_ValueOfTaxBenefitsAgreedToBeSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AreaOfLand">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area of land held.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AreaOfLand</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRentCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative difference between the rental payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense over the term of the leased property by the lessor or lessee, respectively.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7501430&amp;loc=d3e39896-112707<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRentCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65882285&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of other assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15)<br> -URI http://asc.fasb.org/extlink&amp;oid=6876686&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6904-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=28358313&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRestructuring">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRestructuring</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140864-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after cash payment, of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserve">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=27011515&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserve</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringReserveAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringReserveAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cldx_NeedhamExpansionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cldx_NeedhamExpansionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=cldx_BranfordCTMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=cldx_BranfordCTMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6749889072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>May 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of common stock</a></td>
<td class="nump">$ 21,489<span></span>
</td>
<td class="nump">$ 2,551<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=cldx_CantorFitzgeraldAndCompanyAgreementMember', window );">Cantor agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock issued (in shares)</a></td>
<td class="nump">6,731,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from sale of common stock</a></td>
<td class="nump">$ 21,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockIssuedRemainingAuthorizedAmount', window );">Aggregate gross offering price available</a></td>
<td class="nump">$ 23,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=cldx_CantorFitzgeraldAndCompanyAgreementMember', window );">Cantor agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockholdersEquityLineItems', window );"><strong>Stockholders' Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_StockIssuedAuthorizedAmount', window );">Aggregate offering price of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_StockIssuedAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum amount of stock issued authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_StockIssuedAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_StockIssuedRemainingAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of stock issued authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_StockIssuedRemainingAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_StockholdersEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_StockholdersEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Financing Activities<br> -URI http://asc.fasb.org/extlink&amp;oid=6513228<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66902209&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=27012166&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CounterpartyNameAxis=cldx_CantorFitzgeraldAndCompanyAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CounterpartyNameAxis=cldx_CantorFitzgeraldAndCompanyAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6737419376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Plans (Details) - Stock options - $ / shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding at beginning of the period (in shares)</a></td>
<td class="nump">10,218,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">2,283,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Canceled (in shares)</a></td>
<td class="num">(413,100)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options Outstanding at the end of the period (in shares)</a></td>
<td class="nump">12,088,710<span></span>
</td>
<td class="nump">10,218,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Options Vested and Expected to Vest at the end of the period (in shares)</a></td>
<td class="nump">11,931,869<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Options Exercisable at the end of the period (in shares)</a></td>
<td class="nump">7,085,429<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Shares Available for Grant under the 2008 Plan</a></td>
<td class="nump">7,292,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding at beginning of the period (in dollars per share)</a></td>
<td class="nump">$ 11.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">2.34<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Canceled (in dollars per share)</a></td>
<td class="nump">10.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options Outstanding at the end of the period (in dollars per share)</a></td>
<td class="nump">9.49<span></span>
</td>
<td class="nump">$ 11.14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Options Vested and Expected to Vest at the end of the period (in dollars per share)</a></td>
<td class="nump">9.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Options Exercisable at the end of the period (in dollars per share)</a></td>
<td class="nump">$ 10.93<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract', window );"><strong>Weighted Average Remaining Contractual Term (In Years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Options Outstanding at the end of the period</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options Vested and Expected to Vest at the end of the period</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options Exercisable at the end of the period</a></td>
<td class="text">4 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract', window );"><strong>Additional information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant-date fair value (in dollars per share)</a></td>
<td class="nump">$ 1.57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsWeightedAverageRemainingContractualTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalGeneralDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the number of shares into which fully vested and expected to vest stock options outstanding can be converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>As of the balance sheet date, the weighted-average exercise price for outstanding stock options that are fully vested or expected to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options that are exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6746276848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Valuation and Expenses Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Valuation and Expenses Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 3,450<span></span>
</td>
<td class="nump">$ 3,973<span></span>
</td>
<td class="nump">$ 6,989<span></span>
</td>
<td class="nump">$ 7,913<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract', window );"><strong>Assumptions used for fair value of employee and director stock options granted</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected stock price volatility (as a percent)</a></td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum', window );">Expected stock price volatility, minimum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum', window );">Expected stock price volatility, maximum (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
<td class="nump">77.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected option term</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk-free interest rate, minimum (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum (as a percent)</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.30%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Valuation and Expenses Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,871<span></span>
</td>
<td class="nump">$ 2,008<span></span>
</td>
<td class="nump">$ 3,764<span></span>
</td>
<td class="nump">$ 3,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Valuation and Expenses Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 1,579<span></span>
</td>
<td class="nump">$ 1,965<span></span>
</td>
<td class="nump">$ 3,225<span></span>
</td>
<td class="nump">$ 4,089<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5047-113901<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsAndMethodologyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the maximum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=6415400&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=27013229&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6737410208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2017 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified from other comprehensive income</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at December 31, 2016</a></td>
<td class="nump">265,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at June 30, 2017</a></td>
<td class="nump">231,457<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember', window );">Unrealized Gain (Loss) on Marketable Securities</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at December 31, 2016</a></td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at June 30, 2017</a></td>
<td class="num">(19)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Items</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at December 31, 2016</a></td>
<td class="nump">2,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at June 30, 2017</a></td>
<td class="nump">2,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated Other Comprehensive Income</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward', window );"><strong>Changes in accumulated other comprehensive income</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at December 31, 2016</a></td>
<td class="nump">2,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive gain</a></td>
<td class="nump">36<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at June 30, 2017</a></td>
<td class="nump">$ 2,577<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_AccumulatedOtherComprehensiveIncomeLossRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>na</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_AccumulatedOtherComprehensiveIncomeLossRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6928386&amp;loc=d3e21463-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=66004124&amp;loc=SL7669686-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=66004921&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=6877327&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6737570704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Dec. 31, 2014</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">$ 3,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements', window );">Product development and licensing agreements revenue</a></td>
<td class="nump">694<span></span>
</td>
<td class="nump">$ 604<span></span>
</td>
<td class="nump">1,250<span></span>
</td>
<td class="nump">$ 1,057<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromContractsAndGrants', window );">Contracts and grants revenue</a></td>
<td class="nump">3,135<span></span>
</td>
<td class="nump">785<span></span>
</td>
<td class="nump">4,113<span></span>
</td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=cldx_BristolMeyersSquibbCompanyMember', window );">BMS</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_CollaborativeArrangementAgreementTerm', window );">Term of the agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_ReimbursementOfExternalCostsIncurredPercentage', window );">Reimbursement of external costs incurred by the company (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements', window );">Product development and licensing agreements revenue</a></td>
<td class="nump">700<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="nump">1,200<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=cldx_RockefellerUniversityMember', window );">Rockefeller</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromContractsAndGrants', window );">Contracts and grants revenue</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="nump">1,100<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CounterpartyNameAxis=cldx_InternationalAidsVaccineInitiativeMember', window );">IAVI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Revenue</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_RevenueFromContractsAndGrants', window );">Contracts and grants revenue</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_CollaborativeArrangementAgreementTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the term of the collaborative arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_CollaborativeArrangementAgreementTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_ReimbursementOfExternalCostsIncurredPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents percentage of reimbursement of external costs incurred by the company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_ReimbursementOfExternalCostsIncurredPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromContractsAndGrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents revenue earned during the period arising from products sold or services provided under the terms of a contract. Also include revenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_RevenueFromContractsAndGrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_RevenueFromProductDevelopmentAndLicensingAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents revenue from product development and licensing agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_RevenueFromProductDevelopmentAndLicensingAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue as of balance sheet date. Deferred revenue represents collections of cash or other assets related to a revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 605<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 13.A.4(a).Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=65893310&amp;loc=d3e214044-122780<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CounterpartyNameAxis=cldx_BristolMeyersSquibbCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CounterpartyNameAxis=cldx_BristolMeyersSquibbCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CounterpartyNameAxis=cldx_RockefellerUniversityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CounterpartyNameAxis=cldx_RockefellerUniversityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CounterpartyNameAxis=cldx_InternationalAidsVaccineInitiativeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CounterpartyNameAxis=cldx_InternationalAidsVaccineInitiativeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6737641104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Kolltan Acquisition- Purchase Price (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 29, 2016</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Acquisition-date fair value of consideration transferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,200<span></span>
</td>
<td class="nump">$ 48,600<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember', window );">Kolltan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Kolltan Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued', window );">Shares issued as part of consideration (in shares)</a></td>
<td class="nump">18,257,996<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance', window );">Shares issuable in lieu of cash severance obligations (in shares)</a></td>
<td class="nump">437,901<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance', window );">Shares issued in lieu of cash severance obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,637<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessAcquisitionRemainingStockObligation', window );">Remaining obligation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,185<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessAcquisitionMileStonePayments', window );">Maximum amount of milestone payments</a></td>
<td class="nump">$ 172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing price of common stock (in dollars per share)</a></td>
<td class="nump">$ 4.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Acquisition-date fair value of consideration transferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable', window );">Fair value of common stock issued for upfront payment</a></td>
<td class="nump">$ 73,397<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Fair value of contingent consideration</a></td>
<td class="nump">44,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Kolltan transaction expenses paid in cash by the Company</a></td>
<td class="nump">3,768<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Total consideration transferred</a></td>
<td class="nump">$ 121,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent', window );">Contingent consideration, noncurrent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,200<span></span>
</td>
<td class="nump">$ 48,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow', window );">Range of estimated milestone payment, minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh', window );">Range of estimated milestone payment, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 172,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Kolltan | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Acquisition-date fair value of consideration transferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level 3 | Kolltan | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract', window );"><strong>Acquisition-date fair value of consideration transferred</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueInputsDiscountRate', window );">Discount rate (as a percent)</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessAcquisitionMileStonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the maximum amount of milestone payments to Kolltan Stockholders pending certain commercial and product milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessAcquisitionMileStonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessAcquisitionRemainingStockObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the remaining number of shares which are to be issued to certain officers in lieu of cash payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessAcquisitionRemainingStockObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issuable to certain officers in lieu of cash payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessAcquisitionStockIssuableInLieuOfSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the number of shares issued to certain officers in lieu of cash payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessAcquisitionStockIssuedInLieuOfSeverance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of equity interests issued or issuable to acquire entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=73531572&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6578-128477<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=6911251&amp;loc=d3e6613-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any change recognized during the period in the high-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueHigh</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the amount of any change recognized during the period in the low-end of the estimated range of outcomes (undiscounted) of a liability assumed in a business combination arising from an item of contingent consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInTheRangeOfOutcomesContingentConsiderationLiabilityValueLow</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=6911338&amp;loc=d3e6819-128478<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueInputsDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate used to find the present value of an amount to be paid or received in the future as an input to measure fair value.  For example, but not limited to, weighted average cost of capital (WACC), cost of capital, cost of equity and cost of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=66048111&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueInputsDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RangeAxis=us-gaap_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RangeAxis=us-gaap_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6748538048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Kolltan Acquisition - Allocations of Assets and Liabilities (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
<th class="th"><div>Nov. 29, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Summary of fair values of assets acquired and liabilities assumed at acquisition date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 90,976<span></span>
</td>
<td class="nump">$ 90,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember', window );">Kolltan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Kolltan Acquisition</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount', window );">Goodwill expected to be deductible for income tax purposes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract', window );"><strong>Summary of fair values of assets acquired and liabilities assumed at acquisition date</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,160<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets', window );">Other current and long-term assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property and equipment, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,072<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">In-process research and development (IPR&amp;D)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">61,690<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82,011<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred tax liabilities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23,393)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities', window );">Other assumed liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,974)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 121,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract', window );"><strong>Pro Forma Financial Information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 39,500<span></span>
</td>
<td class="nump">$ 84,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted', window );">Basic and Diluted Net Loss Per Common Share</a></td>
<td class="num">$ (0.34)<span></span>
</td>
<td class="num">$ (0.73)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma basic and diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessAcquisitionProFormaEarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other and long-term assets acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherCurrentAndLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cldx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cldx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionProFormaInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionProFormaInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=35744584&amp;loc=d3e6927-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)-(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=65885119&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=75116654&amp;loc=d3e31917-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=73531372&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=73530397&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=35741047&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388280&amp;loc=d3e13770-109266<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=64834752&amp;loc=SL49117168-202975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=cldx_KolltanPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6738651280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th">
<div>Jun. 30, 2017 </div>
<div>state</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfStatesInWhichEntityOperates', window );">Number of states in which the entity primarily operates or has operated and has income tax nexus</a></td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfStatesInWhichEntityOperates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of states the entity operates in as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfStatesInWhichEntityOperates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.7.0.1</span><table class="report" border="0" cellspacing="2" id="idp6891967120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2017</div></th>
<th class="th"><div>Jun. 30, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
<td class="nump">12,185,378<span></span>
</td>
<td class="nump">10,320,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
<td class="nump">12,088,710<span></span>
</td>
<td class="nump">10,260,073<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember', window );">Restricted stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Anti-dilutive securities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive common shares that have not been included in the net loss per common share calculations because the effect would have been anti-dilutive</a></td>
<td class="nump">96,668<span></span>
</td>
<td class="nump">60,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Antidilution<br> -URI http://asc.fasb.org/extlink&amp;oid=6505113<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Diluted Earnings Per Share<br> -URI http://asc.fasb.org/extlink&amp;oid=6510752<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Glossary Contingent Stock Agreement<br> -URI http://asc.fasb.org/extlink&amp;oid=6508534<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cldx_EmployeeConsultantAndNonEmployeeDirectorStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/
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MV6?]/=(/!&V'.Q*-%_7F'U!+ P04    " #T@ A+J'1Z,!T$  #8$@  &
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M"IH0CW=X=M.834:P_?R#V/*-RY]02P,$%     @ ]( (2S\R+I&T 0  T@,
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MBV<WCMEH!-M-/XC-W[CX#5!+ P04    " #T@ A+ ;MD=+0!  #/ P  &0
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MV=3_!M%#D+*["2/4A0^V& H:'X]OPME.8S89'OOY!['E&Y<_ 5!+ P04
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M:&5E=#(P+GAM;&U486_;(!#]*X@?4!QBMU5D6VI:59NT25&G;9^)?;91P7B
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M[?7XE$?#JFZ:4C+_*HK?4$L#!!0    ( /2 "$O'<P;1S0$  )P$   9
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MY9V3=HR=RNO^K[-[JQM5C%E:*T7Z8SAF97\\#[]$T1B& V@,H$L $U<#^!C
MEP:(,4 L#0C&@&!I0#@&A%J -SRL_ND_IDVZ657J[%3# CJEW3IE=V$[O[ON
M9C^=_6_M!-3MW?<-BX.5]]XE&C7W@X8FFG"J>3 U-%4\SBJ>9A5;H/AMUFL+
MO51+L%KJX_FDD@@GX# ![Q.(28)8>Q2#)NHUY:#Q?5][&J9(B ^BB14!K0A@
M)=&>J#!&L0P1P"$"<XA$*^1IT 3S0X1PB! ,P7"""":(ED]I#!/$P(&V[NYC
M<THC"FSSE<!Q$C .QPF8CWO5-VM-A"6%I=T9<!'H?<B,.14B)*,9F?%4R!?"
MTI ,=R0C8"C4#9%A*(YBTY I8R+BS.8(MS@#/9Y$NB-N#L5)"*%; KHPBD++
MRF&XU1GH]22VI,"MS *P=A)+"MRJS.Q5TKGV,(HF:R<.#?PAF3"R/2W+MIW-
M-BT/@X1%H#RF&XJ6&0*R*X8PF%B\'&T,,X>9T"'?^,><W&*6,)O(!R-Q;7&,
MHKG%,2N;&L*D(Y-T+9TL*2R[!;!=L/&6,$P(P43G+9F00+P%LBN\)8P20BC1
M>3N*YG@+9-=X2YA,A'89.F_)W&9 WB+=%=X2)AV%RV%)F":$:*+#DA;1Y!')
M "R79=O.9IN6A]E$YJ[)A.4HFC4$9%<,8=)1<L/6'B.,(X3IL.2 37:S'+.)
M(S;IL.1@%P86QZQL:@B3CIN[,/(M;<PM;T;\A@G ;.+HE<9XNP+0\:WE8N1P
M$SGDAY84&!'\!D1PC B^!!%\&2*0#"!BE$4S'8ED5Q8Y1@2_8?O"<5/S)=L7
M?M/V1>#>%V;O&TOO4:#>MPZ$6U\L:7UAOEFA29^5#8:\#]^"NN^%G]/J-2MK
MYT4UC2KZCS\'I1K9IO0_M<4=9;J_7.3RT'2G47M>#=_IAHM&G<9OD-[E0^CF
M?U!+ P04    " #T@ A+_@PB9]8#  "6$P  &0   'AL+W=O<FMS:&5E=',O
M<VAE970S,2YX;6R5F&MOTS 4AO]*E.];XDMN4UN)%2&00)J&@,]9ZZX125P2
M;X5_CW-9U?F\'N5+<^GKX_<X]N.3+(ZZ^]GOE3+![Z9N^V6X-^9P$T7]9J^:
MLK_6!]7:?W:Z:TIC+[O'J#]TJMR.C9HZXG&<1DU9M>%J,=Z[ZU8+_63JJE5W
M7= _-4W9_;E5M3XN0Q:^W+BO'O=FN!&M%H?R47U5YMOAKK-7T2G*MFI4VU>Z
M#3JU6X;OV,U:QD.#4?&]4L?^[#P84GG0^N=P\6F[#./!D:K5Q@PA2GMX5FM5
MUT,DZ^/7'#0\]3DT/#]_B?YA3-XF\U#V:JWK']76[)=A'@9;M2N?:G.OCQ_5
MG% 2!G/VG]6SJJU\<&+[V.BZ'W^#S5-O=#-'L5::\O=TK-KQ>)S^R=C<##?@
M<P-^:L#DFPW$W$ X#:+)V9CJ^]*4JT6GCT$W/:U#.4P*=B/L8&Z&F^/8C?_9
M;'M[]WG%XVP1/0^!9LWMI.'GFM>*-5 D)TED#9Q<<.B"C^W%*Q<Y#B!@ #$&
MD*\"%$X:DR8;->VHR;-<,B<5JF(R$UF,W4CH1M)TF"=  @,D-)VS %,ZDR8Y
M,^HDO*8*)K"+%+I(01H,!\A@@ RDX8SW;49,7O'<201H4L_TR*&1'&3"<8 "
M!BA )LXBN"V(2SN_N+M4J&J87\RS7%B,5VT,_ AWV<:D*\\D9!XV,-"+='MA
MI!<9QRX?J"B-?68P(A@'9GRCAB'!Q.6887AE,PE<I.Z02/J,<YX(=U"H+.%9
M(CV&,"D80D7F]D1)P(O4TP]F 4LO(.PL^F?B5):(./'-!\P6EET.68:IP/)+
M'F9.S)+AI1+?Q,1T80@OI!? %\\>BZ'!$33<7853:+A&@,2WKW ,%LXNWUFX
MIV) .'"?W2QZO7&XV0"-;V_@F"L<5!]DGYM%;WL!&J\7#"B.:@]?"(P4CI!"
MAA84%W:I2S<C*K.,DYG'$&8/!^PARX-3J(C8PU*.D<)1O>+N\IP6(S!Q*AL8
MYYOD&% < <JWZ#%:>/$?I37FAD#<<.>#H%!(BR1W*SD@*Z3@'FX+C \!ZA):
M[8.2 QFBLK<,81@)\/[BVXN$YP4&,80,,N6#9VD+3 >!RA=W"Q"T+O'U@@$B
MDLOQ+O"2%VC)D^&@2_Z*U-M(E'AJ'X&Y("YYCQ'H18:8 2*O&<P$\1_O,@(S
M0:!R@PPN+3?L^DG)^J&R0O+4 UZ)"2,185SPSJ+L'X: #!F*SCZ0#%^LOI3=
M8]7VP8,V1C?C%Y&=UD;9D/&US6ZORNWIHE8[,YQF]KR;OA1-%T8?YJ]@T>E3
MW.HO4$L#!!0    ( /2 "$O['B%%W0,  *X2   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,R+GAM;)5878^;.!3]*XCW+?C:?$5)I$E29BMUI5&K[CXSB9.@
M LX"F73__1IP4["O)_0E@'/N\3VV[P%[>1/U]^;,>>O\*(NJ6;GGMKTL/*_9
MGWF9-1_$A5?RGZ.HRZR5C_7):RXUSPY]4%EXX/NA5V9YY:Z7?=M+O5Z*:UOD
M%7^IG>9:EEG]WX87XK9RB?NSX4M^.K==@[=>7K(3_\K;;Y>76CYY=Y9#7O*J
MR47EU/RX<I_(XIFR+J!'_)WS6S.Z=SHIKT)\[QX^'5:NWV7$"[YO.XI,7M[X
MEA=%QR3S^%>1NO<^N\#Q_4_VM!<OQ;QF#=^*XI_\T)Y7;NPZ!W[,KD7[1=S^
MY$I0X#I*_6?^Q@L)[S*1?>Q%T?2_SO[:M*)4+#*5,OLQ7/.JO]Z&?\)0A>$!
MH +@'B#[?B^ J@#Z*X"]&\!4 )O;0Z "@KD]A"H@G!L0J8!("_"&T>VG:Y>U
MV7I9BYM3#RONDG4+FRPBN2#V76,___U_<L8:V?JV!I(LO;>.2&$V P9&F#"8
M0G8FA-P1GDS@G@5@66S "(=I!UL3$89:#@])/CXF21$23>NS"2%QB*NEZ)C3
MGH"."8#B! PE8#T!&Q%0+<G- (EZ2-5#$C^)]"&;A4H?H289!VC&@2$9P,<)
M0I0@-"0#$$WS@ E&>?X1)H&&VLU"I1@J\"VS%*$I1XAFP EBE"!&-%--<VSD
M&4=)XFN:9Z'21ZA)R@F:<F*N3#WCQ.R%^%3SG-TL5(JA6!SA&1,?=T ?&6:F
M6Z!O]&2 M@HT+A0(F.Z4)HBQ6#,J!!3X-ED68R>&+))83)F@KOQ$8+Y1$=SJ
M"'UH5<\*,Q8;@T]LN>*62$Q/A)%S3REPCR*_85($=RF"V91NNBC(-KFXM9 (
MH8CU-1L9:Y:PP->]0<&B]V'I0[9IWKBC$<S2=!LGI@]A/CX/EJ(PJY,3W-:(
MZ6L QF>2Z491P'1CFX5*,5226!8)X,8&B+%1RWP!;B) S)*@MB\[W$0 D"RT
M#[.- DWD4F:\QN;!4@6+K+!IWKAS@>E<0"VK!G!/ O8;HX=[$@1S1B\P*YC$
M1J$_A$T3PAT.$/.BS$*!FQ<@'T;68<%]!! ?,=XK8%8^\WVK7KSR :E\:OO:
MQ^N0^O/U4KP.J?DR-_4JT%@OM1HTQ:N58M5JL1UJV=V8VQN[7+QP*/(R-^6:
MVY)N->MZO=%.N.3UJ3_X:)R]N%9ME^6H]7ZX\@3=3EIKWY#%EB#M.[+X.!R=
M_*(?3G+^RNI37C7.JVCE_KW?91^%:+G,WO\@I^G,L\/]H>#'MKN-Y'T]G* ,
M#ZVXJ-,A[WY$M?X?4$L#!!0    ( /2 "$NJ 9;8$00  "P3   9    >&PO
M=V]R:W-H965T<R]S:&5E=#,S+GAM;(U8VXZC.!#]%<3[#+C !J(D4J=OB;0K
MM6:UN\]TXEPT7+) .K-_OUS<&;"/9_,2P)QRG7*JC@O/KV7UO3Y*V3@_\JRH
M%^ZQ:<XSSZNW1YFG]=?R+(OVS;ZL\K1I'ZN#5Y\KF>YZHSSSR/>%EZ>GPEW.
M^[&W:CDO+TUV*N1;Y=27/$^K?U<R*Z\+E[F? ]].AV/3#7C+^3D]R#]D\^?Y
MK6J?O-LLNU,NB_I4%DXE]POW@<TVE'0&/>*OD[S6HWNG"^6]++]W#YO=PO4[
M1C*3VZ:;(FTO'_)19EDW4\OC'S6I>_/9&8[O/V=_Z8-O@WE/:_E89G^?=LUQ
MX<:NLY/[])(UW\KK6JJ N.NHZ'^3'S)KX1V3UL>VS.K^U]E>ZJ;,U2PME3S]
M,5Q/17^]#F_$IQDV(&5 -P-BOS0(E$%PKT&H#,)[#;@RX/<:"&4@[C6(E$%T
MKT&L#.)[#1)ED/PT"/L4&?Z_/B&>TB9=SJORZE1#3I_3KG38+&E3;ML-]AG6
MOVMSHFY'/Y84Q'/OHYM(858#AB:89(IY,3'LAO!:!C<:A&BLR'01^E,7CPC#
MII@GA*$IYAEA BT<A FGF%>$X5/,^HYY-@@C\.(%\#\,^@G"R0211F3 1#VF
MZ#$1TQ9X8V*"),9$0D@D!$2T9%H/&#YR0K'/]37Y/]2$#(=D.""C9>V:&V[B
M1,^[C0E*PL#R!PE(19A4N.;E11B+SYB^+&MA4&E!.E\(LBQ=!/E&@*]6:>O(
M]!)KF(V)X2/AF!")(9$8$-'*>1T;3L)8^/JB %1((]2$3 +))(",IAOKQ' 3
M1*1EW0:!0LNZ,!_+M@_(Z-FB0)/,98'0:PW XH@'EK5AEGV$ 4*Z&BK0V-,7
MSO7]9H-@84R6DF-P1WE@! @)G1"9H?.Q)T4(P"CR+37%L$HS(--<D^D5,S4X
MB?5D?@0HENBH)X1B.NH9H&);73 L^PSH/C>:B-",C,S(3!0SXG]"*-^,S$39
M(\-[" .;"#=:'P 2-C]X@V!@AQ!,]V-N$5P/^A6 A#5HK/YLD.W LEU-I\"Z
MS8!P"]+C,379OE$QK,D,B++0FSEF"NYDVYSVIUAP"0BNL' E+)&$)%)O \C4
M/M '*%1DBT@UEA!E(XUEE(","JX[,O6QHV-;8:R/%-R?=H2%B( 0&6E'9F_Y
MBU7!ND"HY(7NR&P<2406/U@7".E"I/LQ&[XO%-D^OW#-$VCYC#HBT//9ZP@K
M R%EL'QD$*YY0C6OB[("C7/?;/>\T5=R+JM#?^Q2.]OR4C1=)HY&;T<[#]1]
M96OC*S9[9F#\A<U>AX.;G],/YTB_I]7A5-3.>]FTW_;]%_B^+!O9<O>_MBM\
ME.GN]I#)?=/=1NU]-9S?# ]->59G4][M@&SY'U!+ P04    " #T@ A+L=R
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ML%X00"^X_?8'02X>6"L(!ES8C0Z J.LM0V!!(63Q?"C"#A>P4I"E4E!D-]4
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MM6?CB7-%=3+^@ZZVT+>?8<+H29EAHL>BNP)T$\6;_GKC#7>L[!]02P,$%
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M6IXPW\ L;1T@H6\4@BT$?ACA(3$T)&:'%!A6YLQRA0(UOJZ%#8IB\PNT,0$
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MZLCD_L+Q&#*.ZT",>S-&E)AKSMC;C) 2/K<;8:8- "+%7:D!E%V_I+MXQL2
MNQ@^8&/ ?0R(D7GBYNI[-*4TGWG1@)L4?)=Z+6,]@OALS[A5PMT,'*G)Z\/<
M4Z)I,K=XN.L!LWWF"B7^GB) D[GMB]L>,-^[#1<0XR,==X2]L^4"WA\ :1!)
M[";D=X@Y%;P] -(?$G!5\@^YEN -@B -(IG[J.+&)_!^/Y*9#S-!LG :XAH%
ML1D=W/<$\?W<EB2XH0G[0+6X4PGB5+]:#.1^,Z.K,YH]97\7[;ZHN^!%:7/<
MZP]E.Z6T-(3QG2$\F(/]-"CE3MO;U-RWP^EV&&C5C"?W:/K[L/H'4$L#!!0
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M*LO+.)T'-V585@YN_-U%%SG"^S@1>7 *,\^SW 'J>#H5\#O\&O&3;>O(EDM
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M77T(SO]VC<!UEO<99$F83Q>2U^DU.J)?I +U?GQL'"WCE*P*Y('-)S]F11'
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M%XD5RJR4-$]\K$1E?BZ%#4Q%Y*A/;:9TA:GQI8-4@],"-F=-I@S3T-C3?:4
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M8O-N-.H?[>\'Q:\5,KV98),"F%^84KDJ]9;3!=17@*0+X-SGZG=32,TA?_E
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M=ZI:>54JU8=S4STV?/?3J>KC\+_L_B]02P,$%     @ ]( (2^4A,.2P 0
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MN.%Z]2=EF/H3X4[^\WG\!E!+ P04    " #T@ A+,)0TP:\!  ! &@  $P
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M#5!+ 0(4 Q0    ( /2 "$L?(\\#P    !,"   +              "  0
M  !?<F5L<R\N<F5L<U!+ 0(4 Q0    ( /2 "$MF\PM@@@   +$    0
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M965T,RYX;6Q02P$"% ,4    " #T@ A+J'1Z,!T$  #8$@  &
M    @ '^$0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @
M]( (2[T!"-\^!   BA,  !@              ( !418  'AL+W=O<FMS:&5E
M=',O<VAE970U+GAM;%!+ 0(4 Q0    ( /2 "$N9F35ALP$  -(#   8
M          "  <4:  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4
M    " #T@ A+3G@P];0!  #2 P  &               @ &N'   >&PO=V]R
M:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ ]( (2YF;6IJR 0  T@,
M !@              ( !F!X  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+
M 0(4 Q0    ( /2 "$L4B.\6LP$  ,\#   8              "  8 @  !X
M;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4    " #T@ A+X1[T&K,!
M  #2 P  &0              @ %I(@  >&PO=V]R:W-H965T<R]S:&5E=#$P
M+GAM;%!+ 0(4 Q0    ( /2 "$MM:8V5M $  ,\#   9              "
M 5,D  !X;"]W;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ ]( (
M2Q8^D]2S 0  T@,  !D              ( !/B8  'AL+W=O<FMS:&5E=',O
M<VAE970Q,BYX;6Q02P$"% ,4    " #T@ A+/S(ND;0!  #2 P  &0
M        @ $H*   >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0
M   ( /2 "$L!NV1TM $  ,\#   9              "  1,J  !X;"]W;W)K
M<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ ]( (2YG=CK^O 0  T0,
M !D              ( !_BL  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q0
M2P$"% ,4    " #T@ A+;^UFWK(!  #2 P  &0              @ 'D+0
M>&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( /2 "$M&F?O;
MLP$  -(#   9              "  <TO  !X;"]W;W)K<VAE971S+W-H965T
M,3<N>&UL4$L! A0#%     @ ]( (2P5)XE:S 0  T@,  !D
M ( !MS$  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q02P$"% ,4    " #T
M@ A+<[!A:<4!   W!   &0              @ &A,P  >&PO=V]R:W-H965T
M<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( /2 "$MJ$M5>P $  #<$   9
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M970R-"YX;6Q02P$"% ,4    " #T@ A+ PM5 +8!  #1 P  &0
M    @ %L/P  >&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    (
M /2 "$OH< K&P0$  #<$   9              "  5E!  !X;"]W;W)K<VAE
M971S+W-H965T,C8N>&UL4$L! A0#%     @ ]( (2X]N>V6U 0  T@,  !D
M             ( !44,  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"
M% ,4    " #T@ A+G.$><4@"  "S!@  &0              @ $]10  >&PO
M=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( /2 "$L[/N;3I@$
M )T#   9              "  ;Q'  !X;"]W;W)K<VAE971S+W-H965T,CDN
M>&UL4$L! A0#%     @ ]( (2R%V>.CC P  %!4  !D              ( !
MF4D  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " #T@ A+
M_@PB9]8#  "6$P  &0              @ &S30  >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;%!+ 0(4 Q0    ( /2 "$O['B%%W0,  *X2   9
M      "  <!1  !X;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%
M  @ ]( (2ZH!EM@1!   +!,  !D              ( !U%4  'AL+W=O<FMS
M:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " #T@ A+L=R #5,"  !D!P
M&0              @ $<6@  >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+
M 0(4 Q0    ( /2 "$NPCK[I& ,  #0,   9              "  :9<  !X
M;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%     @ ]( (2TEX)KLM
M P  Z@T  !D              ( !]5\  'AL+W=O<FMS:&5E=',O<VAE970S
M-BYX;6Q02P$"% ,4    " #T@ A+=[8I58H"  !O"0  &0
M@ %98P  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( /2
M"$NQVJ)J'@,  .0,   9              "  1IF  !X;"]W;W)K<VAE971S
M+W-H965T,S@N>&UL4$L! A0#%     @ ]( (2SK63XCV @  2@P  !D
M         ( !;VD  'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4
M    " #T@ A+2\L5$O0"  !#"P  &0              @ &<;   >&PO=V]R
M:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( /2 "$M.UBZ"FP$  %@#
M   9              "  <=O  !X;"]W;W)K<VAE971S+W-H965T-#$N>&UL
M4$L! A0#%     @ ]( (2WY^!0PT @  E08  !D              ( !F7$
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M:V)O;VLN>&UL+G)E;'-02P$"% ,4    " #T@ A+,)0TP:\!  ! &@  $P
M            @ ';K   6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     ,P S
+ -<-  "[K@     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/**
 * Rivet Software Inc.
 *
 * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved.
 * Version 2.4.0.3
 *
 */

var Show = {};
Show.LastAR = null,

Show.hideAR = function(){
	Show.LastAR.style.display = 'none';
};

Show.showAR = function ( link, id, win ){
	if( Show.LastAR ){
		Show.hideAR();
	}

	var ref = link;
	do {
		ref = ref.nextSibling;
	} while (ref && ref.nodeName != 'TABLE');

	if (!ref || ref.nodeName != 'TABLE') {
		var tmp = win ?
			win.document.getElementById(id) :
			document.getElementById(id);

		if( tmp ){
			ref = tmp.cloneNode(true);
			ref.id = '';
			link.parentNode.appendChild(ref);
		}
	}

	if( ref ){
		ref.style.display = 'block';
		Show.LastAR = ref;
	}
};

Show.toggleNext = function( link ){
	var ref = link;

	do{
		ref = ref.nextSibling;
	}while( ref.nodeName != 'DIV' );

	if( ref.style &&
		ref.style.display &&
		ref.style.display == 'none' ){
		ref.style.display = 'block';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '+', '-' );
		}else{
			link.innerText = link.innerText.replace( '+', '-' );
		}
	}else{
		ref.style.display = 'none';

		if( link.textContent ){
			link.textContent = link.textContent.replace( '-', '+' );
		}else{
			link.innerText = link.innerText.replace( '-', '+' );
		}
	}
};
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='UTF-8'?>
<FilingSummary>
  <Version>3.7.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>93</ContextCount>
  <ElementCount>208</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>32</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00090 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>10101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>10201 - Disclosure - Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies</Role>
      <ShortName>Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>10301 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>10401 - Disclosure - Marketable Securities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities</Role>
      <ShortName>Marketable Securities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>10501 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>10601 - Disclosure - Other Long-Term Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities</Role>
      <ShortName>Other Long-Term Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>10701 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>10801 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>10901 - Disclosure - Accumulated Other Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome</Role>
      <ShortName>Accumulated Other Comprehensive Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>11001 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureRevenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>11101 - Disclosure - Kolltan Acquisition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition</Role>
      <ShortName>Kolltan Acquisition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>11201 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>11301 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>20202 - Disclosure - Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>30303 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurements</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>30403 - Disclosure - Marketable Securities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables</Role>
      <ShortName>Marketable Securities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureMarketableSecurities</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>30503 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwill</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>30603 - Disclosure - Other Long-Term Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables</Role>
      <ShortName>Other Long-Term Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>30803 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensation</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>30903 - Disclosure - Accumulated Other Comprehensive Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables</Role>
      <ShortName>Accumulated Other Comprehensive Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncome</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>31103 - Disclosure - Kolltan Acquisition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionTables</Role>
      <ShortName>Kolltan Acquisition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisition</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>31303 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureNetLossPerShare</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>40101 - Disclosure - Basis of Presentation - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentationDetails</Role>
      <ShortName>Basis of Presentation - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureBasisOfPresentation</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>40201 - Disclosure - Significant Accounting Policies - (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesDetails</Role>
      <ShortName>Significant Accounting Policies - (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>40301 - Disclosure - Fair Value Measurements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsDetails</Role>
      <ShortName>Fair Value Measurements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureFairValueMeasurementsTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>40401 - Disclosure - Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesDetails</Role>
      <ShortName>Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureMarketableSecuritiesTables</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>40501 - Disclosure - Intangible Assets and Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillDetails</Role>
      <ShortName>Intangible Assets and Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureIntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>40601 - Disclosure - Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureOtherLongTermLiabilitiesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>40701 - Disclosure - Stockholders' Equity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockholdersEquityDetails</Role>
      <ShortName>Stockholders' Equity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureStockholdersEquity</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>40801 - Disclosure - Stock-Based Compensation - Summary of Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationSummaryOfPlansDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>40802 - Disclosure - Stock-Based Compensation - Valuation and Expenses Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureStockBasedCompensationValuationAndExpensesInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Valuation and Expenses Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>40901 - Disclosure - Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureAccumulatedOtherComprehensiveIncomeTables</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>41001 - Disclosure - Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureRevenueDetails</Role>
      <ShortName>Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureRevenue</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>41101 - Disclosure - Kolltan Acquisition- Purchase Price (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionPurchasePriceDetails</Role>
      <ShortName>Kolltan Acquisition- Purchase Price (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>41102 - Disclosure - Kolltan Acquisition - Allocations of Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureKolltanAcquisitionAllocationsOfAssetsAndLiabilitiesDetails</Role>
      <ShortName>Kolltan Acquisition - Allocations of Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>41201 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureIncomeTaxes</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="cldx-20170630.xml">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>41301 - Disclosure - Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.celldextherapeutics.com/role/DisclosureNetLossPerShareTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>cldx-20170630.xml</File>
    <File>cldx-20170630.xsd</File>
    <File>cldx-20170630_cal.xml</File>
    <File>cldx-20170630_def.xml</File>
    <File>cldx-20170630_lab.xml</File>
    <File>cldx-20170630_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies/>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>62
<FILENAME>0001104659-17-050250-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-17-050250-xbrl.zip
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MQB%SK[NN<R]GCD.3ND3]E8>MN_A?@.PD__W*/U^LUVG7> /-_K^GI[]Y3FB
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MM%I890[I6%80P13R&:\\&M^X"(/(PFQLWCVM"0['L31+9CV'&8 DMQ?)T8J
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M9EN-,5DLG#P-&- #N)\*.C,-3T(2+-]<,='O'Q',K3QP%:0R*XP0!W&%(GN
M)8 53J,J_J+ #3U#']<3 YQ!A<)KA67Q+!VWKY:2"8V(I_&0N+T8-*O3H&FN
M )K9P6T5/&L+P+-\UB+PU([,!>!YY4G' ?T!T/O.U>5WXU_@#Z*?="6=,.2^
M\>JJ\Z\K M'M@6AS11!5N(G26 *8<L$90\R*H"E;A66\*Y= RK$345?P/R)X
M%@ RV0= K&'BAR$/$<'!_Y8@GIAR$N?C7<9G7-3B?$"L9 !Q,?[)8>0#? >
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M-9KH8/QLYDGQ#:T136+%A7"CV9R>XA>Q9UM<'/_YOPX/<&$_^HS+^OECO?(
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MCFNR@;)+U7$\6;T+1:/*+_I^",]Q+&>0%H$<Z[<J%.-Y6"AF;C>RPL"X_EK
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MTZES43PJC .C9>P6GNJI1V0#\@!:AATXR4X9OA-3/1FW)@^RV7W U;&P),G
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M8Y;/3'@%N7K:5QN(9KEQUFC^?<*NC=/XP9>+=D7I?IQ0Z F3B7=PT-JC82_
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M*Y6U I[])_,BP(UT_&:VX&SDL0C00M8$]64=5B9O=;J^$..4!F$_X H35JO
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M(%4G52^.JG_F#]Q-Q6>2]I+V%E9[*Z2]I+V%U=ZJUFO:O6OOU#J55E0$=6M
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M%)9&EX>/G"L%Z#$G4$(V!IR)*. #F4LH5AQ+$B(,&_@+7,4WA/-D#$#?^\)
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M#N& <$ X(!P0#FK"0=6D7?W6C34JHX+%*#%=IIKI,MU!H]/O(VH1M3JAUD3
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MF'NX4=DS)WXTKYOD+KAGH3\!"0CU'3))?-=VI]0CP1 T16,W\+%: TX;,8J
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M3;N4&TO3/I6A1K49+X)P&H0T9L1AP_@8];752[U1:AN.PANYL-H:P@'A@'!
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M\W:M:=,N]<@ZU6O:Y'<X:.EE/-:B>9U7HGEF5Y9ZU'MKG[(U;6[&(<MLMIK
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M^#$4Z*S5C/VV<=:0\8IAO ]1[$YHS!S^K&$H%QP^N:-B=N!6#KI;5RX &./
M71R,^:(5(C;?6ALM1&R!B#VW[622>*O4>SX)PMC]6ZR2(J"1@O4!]!>&#(R
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M,0ABGV=!7S.1]G9V!E_]^O/C,/3>_7]02P,$%     @ ]( (2_P!.SN"#@
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MC-GDV5L0B9?$]ZCE7EC"T3*;;Z_ 9-CS))WZ'KD7TKDC,^PS#\S'__ QT^T
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M[QBJT*/^5G";<)C4X,$5C-JJ.1W,E*''"T(\MX8HJ%&&(6YEU$Z;S"BG6B>
MM GS*8KEP?/M\.&N^S#NWJFG\;#?NVM/X)=.N]]^N.VB\:_=[F3\H;$M:KL6
M'QHUY+_HYZ4D+@C7=E1#->0.24R<%F:6S_9@7+<LGR]\&^'V@^",2]WA;+@D
MP8KHMCD0.6"H!3#0[Z0OW$)8EY!F[@B713O"> (_!MV'R1@-[]%PU'UL3WI
M@-H/BG(P>NS^"FR]W[JH/QQ7/>4X/>46NXM[)IY*=XHUHQG_J_WPOVV/?T7W
M_>&7"F@3T'?4M9AP?4GN,96_8>:3 <'J=PW3'?$P92&V!6E-<+X&.%L X5H4
M_**D(2T.)>6A5Z'$?U0(%D)P@.4WL-B4D3&Q? GM(7D FDC-^+U.X[<6AM;2
M*O1*HM<#I?F<@A7;K@O^$2R5GX2PGV"KF0-B 0XSEF_26*YEHD HPMQ&D=@*
MU)*@#A5!7_#YA$BG3_&4,M.PW$5NAO-M&DXM$"F)=242)6166!Y]@.XQ0G=A
M^JYYF1JB#Y/VPZ=>I]]%[?$8]CS:P?TT'-Y]Z?7[%:S'':*WH-UER7$:\)B!
M?9\&MM!@1:^4='19P5L,WG\)QF 0MJT_?.KJUK09$U:P'1W.XG&Y>W(^0)*Q
M*[1:Z:X0UH42E<';1'U(S)(+=#6OE^XA86P_^@G =;E'O56/SX1TM#9A#RA"
M:=[#-J_5'C82D'Q4X 724$)<A=QQ@I(C+(%N04  9J4CE)O<N\*5;_8)5Z)7
M&Y540[;8I-[!+H4I=Y30?WNVSB(Q0=@""%/NLQ:BIMJDF JC0AB-Z9S3&?1J
MF#$M2_@PR?'Y" ::!8O4-EIF8C-NEVG<$N+06AZ*!%8([A\1+!0*W(%8\1A@
MA=3>D;\B(;\=.!6-]54H'1I *!$XV(%9Z9A>!=Y!88*BH8$=L)6+W568%7-!
M/&%]6P@@E6X7-M+>*N5WI"G,.+W+<#82,OZ. BD50,4!TI?EU*T V(UENO(Y
M5&:@WN< %=[-2TJJP"H$%CC2OJ/:#_4JVHV+'#T.'&0;N2(L9ABOTS FA(9S
MY(98%,BM0"T$ZB/Y3KB? BYZ;02GU4R#$S)6UM\S.+T[Z+P#DXPH1D8PN<*G
MH,>NII()?D[[><DB,R(9\8F &6GN"HI"4#P03UT6'!$Y7F"9FK"VB\V09 0@
M0 !2$A"(0%I&!<SA<;Z]XGV%XGZ7S<OTL=F.N!]Z%3U5@?8#0H 3%?XI%@@,
M24U 7C7AO\)7 @.!%7S[QP6ST3-0FL%[G08OYSY@!=V1@H79".YF, /Y)@WD
MKLN %:+'B"!FP[F#VHSEVS26QLM%%9"'1ZVR8332FD%\GP8Q+X)5(7CT4%8V
MG,49S=A>I[$M%M:JD#XTPI(-;"Z=$<=6*XUCUM6]"K1#]OK9B&43F>'*V&FD
M]_T56@=?QLJY06N@-.'VNO#5+'A?W7X]8O@F!\="/&9$RU_:JK ]POEW'J"Y
MA&84"YZ&5\ =98<Q]AT'RQ5,H SSW+%9@M4,;HD3=%44U*!G9%5'A?E1,%<Q
M4/V@OCIX5J^)F_A0H%0G*"AK5Z](1]WS>T5<9?"A0UAI\E.'JI\<?^^:TRM*
M<)K[P-Z7,BJP][N>D0/H5JD1-,-EC0J5@X,*(U]:"Y@ 1Y):>6@5Y#*C6.QZ
M1QU%HI&672&\_\6/W.0+*0HS<CNN@500'18DRH$IA\H,5:'K(?]7@*E_5'+"
M1S)#.C?@C4J#]['F4F?)5*H]_6ZA$S.JM([U*&7C[Z#NQ;/#(A(EWY#R3V.\
M;:&PXD@$EE9*2BIW(0@12R+5\58C:GP--8ZF%F!15JTM^$Y1*^@H9;7:[%NG
MJ!3#T[)* 0MA+Z//A\9VHL;PS69"1YW.$503TD,\,ZGKCNRD05K8?I@O8#?G
M0\!85TDGZZW+>NOM!30A:G>)YJ2S5A9J"Y-R@VNOAABSD^:T(I-'/=37S'N:
M(IU[M1PJ1X0DF4VU2",TB_HMSJ>JFG&EFE'&'-D9=PLV(&)0-;\I7J<QP:NI
M$V0R-@CSW.A-?2TJU9XP/[)NT,?:H["^D1EX,D1^YE3GI_96 ^),B0Q<%#5'
M_6ZD"N:W("_QC2T<3'G/(XY:G4$/?^IZU/.5%I^D\)<?:SJ=[@T%DAK"4"JQ
MY7VL>5+=[N>4,76H%?T>T,(L184]T?78O@P_OLG5Z19(/A&>R)>=4BB?Y.2T
M,:7S:(<5)C0K1AYH&;0'WE$^_Y%*1@JN^U>PP;^7PAE)8?N6=P=OF%B&FO1A
M;\A=:&5[+DGT?7?8@?=BW6ISTAR.X. ORU5A@Y@4#LJF0;8.4%82FT:YL(LD
M("]@L%O!-1[Z(IW$V:;))#HS(Z2'1N(D+M2U+4&Y>9CG<QU03 ^3\JPG-F2*
M*C"!'6J'P?Q=*VFT)&-F3PGG2"^B.TY?.;A3W"LWG_1AE;*AL_=XZ/@';[8O
MGW96 _P?(6\9=H,;BXDN<JB@/3J,[=TLH%Q:_I3T7FY):3MSPMOPPE8O4XMC
M=O')+8Q[XP,;)FU=]QA@)X3]W!DBPW, ETU*U7P5OE/+P!@S,IQ-\'.'<%#0
M2UJ@$/5!:T2V4NEU(:5KX-I[!E7U)Q@;;=7+O3T1'3(6S$[HN9OTYRA9 -"1
M)K\7\LN"6@MUD)G,63_P7:]#!C N/?B?)'4NRYBT0-2N RU04E4=NDR=#"=6
MJLYJ33+"*^WM/6%I#Y=:IR^$SA>P/6_#9@7/R2-1\Q6,R,@1\C%3U\NS/(,?
M7?.I31OI2S;;*V,NQ>DN>>DF9ZT"1JI3P^GS^). /L;#C<[ Y]2B2\R&4T;G
MX<C>7MI+\)S<>M_^CJF6 O.86IJ2&>&GW@![X6_MF4?DD)/) AHV7\ /0OY-
ML'3;CI >_5,-;#<YXH\M^"77#YM,BZV1J0U#42V_4&]!.:BI5(,&NNYG+@EF
M2K]/T EJ)>$H(.]E-Z*Q95YJ,WYP_SF"E4O*/B^+EYD+MO159Z%@G?0RO[>$
M$XL#'&,8!BH><V#'$G].1XMFR1?L9P6'7_RU^3'7FX30DUAKTG;K.DLF5H2H
MG,6^NO6CO(T'P:/W=U02RP/UE<,5.,XI7^4 &3_9=TD-TENA9.B3AN_)<%L<
MDU8[@FC\%24V#*W2>[:7#<GIOMKV].8SL>_.VICG41W4S]>0SC!S<S$]SB8]
M'ISAY^V.^D!D BBZ,]A5=(CW1 A/)(OHJ^.*C5#4G@)^J(D.F!MB_1*?=A]@
MI7VDG$AO.L!G5Y,BA6UJ$+?2-YDG"\PG1)TV8TG9JN<LP40JFK-K*2LEZZP6
M]+1!=U\M5Z[+(TS!8"85U8G-MP^GP5@'NH['G+ S3A>I,_6EJU\/9]UG\$,X
M9FIWZX*JO@H3CXBTU.6W.5D?-Y;DRCY5@A5[&5#]E-4K?= &Y;:O(N'&5!?I
M<[;R?*=[S):R2D=2UQ-L0%8PT8[_\.ETJD8$YO&UD, *!>A,6A_HN[VH"6YA
MHA+RGGI_SHG$S [_9BRH%GMJF[8HPW"N1M'.>,]U?6*W?6\AI-H-!NMR+1F*
MS24YK\B$2?\X\E_ $";:,[=(^-G':(&E@RU]3Q[<ILV1L8/F7 =#QW<I)ZZ;
M^.(E@7F/]RGQA[,Q42=%^L9C.&>69C/Y&>JLRCV112.MV( R]14H)^%)FFLP
M0A;M3[K#="Q_--(2UH$IY;JN1V*).5<S0,\&6CJC>)TK31E#ZBL*R6T/] LG
M<DN5FQ5<? L=CH!SVZP_HL+SWBH<W5(;?XSAA=#8K./,5XX'0NP%=KK/X"*Y
MB>A>8+O<TG-=+:+Q$T_L$9BK2&4CQ9F#G3'?CZ2X5U>7NU@JURC^.$ZEU+%@
M#-Q1YGOK ,=!$DQ[4<URLBMH[!JH]N_E4^0QOJ17L>Y/!WO<05.T;S31<!,9
M^I/=9V+Y*HJN0E[$\U@8FDA9YT 99W:1.KV3O?O::KYYO[5;W7IYKM,JZ'%U
M]>XZI=S&RW-5;C* *6XNL;.I7OKUN2K8@3$V$]*^G6S'E5+OSU7%=0ZQ,<PW
M-I:V^WFI_LKKIL:[R<[5 /KN0'3]>(*?X[S0MP+>N$O!;= Z3M$3&:0\V__(
M9C&QAL=QH^ 0/+[%9UCV#2SGL> _D">V:MMBJ2[9KM/Z2<'AT0H^8]')^%;!
MOZG(_"$"SBA$W^/Z $9)PZQ-;?<W;%GJ.JOZ#%Y?+MB<8$K0G\-,$WRN'GQ'
M^\M_ 5!+ P04    " #T@ A+X\<E3Z$.   PW0  %0   &-L9'@M,C Q-S V
M,S!?8V%L+GAM;.U=2Y/B.!*^;\3^!V_-9?9 \:IW=,^$"ZAN8BBH*.CIV=.$
MRQ:@&&,SDJG'_/I-&1MLL&S9&"Q#7[H+D%+Z,C^G4BE9^O3K^\Q47A&AV+8^
MG]7/:V<*LG3;P-;D\]F"5C2J8WSVZR___M>G_U0J2HL@S4&&\O*A/")"L&DJ
M+9O,;:(Y($"I5+R"?]P_]Q3#UA<S9#F*[M5ZP\YT5>^>8&."%.7ZO'%>K]7.
M:^O:]QJ%TB#/%0,_KW[QV[>M.^6FVJPV:O5KY?KNHGE7:RI/CZMRCX!@C),*
MFMCZZX[]\P(-*N\4WU%]BF9:S]9=/)_/IHXSOZM6W][>SM]?B'ENDPF(JC6K
MJUK<$NQ3Q2]685]5ZHU*LW[^3HTS!=1N4;=M@4;\XM##4.FWIE^V7OWCL3=T
M.U_!%G4T2U_7VFK%JU>_O;VMNK^NBD+S.*9#*]&@/47Y1&P3/:.QXLJX<S[F
MZ/,9Q;.YR=IVOYL2-/Y\IIO&>X59H';5K#'\/PT=,"/C1LNV#&2!N>$/:IO8
M8.:]UTS6RG"*D$//%-;,M^=NJ%\Z,DT#O3M31+0Y6CA8I^>Z/:NRLM54TEWD
M0D:H[A?UZE<Z& _F:/E(4=6"0K,Y05.H@%]1SZ;YJR1-TU+JJZ71Z8-IO^U7
M-8%6#JB%-J:Z:=,%00\:)K]KY@(](HU]=KO51HZ&S2S 1047@O51(W]!!UY,
M-$3Z@F 'HUR@QLHM!&G7 I\ZP= CE5)P2?#8?;%MXPT&R3P BX@O!/> ];QG
M6Y,1(K,>UEZPF9N5$V5+:NE]FUI26[<T4V_LT^!> X5@_\TV3;"+JO^]P!2S
MD54U32_"A$%E9:J<'X%=FDVM)QWTNS!=V3WXS=,-Z]&^HK: 04 @@AK&ZEOL
ML'8A*J[!I$)9R86_6X-^N],?=MKLK^&@UVVK(_APK_;4?JNC#+]V.J-A"OPN
M>L /B@UUR56T3<(D\<2YHL8:?7'EP1QKHFES-D&YJB+3H?XWC$Y7E5K=FS+\
MY'W]Y])POF13>T&F.U,+_5@MK&.M!2&@Z]C^>67^O&I>-:^;-U?UF_IM_;+6
MN+@.]#Q *96$06A$]^7#GULL"]O**U&EB]G,E5;!0 >__IC8LVWU>8W9:3IN
M$P,1F$*?*0L*_;'GK"W-/%/>$)Y,'?>7(LS"@E86R<-_'7 %KYK)@CO5:6F$
M?, TWXW[..82JBNK&>.,M6W@[%!E-;SZ"LZ<!;H/-AEJX7CWQ5E_2GABTTDY
M#C+D =JC14,Z6NBZO;#<H=\-FIZ1CH#N );VD9- !I&Z1T*!S% ]PS=E,_P3
M07,-&YWW.0NN?%PBH[9 S>,P>E:@GLDOY#.Y/4?$^7B"V-D!.&QDF[-0&"C,
MM36_BJQ&CC9E2ARR^NO-23WTO_.NFPNV1.//[CFV%*D:UL45Z.)&6IMFQB.K
M2PZXE[YMZ;%..+)LF:PG#D!6=YKPN)7QD1)Y;"YELT,@906>?>C8^E]3VX2^
M4N;EG0^.?9*K%0PFN=_R44O4%D'2)0&2=48=Z'=\P+Q=4&K#178NUFQQJ&2U
MGC^C>](^V#1.;*8;+BRU%>/ZR)_?"@"4V*!D@0SAIY);_KC,F@*CK'.>Y6J>
MJ%TYI<.(KP'Q;5FMF@:AU'.=  :Q"4]D!:DMF]&D">AD?5*%@^_M@E);43B6
M%<0EJ_V>0!8"VBW1QJT%1I24SX*"UHC,_ JADS46:MFSF6TE&G&SV!%94 B:
MK(^A:AAXV94G#1M=JZ7-L:.9 4R\F#:QXA&9."-862,BB-47,Z9\M%QG"FVV
M[EJZ/7.W7/>1,QB/M'?^K":-E&.B0P[(94TU/[.M>!8R.AJQL#6A :QM-,8Z
MYD7-R17#>KBI-2YK965 1K#B>>U/U8V=C8?:[ICJC8R C;A[(1NB>R&'(_CO
ML=,?#97!@S)XZCRKHRX44-0^*_GX]-SY"M6ZOW>4WF H^6;)")>0X$YC:Q3A
M":#UM2];;4P:V8%1SWMT[C6*=0ZLE%+D\Q$"E@QZACSPBL3Z<X)M @[+C2D+
M2:LLG8,U6</EY5.V2\IGYCSL%I%L$80NZ^SN&;TB:\%=(/1_EL^<HHJ/&MIC
M,.5OI^T7.-@W?B\> -03L8V%[K3A&]-V=Q*Y+T_HS"-9$W5"T'*\WK!15C'R
MV3+6(FL#Y@JX"$-#&.8035^^/D6T9)-N5S@:XPE"DS6MTK*IVW5O0R?/?VX6
M"V.\!8SUTOI1(6R)]JL4-O!1!'IB;V8$'(B'A3L:QM21S[1"!HH:'].BE#6X
M^8(L(+<)0%1CABU,'4;U5Q1OY81:1V/G+#AE=<?W"QCR$:40S+]@RU48&V#
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MJ&3+)[9P_,#YQ:%9P(I^9B8O"O>]:.;XH444MT';P)>#VI^AV1/"-I$MPK6
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M]LT?:V0?Z!+#<[!'?LP]NJ06"DFO2U.2*<9W:JFH-(XQ7X^2.?8C[,<+/@R
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M"#VYPY&+"+E'A*X]759&[I)=J8WF+ %9F:6OV1?"SD^-Z5 4O!;% .3ZM78
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M4A=3!T^DRW9Q4W#'Z1)UDT^AC!)HHKES%DS9"(U6"@A+Q"-O#N',T51$<FI
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M']XM"(N_[WB!<VK3[1.;IG]XSW_[K=G1=_JV16-ZR^-BR,.^SK'#P;5<!G'
MUYHZ9%A9/#B"(M1']I$%=CFRO_G^NZ;8?O_-=XL_O'^_^/Z[/_*H??_-N\4?
MWW^[^/:/?] 2] O"1.RH';O/U!O\9-& ,RZ.PY/56]Z=Y3I7_IFU<V/+D[Y&
MS?=2JHB<)M2=+QU_::V%F$HZ&-_[D$BN@H .XOHDU;(HO71DZ'#,Y "<7.4
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MQDD"&$0NC#^;^&)*Q],P)JL@9/&=(V"-AT![FN5IO_O2_C5QX>KR- U H;_
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M?+9\^ NYO+[]F\%\QRQDP?N[- '8Z1Z6=J_\_"#<TH[=9]Z=BKM$"?M=^L?
M;XL#;<*11XQ>$ _.Q6B0C#@*-3LXY. $V$$R0\C3GKQ)MSF^DLYB%_9D=SK!
M(E*89'QY! FB'$U.JB+97A6$!M=)EL5EQ<?@GD*0NQXMG==Y#!1Q;&'!D50A
MY\0Q 2Y=51Q!#V*^'-7=WAM?TLU?-BO)S2+'AQ/A2&(WGC5.J/.#G&^ZL]_F
MO5JV7X^,A,\A[Z[M\IZ'_>Q1OF;O._)MPYJ/HE@5.4EV 4 F/95ZB$FLD_E]
M(T16LB"Y&I'71U)DAE0FAZ#5[PG'7K8="G]+EY;/W<B&M!5PE_(NI%LWV4;%
M79#:Y Q]A2&GAF$@E49(O20AIH^!#@TXWB/4DC>RXJ]@=3;7S<,LT[X@DGZ]
M//.]@,FG:SANU#A\,826G#%  @70JMRN,7RW2]K%LCQZNV*#.398BO=WS/_X
MXM?$Y2D=:S!6KHR<=+J!4,JCJ%03,:ET=*!W=L'R1C"+0I'=1:35R)02KI7D
M:DUQQT2@9 FZ0 F\HB%0L3R>:L5P>I'LF@=U8%.*^E'3K*2V,/*X;W:RM-E3
M61)Q7+<8/.@@_ G\[!!9L)G9Q%A.P@7%D],C)\UG)#D8R]"G.!O/I,.,NL&0
M0CWDL:KL>GU"MXI*B"-8W79=V:U 1SZD)V]2-2/E.>F6VFP,]S\&_@E?)C0>
MUE<^FZLPF\ZI^*^TAGIF[=S8\MH?FU87@#S0NX-Q\"2U8FW$H=_#B?Y91X0*
M\B93]E5YQ3Q5:'P[8D),1#K9Z&#G@ _(TV<O11Y9L[L(QX L[7QI@Y]BO:<V
M=9]AO:%N%;&KC-E1AP(DS>S1(&!6!*+BAV8.R51*Z8PDK:;F]M-"TPT#D^1Q
M!V]KNLXY7=$PI%E6QPR3QD31O87-CDZZ@-3,*RJ29D4PG1S2S#2I[FP@+P7;
M&-F)AW#-)"AE<!0PG"4AO\-H>E6Q8A ']A4G1KK13$WEV=%*$P@MDYN*FK.B
MC48'=$]J>"P<#NGQD,,H6#3Q((;)RIUXT!O.@-AVF##,BME5YR%<B[#9$4,7
MD-3F,4V29D4<G1P::V:3*A>'C(1Z>74 RTK))%@U@E*7JA[/T*,/[31)F!W7
MM,+1920R5U9I]V+D,0E"]A@/$^%\@\L8+P36X-9) ')RZ Y&O\M[B*FAAQ/F
M+^&-.95YU'<!3PMB-B"61*6W]K1#T"'A]>2MI>ER"SH>%4=L1[I8W5WX//FW
M)X@*W-Q1\OQXNZ^#(W%Z;LY\+U9/C>CAQ>HJ" WNQC-X;$J=Z)+9!N=YV1S[
MQHKAC/_^=E4<_"_._=>@W4<.<C;K#8U,7)V%(.:H_K[TWQ$2&D7H\//FL#J3
M::V]G&*&<:;'![1$,B1P 5L5E E)QMJG]['3EUB[$(MB7>QDT@6"$H&H5,1,
M&IWL[TT4J1:X1I_JF8(9U'?-)H*!6;YA/\V"!-)'Z-IN#*O4FUOPU[G>&/B'
ME>84]+6VZPSX[.E!XW=XQW=?>G0Q6XQ'%-FE>X?PU'++?=Q. N86ZZU@- 9]
M;>TY17^[$SII(-.V$-=R%^+-<=-W<R<$A2NHN*7<B /&I=;!*SOXZ:([&/V6
M11'310\GS"]OHMJOF0RJ*H#0$<FEZUN^/=*>37?A\R2@GB JD%-'R?,CKKX.
MCD1JN3GSW;.9&M'#/9LJ")'LV5Q%4<)LH[<KZ9%JA?7INGK(V4K9];H]F,I*
MB#E&W78]>RR9#I@XR(_1F]]1&<=[(,]="8&(9S5:$5MX'XWFO<*C/M/X?[#+
M!G+S=F!RP5C>3@.C8*:LM/\L%YX1H1T[6;N3G)><"755&*QI3YBW5B[9/$6-
MYJ7,RL)C_NN+[<X+]I224^K3E1M7XX!Q0C9X_(<_LKN#T6_RA)@!>CAA?A*$
M:F5G,JBJ #+X(A\S;^D[\!]8L'YF0S*X!L8?)CR\Z%$#:$<1R,FD#R"E1_PZ
MU$=,*+W<&+0* 'LF(ME:H6^1/OM)*NY&&7K<;TI<TE="JFZ%U4)FEDI@*><C
M"S+V8[%4[CL5Y JY^KP@2D+:LCRL0>P,*$<'<(<T-$0F<FK2XMK@1<L%26V0
MMFL@)JNZ>%(88GSQUSB"D%CS #<<@R&>)I!?17?<F'D<,?J%S#C.:1)_#.)_
MT/C.<IU:6)6KHV>D;D"4F4>M+FJ&Z>A"?R81J3-E321319Z2F!%,3/:P<LC4
MF2*+B<!0.DS#QCZVESCB8B/RA!(/R6[G\9=T+2^CW"M_%81;/O]M>RM9N39R
M,ND(0RFIOEI5Q%32U8/>]U,D/20?H!!)E?%1QU10Y(.+$B;%**8/(=B>\P)A
M_MV[;S^\XT$.OQ'/"T2P9DR=Q^"2N4+#OP:>%UO^Q0NU$S:DH>RW#S2.O?1)
M[0?Z3$-883Y 28<\I$2@#2J@AL'"#).%$]@);Y(5KZ7H\ZUO[-S#PWB1..>[
MH>39\A*^%1)QHXC+K8(CP#;KFN'%'IJ91%@@DR@W"KIGSZ4)W]^%8-REIW+?
MCD(^511L'DVAG CMY#$@0C])#2"Y!? '4MC -Y\R*Z8E:S2@%4UM50:MML5!
M,ZT#;;I!WVVXMOST58JSP(\"SW6L] W+.Q%;Z8L5Z53;\A[8;[@+;2<E=<E&
MVD^, J$\G-0B&/%@4Z]_?0/XU(K<2,S@"I7F I*;<[M*YXJNOZX!KZH<\D"I
M=4UN]$>%$#?@>EL'-\9")OGT2%]B<LK:W"_C3(44SIN-Z"F.L"L\NV,T9$M/
MO-<@TE@!>2"V.WOP[G!-:<2AJ6!T[Q&?N_;=E6O#RYY2F&9Z#"[@%88=NP\D
MPCFD;KE#M3+RMMT-A-+JG5)-Q&V^HP,CM7\4_14.*,Q1P:7EAC_#:DBQCMC6
MH;5401[V*@[+P=Y4'G&(*YG=MS6#<,*EDQMJ@>S*9!EF6W%;/]969X;MN+'7
M:JPPLY:LCYBEIBS)'[]K:MU5FLQM'!$LI;:!%V_3;!;QOL@[U?H0; <!R&.[
M.QCE%PI4:R..^AY.](T%9%G.),^O_-3WPL0C%'SG3&Q9/8:6DS^>5)!&6S<X
MHKKY1-DH0-?$I%9=\XC@<5P>GOF,/W3,WWX7"5!S'A#6271 WO SZ>GF<&IB
M^K;85Z4CL CFM&B11\:T/P:!\]GU/(; E1\SEUQX(NK ^Y9A1U<9R#FQ%R0R
MT742@)B]^OG1GY(R%?)KZYD-R".D;8316<AKB)'&T4 W"7./$GW]1Z:.1\=Q
MS$S9#;?.WR>&!BN#\,2RTCMGRAVK4D7D3*'N?.DT3VLMQ(S0P?B^33U].R_P
MUR>/--SB>$6OWN^V[E&MYFQ;>F-'J%!MEFU='Z\?/12)JY>;$ )<\<YSZ&P"
MSV$(B1GUQR!NZ]-:*R&/<C6G2T<E&FL@CFU%PWN?!Y#$_SY=;L+6F-6[L"[U
M9]G$%;LSY<JS:_AC\'I5#,"]8(JKBS,+B#E2*#SD^2+ATC$_>GM//7BIX"R(
MXHC?:0'CG>QQ@I8><+!0Y/2A!S294X9)1$PTFAP;%&PGIR";R.IG$'"G,B!M
M??-PJ:\EY)IAZQ5SU2)?0]"U>-8WZJ2>7:2'SBT@J0F$V[ @W(H3'OLD?Z/'
M_&C -(#X: NL".F&&>(^TRO?#K84!DAMO*10#3GQJ#I>2B+44@<Q=2B;WCMI
MD*R " WDS74015^):8'YZ!\=@Z5M)]M$$*%8]ZI"16>FC^)BPCU]IGY"EV'(
M;!?G05MW:_K*0!K:@R ILGAT%( PZ(?YT3]+!]=BH'G7]5:]A;R&!E[9D_63
M@#XY36^'^K;UQXT;$9JF^-A:>_)$21*E26BL'>2CXZEJ&-_O/,IZ/Z<8.N_$
M>3TX@LA*0^X0/W;C_>\C$DGWS$+A")/@\_ 41P(LR:^I<]9,#K)\[2Y5262=
M.%8:#8$S@&TU9;!((M>G4<2&.$^NK_2F7DL5I*S;Q>%2BHN&\@@'#9W,[MMJ
MLW1)4E9-5"U8?==,N?+\6K7B?IE:S7FU]#&8.E-#)#TXNJZ)@4 5_&(N_FB]
M*)]I;*Z!/,P5W"W?>*HMCCB@5:SN?T27KV@QX6:O%QYYV'Y%L+'*_-IMRU6]
M^O+S:KDZ3Y=G31=7MS.1TR;C]<(*8:(/3_'P?:66+J:A./(X;7-4CM&ZLHCC
ML]7D(8\IP28)/"DE=DWQ--:VGJ6I_,R::V.?4EMX1@U6'[%FDHL6B^+:]'@.
MZPG1FBV.C_2SMU\ZP2ZFCI3"+ Q\]J,ME@]YGK&]^/_&K8XAPI &K!Z0\JV/
MWI*P;X$,=TS/H2"K2(^WXXH.MCM\L//$$H:62I=,)?'&$ALK[G;'^EF^F9+O
MDZRR/-$DI+L@A/IO87,=GN")%OR%(C<B?A 3S]VZ,=^669!?$XL)@$7Z[#$?
M+O1E1VTH$H3,G#AA0H7*B;=7S'U KIFDJDOY#4O*%R+?X9Y\2O]K=L?%,%XG
MK7B9?(;[\Y"N9( 8I)W(4&#*#W-WDX%XC-C;E0&1,P=^,8;//;7I08I9))22
MYS,4Z0G2K(/.K7\/F8!"9BI/]*Z<M5-=#')*Z0M,96Y/11F(*:6W*\-382ZR
MU!F94L*/I:=JB7B(X-,CSU]EG%HFQ^G!WE G\?@8O1@^6T6R$4^ZI!XE3_^D
M,.@.R KP%0]N;5&D&LT<N5UENY;2=F)TNI?^=19P$F7VPK,SKD-#/O)OO0^K
M50-R_AH!SM*=6GWB$;/>&%[J"/3\Y(%L#GG:R_]>D,(D4K()#5EBA1>6#RSQ
M0/B>/_L&OX 3_Y8/JQ1V@:M=PE6FVFW665FQS+7@YYI<TV>&[P?B^KL$!^<N
MGRW7@U8!#^U9'BT20;*.B[$-<TL #F74B;:WV-FPZS#@JBFUG\Q9\.A UW1$
M=V[""0OMD\@JI3TE93,04J4I!)/MU@KW ."VR!<;Y<H7Q/;8J--=N<!Y;.AY
MA#(&FCO,^;?TG2P97T=FZR)I-F36&9YJ_E(6,PO*ZNZ-#I9JSAR)D)?,P.06
M,(DY[X+X-$XWK/([F]86-I/$2Z4+#N1Z0 K.NDMM.10B_5K@KR$QFI07K9%B
M^LI 2BZ#("ENM'44@'TWM[<_O>^S64\L!D+YFAJ+C8#?8?8@=U\,N?NDB<N"
M;Z]&=&>Q20WU]EE-L>P&$Z$GRX,WKTFTH73JS=3)\9.YILAX2 XS'AKG8_/H
M-+0I#"._>QK%86+'":S!LG_0\)F>[A^9 9 Q)(K51WY=)"$E9PWP5(_\E,7,
M8N37W1L=@5322E*UL+@'BD5^GB@V3CA8T,K7Z<(T41%<O;;M,&$_>I059W^0
M[,) 144B(CE5$$\A=+L3US)3ISK.20<(G@U1#06OFK?Z2IT%C0UV3D><RHG#
M9#,6A!M"4DL6)+,%(<.9 [)8?(LX6@%7EY,?!E:[V.Z\8$_I ^-]UZ;56"T]
M;@O["?H+.UC[[K^H<T=#-Q!)VM3)3K^^V7#@2%!74Z-F9;-@S+%\UD&DF6TD
M-:Z!60L+Q;@RLY$((T5.1X0\BQE^SK\IVK:<*!/.F_L1BEV.HTR7R\]6Z,C]
M%!Q1$BA&4;(5O^L]V!RD9#:DJQ/4MD%H?PVSH%>MCNH>G*8F$6[3T>@T-XQ(
MEB&D4'006Q)</*%:=JY&.AS#BM&L=X--&L<-J<W8LC3HC<@ZM'PVT\? M%)B
M4+[D6I&)%&X8=CTUTU/J;+AT$&PU9V;ZB)P%6P[S3,N)&:7TMUE28'QD: C!
M8M)N;R!E('_76MZ6%ELF=@E+MW<JX<F/86L\;SU+%NL.4,\3U//BJQ[NC'8F
M>G%P*!HA.1F"RRH4G#B,C0[&82+'K7RX.6:CKFA%PQ#'R*N8\E\YE%__IDYZ
M\ @\8U8N?4?:^>:C7.IT'(GITC(;3M,*:]T>L085LV!"O9[JV5O.UP +D[(#
MAIE1?.XE'VY)[4)(GD@0+D9Z!8M&^4V2]/BFC*Y\4\1*T;7B].))T5L!,6,@
MVR6#UG&])&8CU.*\^<4+3\SA7#(N@2%U$J?+L5WS38VB:#:4JQO<FOFQ)BVS
M(%[MSFJ914M&R3=.,K,(-! B&<9W>ZJ2<F%C891P[X(8>@3+XV=84]C9W'K+
M@(U ;9J+:&.QW\.9UR=*?9A^BX_ABL.N<)C<@QQA.S%3SVL3V_)LF,>+JY?4
MMI)(/ U!5RNX8_TY2#Q'2.>2(4?126:(R42SSS2*Q:.-OG-F19N:SUM9$#FI
MUCM73B5[6 HQJ348VS^#:BZ2#T9 J*E$L=J= R$+%IS1AE VD&)#L=S/RGMK
M*+,YW89G?,7PRI=+,&YR=VS<"A[4 #I4)O+XU@*98M*G=H&(64./7Z.D@X)\
M?,("Z&-+Q5(CTA'.T; &?VA>NSZ]BNDVTOQ99+FO-$2/H-,1IKG05QBJQ[X9
M"U<PA7!;\"5TFP[#L7)'UEPW_3%DTY)S*E;D'ZV7_-;M6<!^$^T"WV'Z\U,>
M!\CU%(&4?(8 DM\U[5@?^U73ON[TC0"NCSBI0A);+W(6LN?\W!2;D >?^052
MZ<8.E&:S[L06TVF^$B*2^-+0=B-Z>/(]G;L?SK%MIMG-+@$Y#E]$M3RRLUSG
MQ/5/;&OGQNS?GS>L;$@M#Q:.)[[!BNNSV++2XB,9N+LZ-2Y7/FLL<#V,]6IE
M=*I;*YH4G>4-C8H$@ZS Q\ /R_D&&^:,.N4C[1]&@[(AVV=_X8@'J_I]')X?
M-,L+FB8;+C*#0B3+VLW/*W/X3O>2T9<A_36AOKU?OKAU,T>UFG,)OW;W*P.K
MOMH<0D;!^K[!( DFN63R"61C:.U5?I\'6\L]'+AVJSF7UM[N?F5KKZ\VA]:N
M8+U>ZI<;OE!D.@7T)! L.F)@-ORCO'>^H=LG&G: L*+J# F@#H V!CBL-S,*
MJ#5?\_!/&OU]$IH0D<!4(" (^=-]_N-?7!JRH-GL>=)CM2%N<^6YA+T2"#4#
MW8::<PA]-0=T]'ZY>)3#W>@8ALX#WR89<PF%+I"T=H5U N80&)W\T-TY2K^7
MP@;=8'D28-H!,, <5_P] $Z4WZ@-D"MKS(45ZMVMY(#CXG.(^ :K-31C(5T\
M*/$-EC'O""Z+%S.^01"C U:^KUN.!^G6,1<>T FI[AV9ZQD<(1K'3XTOMQU>
M**M^R>UHOR9]VNW:]/$BA/AB>KE-H)*#5+P;O7R*XM"RXQI85>HAIS!EUV5:
M:JV$F&K4;>_;O(6&'\PU9[A!D-Y&N"AN$%2X7 -1E_K(FW=G*.1FKEP9<7/O
M[L.0>ROY;1PB*5O(T_9"H9F><#H\;@*?[M,K.V25^$YZ8.W@8H_!7J_V':XZ
MZFRJ@)P(VITM=7"UI1&'NH+1O;NTIA?GS 3RB-[>X+IF5SMBZ3K"F4&4MKFJ
M- K%'*.M-@\;=4[:UP:QY36&Z&C./H+JBM?"Y9=JS06L-+?N/J=4KHP\E+N!
M(,>U6DW$0=[1@=XKRH4:DY/-ZG>MS_*W5)<1#+3C?8?YYS"1R -#!V"E6>H
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MD%JWJVO+/QPM519 'J_'SLCA6?P5<316&-E[?,Y$04,#86;"2Z,S%R\[RX^
M.**=95/RAA%+]&MBA92L*(V/[ET:.I(,-R3KNL+*@L@CJMZYVL/(O!3B"&LP
M5L]!9"X3P3G6,7RC+SMX @Q)M*4G=5M2@K14F5,$UCC<=C%@!BD^E,S6>E'
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M!F8? 0,)6$@^"1L-G3=$"7>ZR9-VWS7X#%AQN-CNO&!/*62(2[S88A[YSL?
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MZS3F=9(99B49'_@<';&43>(*D&8Z:KYWHU\N0TJO?.84C>*I%K%K],Z!?Z>
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MVAO"?@1R?:)]F-;\N'8T''.:M22:+= 4A%M0"0Y^';%598X7+@\E3TW;@F#
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M*?FT)II;&,WGC0/*NR"&/1?+\_8DA]1.'Z('/1&)-U9,-A;[O1_$XB2 ZZ=
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M"N8H63/R_.7=? $E"K;;!0FCJQW0>MS Z2BEKN6>M:MHY2W\[@+H<$&,F@H
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M,^8-F*-X)LYRS9\+3,;23O/TV]D(3YN+ QJ#.1PN)-UK=:8'(![#P.'"Q&:
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MH%_]>8_(6D12Q6-BI:M($US=7_5J?Q3^V(/WK7_Q'N+2G2Z'X+L6#5]DQA.
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MS^ROGS.(Y%M+__O_ 5!+ 0(4 Q0    ( /2 "$L]HT0$Z[   ,WX$  1
M          "  0    !C;&1X+3(P,3<P-C,P+GAM;%!+ 0(4 Q0    ( /2
M"$O\ 3L[@@X  '^5   1              "  1JQ  !C;&1X+3(P,3<P-C,P
M+GAS9%!+ 0(4 Q0    ( /2 "$OCQR5/H0X  ##=   5              "
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8;6Q02P4&      8 !@"* 0  $8(!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
